Sentence,class,file
"J Biomed Mater Res A , http://dx.doi.org/10.1002/jbm.a.34783 (2013).",Non-OADS,/arxiv_data1/oa_pdf/f7/af/srep02203.PMC3712317.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f7/af/srep02203.PMC3712317.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2203 | DOI: 10.1038/srep02203 7",Non-OADS,/arxiv_data1/oa_pdf/f7/af/srep02203.PMC3712317.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2207 | DOI: 10.1038/srep02207 5",Non-OADS,/arxiv_data1/oa_pdf/a4/bf/srep02207.PMC3712320.pdf
"A., Bedell, J., Selenic, D., Young, C. & Deitcher, D. Obesity in the South Bronx: A look across generations, New York, NY: New York City Department of Health and Mental Hygiene, 2007. http://www.nyc.gov/html/doh/ downloads/pdf/dpho/dpho-bronx-obesity.pdf.",Non-OADS,/arxiv_data1/oa_pdf/30/57/srep02164.PMC3712321.pdf
"National Institute of Health: National Heart, Lung and Blood Institute, 2007.http://www.nhlbi.nih.gov/guidelines/asthma/.",Non-OADS,/arxiv_data1/oa_pdf/30/57/srep02164.PMC3712321.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/30/57/srep02164.PMC3712321.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2164 | DOI: 10.1038/srep02164 11",Non-OADS,/arxiv_data1/oa_pdf/30/57/srep02164.PMC3712321.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/view/174 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"On a tremor screening questionnaire, he complained of tremor andindicated that he had been diagnosed as ‘‘essential tremor’’ (ET) byFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
Cranial-predominant Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
Cranial-predominant Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
Cranial-predominant Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"J Neural Transm Suppl 1999;56: 211–220, doi: http://dx.doi.org/10.1007/978-3-7091-6360-3_14.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Pract Neurol 2007;7:222–233, doi: http://dx.doi.org/10.1136/jnnp.2007.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2013;28:117–119, doi: http://dx.doi.org/10.1002/mds.25317.5.Louis ED, Rios E, Applegate LM, Hernandez NC, Andrews HF.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2006;21:1872–1878, doi: http://dx.doi.org/10.1002/mds.21069.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2013;28:145–152, doi: http://dx.doi.org/10.1002/mds.25220.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Clin Neurol Neurosurg 2007;109:784–785, doi: http://dx.doi.org/10.1016/j.clineuro.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2007;22:1491–1495, doi: http://dx.doi.org/10.1002/mds.21531.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2011;26:1582–1592, doi: http://dx.doi.org/10.1002/mds.23692.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2008;23:159– 167, doi: http://dx.doi.org/10.1002/mds.21776.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2011;26:391–398, doi: http://dx.doi.org/ 10.1002/mds.23512.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Brain 2007;130:3297– 3307, doi: http://dx.doi.org/10.1093/brain/awm266.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Acta Neuropathol 2008;115:509–532, doi: http://dx.doi.org/10.1007/s00401-007- 0311-9.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"J Neuropathol Exp Neurol 2013;72:8–17, doi: http://dx.doi.org/10.1097/NEN.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"J Neuropathol Exp Neurol 2010;69:262–271, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Neurology 1994;44:2015–2019, doi: http://dx.doi.org/10.1212/ WNL.44.11.2015.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Parkinsonism Relat Disord 2011;17:365–371, doi: http://dx.doi.org/10.1016/j.parkreldis.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Acta Neuropathol 2005; 109:14–24, doi: http://dx.doi.org/10.1007/s00401-004-0950-z.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Arch Neurol 2006;63:1100–1104, doi: http://dx.doi.org/10.1001/archneur.63.8.1100.Cranial-predominant Tremor Louis ED, Bain PG, Hallett M, et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Neuroepidemiology 1997;16:124–133, doi: http://dx.doi.org/10.1159/ 000109681.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Arch Neurol 1998;55:222–227, doi: http://dx.doi.org/10.1001/archneur.55.2.222.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2001;16:899–906, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"J Neurol Neurosurg Psychiatry 2013;84:404–408, doi: http://dx.doi.org/10.1136/jnnp-2012- 303782.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2007;22:203–206, doi: http://dx.doi.org/10.1002/mds.21252.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 2007;22:2018–2030, doi: http://dx.doi.org/10.1002/mds.21493.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"J Clin Neurosci 2007;14:245–248, doi: http://dx.doi.org/10.1016/j.jocn.2006.01.015.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"A quantitative assessment of tremor and ataxia in FMR1 premutation carriers using CATSYS.Am J Med Genet A 2008;146A:629–635, doi: http://dx.doi.org/10.1002/ajmg.a.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Rev Neurol (Paris) 2007;163:1091–1095, doi: http://dx.doi.org/10.1016/S0035- 3787(07)74182-6.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Mov Disord 1993;8: 335–338, doi: http://dx.doi.org/10.1002/mds.870080314.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Ann Neurol 1983;13:97–99, doi: http://dx.doi.org/10.1002/ana.410130121.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"JAMA 1971;216:1459–1463, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Brain Res2002;930:170–181, doi: http://dx.doi.org/10.1016/S0006-8993(02)02244- 8.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Acta Neuropathol 2012 124:693– 704, doi: http://dx.doi.org/10.1007/s00401-012-1017-1.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"J Neurol Sci 2010;289:138– 143, doi: http://dx.doi.org/10.1016/j.jns.2009.08.036.",OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
"Neurology 1996;47:1–9, doi: http://dx.doi.org/10.1212/WNL.47.1.1.Louis ED, Bain PG, Hallett M, et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
Cranial-predominant Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/bd/44/tre-03-174-4112-1.PMC3712322.pdf
Available from: http://www.unido.org/ index.php?id=5279.,Non-OADS,/arxiv_data1/oa_pdf/cd/bc/IJEM-17-367.PMC3712364.pdf
"Endocrine disruptors., Available from: http://www.niehs.nih.gov/ health/topics/agents/endocrine/index.cfm.",OADS,/arxiv_data1/oa_pdf/cd/bc/IJEM-17-367.PMC3712364.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/cd/bc/IJEM-17-367.PMC3712364.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/50/23/IJEM-17-370.PMC3712365.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/00/af/IJEM-17-373.PMC3712366.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/00/af/IJEM-17-373.PMC3712366.pdf
Available from: http://www.sign.ac.uk.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Available from:  http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Available  from: http://www.mindtools.com/pages/article/newTMC_05_1.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
htm http://www.mindtools.com/pages/article/worksheets/ SWOTAnalysisWorksheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Available form: http://www.exeter.ac.uk/fch/work‑ experience/ handbook.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Available  form: http://eclkc.ohs.acf.hhs.gov/hslc/tta‑system/operations/mgmt‑ admin/planning/planning/2SWOTAnalysisS.htm.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Available from: http://www.managing‑change.net/ johari‑window‑model.html.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Available form: http://cgp.pickerinstitute.org/?page_ id=1319.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Available from: http://www.dawnstudy.com/summit2008/ downloads/22_Brownson.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ee/9d/IJEM-17-376.PMC3712367.pdf
Available from: http://diabetesinfodesk.com/study ‑predicts‑growing‑ demand‑for ‑diabetes‑educators/.,Non-OADS,/arxiv_data1/oa_pdf/49/1c/IJEM-17-396.PMC3712368.pdf
Available  from: http://www.worldwidediabetes.org/education/role/.,Non-OADS,/arxiv_data1/oa_pdf/49/1c/IJEM-17-396.PMC3712368.pdf
"[9,10] Kyoto Encyclopedia of  Genes  and Genomes  (KEGG; http://www.genome.jp/kegg/)  was used for visualizing genes in pathways.",OADS,/arxiv_data1/oa_pdf/d0/f7/IJEM-17-446.PMC3712374.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs312/en/[Last accessed on 2011 Aug 05].,Non-OADS,/arxiv_data1/oa_pdf/c8/9b/IJEM-17-486.PMC3712381.pdf
The Lagos State  programme.Availablefrom http://www.lsmoh.com/programme_info.,Non-OADS,/arxiv_data1/oa_pdf/c8/9b/IJEM-17-486.PMC3712381.pdf
"Available from: http://www.diabetesatlas.org.,",Non-OADS,/arxiv_data1/oa_pdf/54/1d/IJEM-17-496.PMC3712383.pdf
: Microalbuminuria in diabetic nephropathyIndian Journal of Endocrinology and Metabolism / May-Jun 2013 / Vol 17 | Issue 3 504http://www.idf.org/diabetesatlas/5e/the‑global‑burden.,Non-OADS,/arxiv_data1/oa_pdf/54/1d/IJEM-17-496.PMC3712383.pdf
Available from: http://Www.Apps.Who.Int/Bmi/Index.Jsp.,OADS,/arxiv_data1/oa_pdf/54/1d/IJEM-17-496.PMC3712383.pdf
"42, Supple.1, 2013, pp: 129-133 Original Article 129 Available at: http://ijph.tums.ac.ir Dental Curriculum Revision in Iran: Dentists’ Perspective on Achievement of Essential Competencies through National Curriculum A Fazel1,2, A Jafari2, *MR Khami2, L Seddighpour2, MJKharrazifard3, M Nassibi4, R Yazdani2, M Soroush2 1.Council for Dental Education, Ministry of Health and Medical Education, Tehran, Iran 2.School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran 3.School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 4.School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran *Corresponding Author: Tel:+98-21-88015960 Email: mkhami@tums.ac.ir (Received 21 Apr 2012; accepted 12 Nov 2012) Introduction The first post -revolutionary national dental curriculum revision in Iran was conducted in 1982.",Non-OADS,/arxiv_data1/oa_pdf/85/75/ijph-42-129.PMC3712582.pdf
":Dental Curriculum Revision in Iran … Available at: http://ijph.tums.ac.ir 130try (2, 3).",Non-OADS,/arxiv_data1/oa_pdf/85/75/ijph-42-129.PMC3712582.pdf
"42, Supple.1, 2013 , p: 129-133 Iran's Health System; a Step Toward the 2025 Outlook 131 Available at: http://ijph.tums.ac.irTable 1:The distribution of a sample of Iranian dentists (n=250) according to the ir current set - tings of practice Settings of dental practice Frequency (%)* Urban health center 56 Private office 50 Rural Health Center 33 State dental clinic 32 Private dental clinic 30 State hospital 7 Others 5 Private hospital 2 * Since it was possible for the respondents to choose more than one option, the sum of the percentages is more than 100.",Non-OADS,/arxiv_data1/oa_pdf/85/75/ijph-42-129.PMC3712582.pdf
:Dental Curriculum Revision in Iran … Available at: http://ijph.tums.ac.ir 132Discussion The present study investigated dentists’ perspec - tive on the capability of current national dental curriculum to cover minimum competency requirements for an Iranian dentist.,Non-OADS,/arxiv_data1/oa_pdf/85/75/ijph-42-129.PMC3712582.pdf
"42, Supple.1, 2013 , p: 129-133 Iran's Health System; a Step Toward the 2025 Outlook 133 Available at: http://ijph.tums.ac.ir1998) (Summary in English).",Non-OADS,/arxiv_data1/oa_pdf/85/75/ijph-42-129.PMC3712582.pdf
"42, Supple.1, 2013, pp .18-22 Original Article 18 Available at: http://ijph.tums.ac.ir Health System Vision of Iran in 2025 NRostamigooran1, H Esmailzadeh2, F Rajab i2, 3,R Majdzadeh2, 3, 4, *B Larijani1, 5, *M Vahid Dastgerdi6,7 1.Health Policy Council, Ministry of Health and Medical Education, Tehran, Iran 2.Center For Academic And Health Policy , Tehran University of Medical Science, Tehran, Iran 3.Community Based Participatory Research Center, Tehran University of Medical Science, Tehran, Iran 4.Knowledge Utilization Re search Center, Tehran University of Medical Science, Tehran, Iran 5.Endocrinology and Metabolism Research Centre, Tehran University of Medical Sciences, Tehran, Iran 6.Minister, Ministry of Health and Medical Education, Iran 7.Dept.",Non-OADS,/arxiv_data1/oa_pdf/c2/72/ijph-42-18.PMC3712583.pdf
":Health System Vision of Iran … 19 Available at: http://ijph.tums.ac.irHealth system of Iran has experienced some d e- velopments in response to changes, the most i m- portant o f which is establishing health networks and integrating educational system in health care system having important accomplishments after the Islamic Revolution (4 -6).",Non-OADS,/arxiv_data1/oa_pdf/c2/72/ijph-42-18.PMC3712583.pdf
"42, Supple.1, 2013 ,p: 18-22 Iran's Health System; a Step Toward the 2025 Outlook Available at: http://ijph.tums.ac.ir 20and required health services to consciously decide and select their health care opportunities), people are faced with least level of risk from health treats in a healthy environment ,society and families fol - lowing a healthy life style based on Islamic -Iranian doctrines and also man’s new scientific achieve - ments.",Non-OADS,/arxiv_data1/oa_pdf/c2/72/ijph-42-18.PMC3712583.pdf
":Health System Vision of Iran … 21 Available at: http://ijph.tums.ac.irDuring this study ideas of two groups , experts and policy makers, were systematically investi - gated while opinions of lay people and general public were less paid attention to; even though review of the Iran’s institutional law and cultural and religious literature which is believed as reflec - tion of society’s reasonable values, were taken into consideration at the stage of reviewing docume n- taries.",Non-OADS,/arxiv_data1/oa_pdf/c2/72/ijph-42-18.PMC3712583.pdf
"42, Supple.1, 2013 ,p: 18-22 Iran's Health System; a Step Toward the 2025 Outlook Available at: http://ijph.tums.ac.ir 22Ethical considerations Ethical issues (Including plagiarism, Informed Consent, misconduct, data fabrication and/or fa l- sification, double publication and/or submis sion, redundancy, etc) have been completely ob served by the authors.",Non-OADS,/arxiv_data1/oa_pdf/c2/72/ijph-42-18.PMC3712583.pdf
"Retrived 1/ 17/2012, available from http://rc.majlis.ir/fa/law/show/132295 .",OADS,/arxiv_data1/oa_pdf/c2/72/ijph-42-18.PMC3712583.pdf
"42, Supple.1, 2013, pp: 125 -128 National Report 125 Available at: http://ijph.tums.ac.ir Challenges of Implementing Iranian National Laboratory Standards *N Safadel, P Dahim, S Anjarani, , M Rahnamaye Farzami, S Mirab Samiee, R Amini, Sh Farsi, S Mahdavi , K Khodaverdian , F Rashed Marandi Reference Health Laboratories Research Center, Ministry of Health & Medical Education, Tehran, Iran *Corresponding Author: Email:safadel@health.gov.ir (Received 18 May 2012; accepted 21 Oct 2012) Introduction There is a specific hierarchy of laboratory services inMinisrry of Health (MOH ), Iran.Although there are 31 provinces In Iran, MOH has divided the country to 49 regions each of which is under supervision of  its dedicated medical university.",Non-OADS,/arxiv_data1/oa_pdf/0b/01/ijph-42-125.PMC3712584.pdf
:Challenges of Implementing Iranian National Laboratory … Available at: http://ijph.tums.ac.ir 126and strategy of Reference Health Laboratory (RHL) to overcome the obstacles will be presented.,Non-OADS,/arxiv_data1/oa_pdf/0b/01/ijph-42-125.PMC3712584.pdf
"42, Supple.1, 2013 , p: 125-128 Iran's Health System; a Step Toward the 2025 Outlook 127 Available at: http://ijph.tums.ac.irprograms were held throughout the country, al - though evaluating the effectiveness of these train - ing courses is very difficult and challenging.",Non-OADS,/arxiv_data1/oa_pdf/0b/01/ijph-42-125.PMC3712584.pdf
:Challenges of Implementing Iranian National Laboratory … Available at: http://ijph.tums.ac.ir 128Medical Laboratories.,Non-OADS,/arxiv_data1/oa_pdf/0b/01/ijph-42-125.PMC3712584.pdf
"42, Supple.1, 2013, pp: 55-59 National Report 55 Available at: http://ijph.tums.ac.ir Trend of Knowledge Production of Research Centers in the Field of Medical Sciences in Iran K Falahat1, MB Eftekhari1, 2, E Habibi1, Sh Djalalinia1, 3, N Peykari1, 3, P Owlia1, 4, H Malekaf zali5, M Ghanei1, *Sh Mojarrab1 1.Deputy of Research & Technology, Ministry of Health & Medical Education, Tehran, Iran 2.Social Determinants of Health Research Center, University of Welfare and Rehabilitation, Tehran, Iran 3.Endocrine and Metaboli sm Research Center, Tehran University of Medical Sciences, Tehran, Iran 4.Dept.",Non-OADS,/arxiv_data1/oa_pdf/6f/20/ijph-42-55.PMC3712585.pdf
":Trend of Knowledge Production of Research Centers … Available at: http://ijph.tums.ac.ir 56organization with many different purposes such as promoting qualitative and quantitative health re - search, improving the human and physical re - sources for health research, researching in priority areas and benefit from results of research in prac - tice (4).",Non-OADS,/arxiv_data1/oa_pdf/6f/20/ijph-42-55.PMC3712585.pdf
"42, Supple.1, 2013 , p: 55-59 Iran's Health System; a Step Toward the 2025 Outlook 57 Available at: http://ijph.tums.ac.irIran between 1999 -2009 includes: medical science 6520, Biology and Biochemistry 1461, Pharmacol - ogy and Toxicology 1274, Neuroscience and Behavior 681, Molecular and Genetic Sciences 408, Microbiology 270, Immunology 323, and Psychologyand Psychotherapy 270.",Non-OADS,/arxiv_data1/oa_pdf/6f/20/ijph-42-55.PMC3712585.pdf
":Trend of Knowledge Production of Research Centers … Available at: http://ijph.tums.ac.ir 58(COHRED), the Global Forum on Health Re - search and other agencies concerned with interna - tional health have consistently emphasized that a primary function of sustainable knowledge sys - tems is needed to create and continuously im - prove the human and physical resources for health research (12).",Non-OADS,/arxiv_data1/oa_pdf/6f/20/ijph-42-55.PMC3712585.pdf
"42, Supple.1, 2013 , p: 55-59 Iran's Health System; a Step Toward the 2025 Outlook 59 Available at: http://ijph.tums.ac.irer'sapproach.",Non-OADS,/arxiv_data1/oa_pdf/6f/20/ijph-42-55.PMC3712585.pdf
"11.Scientometric Unit Report, Available from: http://www.hbi.ir/NSite/SpecialFullStory/ News/?Id=636&Level=11 (Accessed Date: 14 Feb 2012) 12.Burdick W, Morahan P, Norcini J (2007).",OADS,/arxiv_data1/oa_pdf/6f/20/ijph-42-55.PMC3712585.pdf
Available from:http://ictb.ir/index.php/1389 -12- 02-12-27-38(Accessed Date: 23 Dec 2012),Non-OADS,/arxiv_data1/oa_pdf/6f/20/ijph-42-55.PMC3712585.pdf
"42, Supple.1, 2013, pp: 134 -140 Original Article 134 Available at: http://ijph.tums.ac.ir Accreditation the Education Development Centers of Medical - Sciences Universities: Another Step toward Quality Improvement in Education AA Haghdoost1, *N Momtaz manesh2, F Shoghi3, MMohagheghi4, MH Mehrolhassani5 1.Research Center for Modeling in Health, Kerman University of Medical Sciences, Kerman, Iran 2.School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 3.The Ministry of Health and Medical Education, Tehran, Iran 4.Deputy ministry for Education, The Ministry of Health and Medical Education, Tehran, Iran 5.Health Management Department, Research Center for Health Services Management, Kerman University of Medical Sciences, Kerman, Iran *Corresponding Author: Tel:+982188364224 Email :momtazmanesh@ sbmu.ac.ir (Received 10 May 2012; accepted 25 Sep 2012) Introduction Capable staff and an efficient system are essential requirements in order to provide an acceptable level of health services in a community.",Non-OADS,/arxiv_data1/oa_pdf/35/ba/ijph-42-134.PMC3712586.pdf
:Accreditation the Education Development Centers … Available at: http://ijph.tums.ac.ir 135improving the quality and resp onsibility of an i n- stitute or university course.,Non-OADS,/arxiv_data1/oa_pdf/35/ba/ijph-42-134.PMC3712586.pdf
"42, Supple.1, 2013 , p: 134-140 Iran's Health System; a Step Toward the 2025 Outlook 136 Available at: http://ijph.tums.ac.ir3-Making a team for external assessment 4-Site visit 5-Reporting the external team's report 6-Assessment of the report by expert co m- mittee 7-Finalizing the report and decision making accordingly Having reviewed all available documents and shared experiences , the team decided to design a set of standards in two levels which were basic (essential) and quality improvement standards.",Non-OADS,/arxiv_data1/oa_pdf/35/ba/ijph-42-134.PMC3712586.pdf
:Accreditation the Education Development Centers … Available at: http://ijph.tums.ac.ir 137its structure in order to execute the tasked issues.,Non-OADS,/arxiv_data1/oa_pdf/35/ba/ijph-42-134.PMC3712586.pdf
"42, Supple.1, 2013 , p: 134-140 Iran's Health System; a Step Toward the 2025 Outlook 138 Available at: http://ijph.tums.ac.irResults Findings delineated that all medical -sciences EDCs of Iran were capable of taking part in the project and presented required data and information to execute the project which showed that the defined indices were meas urable and perceivable.",Non-OADS,/arxiv_data1/oa_pdf/35/ba/ijph-42-134.PMC3712586.pdf
":Accreditation the Education Development Centers … Available at: http://ijph.tums.ac.ir 139Fixing 2 as the number of clusters, the averages of distances from the centers were dropped from 2.03 to 0.44 in cluster 1, and from 0.97 to 0.14 in cluster 2.",Non-OADS,/arxiv_data1/oa_pdf/35/ba/ijph-42-134.PMC3712586.pdf
"42, Supple.1, 2013 , p: 134-140 Iran's Health System; a Step Toward the 2025 Outlook 140 Available at: http://ijph.tums.ac.irAlthough, this study might be unique, because of its approach to the concept of accreditation in the assessment of the quality EDCs activi ties; we did not check the validity of universities responses in field observation.",Non-OADS,/arxiv_data1/oa_pdf/35/ba/ijph-42-134.PMC3712586.pdf
"42, Supple.1, 2013, pp: 98-104 National Report 98 Available at: http://ijph.tums.ac.ir Counseling and Harm Reduction Centers for Vulnerable Women to HIV/AIDS in Iran N Fahimfar1, 2, *A Sedaghat1, H Hatami2, K Kamali1, MM Gooya1 1.Center for Disease Control (CDC), Ministry of Health and Medical Education, Tehran, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/76/c2/ijph-42-98.PMC3712587.pdf
:Counseling and Harm Reduction Centers … Available at: http://ijph.tums.ac.ir 99sion (2.5%).,Non-OADS,/arxiv_data1/oa_pdf/76/c2/ijph-42-98.PMC3712587.pdf
"42, Supple.1, 2013 , p: 98-104 Iran's Health System; a Step Toward the 2025 Outlook 100 Available at: http://ijph.tums.ac.irNumber Total:442Percent (%) Age (year) < 15 2 0.5 15-24 91 20.6 25-34 160 36.2 35-44 154 34.8 ≥ 45 35 7.9 Marital StatusUnmarried 75 17 MarriedLiving with spouses200 45.2 Divorced 115 26 Widow 52 11.8 Education Illiterate 63 14.3 Low educated322 72.9 Literate Diploma 43 9.7 High educated14 3.2 Occupation Jobless 137 31 House wife 180 40.7 Employed 125 28.3 Fourteen percent of clients were illiterate and 12.9 % have diploma or university education.",Non-OADS,/arxiv_data1/oa_pdf/76/c2/ijph-42-98.PMC3712587.pdf
:Counseling and Harm Reduction Centers … Available at: http://ijph.tums.ac.ir 101services was counseling and 71.2% of high risk sexually women profited by it.,Non-OADS,/arxiv_data1/oa_pdf/76/c2/ijph-42-98.PMC3712587.pdf
:Counseling and Harm Reduction Centers … Available at: http://ijph.tums.ac.ir 103of their behaviors and some important questions can be mentioned in future studies.,Non-OADS,/arxiv_data1/oa_pdf/76/c2/ijph-42-98.PMC3712587.pdf
"42, Supple.1, 2013 , p: 98-104 Iran's Health System; a Step Toward the 2025 Outlook 104 Available at: http://ijph.tums.ac.ir18.Tehrani A, Amirkhani M. A, Haghdoost A.",Non-OADS,/arxiv_data1/oa_pdf/76/c2/ijph-42-98.PMC3712587.pdf
"Available from: http://www.un.org/esa/population/publications/ concise2005/PopdevHIVAIDS 22.Dinkelman T, Lam D, Leibbrandt M (2007).",OADS,/arxiv_data1/oa_pdf/76/c2/ijph-42-98.PMC3712587.pdf
"Available from: http://www.unicef.org/infobycountry 24.ReedE,GuptaJ,Biradavolu M,Devireddy V,Blankenship KM (2010).",Non-OADS,/arxiv_data1/oa_pdf/76/c2/ijph-42-98.PMC3712587.pdf
"42, Supple.1, 2013, pp:113 -118 Original Article 113 Available at: http://ijph.tums.ac.ir Urbanization and Non -Communicable Risk Factors in the Capital City of 6 Big Provinces of Iran *SHYarahmadi1,KEtemad1,ARMahdavi Hazaveh1,NAzhang1 1.Endocrine and Metabolic Office, Center for Non -communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran *Corresponding Author: Tel:009821-66700143; E -mail:drshyarahmadi@yahoo.com (Received 26 Mar 2012; accepted 14 Sep 2012) Introduction Significant demographic, social and economic changes have been happened in countries include rapid urbanization, expanded education, increased industrialization, rising incomes in past few dec - ades.",Non-OADS,/arxiv_data1/oa_pdf/7e/d9/ijph-42-113.PMC3712588.pdf
":Urbanization and Non -Communicable Risk Factors … Available at: http://ijph.tums.ac.ir 114modifiableparameters include those factors that are beyond the control of the individual, s uch as age, sex and genetic factors (2).",Non-OADS,/arxiv_data1/oa_pdf/7e/d9/ijph-42-113.PMC3712588.pdf
"42, Supple.1, 2013 , p: 113-118 Iran's Health System; a Step Toward the 2025 Outlook 115 Available at: http://ijph.tums.ac.irusing a stadiometer.",Non-OADS,/arxiv_data1/oa_pdf/7e/d9/ijph-42-113.PMC3712588.pdf
:Urbanization and Non -Communicable Risk Factors … Available at: http://ijph.tums.ac.ir 11630% male) (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/7e/d9/ijph-42-113.PMC3712588.pdf
"42, Supple.1, 2013 , p: 113-118 Iran's Health System; a Step Toward the 2025 Outlook 117 Available at: http://ijph.tums.ac.irnean region and may be controlled by marked changes in lifestyle (23).",Non-OADS,/arxiv_data1/oa_pdf/7e/d9/ijph-42-113.PMC3712588.pdf
Available from http://www.who.int/topics/chronic_diseases/en/ .,Non-OADS,/arxiv_data1/oa_pdf/7e/d9/ijph-42-113.PMC3712588.pdf
":Urbanization and Non -Communicable Risk Factors … Available at: http://ijph.tums.ac.ir 11815.Azimi-Nezhad M ,Ghayour-Mobarhan M , Parizadeh MR ,Safarian M ,Esmaeili H , Parizadeh SM , et al (2008) Prevalence of type 2diabetes mellitus in Iran and its relationship with gender, urbanization, education, marital status and occupation.",Non-OADS,/arxiv_data1/oa_pdf/7e/d9/ijph-42-113.PMC3712588.pdf
Available from http://www.diabetesatlas.org .19.Asgari F (20 09).Iran-non-communicable diseases risk factors surveillance -Data book for 2007.,Non-OADS,/arxiv_data1/oa_pdf/7e/d9/ijph-42-113.PMC3712588.pdf
"42, Supple.1, 2013, pp: 84-87 National Report 84 Available at: http://ijph.tums.ac.ir Health Observatories in Iran A Rashidian1, 2, *B Damari3, BLarijani4, A Vosoogh Moghadda5, S Alikhani6, K Shadpour7, A Khosravi7 1.Dept.",Non-OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
:Health Observatories … Available at: http://ijph.tums.ac.ir 85Making active tools for warning society and predicting the future Monitoring  health condition of specific population groups Recording what happens within the health sector and determining of information de - fects.,Non-OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
"42, Supple.1, 2013 , p: 84-87 Iran's Health System; a Step Toward the 2025 Outlook 86 Available at: http://ijph.tums.ac.ir6.Have a transparent work div ision for information production 7.Devise a coordinated system for quality control of data production 8.Agree on a distinct focal point  reference person/institution at national level 9.Secure transparency and practicality of observatory system productions 10.Avoid any complex structure within the HOS Based on the above mentioned principles and what is drawn of questionnaire and FGDs, health observatory in Iran is defined as “a national, vir - tual, and policy -oriented network which is responsible for systematic and constant observing health conditions and problems of people throughout the country, to support “efficient and evidence-based” policy, programs, decision mak - ing, and performing ; final goal of observatory sys - tem is cooperating in protection, promot ion, and improvement of people’s health and declining health injustice.",Non-OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
Available from: http://www.apho.org.uk/resource/item.aspx?,Non-OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
RID=39291 3.http://www.ospc.es/Docs/Report_Interna - tional%20Forum_Health%20Observatories_ OSPC_2009.pdf 4.Anonymous (2012).,Non-OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
Saskatoon Health Region Pub lic Health Observatory: Available from: http://www.saskatoonhealthregion.ca/your_h ealth/ps_public_health_pho_about.htm,Non-OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
:Health Observatories … Available at: http://ijph.tums.ac.ir 875.GattiniC (2009).,Non-OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
Available from: http://bvsdss.icict.fiocruz.br/home/bvsdss/b vs/htdocs/local/File/national_healt.pdf 6.Zare M (2007).,Non-OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
"Available from:http://omana.behdasht.gov.ir/index.aspx?sitei d=126&pageid=958 7.Larijani B, Delavari A, Damari B, Vosoogh Moghadam A, Majdzadeh R (2009) .",OADS,/arxiv_data1/oa_pdf/b9/7a/ijph-42-84.PMC3712589.pdf
"42, Supple.1, 2013, pp: 155 -160 Original Article 155 Available at: http://ijph.tums.ac.ir Determinants of Catastrophic Health Expenditure in Iran M Abolhallaje1, 4, SA Hasani2, P Bastani3, M Ramezanian4, * M Kazemian5 1.",Non-OADS,/arxiv_data1/oa_pdf/8b/c8/ijph-42-155.PMC3712590.pdf
:Determinants of Catastrophic Health Expenditure … Available at: http://ijph.tums.ac.ir 156to reduce the constraint impact on access to health care.,Non-OADS,/arxiv_data1/oa_pdf/8b/c8/ijph-42-155.PMC3712590.pdf
"42, Supple.1, 2013 , p: 155-160 Iran's Health System; a Step Toward the 2025 Outlook 157 Available at: http://ijph.tums.ac.irTable 2 shows the share of health services from the two main groups of providers, the public and private sectors.",Non-OADS,/arxiv_data1/oa_pdf/8b/c8/ijph-42-155.PMC3712590.pdf
:Determinants of Catastrophic Health Expenditure … Available at: http://ijph.tums.ac.ir 158Table 5 demonstrates the determinants of unfair and catastrophic payments by households regard -ing households’ payments and government expenditure policy rules.,Non-OADS,/arxiv_data1/oa_pdf/8b/c8/ijph-42-155.PMC3712590.pdf
"42, Supple.1, 2013 , p: 155-160 Iran's Health System; a Step Toward the 2025 Outlook 159 Available at: http://ijph.tums.ac.irDiscussion High level of out -of-pocket, about 40 percent of health expenditure and more, leaves households at the risk of unpredictable changes in his economic life that may cause catastrophe (10).",Non-OADS,/arxiv_data1/oa_pdf/8b/c8/ijph-42-155.PMC3712590.pdf
":Determinants of Catastrophic Health Expenditure … Available at: http://ijph.tums.ac.ir 160-Lack of well organized services by the public sector hospitals and clinics The reasons, whatever they may be, drive the pub - licto pay more than 52 percent of total health ex - penditure from their own pocket.",Non-OADS,/arxiv_data1/oa_pdf/8b/c8/ijph-42-155.PMC3712590.pdf
"Cata - strophic Health Expenditure and House hold Well-Being,Available : http://sticerd.lse.ac.uk/DARP 2.Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray C (2003).",Non-OADS,/arxiv_data1/oa_pdf/8b/c8/ijph-42-155.PMC3712590.pdf
"42, Supple.1, 2013, pp: 161-165 Original Article 161 Available at: http://ijph.tums.ac.ir Equality in Distribution of Human Resources: the Case of Iran’s Ministry of Health and Medical Education H Mobaraki1, 2, *A Hassani3, 4, T Kashkalani2, R Khalilnejad2, E Ehsani Chimeh2 1.Faculty of Rehabilitation School, Tehran University of Medical Sciences, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/f5/04/ijph-42-161.PMC3712591.pdf
":Equality in Distribution of Human Resources … Available at: http://ijph.tums.ac.ir 162ple, “in most developing countries, the health workforce is concentrated in the big towns and cities, while rural areas can only boast of about 23% and 38% of the country's doctors a nd nurses respectively (6).Developed countries expose the matter,too;dealing with health inequalities is high on the UK Government agenda (7).",Non-OADS,/arxiv_data1/oa_pdf/f5/04/ijph-42-161.PMC3712591.pdf
"42, Supple.1, 2013 , p: 161-165 Iran's Health System; a Step Toward the 2025 Outlook 163 Available at: http://ijph.tums.ac.irThe Robin Hood index is some other measure of the inequalities of income distribution.",Non-OADS,/arxiv_data1/oa_pdf/f5/04/ijph-42-161.PMC3712591.pdf
:Equality in Distribution of Human Resources … Available at: http://ijph.tums.ac.ir 164conclude that distribution in Iran's MOH&ME was more equitable than Tanzania but the important issue that differ their study from this study is con sidering the difference of distribu tion between rural and urban districts (20) .,Non-OADS,/arxiv_data1/oa_pdf/f5/04/ijph-42-161.PMC3712591.pdf
"42, Supple.1, 2013 , p: 161-165 Iran's Health System; a Step Toward the 2025 Outlook 165 Available at: http://ijph.tums.ac.ir13.Gini C (1909).",Non-OADS,/arxiv_data1/oa_pdf/f5/04/ijph-42-161.PMC3712591.pdf
"42, Supple.1, 2013, pp: 105-112 Original Article 105 Available at: http://ijph.tums.ac.ir What to Do To Promote Mental Health of the Society A Hajebi1, *B Damari2, A Vosoogh Moghaddam3, A Nasehi4, A Nikfarjam4, J Bolhari1 1.Mental Health Research Center, Tehran Psychiatry Institute, Psychiatry Group of Tehran University of Medical Science and Health Services, Tehran, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
":What to Do To Promote Mental Health … Available at: http://ijph.tums.ac.ir 106ciety’s productive force, family burden) of diseases and mental disorders are exorbi - tant.",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
"42, Supple.1, 2013 , p: 105-112 Iran's Health System; a Step Toward the 2025 Outlook 107 Available at: http://ijph.tums.ac.irmental health programs is guaranteed despite managers’ replacem ent.",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
":What to Do To Promote Mental Health … Available at: http://ijph.tums.ac.ir 10821%, in which depression and anxiety had higher prevalence rate.",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
"42, Supple.1, 2013 , p: 105-112 Iran's Health System; a Step Toward the 2025 Outlook 109 Available at: http://ijph.tums.ac.irwho come to rural health centers and refer 20% of them to specialists.",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
":What to Do To Promote Mental Health … Available at: http://ijph.tums.ac.ir 110Table 2:Mental health promotion interventions Fundamental InterventionsFirst Level Prevention1.Forming an advisor and advocacy group for influencing healthy public policies (particularly in mental health) 2.Determining role of governmental organizations, nongovernmental and private sections (NGOs and Islamic Councils) in promoting mental health 3.Approving mental health law and monit oring their implementation 4.Develop and implement a comprehensive program for preventing social violence 5.Redesigning mental health programs in standard form of “health programs” 6.Develop and implement mental health promotion program for children, adolescen ts, and pregnant women 7.Composing charter of “Iranians’ mental health” 8.Continuance and completion of mental health integration program into PHC networks and other routine programs 9.Designing and applying educational program of promoting knowledge and at titude of pol - icy makers and senior managers of the country on the more priority areas of mental health 10.Formulating educational content of promoting spiritual, social, and mental health of stu - dents 11.Design and implement mental health promotion program in workplace 12.Advocacy and cooperation to use appropriate language and method of promoting people’s knowledge on mental health 13.Performing classified and targeted programs in “mental health week” 14.Designing and implementing mental health promotion program fo r health system workersSecond level prevention15.Reviewing structure for provision of mental health services 16.Developing clinical practice guidelines for prevention, care, and referral of the mentally -ill patients in family physician program 17.Development program of mental health specialty services within the country’s medical care system 18.Planning and practicing screening package and taking care of mentally -ill patients in 19.Develop and implement service package for mental health in peri -urban areas 20.Formulating and establishing program for promoting psychiatric emergency services 21.Planning and conducting rehabilitation programs including promoting mental health profi - ciency among all medical care groups 22.Making community -oriented mental health c enters and deploying or merging it in PHC networks 23.Implementing programs to encourage hospitals to allocate 10% of hospital beds and the psychosomatic wards 24.Designing and implementing monitoring systems to oversee the mental health services in privatesector 25.Establishing a hospital particularly for criminals having psychiatric disorders 26.Third level Prevention27.Formulating or reviewing mental patients support package 28.Planning and practicing advocacy programs to increase insurance coverage to take care of chronic mentally -ill patients 29.Designing and implementation rehabilitating service package for psychiatric patients 30.Formulating and notifying protocol of self -aid groups specified to mentally -ill patients",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
"42, Supple.1, 2013 , p: 105-112 Iran's Health System; a Step Toward the 2025 Outlook 111 Available at: http://ijph.tums.ac.irDiscussion Although available studies are not sufficient enough to show increasing trend of incidence, prevalence, and burden of mental diseases, experts and stakeholders believe those diseases have a ri s- ing trend; previous and current interventions do not have adequ ate effectiveness and coverage and need urgent measures while in developing coun - tries, 90% of the affected have no access to pro p- er treatment.",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
":What to Do To Promote Mental Health … Available at: http://ijph.tums.ac.ir 112References 1.Noorbala AA, Mohammad K, Bagheri Yazdi SA, Yasami MT (2001).",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
Avail a- ble from: http://www.who.int/governance/eb/who _constitution_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
Available from: http://www.who.int/wh r/2001/en/ .,OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
"5th5-years economical, social and cultural development plan act of Iran, Available from: http://rc.majlis.ir/fa/law/show/790196 .",Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
Available form: http://www.who.int/mental_health/evi - dence/en/prevention_of_mental_disorders _sr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
Available form:http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
Available from: http://www.dadkhahi.net/law/hoghoogh/ h_edari_estekhdami/ghanoon_barbameh_ 4.htm.,Non-OADS,/arxiv_data1/oa_pdf/f2/7a/ijph-42-105.PMC3712592.pdf
"42, Supple.1, 2013, pp : 1-8 National Report 1 Available at: http://ijph.tums.ac.ir The Code of Ethics for Nurses F Zahedi1,2, M Sanjari1, M Aala1, M Peymani1, K Aramesh2, A Parsapour2, SS Bagher Mad dah3, MA Cheraghi4, GH Mirzabeigi5, *B Larijani1,2, *M Vahid Dastgerdi6,7 1.Endocrinology and Metabolism Research Centre, Tehran University of Medical Sciences, Tehran, Iran 2.Medical Ethics and History of Medicine Research Centre, Tehran University of Medical Sciences, Tehran, Iran 3.University of Social Welfare and Rehabilitation Sciences, Tehran, Iran 4.Faculty of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran 5.Iranian Nursing Organization, Tehran, Iran 6.Minister, Ministry of Health and Medical Education, Iran 7.Dept.",Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
:The Code of Ethics … Available at: http://ijph.tums.ac.ir 2codes can also support nurses in their practice and reduce their moral distress.,Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
"42, Supple.1, 2013, pp: 1-8 Iran's Health System; a Step Toward the 2025 Outlook 3 Available at: http://ijph.tums.ac.irCo-workers”, and “Nursing, Education and Re - search”,including 71 provisions in total.",Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
":The Code of Ethics … Available at: http://ijph.tums.ac.ir 4Hashemi F, Heidari A, Joudaki K, Joulaie S, Ka - rimi M, Kashaninia Z, Kazemian M, Milanifar AR, Mobasher M, Namazi HR, NazariEshtehardi M, Parsayekta Z, Saber S, Sahebjam S, Salemi S, Sho - jaee AA, Soufizadeh M, Tafti F, Vasko oeKh, YadavarNikravesh M. The representatives of Health Policy council of MOHME, The Institution (Nahad) of Representa - tive of the Supreme Leaderin TUMS, MedicalEthics and History of Medicine Research Center of TUMS, Iranian Nursing Organization, Medica l Council of Islamic Republic of Iran, Office of Nursing Advisors to MOHME, Academy of Medical Sciences and also Nursing Board of Ministry of Health and Medical Education were among the members of the Task Force.",Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
"42, Supple.1, 2013, pp: 1-8 Iran's Health System; a Step Toward the 2025 Outlook 5 Available at: http://ijph.tums.ac.ir1-5.Be sensitive to the challenges and ethical is - sues, in both community and workplace, that could undermine the sanctity of the nursing profession; and offer theappropri- ate solution when is necessary.",Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
:The Code of Ethics … Available at: http://ijph.tums.ac.ir 6guardian consent.,Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
"42, Supple.1, 2013, pp: 1-8 Iran's Health System; a Step Toward the 2025 Outlook 7 Available at: http://ijph.tums.ac.ir4-3.Share his/her professional knowledge and experience with other colleagues.",Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
Available from: http://www.icn.ch/images/stories/docu - ments/about/icncode_english.pdf 2.American Nurses Association (2001).,Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
:The Code of Ethics … Available at: http://ijph.tums.ac.ir 8http://www.nursingworld.org/MainMenuCa - tegories/EthicsStandards/Tools -You-Need/Code - of-Ethics.pdf 3.Canadian Nurse Association (2008).,Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
"Available : http://www.cna -nurses.ca/CNA/documents/pdf/publica - tions/Code_of_Ethics_2008_e.pdf 4.Borhani F, Alhani F, Mohammadi I, Abbasza - deh A (2009).",Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
"Availa - ble from: http://siasat.behdasht.gov.ir/index.aspx?siteid=291 &pageid=36742 12.Zahedi F, Larijani B.",Non-OADS,/arxiv_data1/oa_pdf/72/0b/ijph-42-1.PMC3712593.pdf
"42, Supple.1, 2013, pp: 50-54 National Report 50 Available at: http://ijph.tums.ac.ir Development and Implementation of Health Technology Assess - ment: A Policy Study SH Doaee1, *A Olyaeemanesh1, 2, SH Emami3,  M Mobinizadeh1, P Abooee2, M Nejati1, GS Zolani1 1.Dept.of Health Technology Assessment (HTA), Deputy of Curative Affairs, Ministry of Health and Medical Education, Tehran, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/51/f4/ijph-42-50.PMC3712594.pdf
":Development and Implementation of Health Technology … Available at: http://ijph.tums.ac.ir 51have been formed in Malaysia, Philippine, Thail - and, China, and Pa kistan.",Non-OADS,/arxiv_data1/oa_pdf/51/f4/ijph-42-50.PMC3712594.pdf
"42, Supple.1, 2013 , p: 50-54 Iran's Health System; a Step Toward the 2025 Outlook 52 Available at: http://ijph.tums.ac.irEstablishment of a new field in HTA subject in medical universi ties for PhD degree.",Non-OADS,/arxiv_data1/oa_pdf/51/f4/ijph-42-50.PMC3712594.pdf
:Development and Implementation of Health Technology … Available at: http://ijph.tums.ac.ir 53conductors of health technology appraisal projects in various research centers (11).,OADS,/arxiv_data1/oa_pdf/51/f4/ijph-42-50.PMC3712594.pdf
"42, Supple.1, 2013 , p: 50-54 Iran's Health System; a Step Toward the 2025 Outlook 54 Available at: http://ijph.tums.ac.irConclusion Since evidence based on decision making including HTA provides minimum adverse impacts on the system, policy makers should strongly support this field.",Non-OADS,/arxiv_data1/oa_pdf/51/f4/ijph-42-50.PMC3712594.pdf
Available at: URL:http://www.who.int.,Non-OADS,/arxiv_data1/oa_pdf/51/f4/ijph-42-50.PMC3712594.pdf
"42, Supple.1, 2013, pp: 66-73 Original Article 66 Available at: http://ijph.tums.ac.ir Designing a Minimum Data Set for Breast Cancer: a Starting Point for Breast Cancer Registration in Iran M Ghaneie1, A Rezaie1, *N R Ghorbani1, 2, RN Heidari1, M Arjomandi1, M Zare1 1.Deputy of Research & Technology, Ministry of Health, Treatment and Medical Education, Tehran, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/57/e0/ijph-42-66.PMC3712595.pdf
:Designing a Minimum Data Set for Breast Cancer … Available at: http://ijph.tums.ac.,Non-OADS,/arxiv_data1/oa_pdf/57/e0/ijph-42-66.PMC3712595.pdf
"42, Supple.1, 2013 , p: 66-73 Iran's Health System; a Step Toward the 2025 Outlook 68 Available at: http://ijph.tums.ac.irluated throughout several meetings that have been carried out.",Non-OADS,/arxiv_data1/oa_pdf/57/e0/ijph-42-66.PMC3712595.pdf
:Designing a Minimum Data Set for Breast Cancer … Available at: http://ijph.tums.ac.,Non-OADS,/arxiv_data1/oa_pdf/57/e0/ijph-42-66.PMC3712595.pdf
"42, Supple.1, 2013 , p: 66-73 Iran's Health System; a Step Toward the 2025 Outlook 70 Available at: http://ijph.tums.ac.irIn the analysis stage, the fact that at the present time there is no standard and uniform MDS available in the country, this data set was based on the tables on comparative evaluation of the MDS for breast cancer and the model that was ap - proved by the experts in the format consisting of 11 sections in the form of fields in closed struc - tured arra ngements with consideration to coding responses which is presented in the following manner: The first section includes hospital data that in - clude: name of the hospital and hospital details.",Non-OADS,/arxiv_data1/oa_pdf/57/e0/ijph-42-66.PMC3712595.pdf
:Designing a Minimum Data Set for Breast Cancer … Available at: http://ijph.tums.ac.,Non-OADS,/arxiv_data1/oa_pdf/57/e0/ijph-42-66.PMC3712595.pdf
"42, Supple.1, 2013 , p: 66-73 Iran's Health System; a Step Toward the 2025 Outlook 72 Available at: http://ijph.tums.ac.irwork composed of specialists in epidemiology, biostatistics, health information managers, and other specialist depending of the type of the MDS to be developed in order that different dimensions willbe considered.",Non-OADS,/arxiv_data1/oa_pdf/57/e0/ijph-42-66.PMC3712595.pdf
:Designing a Minimum Data Set for Breast Cancer … Available at: http://ijph.tums.ac.,Non-OADS,/arxiv_data1/oa_pdf/57/e0/ijph-42-66.PMC3712595.pdf
"42, Supple.1, 2013, pp: 23-30 Original Article 23 Available at: http://ijph.tums.ac.ir Future of Health Care Delivery in Iran, Opportunities and Threats F Rajabi1, 2, *H Esmailzadeh2, N Rostamigooran3, R Majdzadeh2, 4, L Doshmangir5 1.Community Based Participatory Research Center (CBPR), Tehran University of Medical Sciences, Tehran, Iran 2.Center for Academic and Health Policy (CAHP), Tehran University of Medical Sciences, Tehran, Iran 3.Health Policy Council, Ministry of Health and Medical Education, Tehran, Iran 4.School of Public Health, Tehran University of Medical Sciences, Tehran, Iran 5.School of Health Management and Medical Information, Tehran University of Medical Sciences, Tehran, Iran *Corresponding Author: Email:Esmailzad@tums.ac.ir (Received 24Feb2012; accepted 11Oct2012) Introduction Today, world and especially Asia region is subject to rapid and extensive social, political, economic, environmental and technological changes.",Non-OADS,/arxiv_data1/oa_pdf/db/cd/ijph-42-23.PMC3712596.pdf
":Future of Health Care Delivery in Iran … Available at: http://ijph.tums.ac.ir 24Iran in2025, has developed short and medium term plans in different fields of education, re - search and health services delivery with the aim of promoting health of societies (5 -6).",Non-OADS,/arxiv_data1/oa_pdf/db/cd/ijph-42-23.PMC3712596.pdf
"42, Supple.1, 2013 , p: 23-30 Iran's Health System; a Step Toward the 2025 Outlook 25 Available at: http://ijph.tums.ac.irthat their key trends, had important effects on health services delivery, and therefore are the fo - cus of this study.",Non-OADS,/arxiv_data1/oa_pdf/db/cd/ijph-42-23.PMC3712596.pdf
":Future of Health Care Delivery in Iran … Available at: http://ijph.tums.ac.ir 26Opportunity High preventable burden of non -communicable disease(1,2) Increasing bio -environmental pollutionThreat Increasing  physical, mental, and social burden of bio -environmental pollution(1) Increasing slums Threat Poor access to required health care services in slums(3) Increasing exposure to different health risk f actors in slums(1) increasing inequity in health due to mentioned events in slums(3) Increasing private sector partnership in health care deli - veryThreat Increasing health care cost with potential to increase in unwarranted medical procedures and prescr iption medicines(induced demand)(5) Weak public system capacity to regulate private sector including for disease surveillance(3,5) Potential to increase Out of Pocket payment(5) Private sector participate mostly in the fields with most expected return of capital like expensive and sub specialized  diagnostic and treatment procedures and primary and preventive care will be ignored more than before (3) Opportunity Increasing health care delivery capacity due to new partners in provi - sion and financing of health services(3,5) Increasing in the quality of health care delivery in public sector due to benchmark setting and competition with private sector(2) Moving toward Knowledge based societyThreat Community dissatisfaction with health care services not a ccording to their increased expectations(1) Opportunity Increasing scientific literacy in the community(1) Increasing health literacy in the community(1) Increasing peoples willingness to participate in diagnosis and treatment decision making(1) Using  the capacities provided in the knowledge based society in order to control behavioral risk factors of health(1) Self care education and decreasing the demand for health care ser - vices(1,3,5) Increasing knowledge production by research in health system which can lead to community health promotion(2) Increased tendency for higher education helps health system for hu - man resource generation in priority fields and areas(4) Improved Continuous Medical Education cause better health care deli - very and increased heal th system performance (4,5) Development of information and communication technologyThreat Uncontrolled public distribution of health information and advertise - ment can lead to induced demand and increasing health care cost(1,5) Uncontrolled public distribution of health information can cause nega - tive effects on population health(1) OpportunityTable 1: Cond…",Non-OADS,/arxiv_data1/oa_pdf/db/cd/ijph-42-23.PMC3712596.pdf
"42, Supple.1, 2013 , p: 23-30 Iran's Health System; a Step Toward the 2025 Outlook 27 Available at: http://ijph.tums.ac.irFacilitated access to correct health system data when needed for deci - sion making(2) Facilitated evidence informed decision making in all l evels which leads to more effective health care with less cost and side effects(2,3,4,5) Access to health care indexes and standards provides opportunity for national and international comparisons and so finding challenges and weaknesses(3,4,5) Establishme nt of E-health and E -medicine can result increased access to health care services and so increasing the equity in health(1,2,3,4,5) Facilitate establishment of referral system in different levels all over the country(3) Increased use of  high technologies in health systemThreat Increased demand for unnecessary health care services provided using new high technologies(1,3,5) Decision making about new technologies without considering local evidences and technology assessment results causes Reducing allocative efficiency in health system(5) Reduced attention to public health and primary health care(5) Increasing incidence of unknown side effects of new technologies be - cause of frequent use of them (1 ) Opportunity Increased quality of health care serv ices and patients quality of life by using new technologies in prevention, diagnosis and treatment of dis - eases(2,5) Development in medical device and drug production in Iran leads to increased income and decreased cost of health system(2,5) Using new tech nologies in medical education result in better medical education(4) Development of traditional and alternative medicineOpportunity Scientific development of traditional medicine in Iran can cause utiliza - tion of this knowledge as beneficial services f or community(2) Traditional and alternative medicine in Iran can help health tour - ism(2 ,5) 1-health care receivers, 2 -technical and scientific capabilities, 3 -health system structure, 4 -health care providers, 5 - health system financing Discussion In this research, the experts of health system at - tempted to compile the key opportunities and threats that health system in Iran is facing as the results of different trends in the next 15 years.",Non-OADS,/arxiv_data1/oa_pdf/db/cd/ijph-42-23.PMC3712596.pdf
":Future of Health Care Delivery in Iran … Available at: http://ijph.tums.ac.ir 28and their impact on health system (1, 9).",Non-OADS,/arxiv_data1/oa_pdf/db/cd/ijph-42-23.PMC3712596.pdf
"42, Supple.1, 2013 , p: 23-30 Iran's Health System; a Step Toward the 2025 Outlook 29 Available at: http://ijph.tums.ac.irIncrease in political and financial support for new technologies and innovations, in the country create an opportunity for the health system to im - prove its services, equipment and medicines with the first hand innovation, which can lead to community health promotion.",Non-OADS,/arxiv_data1/oa_pdf/db/cd/ijph-42-23.PMC3712596.pdf
":Future of Health Care Delivery in Iran … Available at: http://ijph.tums.ac.ir 30ed, United Nations Industrial Development Organization.",Non-OADS,/arxiv_data1/oa_pdf/db/cd/ijph-42-23.PMC3712596.pdf
"42, Supple.1, 2013, pp: 141 -146 National Report 141 Available at: http://ijph.tums.ac.ir The Trend of Governmental Support from Post -Graduated Iranian Students in Medical Fields to Study Abroad AA Haghdoost1, M Ghazi2, Z Rafiee2, *M Afshari1 1.Research Center for Modeling in Health, Kerman University of Medical Sciences, Kerman, Iran 2.The Center for Management of Students’ Affairs, the Ministry of Health and Medical Education, Tehran, Iran *Corresponding Author: Email:mehdiafshari16@yahoo.com (Received 18May2012; accepted 15Nov2012) Introduction Production and utilization of knowledge and sciences is one of the main components of the technological and economic development.",Non-OADS,/arxiv_data1/oa_pdf/57/e1/ijph-42-141.PMC3712597.pdf
":The Trend of Governmental Support … Available at: http://ijph.tums.ac.ir 142main reasons for choosing these countries were 1) acceptable English skills of Iranian students com - paring to the other languages, 2) obtaining easy acceptance from these countries, and 3) restric - tions for Iranian students to get acceptance from universities in the USA and Canada (5).",Non-OADS,/arxiv_data1/oa_pdf/57/e1/ijph-42-141.PMC3712597.pdf
"42, Supple.1, 2013 , p: 141-146 Iran's Health System; a Step Toward the 2025 Outlook 143 Available at: http://ijph.tums.ac.irThe number of awarded scholarships varied from 24 in the 1983 to 263 in 1992, which was the highest annual number of scholarships, and decreased to 46 in 2009 (fig 1,2).",Non-OADS,/arxiv_data1/oa_pdf/57/e1/ijph-42-141.PMC3712597.pdf
":The Trend of Governmental Support … Available at: http://ijph.tums.ac.ir 144During this period of time, a group of students requested to swap their supporting scholarships from study abroad to studying in Iranian universities.",Non-OADS,/arxiv_data1/oa_pdf/57/e1/ijph-42-141.PMC3712597.pdf
"42, Supple.1, 2013 , p: 141-146 Iran's Health System; a Step Toward the 2025 Outlook 145 Available at: http://ijph.tums.ac.irmedicine or masters in early 80s.",Non-OADS,/arxiv_data1/oa_pdf/57/e1/ijph-42-141.PMC3712597.pdf
":The Trend of Governmental Support … Available at: http://ijph.tums.ac.ir 146In conclusion, although the improvement of the quality and quanti ty of post -graduate education has been one of the main strategic objectives of MOHME, based on the national long -term development plan, different approaches in last two decades were taken.",Non-OADS,/arxiv_data1/oa_pdf/57/e1/ijph-42-141.PMC3712597.pdf
"42, Supple.1, 2013, pp: 119 -124 Original Article 119 Available at: http://ijph.tums.ac.ir Quality Assurance Program for Molecular Medicine Laboratories *M Hajia, N Safadel, S Mirab Samiee, P Dahim,  S Anjarani,  N Nafisi, A Sohrabi, M Rafiee, F Sabzavi, B Entekhabi HealthReference Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran *Corresponding Author: Email:massoudhajia@yahoo.com (Received 05 Jun 2012; accepted 11 Nov 2012) Introduction Nucleic acid amplification testing (NAT) in clini - cal specimens are increasingly used as a diagnostic tool in private clinical laboratories (1 -3).",Non-OADS,/arxiv_data1/oa_pdf/67/d3/ijph-42-119.PMC3712598.pdf
":Quality Assurance Program for Molecular Medicine … Available at: http://ijph.tums.ac.ir 120clinical service, a laboratory must maintain suitable quality in this area if accurate clinical information is to be provided to clinicians (10).",Non-OADS,/arxiv_data1/oa_pdf/67/d3/ijph-42-119.PMC3712598.pdf
"42, Supple.1, 2013 , p: 119-124 Iran's Health System; a Step Toward the 2025 Outlook 121 Available at: http://ijph.tums.ac.irResults Issued Protocols Following guidelines were issued by the Virology and Molecular Biology Committee after several nonstop working (13): 1-Diagnostic molecular laboratory (especially for laboratory buildings and equipments),   February 2008.",Non-OADS,/arxiv_data1/oa_pdf/67/d3/ijph-42-119.PMC3712598.pdf
":Quality Assurance Program for Molecular Medicine … Available at: http://ijph.tums.ac.ir 122instruments, applied diagnostic protocols, quality assurance and control, and finally reporting.",Non-OADS,/arxiv_data1/oa_pdf/67/d3/ijph-42-119.PMC3712598.pdf
"42, Supple.1, 2013 , p: 119-124 Iran's Health System; a Step Toward the 2025 Outlook 123 Available at: http://ijph.tums.ac.irinstruments while bench marking showed only 23% ofthe laboratories had provided all required equipments.",Non-OADS,/arxiv_data1/oa_pdf/67/d3/ijph-42-119.PMC3712598.pdf
:Quality Assurance Program for Molecular Medicine … Available at: http://ijph.tums.ac.ir 124extraction from urinespecimens.,Non-OADS,/arxiv_data1/oa_pdf/67/d3/ijph-42-119.PMC3712598.pdf
"42, Supple.1, 2013, pp: 74-77National Report 74 Available at: http://ijph.tums.ac.ir The Evaluation of International Relationship Role in Promotion of Health System Research HH Kohanzad1,   M Ghanei1,*P Owlia2 1.Deputy Minister for Research & Technology, Ministry of Health, Treatment and Education, Iran 2.Molecular Microbiology Research Center, Shahed University, Tehran, Iran *Corresponding Author: Tel:+98 21 88964792 Email :owlia@yahoo.com (Received 18Mar2012; accepted 11Oct2012) Introduction The sheer volume of international collaborations has been increased substantially during the last 20 years (1, 2) .This increase is also noticed in the number of internationally co -authored papers between the developed (usually referred to in political jar gon as the ‘North’) and developing and emerging countries (usually referred to as the ‘South’, for example, India and Bangladesh, Mexico and Brazil, China and Pakistan).",Non-OADS,/arxiv_data1/oa_pdf/89/90/ijph-42-74.PMC3712599.pdf
:The Evaluation of International Relationship … Available at: http://ijph.tums.ac.ir 75significance.,Non-OADS,/arxiv_data1/oa_pdf/89/90/ijph-42-74.PMC3712599.pdf
"42, Supple.1, 2013 , p: 74-77 Iran's Health System; a Step Toward the 2025 Outlook 76 Available at: http://ijph.tums.ac.irinternational collaboration effects on citation per paper which have a significant correlation ( P <0.0001) betwee n them (Fig.",Non-OADS,/arxiv_data1/oa_pdf/89/90/ijph-42-74.PMC3712599.pdf
:The Evaluation of International Relationship … Available at: http://ijph.tums.ac.ir 774.Block M (2006).,Non-OADS,/arxiv_data1/oa_pdf/89/90/ijph-42-74.PMC3712599.pdf
"Available from:http://www.scopu s.com 11.Keshavarz M ohammadi N, Zaree F, de Leeuw,Emamjomeh MM (2011).",Non-OADS,/arxiv_data1/oa_pdf/89/90/ijph-42-74.PMC3712599.pdf
"42, Supple.1, 2013, pp: 147-154 Review Article 147 Available at: http://ijph.tums.ac.ir Necessity of Accreditation Standards for Quality Assurance of Medical Basic Sciences *M Rezaeian1, Z Jalili2, N Nakhaee2, J Jahroomi Shirazi1, AR Jafari3 1.",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
:Necessity of Accreditation Standards … Available at: http://ijph.tums.ac.ir 1480102030405060 200… 200… 200… 200… 200… 200… 200… 200… 200… 201… 201…MS Ph.D Fig.,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
"42, Supple.1, 2013 , p: 147-154 Iran's Health System; a Step Toward the 2025 Outlook 149 Available at: http://ijph.tums.ac.irIranian Ministry of Health and Medical Education has taken measures since 2003 to formulate such standards.",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
:Necessity of Accreditation Standards … Available at: http://ijph.tums.ac.ir 150invited groups of medical educators from 6 continents to meet to develop global standards (19).,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
"42, Supple.1, 2013 , p: 147-154 Iran's Health System; a Step Toward the 2025 Outlook 151 Available at: http://ijph.tums.ac.irorganization concerned with education and training of medical doctors, is the improvement of health of all people through promotion of high - quality medical education.",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
":Necessity of Accreditation Standards … Available at: http://ijph.tums.ac.ir 152Combination of Insti tutional Self -evaluation and External Peer Review, and Recognition and Accreditation.",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
"42, Supple.1, 2013 , p: 147-154 Iran's Health System; a Step Toward the 2025 Outlook 153 Available at: http://ijph.tums.ac.irThe social accountability of medical educational must be in all acc reditation process at all levels (26) The new WHO/WFME strategic partnership to improve medical education will have a central role in reform processes and in promotion of efficient and transparent national accreditation system worldwide (2).",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
"Available from : http://www.iaomc.org/wfme.htm 7.Mizazade A, Tvakoli S, Yazdani K, Taj M (2004).",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
:Necessity of Accreditation Standards … Available at: http://ijph.tums.ac.ir 1549.Comhairle nan Dochtuiri Leighis -Medical Council (2010).,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
Available from: http://www.wfme.org 10.New England Association of schools and colleges (NEASC) (2011).,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
"Available from :http://www.iaomc.org/wfme.htm 11.Wood D, M arc B (2009).",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
Copenhagen: WFME; Accessed 20 April 2009 Available from: http://wfme.org .,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
"Available from: http://wfme.org Accessed 20 April 2006 17.Van Zanten M, Boulet J, Simon FA (2010).",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
Available from : http://www.iaomc.org/wfme.htm 19.WFME Global Standards in Medical Education (2003).,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
"Geneva/Copenhagen: WHO; Available from:http://wfme.org Accessed 20 April 2009 21.The Executive Council, the World Federation for Medical Education(1998).",Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
Available from: http://wfme.org 23.Bologna Working Group on Qualifications Framework of qualifications of the European higher education area (2005).,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
Copenhagen: Ministry of Science Technology and Innovation; Available From: http://www.bologna - bergen2005.no/DOCS/O -Main doc/o5o218QFEHEA.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
Available at: (http://www.wfme.org ).,Non-OADS,/arxiv_data1/oa_pdf/7f/a7/ijph-42-147.PMC3712600.pdf
"42, Supple.1, 2013, pp: 60-65 Original Article 60 Available at: http://ijph.tums.ac.ir The Analysis of Health Research System Evaluation in Medical Sciences Universities Sh Djalalinia1, 2, N Peykari1,2, P Owlia3,1,M Baradaran Eftekhari1,4, *E Habibi1, K Falahat1,   Sh Mojarrab1, H Malekafzali5, M Ghanei1 1.Deputy of Research & Technology, Ministry of Health & Medical Education, Iran 2.Non Communicable Disease Research Center, Endocrine and Metabolism Research Institute, Tehran University of Medical Sciences,Tehran, Iran 3.Molecular Microbiology Research Center, Shahed University, Tehran, Iran 4.Social Determinants of Health Research Center, University of Welfare and Rehabilitation, Tehran, Iran 5.Health Research Institute of Tehran, Tehran University of Medical Sci ences, Tehran, Iran *Corresponding Author: elha@hbi.ir (Received 05May2012; accepted 19Nov2012) Introduction Evaluation as a general refers to the determination of the quality of a program based on the formulat- ing a judgment (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
:The Analysis of Health Research System Evaluation … Available at: http://ijph.tums.ac.ir 61coordinated and dynamic collec tion for achieving the visionary g oals of the coun try by 2025 (12 -14).,Non-OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
"42, Supple.1, 2013 , p: 60-65 Iran's Health System; a Step Toward the 2025 Outlook 62 Available at: http://ijph.tums.ac.irTable 1:Under monitoring obtained achievements of Stewardship axes Stewardship axes indicatorsPredetermined stan - dard out put Health research priority settingFoundationHealth research priority setting process is com - pleted all of the medical sciences universities.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
:The Analysis of Health Research System Evaluation … Available at: http://ijph.tums.ac.ir 63Also indexed papers in international databases per academic member proportion rose from 0.36 in 2002 to 0.82 in 2010.,Non-OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
"42, Supple.1, 2013 , p: 60-65 Iran's Health System; a Step Toward the 2025 Outlook 64 Available at: http://ijph.tums.ac.irpapers from 2000, with a notable surge after 2004, approached 15,000 papers by 2009 (27).",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
Available from: http://ed.stju.edu.cn/ranking.htm.,OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
:The Analysis of Health Research System Evaluation … Available at: http://ijph.tums.ac.ir 658.Anonymous (2011).,Non-OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
Available from: http://www.thes.co.uk/worldranking.,Non-OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
Available from: http://www.webometrics.info/methodlogy .html.,OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
Available from: http://www.rand.org/pubs/technical_re - ports/2008/RAND_TR629.sum.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
Available from: http://www.who.int/kms/en .,OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
Health Research Systems Analysis (HRSA)concepts and indicators Available from: http://www.who.int/rpc/health_research/ concepts/indicators/en/index.html.,OADS,/arxiv_data1/oa_pdf/7e/e8/ijph-42-60.PMC3712601.pdf
"42, Supple.1, 2013, pp: 166-173 National Report 166 Available at: http://ijph.tums.ac.ir Allocation of Health Resources According To the Type and Size of Iranian Governmental Hospitals SA Hassani1, M Abolhallaje2, S Inanlo2, H Hosseini2, K Pourmohammadi3, P Bastani 4, MRamezanian2, *A Barati Marnani4 1.Emergency Medicine Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran 2.Budget and Performance Monitoring Office, Ministry of Health and Medical Education, Tehran, Iran 3.School of Management and Medical Information, Shiraz University of medical sciences, Shiraz, Iran 4.School of Management and Information Sciences, Tehran University of Medical Sciences, Tehran, Iran *Corresponding Author: Tel: +98-912-3490430 Email: baratimarnani@gmail.com (Received 21 May 2012; accepted 15 Sep 2012) Introduction Due to ever rising environmental complexities, optimized consumption of resources and increas- ing of profitability in health organizations changed into the center of managers` attention (1).",Non-OADS,/arxiv_data1/oa_pdf/89/32/ijph-42-166.PMC3712602.pdf
":Allocation of Health Resources … Available at: http://ijph.tums.ac.ir 167Furthermore there are lots of problems for hospitals including management of financial af - fairs, daily costs, hospitalization period, and opti - mized applying of resources, distribution of facili - ties, optimized allo cation of resources and active beds, physical space and correct localization for facing these problems (7).",Non-OADS,/arxiv_data1/oa_pdf/89/32/ijph-42-166.PMC3712602.pdf
"42, Supple.1, 2013 , p: 166-173 Iran's Health System; a Step Toward the 2025 Outlook 168 Available at: http://ijph.tums.ac.irHuman force with separation of type & academic records, job group, share of this force in benefit - ing/deprived areas, educational/therapeutic hospitals and different criteria of hospitals (Below 50 beds (Group A), 51 to 150 beds (Group B), 151 to 300 beds(Group C)and over 300 beds (Group D ).",Non-OADS,/arxiv_data1/oa_pdf/89/32/ijph-42-166.PMC3712602.pdf
:Allocation of Health Resources … Available at: http://ijph.tums.ac.ir 169Human resources index has been displayed in Ta - ble 2.,OADS,/arxiv_data1/oa_pdf/89/32/ijph-42-166.PMC3712602.pdf
"42, Supple.1, 2013 , p: 166-173 Iran's Health System; a Step Toward the 2025 Outlook 170 Available at: http://ijph.tums.ac.irAlso the allocated metering for each bed is respec - tively 347, 144, 294, 600 sqm at hospitals of groups A to D while such an index in building isrespectively for 104, 87, 100, 251 sqm as well (Ta - ble 3).",Non-OADS,/arxiv_data1/oa_pdf/89/32/ijph-42-166.PMC3712602.pdf
:Allocation of Health Resources … Available at: http://ijph.tums.ac.ir 171costs.,Non-OADS,/arxiv_data1/oa_pdf/89/32/ijph-42-166.PMC3712602.pdf
"42, Supple.1, 2013 , p: 166-173 Iran's Health System; a Step Toward the 2025 Outlook 172 Available at: http://ijph.tums.ac.irHarrison estimated the additional number of hu - man force in 2004 at USA about 9065 cases.",Non-OADS,/arxiv_data1/oa_pdf/89/32/ijph-42-166.PMC3712602.pdf
:Allocation of Health Resources … Available at: http://ijph.tums.ac.ir 173References 1.Smith S (2009).,Non-OADS,/arxiv_data1/oa_pdf/89/32/ijph-42-166.PMC3712602.pdf
"42, Supple.1, 2013, pp: 78-83 National Report 78 Available at: http://ijph.tums.ac.ir Iranian Health Research Networks and Vision of Iran by 2025: A Case of Virtual Health Network in EMRI AA Keshtkar , * Sh Djalalinia , P Khashayar, N Peykari , Z Mohammdi , B Larijani Endocrinology & Metabolism Research Centre, Endocrinology & Metabolism Research Institute, Tehran University of Medical Scien ces, Tehran, Iran *Corresponding Author: shdjalalinia@hotmail.com (Received 14 May 2012; accepted 21 Nov 2012) Introduction In Iran, the science and technology health plan was developed based on the vision of Iran by 2025, as the main national convention.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
:Iranian Health Research Networks and Vision … Available at: http://ijph.tums.ac.ir 79prospects for goals of health research based on the visions of Iran by 2025.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
"42, Supple.1, 2013 , p: 78-83 Iran's Health System; a Step Toward the 2025 Outlook 80 Available at: http://ijph.tums.ac.ir-Participatory health research priority setting Establishing strong information technology sys - tems to communicate information to members and their utilization -Participatory approach for designing or validating of standard guidelines for cooperation in the prevention, diagnosis and treatment related areas -Coverage and centralize al l facilities, equipment, manpower to accomplish the mission of network Results There are currently 27 research networks operating under the supervision of the Deputy of Research and Technology at MOHME.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
:Iranian Health Research Networks and Vision … Available at: http://ijph.tums.ac.ir 81enable us to reach to c ountry health research visions (22).,Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
"42, Supple.1, 2013 , p: 78-83 Iran's Health System; a Step Toward the 2025 Outlook 82 Available at: http://ijph.tums.ac.ir-The core system should monitor members’ communication to achieve the subjective factors suchas idea generation, leadership, and problem - solving skills; -Recourses and infrastructures should be provided based on special members’ requirement.",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
Available from: http://ncris.innovation.gov.au/Capabilities /Pages/PopHealth.aspx.,OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
Available from: http://mhrn.net/page.php?slct_pg_id=35 &sid=1&slc_lang=fa.,OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
:Iranian Health Research Networks and Vision … Available at: http://ijph.tums.ac.ir 8318.Anonymous (2011).,Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
Available from: http://www.hbi.ir/NSite/SpecialService/?,Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
"Available from: http://www.uwo.ca/fammed/csfm/siiren/ aboutus/index.html 23.Khashayar P, Aalaa M, Mahmoudzadeh B, Peymani M, KHazraei Z, Sanjari M, Amini M, Torabi M, Larijani B(2012) Virtual Clinic: Core Solution to Diabetic Patient Relationship Management .",Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
Available from: http://www.slideshare.net/digicmb/virtual -research-networks-towards-research-20.,Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
Available at: http://www.rand.org/pubs/technical_re - ports/2008/RAND_TR629.sum.pdf,Non-OADS,/arxiv_data1/oa_pdf/66/c7/ijph-42-78.PMC3712603.pdf
"42, Supple.1, 2013, pp: 13-17 National Report 13 Available at: http://ijph.tums.ac.ir Iran Health System Reform Plan Methodology H Esmailzadeh1, *F Rajabi1, 2, N Rostamigooran3, R Majdzadeh2, 4 1.Center for Academic and Health Policy (CAHP), Tehran University of Medical Sciences, Tehran, Iran 2.Community Based Participatory Research Center (CBPR), Tehran University of Medical Sciences, Tehran, Iran 3.Health Policy Council, Ministry of Health And Medical Education, Tehran, Iran 4.School of Public Health, Tehran University of Me dical Sciences, Tehran, Iran *Corresponding Author: Email:frajabi@tums.ac.ir (Received 10Jan2012; accepted 26Oct2012) Introduction Health is an issue that is in transition and under - goes rapid changes.",Non-OADS,/arxiv_data1/oa_pdf/1b/aa/ijph-42-13.PMC3712604.pdf
":Iran Health System Reform Plan … Available at: http://ijph.tums.ac.ir 14achievements of Iran's Vision 2025 and Iran's Health Innovation and Science Development Plan , put compilation of the health system reform plan on its agenda.",Non-OADS,/arxiv_data1/oa_pdf/1b/aa/ijph-42-13.PMC3712604.pdf
"42, Supple.1, 2013 , p: 13-17 Iran's Health System; a Step Toward the 2025 Outlook 15 Available at: http://ijph.tums.ac.ir4-Challenges and opportunities Review: In order to determine the main cause of health system challenges, it was advised to do root cause analysis using Problem Tree Analysis (5 Why technique) and system dynamics modeling.",Non-OADS,/arxiv_data1/oa_pdf/1b/aa/ijph-42-13.PMC3712604.pdf
":Iran Health System Reform Plan … Available at: http://ijph.tums.ac.ir 16field and there was no chance for change in differ - ent fields (8, 13 -14).",Non-OADS,/arxiv_data1/oa_pdf/1b/aa/ijph-42-13.PMC3712604.pdf
"42, Supple.1, 2013 , p: 13-17 Iran's Health System; a Step Toward the 2025 Outlook 17 Available at: http://ijph.tums.ac.irwww.harvardschoolofpublichealth.org 5.Anonymous (2006).",Non-OADS,/arxiv_data1/oa_pdf/1b/aa/ijph-42-13.PMC3712604.pdf
Iran.Available from: http://vision1404.ir 13.Frenk J (1994).,Non-OADS,/arxiv_data1/oa_pdf/1b/aa/ijph-42-13.PMC3712604.pdf
"42, Supple.1, 2013 Editorial i Available at: http://ijph.tums.ac.ir Islamic Republic of Iran’s Health System: Achievements and Prospective M Vahid Dastgerdi Minister, Ministry of Health and Medical Education, Iran Health is a valuable asset which paves the way for the development of pe rsonal capabilities and helps the steady development of the society (1).",Non-OADS,/arxiv_data1/oa_pdf/ec/cf/ijph-42-0.PMC3712605.pdf
"42, Supple.1, 2013 Iran's Health System; a Step Toward the 2025 Outlook Available at: http://ijph.tums.ac.ir ii(9), achieving scientific excellence and expanding scientific bound aries is only possible by creative and innovative healthcare personnel.",Non-OADS,/arxiv_data1/oa_pdf/ec/cf/ijph-42-0.PMC3712605.pdf
Available: http://rc.majlis.ir/fa/content/iran _constitution 3.Manenti  A( 2011).,Non-OADS,/arxiv_data1/oa_pdf/ec/cf/ijph-42-0.PMC3712605.pdf
Avail a- ble::http://rc.majlis.ir/fa/law/show/790196.,Non-OADS,/arxiv_data1/oa_pdf/ec/cf/ijph-42-0.PMC3712605.pdf
1) :27- 28 10.http://www.nature.com/polopoly_fs/7.8 087.1355853889!/image/cube%20map _web.jpg_gen/derivatives/lightbox/cu be%20map_web.jpg 11.Available from :http://www.hbi.ir/,Non-OADS,/arxiv_data1/oa_pdf/ec/cf/ijph-42-0.PMC3712605.pdf
"42, Supple.1, 2013, pp: 9-12 National Report 9 Available at: http://ijph.tums.ac.ir Implementation of Patient’s Rights Charter: a Report from Ministry of Health and Medical Education, Iran A R Parsapoor1, P Salari1, *B Larijani2 1.Medical Ethics and History of Medicine Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran 2.Endocrinology and Metabolism Research Institute and Medical Ethics and History of medicine Research Center, Tehran University of Medical Sciences, Tehran, Ira n. *Corresponding Author: Tel:+9821-66953832 Email:mehr@tums.ac.ir (Received 18Mar2012; accepted 11Oct2012) Introduction Physical, mental, spiritual and social health are considered as the most important dimensions of individuals and according to the article 29 constitution of Iran its development is one of the most important commitments of Iranian govern - ment (1).",Non-OADS,/arxiv_data1/oa_pdf/0c/4b/ijph-42-9.PMC3712606.pdf
:Implementation of Patient’s Rights Charter … Available at: http://ijph.tums.ac.ir 10codified the first draft of the strategies of the MOH for implementation of Patient’s Rights Charter.,Non-OADS,/arxiv_data1/oa_pdf/0c/4b/ijph-42-9.PMC3712606.pdf
"42, Supple.1, 2013 , p: 9-12 Iran's Health System; a Step Toward the 2025 Outlook 11 Available at: http://ijph.tums.ac.irThirdly the draft was assessed by the department of medical ethics and education of Academy of Medical Sciences and participation of MOH, Medical Council, and medical associations.",Non-OADS,/arxiv_data1/oa_pdf/0c/4b/ijph-42-9.PMC3712606.pdf
":Implementation of Patient’s Rights Charter … Available at: http://ijph.tums.ac.ir 12ethical knowledge in the different levels and make it practical and standardizing health care services, the curriculum was re -assessed in several experts meetings and finally 33 topics was chosen for re si- dents which were approved by the Higher Council of Medical Ethics of MOH.",Non-OADS,/arxiv_data1/oa_pdf/0c/4b/ijph-42-9.PMC3712606.pdf
"Available : http://en.wikipedia.org/wiki/Constitu tion of the Islamic Republic of Iran 2.Larijani B, Delavari A, Damari B, Vosoogh Moghadam A, Majdzadeh R (2009).",Non-OADS,/arxiv_data1/oa_pdf/0c/4b/ijph-42-9.PMC3712606.pdf
"42, Supple.1, 2013, pp: 88-92 Original Article 88 Available at: http://ijph.tums.ac.ir Determining Dimensions of Iranians’ Individual Social Health: A Qualitative Approach KAbachizadeh1, SOmidnia2, N Memaryan2, * AA Nasehi3, M Rasouli4, B Tayefi1, A Nikfarjam3 1.Dept.",Non-OADS,/arxiv_data1/oa_pdf/5b/51/ijph-42-88.PMC3712607.pdf
":Determining Dimensions of Iranians’ Individual … Available at: http://ijph.tums.ac .ir 89being that concerns how he gets along with other people, how other people react to him, and how he interacts with social institutions and social mores and vice versa ” (5).",Non-OADS,/arxiv_data1/oa_pdf/5b/51/ijph-42-88.PMC3712607.pdf
"42, Supple.1, 2013 , p: 88-92 Iran's Health System; a Step Toward the 2025 Outlook 90 Available at: http://ijph.tums.ac.irfriendliness and affection 14 -acceptance of an individual as a society member 15 -individual re - spect 16-individual appreci ation 17-supporting through law.",Non-OADS,/arxiv_data1/oa_pdf/5b/51/ijph-42-88.PMC3712607.pdf
":Determining Dimensions of Iranians’ Individual … Available at: http://ijph.tums.ac .ir 91plex construct in terms of conceptualization and measurement (8, 9).",Non-OADS,/arxiv_data1/oa_pdf/5b/51/ijph-42-88.PMC3712607.pdf
"Available from https://apps.who.int/aboutwho/en/definition.htm l. 2.Wallace RB, Kohatsu N (2006).",OADS,/arxiv_data1/oa_pdf/5b/51/ijph-42-88.PMC3712607.pdf
"42, Supple.1, 2013 , p: 88-92 Iran's Health System; a Step Toward the 2025 Outlook 92 Available at: http://ijph.tums.ac.irConsumer Survey (MHSIP).",Non-OADS,/arxiv_data1/oa_pdf/5b/51/ijph-42-88.PMC3712607.pdf
"42, Supple.1, 2013, pp: 31-35 National Report 31 Available at: http://ijph.tums.ac.ir Intersectoral Collaboration to Develop Health Equity Indicators in Iran M Beheshtian1, *A Olyaee Manesh2, SH Bonakdar1, H Malek Afzali3, B Larijani4,L Hosseini1, M Zakeri1, *MVahid Dastgerdi5,6 1.Social Determinant of Health Secretariat, Health Policy Council, Ministry of Health and Medical Education, Iran 2.National Institute for Health Research, Tehran University of Medical Science, Iran 3.Dept.",Non-OADS,/arxiv_data1/oa_pdf/1c/99/ijph-42-31.PMC3712608.pdf
":Intersectoral Collaboration to Develop Health Equity … Available at: http://ijph.tums.ac.ir 32medical services, health status and life conditions (4).",Non-OADS,/arxiv_data1/oa_pdf/1c/99/ijph-42-31.PMC3712608.pdf
"42, Supple.1, 2013 , p: 31-35 Iran's Health System; a Step Toward the 2025 Outlook 33 Available at: http://ijph.tums.ac.irand infrastructure, human and social development, economic development and governance combined with data sources .After holding series of consultative meetings in SDH secretariat, 52 indicators for health equity is prepared and showed them to High Health & food security council.",Non-OADS,/arxiv_data1/oa_pdf/1c/99/ijph-42-31.PMC3712608.pdf
:Intersectoral Collaboration to Develop Health Equity … Available at: http://ijph.tums.ac.ir 34The sources for collecting 40 indicators are registration system and for 12 remaining indica - tors is survey.,OADS,/arxiv_data1/oa_pdf/1c/99/ijph-42-31.PMC3712608.pdf
"42, Supple.1, 2013 , p: 31-35 Iran's Health System; a Step Toward the 2025 Outlook 35 Available at: http://ijph.tums.ac.irsystems to address health equity challenges.",Non-OADS,/arxiv_data1/oa_pdf/1c/99/ijph-42-31.PMC3712608.pdf
"42, Supple.1, 2013, pp: 36-41 Original Article 36 Available at: http://ijph.tums.ac.ir Ways to Improve the Current Performance of the Boards of Trustees of Medical Universities in Iran B Damari1,H Aminloo2, H Farzan2, M Rahbari3, *S Alikhani2 1.",Non-OADS,/arxiv_data1/oa_pdf/82/e1/ijph-42-36.PMC3712609.pdf
:Ways to Improve the Current Performance … Available at: http://ijph.tums.a c.ir 37adopted by both Senate and Parliament to form a board of trustees for the University of Tehran.,Non-OADS,/arxiv_data1/oa_pdf/82/e1/ijph-42-36.PMC3712609.pdf
"42, Supple.1, 2013 , p: 36-41 Iran's Health System; a Step Toward the 2025 Outlook 38 Available at: http://ijph.tums.ac.irElevenuniversities/institutes couldn’t provide the response on time.",Non-OADS,/arxiv_data1/oa_pdf/82/e1/ijph-42-36.PMC3712609.pdf
":Ways to Improve the Current Performance … Available at: http://ijph.tums.a c.ir 39bers who are not local, interrupted attendance of members in the board meetings, avoidance of the boards to get involv ed in strategic policy -making, frequent change of chancellors, holding the meet - ings out of university, the attitude of members who designated for more than one board, lack of supervising mechanism on member’s perfor - mance, lack of evaluation mechanism for past resolutions, little role of the boards in appoint - ment of chancellors, weak university -board relationship and the current conflict of inspecting organs with Article 49 of the 4thDevelopment Program that allows the boards to make decisions independent to current monetary and employment laws (6).3-Some training needs were mentioned to im - prove the capacity of board members to under - take their job.",Non-OADS,/arxiv_data1/oa_pdf/82/e1/ijph-42-36.PMC3712609.pdf
"42, Supple.1, 2013 , p: 36-41 Iran's Health System; a Step Toward the 2025 Outlook 40 Available at: http://ijph.tums.ac.irDiscussion We could not find any similar network of boards of trustees through review of international litera - ture; however, there was a few studies addressed the function and performance of board of trustees of Iranian non -medical universities.",Non-OADS,/arxiv_data1/oa_pdf/82/e1/ijph-42-36.PMC3712609.pdf
:Ways to Improve the Current Performance … Available at: http://ijph.tums.a c.ir 41enhancement of the capacity at Ministerial level to act as a national co nsulting and su - pervisory body; promoting competition between the boards; updating the legisla - tion that can affect the performance of the boards including those that should allow to change the composition of the board members; updating the duties and man - dates of the boards according to the emerging national strategic plans and vi - sions.,Non-OADS,/arxiv_data1/oa_pdf/82/e1/ijph-42-36.PMC3712609.pdf
"42, Supple.1, 2013, pp: 93-97 Original Article 93 Available at: http://ijph.tums.ac.ir Mortality Causes in Children 1 -59 Months in Iran *M Rahbar, M Ahmadi, HR  Lornejad, A  Habibelahi, T Sanaei -Shoar, AR Mesdeaghinia Deputy for Public Health, Ministry of Health and Medical Education, Tehran, Iran *Corresponding Author: Tel:+98 21 66701731 Email:mrzrahbar@yahoo.com (Received 12 Mar 2012; accepted 19 Oct 2012) Introduction Being awareness of mortality status in community and its common causes has an effective role on planning in health and education priorities (1).",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijph-42-93.PMC3712610.pdf
":Mortality Causes in Children … Available at: http://ijph.tums.ac.ir 94rence like as the place, season, literacy of mother and etc.",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijph-42-93.PMC3712610.pdf
"42, Supple.1, 2013 , p: 93-97 Iran's Health System; a Step Toward the 2025 Outlook 95 Available at: http://ijph.tums.ac.irdeaths in children aged 1 -59 months were related to illiterate mothers (37%).",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijph-42-93.PMC3712610.pdf
":Mortality Causes in Children … Available at: http://ijph.tums.ac.ir 96urban areas (1, 3, 7, and 11).",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijph-42-93.PMC3712610.pdf
"42, Supple.1, 2013 , p: 93-97 Iran's Health System; a Step Toward the 2025 Outlook 97 Available at: http://ijph.tums.ac.irMillennium Development Goal 4.",Non-OADS,/arxiv_data1/oa_pdf/7f/4b/ijph-42-93.PMC3712610.pdf
"42, Supple.1, 2013, pp: 42-49 National Report 42 Available at: http://ijph.tums.ac.ir Health in the 5th 5 -years Development Plan of Iran: Main Challenges, General Policies and Strategies A Vosoogh Moghaddam1, *B Damari2, S Alikhani3, MH Salarianzedeh4, NRostamigooran5, A Delavari6, B Larijani7 1.Health Development Plan Coordination, Health Policy Council, Ministry of Health and Medical Education, Tehran, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
":Health in the 5th 5 -years Development Plan … Available at: http://ijph.tums.ac .ir 43tem includes the resources, actors, and institutions related to the financing, regulation, and provision of health actions.",Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
"42, Supple.1, 2013 , p: 42-49 Iran's Health System; a Step Toward the 2025 Outlook 44 Available at: http://ijph.tums.ac.irFive development plans have been prepared after the Islamic Revolution of 1979; among them, the 4thand 5thplans are targeting Iran Vision 2025.",Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
":Health in the 5th 5 -years Development Plan … Available at: http://ijph.tums.ac .ir 45Table 1:Iranian health system functions challenges Stewardship Disintegration of health governance bodies Conflict of interest in some of policy makers and managers Weakness in hiring skilled human resources for policy making, planning and effective monitoring Lake of agreed instruction for health policy making and planning process and proce dures.",Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
"42, Supple.1, 2013 , p: 42-49 Iran's Health System; a Step Toward the 2025 Outlook 46 Available at: http://ijph.tums.ac.irReduction of real value of salaries due to price inflation.",Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
:Health in the 5th 5 -years Development Plan … Available at: http://ijph.tums.ac .ir 47health special taskforce in MOHME and defended in the DPSPC.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
"42, Supple.1, 2013 , p: 42-49 Iran's Health System; a Step Toward the 2025 Outlook 48 Available at: http://ijph.tums.ac.iraccident injuries.",Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
:Health in the 5th 5 -years Development Plan … Available at: http://ijph.tums.ac .ir 49References 1.Marmot M (2007).,Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
Available from: http://siasat.behdasht.gov.ir/index.aspx?siteid =291&pageid=31686 3.World Health Organization (2000).,OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
Available from: http://hdr.undp.org/en/reports/global/hdr2 005/ 6.Research Center for Islamic Consultancy Parliament .,Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
Available from:http://rc.majlis.ir/fa/content/iran_constitution 7.Vosoogh A. Damari B. Salarianzadeh H. Rostami N (2011).,Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
Available from: http://www.vision1404.ir/fa/News48.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
Available from: http://english.khamenei.ir//index.php 12.Research Center for Islamic Consultancy Parliament.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
Available from: http://rc.majlis.ir/fa/law/show/790196.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/ijph-42-42.PMC3712611.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/87/det243.PMC3712662.pdf
"For example, similar to the effects of BRCA1 loss on pericentromeres, it has been previously Chromatin remodeling, BRCA1, SAHF   and cellular senescence Zhigang t u, Katherine M. a ird and r ugang Zhang* Gene Expression and r egulation Program; t he Wistar i nstitute; Philadelphia, P a usa *Correspondence to: Rugang Zhang; Email: rzhang@wistar.org Submitted: 04/02/13; Accepted: 04/17/13http://dx.doi.org/10.4161/cc.24986Comment on: Tu Z, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
Mol Cell Biol 2013; 33:1819-29; PMID:23438604; http://dx.doi.org/10.1128/MCB.01744-12demonstrated that BRG1 deletion results  in dissolution of pericentromeric hetero - chromatin.5 These findings support the  notion that the BRCA1 and BRG1 com - plex is critical for constitutive heterochro - matin structure at pericentromeres.,OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
Cell 2003; 113:703-16;  PMID:12809602; http://dx.doi.org/10.1016/S0092- 8674(03)00401-X 2.,OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
Dev Cell 2011; 21:1077-91;  PMID:22137763; http://dx.doi.org/10.1016/j.dev-cel.2011.10.010SAHF formation and likely for silencing  proliferation-promoting genes through SAHF formation.,OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
J Cell Biol 2001; 155:911-21;  PMID:11739404; http://dx.doi.org/10.1083/ jcb.200108049 4.,OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
Nature 2011; 477:179-84;  PMID:21901007; http://dx.doi.org/10.1038/nature10371 5.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
Mol Biol Cell 2009; 20:3192- 9; PMID:19458193; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
Mol Cell Biol 2013; 33:1819-29; PMID:23438604; http://dx.doi.org/10.1128/ MCB.01744-12 7.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
Cell 1994; 79:119-30; PMID:7923370; http://dx.doi.org/10.1016/0092- 8674(94)90405-7 8.,OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
Proc Natl Acad Sci USA 2012; 109:8971-6; PMID:22615382; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/2b/cc-12-1653.PMC3713120.pdf
"Cell Cycle 2013; 12:1251–66;   PMID:23518499; http://dx.doi.org/10.4161/cc.24313 Niels Ødum; Department of International Health, Immunology and Microbiology; Copenhagen University; Copenhagen, Denmark;   Email: ndum@sund.ku.dk; http://dx.doi.org/10.4161/cc.25069 Cancer recurrence is associated with treat - ment failure and is the main cause of death,1  and thus remains to be a major clinical chal- lenge.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
"Cell Cycle 2013; 12:1433–49;   PMID:23574718; http://dx.doi.org/10.4161/cc.24550 Jan J. Brosens1,* and Eric W.-F .",OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
"Lam2; 1Division of Reproductive Health; Clinical Sciences Research Laboratories; University Hospital; Warwick Medical School;  Coventry, UK; 2Department of Surgery and Cancer; Imperial Centre for T ranslational and Experimental Medicine (ICTEM); Imperial College London; London, UK;  *Email: J.J.Brosens@warwick.ac.uk; http://dx.doi.org/10.4161/cc.25070 senescence is an inbuilt cellular response that  leads to irreversible cell cycle arrest.1 it plays  a critical role in both aging and tumor sup - pression.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Kröger N. Curr Opin Oncol 2011; 23:203-8;  PMiD:21157340; http://dx.doi.org/10.1097/ CCO.0b013e328342c6c8 2.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Ann Oncol 2012; 23:891-7;  PMiD:21821547; http://dx.doi.org/10.1093/annonc/ mdr3403.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Br J Cancer 2012; 106:133- 40; PMiD:22108518; http://dx.doi.org/10.1038/bjc.2011.504 4.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Nat Rev Cancer 2009; 9:153- 66; PMiD:19238148; http://dx.doi.org/10.1038/ nrc2602 5.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Nat Rev Cancer 2007; 7:495-507; PMiD:17568790; http://dx.doi.org/10.1038/nrc2169 7.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cell Cycle 2013; 12:1251-66; PMiD:23518499; http://dx.doi.org/10.4161/ cc.24313 Figure 1.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
"Cell Cycle 2013; 12:1416–23;   PMID:23574720; http://dx.doi.org/10.4161/cc.24527 Alexandre Blais; Ottawa Institute of Systems Biology; Department of Biochemistry, Microbiology and Immunology; Faculty of Medicine; University of Ottawa;   Ottawa, ON Canada; Email: alexandre.blais@uottawa.ca; http://dx.doi.org/10.4161/cc.25071 Cell proliferation and differentiation are two  intimately connected fundamental processes.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Nat Rev Cancer 2010; 10:51-7;  PMiD:20029423; http://dx.doi.org/10.1038/nrc2772 2.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cell Cycle 2013; 12:1433-49;  PMiD:23574718; http://dx.doi.org/10.4161/cc.24550 3.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
J Biol Chem 2000; 275:21960- 8; PMiD:10791951; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
e ndocr Relat Cancer 2012;  19:R255-79; PMiD:23045324; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Hum Reprod Update 2009; 15:119-38; PMiD:18936037; http://dx.doi.org/10.1093/humupd/dmn044 6.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Oncogene 2008; 27:9-19;  PMiD:17599040; http://dx.doi.org/10.1038/ sj.onc.1210626 7.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Mol endocrinol 2006; 20:35-44; PMiD:16123151; http://dx.doi.org/10.1210/me.2005-0275 8.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
J Clin invest 2010; 120:803-15;  PMiD:20124728; http://dx.doi.org/10.1172/ JCi40051,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cell Cycle 2013; 12:1416- 23; PMiD:23574720; http://dx.doi.org/10.4161/ cc.24527 2.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Curr Opin Cell Biol 2007; 19:658-62; PMiD:18023996; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Nat Rev Mol Cell Biol 2013; 14:297- 306; PMiD:23594950; http://dx.doi.org/10.1038/nrm3567 4.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
"Oncogene 2001; 20:6152-63;  PMiD:11593423; http://dx.doi.org/10.1038/ sj.onc.1204793 5. isaac Ce , et al.",OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Mol Cell Biol 2006; 26:3659-71;  PMiD:16612004; http://dx.doi.org/10.1128/ MCB.26.9.3659-3671.2006 6.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
J Neurosci 2012; 32:14809-14; PMiD:23077065; http://dx.doi.org/10.1523/ JNeUROsCi.1912-12.2012 7.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Mol Cell 2011; 43:663-72; PMiD:21855804; http://dx.doi.org/10.1016/j.mol- cel.2011.06.029 8.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cell 2003; 113:703-16; PMiD:12809602; http://dx.doi.org/10.1016/s0092- 8674(03)00401-XFigure 1.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
"Cell Cycle 2013; 12:1433–49;   PMID:23574718; http://dx.doi.org/10.4161/cc.24550 Steffi Oesterreich,1,2,* Robert Edwards1,3 and Anda Vlad 1,3; 1Womens Cancer Research Center; University of Pittsburgh Cancer Institute and Magee-Womens Research  Institute; University of Pittsburgh; Pittsburgh, PA USA; 2Department of Pharmacology and Chemical Biology; University of Pittsburgh; Pittsburgh, PA USA; 3De- partment of Obstetrics, Gynecology and Reproductive Sciences; University of Pittsburgh School of Medicine; Pittsburgh, PA USA; *Email: oesterreichs@upmc.edu;  http://dx.doi.org/10.4161/cc.25072 increasing epidemiological evidence suggests  a role of steroid hormones in the develop - ment and progression of certain molecular  subtypes of ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
endocr Relat Cancer 2012;  19:R255-79; PMiD:23045324; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cell Cycle 2013; 12:1433-49; PMiD:23574718; http://dx.doi.org/10.4161/ cc.24550 3.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
i nt J Gynecol Cancer 2007; 17:325-38;  PMiD:17362310; http://dx.doi.org/10.1111/j.1525- 1438.2006.00749.x 4.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Nat Rev Cancer 2009; 9:81-94; PMiD:19132009; http://dx.doi.org/10.1038/nrc2560 6.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cancer J 2011; 17:351-8; PMiD:21952286; http://dx.doi.org/10.1097/ PPO.0b013e3182325d4dFigure 1. s chematic representation of PR action as target in different subtypes of ovarian cancer.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
"Cell Cycle 2013; 12:1424–32;   PMID:23574719; http://dx.doi.org/10.4161/cc.24528 Zhiyuan Shen,* Steven C. Huhn and Bruce G. Haffty; The Cancer Institute of New Jersey; Department of Radiation Oncology; Robert Wood Johnson Medical  School; New Brunswick, NJ USA; *Email: ashenzh@umdnj.edu; http://dx.doi.org/10.4161/cc.25073 when a mammalian cell exits G1 and enters  the s -phase, it becomes committed to the  completion of the entire cell cycle until the  next G1 phase, where a quiescent status can  be reached.",Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
"5 References 1. shen Z. J Mol Cell Biol 2011; 3:1-3; PMiD:21278445;  http://dx.doi.org/10.1093/jmcb/mjq057 2. y e C, et al.",OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cell Cycle 2013; 12:1424-32;  PMiD:23574719; http://dx.doi.org/10.4161/ cc.24528 3.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cell Cycle 2011; 10:1468-76;  PMiD:21455017; http://dx.doi.org/10.4161/ cc.10.9.15510 4.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Curr Biol 2006; 16:1194-200; PMiD:16782009; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Cancer Res Treat 2011; 43:75-82; PMiD:21811422; http://dx.doi.org/10.4143/ crt.2011.43.2.75 7.,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
Lancet Oncol 2013; 14:e28-37; PMiD:23276369; http://dx.doi.org/10.1016/s1470- 2045(12)70510-7,Non-OADS,/arxiv_data1/oa_pdf/c6/7e/cc-12-1660.PMC3713121.pdf
"Cell Cycle 2013; 12:1251–66;   PMID:23518499; http://dx.doi.org/10.4161/cc.24313 Niels Ødum; Department of International Health, Immunology and Microbiology; Copenhagen University; Copenhagen, Denmark;   Email: ndum@sund.ku.dk; http://dx.doi.org/10.4161/cc.25069 Cancer recurrence is associated with treat - ment failure and is the main cause of death,1  and thus remains to be a major clinical chal- lenge.",Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
"Cell Cycle 2013; 12:1433–49;   PMID:23574718; http://dx.doi.org/10.4161/cc.24550 Jan J. Brosens1,* and Eric W.-F .",OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
"Lam2; 1Division of Reproductive Health; Clinical Sciences Research Laboratories; University Hospital; Warwick Medical School;  Coventry, UK; 2Department of Surgery and Cancer; Imperial Centre for T ranslational and Experimental Medicine (ICTEM); Imperial College London; London, UK;  *Email: J.J.Brosens@warwick.ac.uk; http://dx.doi.org/10.4161/cc.25070 senescence is an inbuilt cellular response that  leads to irreversible cell cycle arrest.1 it plays  a critical role in both aging and tumor sup - pression.",Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Kröger N. Curr Opin Oncol 2011; 23:203-8;  PMiD:21157340; http://dx.doi.org/10.1097/ CCO.0b013e328342c6c8 2.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Ann Oncol 2012; 23:891-7;  PMiD:21821547; http://dx.doi.org/10.1093/annonc/ mdr3403.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Br J Cancer 2012; 106:133- 40; PMiD:22108518; http://dx.doi.org/10.1038/bjc.2011.504 4.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Nat Rev Cancer 2009; 9:153- 66; PMiD:19238148; http://dx.doi.org/10.1038/ nrc2602 5.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Nat Rev Cancer 2007; 7:495-507; PMiD:17568790; http://dx.doi.org/10.1038/nrc2169 7.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cell Cycle 2013; 12:1251-66; PMiD:23518499; http://dx.doi.org/10.4161/ cc.24313 Figure 1.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
"Cell Cycle 2013; 12:1416–23;   PMID:23574720; http://dx.doi.org/10.4161/cc.24527 Alexandre Blais; Ottawa Institute of Systems Biology; Department of Biochemistry, Microbiology and Immunology; Faculty of Medicine; University of Ottawa;   Ottawa, ON Canada; Email: alexandre.blais@uottawa.ca; http://dx.doi.org/10.4161/cc.25071 Cell proliferation and differentiation are two  intimately connected fundamental processes.",Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Nat Rev Cancer 2010; 10:51-7;  PMiD:20029423; http://dx.doi.org/10.1038/nrc2772 2.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cell Cycle 2013; 12:1433-49;  PMiD:23574718; http://dx.doi.org/10.4161/cc.24550 3.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
J Biol Chem 2000; 275:21960- 8; PMiD:10791951; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
e ndocr Relat Cancer 2012;  19:R255-79; PMiD:23045324; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Hum Reprod Update 2009; 15:119-38; PMiD:18936037; http://dx.doi.org/10.1093/humupd/dmn044 6.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Oncogene 2008; 27:9-19;  PMiD:17599040; http://dx.doi.org/10.1038/ sj.onc.1210626 7.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Mol endocrinol 2006; 20:35-44; PMiD:16123151; http://dx.doi.org/10.1210/me.2005-0275 8.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
J Clin invest 2010; 120:803-15;  PMiD:20124728; http://dx.doi.org/10.1172/ JCi40051,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cell Cycle 2013; 12:1416- 23; PMiD:23574720; http://dx.doi.org/10.4161/ cc.24527 2.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Curr Opin Cell Biol 2007; 19:658-62; PMiD:18023996; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Nat Rev Mol Cell Biol 2013; 14:297- 306; PMiD:23594950; http://dx.doi.org/10.1038/nrm3567 4.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
"Oncogene 2001; 20:6152-63;  PMiD:11593423; http://dx.doi.org/10.1038/ sj.onc.1204793 5. isaac Ce , et al.",OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Mol Cell Biol 2006; 26:3659-71;  PMiD:16612004; http://dx.doi.org/10.1128/ MCB.26.9.3659-3671.2006 6.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
J Neurosci 2012; 32:14809-14; PMiD:23077065; http://dx.doi.org/10.1523/ JNeUROsCi.1912-12.2012 7.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Mol Cell 2011; 43:663-72; PMiD:21855804; http://dx.doi.org/10.1016/j.mol- cel.2011.06.029 8.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cell 2003; 113:703-16; PMiD:12809602; http://dx.doi.org/10.1016/s0092- 8674(03)00401-XFigure 1.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
"Cell Cycle 2013; 12:1433–49;   PMID:23574718; http://dx.doi.org/10.4161/cc.24550 Steffi Oesterreich,1,2,* Robert Edwards1,3 and Anda Vlad 1,3; 1Womens Cancer Research Center; University of Pittsburgh Cancer Institute and Magee-Womens Research  Institute; University of Pittsburgh; Pittsburgh, PA USA; 2Department of Pharmacology and Chemical Biology; University of Pittsburgh; Pittsburgh, PA USA; 3De- partment of Obstetrics, Gynecology and Reproductive Sciences; University of Pittsburgh School of Medicine; Pittsburgh, PA USA; *Email: oesterreichs@upmc.edu;  http://dx.doi.org/10.4161/cc.25072 increasing epidemiological evidence suggests  a role of steroid hormones in the develop - ment and progression of certain molecular  subtypes of ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
endocr Relat Cancer 2012;  19:R255-79; PMiD:23045324; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cell Cycle 2013; 12:1433-49; PMiD:23574718; http://dx.doi.org/10.4161/ cc.24550 3.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
i nt J Gynecol Cancer 2007; 17:325-38;  PMiD:17362310; http://dx.doi.org/10.1111/j.1525- 1438.2006.00749.x 4.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Nat Rev Cancer 2009; 9:81-94; PMiD:19132009; http://dx.doi.org/10.1038/nrc2560 6.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cancer J 2011; 17:351-8; PMiD:21952286; http://dx.doi.org/10.1097/ PPO.0b013e3182325d4dFigure 1. s chematic representation of PR action as target in different subtypes of ovarian cancer.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
"Cell Cycle 2013; 12:1424–32;   PMID:23574719; http://dx.doi.org/10.4161/cc.24528 Zhiyuan Shen,* Steven C. Huhn and Bruce G. Haffty; The Cancer Institute of New Jersey; Department of Radiation Oncology; Robert Wood Johnson Medical  School; New Brunswick, NJ USA; *Email: ashenzh@umdnj.edu; http://dx.doi.org/10.4161/cc.25073 when a mammalian cell exits G1 and enters  the s -phase, it becomes committed to the  completion of the entire cell cycle until the  next G1 phase, where a quiescent status can  be reached.",Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
"5 References 1. shen Z. J Mol Cell Biol 2011; 3:1-3; PMiD:21278445;  http://dx.doi.org/10.1093/jmcb/mjq057 2. y e C, et al.",OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cell Cycle 2013; 12:1424-32;  PMiD:23574719; http://dx.doi.org/10.4161/ cc.24528 3.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cell Cycle 2011; 10:1468-76;  PMiD:21455017; http://dx.doi.org/10.4161/ cc.10.9.15510 4.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Curr Biol 2006; 16:1194-200; PMiD:16782009; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Cancer Res Treat 2011; 43:75-82; PMiD:21811422; http://dx.doi.org/10.4143/ crt.2011.43.2.75 7.,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
Lancet Oncol 2013; 14:e28-37; PMiD:23276369; http://dx.doi.org/10.1016/s1470- 2045(12)70510-7,Non-OADS,/arxiv_data1/oa_pdf/38/e7/cc-12-1661.PMC3713122.pdf
"Cell Cycle 2013; 12:1251–66;   PMID:23518499; http://dx.doi.org/10.4161/cc.24313 Niels Ødum; Department of International Health, Immunology and Microbiology; Copenhagen University; Copenhagen, Denmark;   Email: ndum@sund.ku.dk; http://dx.doi.org/10.4161/cc.25069 Cancer recurrence is associated with treat - ment failure and is the main cause of death,1  and thus remains to be a major clinical chal- lenge.",Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
"Cell Cycle 2013; 12:1433–49;   PMID:23574718; http://dx.doi.org/10.4161/cc.24550 Jan J. Brosens1,* and Eric W.-F .",OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
"Lam2; 1Division of Reproductive Health; Clinical Sciences Research Laboratories; University Hospital; Warwick Medical School;  Coventry, UK; 2Department of Surgery and Cancer; Imperial Centre for T ranslational and Experimental Medicine (ICTEM); Imperial College London; London, UK;  *Email: J.J.Brosens@warwick.ac.uk; http://dx.doi.org/10.4161/cc.25070 senescence is an inbuilt cellular response that  leads to irreversible cell cycle arrest.1 it plays  a critical role in both aging and tumor sup - pression.",Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Kröger N. Curr Opin Oncol 2011; 23:203-8;  PMiD:21157340; http://dx.doi.org/10.1097/ CCO.0b013e328342c6c8 2.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Ann Oncol 2012; 23:891-7;  PMiD:21821547; http://dx.doi.org/10.1093/annonc/ mdr3403.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Br J Cancer 2012; 106:133- 40; PMiD:22108518; http://dx.doi.org/10.1038/bjc.2011.504 4.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Nat Rev Cancer 2009; 9:153- 66; PMiD:19238148; http://dx.doi.org/10.1038/ nrc2602 5.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Nat Rev Cancer 2007; 7:495-507; PMiD:17568790; http://dx.doi.org/10.1038/nrc2169 7.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cell Cycle 2013; 12:1251-66; PMiD:23518499; http://dx.doi.org/10.4161/ cc.24313 Figure 1.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
"Cell Cycle 2013; 12:1416–23;   PMID:23574720; http://dx.doi.org/10.4161/cc.24527 Alexandre Blais; Ottawa Institute of Systems Biology; Department of Biochemistry, Microbiology and Immunology; Faculty of Medicine; University of Ottawa;   Ottawa, ON Canada; Email: alexandre.blais@uottawa.ca; http://dx.doi.org/10.4161/cc.25071 Cell proliferation and differentiation are two  intimately connected fundamental processes.",Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Nat Rev Cancer 2010; 10:51-7;  PMiD:20029423; http://dx.doi.org/10.1038/nrc2772 2.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cell Cycle 2013; 12:1433-49;  PMiD:23574718; http://dx.doi.org/10.4161/cc.24550 3.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
J Biol Chem 2000; 275:21960- 8; PMiD:10791951; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
e ndocr Relat Cancer 2012;  19:R255-79; PMiD:23045324; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Hum Reprod Update 2009; 15:119-38; PMiD:18936037; http://dx.doi.org/10.1093/humupd/dmn044 6.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Oncogene 2008; 27:9-19;  PMiD:17599040; http://dx.doi.org/10.1038/ sj.onc.1210626 7.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Mol endocrinol 2006; 20:35-44; PMiD:16123151; http://dx.doi.org/10.1210/me.2005-0275 8.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
J Clin invest 2010; 120:803-15;  PMiD:20124728; http://dx.doi.org/10.1172/ JCi40051,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cell Cycle 2013; 12:1416- 23; PMiD:23574720; http://dx.doi.org/10.4161/ cc.24527 2.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Curr Opin Cell Biol 2007; 19:658-62; PMiD:18023996; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Nat Rev Mol Cell Biol 2013; 14:297- 306; PMiD:23594950; http://dx.doi.org/10.1038/nrm3567 4.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
"Oncogene 2001; 20:6152-63;  PMiD:11593423; http://dx.doi.org/10.1038/ sj.onc.1204793 5. isaac Ce , et al.",OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Mol Cell Biol 2006; 26:3659-71;  PMiD:16612004; http://dx.doi.org/10.1128/ MCB.26.9.3659-3671.2006 6.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
J Neurosci 2012; 32:14809-14; PMiD:23077065; http://dx.doi.org/10.1523/ JNeUROsCi.1912-12.2012 7.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Mol Cell 2011; 43:663-72; PMiD:21855804; http://dx.doi.org/10.1016/j.mol- cel.2011.06.029 8.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cell 2003; 113:703-16; PMiD:12809602; http://dx.doi.org/10.1016/s0092- 8674(03)00401-XFigure 1.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
"Cell Cycle 2013; 12:1433–49;   PMID:23574718; http://dx.doi.org/10.4161/cc.24550 Steffi Oesterreich,1,2,* Robert Edwards1,3 and Anda Vlad 1,3; 1Womens Cancer Research Center; University of Pittsburgh Cancer Institute and Magee-Womens Research  Institute; University of Pittsburgh; Pittsburgh, PA USA; 2Department of Pharmacology and Chemical Biology; University of Pittsburgh; Pittsburgh, PA USA; 3De- partment of Obstetrics, Gynecology and Reproductive Sciences; University of Pittsburgh School of Medicine; Pittsburgh, PA USA; *Email: oesterreichs@upmc.edu;  http://dx.doi.org/10.4161/cc.25072 increasing epidemiological evidence suggests  a role of steroid hormones in the develop - ment and progression of certain molecular  subtypes of ovarian cancer.",Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
endocr Relat Cancer 2012;  19:R255-79; PMiD:23045324; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cell Cycle 2013; 12:1433-49; PMiD:23574718; http://dx.doi.org/10.4161/ cc.24550 3.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
i nt J Gynecol Cancer 2007; 17:325-38;  PMiD:17362310; http://dx.doi.org/10.1111/j.1525- 1438.2006.00749.x 4.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Nat Rev Cancer 2009; 9:81-94; PMiD:19132009; http://dx.doi.org/10.1038/nrc2560 6.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cancer J 2011; 17:351-8; PMiD:21952286; http://dx.doi.org/10.1097/ PPO.0b013e3182325d4dFigure 1. s chematic representation of PR action as target in different subtypes of ovarian cancer.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
"Cell Cycle 2013; 12:1424–32;   PMID:23574719; http://dx.doi.org/10.4161/cc.24528 Zhiyuan Shen,* Steven C. Huhn and Bruce G. Haffty; The Cancer Institute of New Jersey; Department of Radiation Oncology; Robert Wood Johnson Medical  School; New Brunswick, NJ USA; *Email: ashenzh@umdnj.edu; http://dx.doi.org/10.4161/cc.25073 when a mammalian cell exits G1 and enters  the s -phase, it becomes committed to the  completion of the entire cell cycle until the  next G1 phase, where a quiescent status can  be reached.",Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
"5 References 1. shen Z. J Mol Cell Biol 2011; 3:1-3; PMiD:21278445;  http://dx.doi.org/10.1093/jmcb/mjq057 2. y e C, et al.",OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cell Cycle 2013; 12:1424-32;  PMiD:23574719; http://dx.doi.org/10.4161/ cc.24528 3.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cell Cycle 2011; 10:1468-76;  PMiD:21455017; http://dx.doi.org/10.4161/ cc.10.9.15510 4.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Curr Biol 2006; 16:1194-200; PMiD:16782009; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Cancer Res Treat 2011; 43:75-82; PMiD:21811422; http://dx.doi.org/10.4143/ crt.2011.43.2.75 7.,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
Lancet Oncol 2013; 14:e28-37; PMiD:23276369; http://dx.doi.org/10.1016/s1470- 2045(12)70510-7,Non-OADS,/arxiv_data1/oa_pdf/95/91/cc-12-1662.PMC3713123.pdf
"www.landesbioscience.com Cell Cycle 1679Cell Cycle 12:11, 1679–1687; June 1, 2013; © 2013 Landes Bioscience RepoR t RepoR t *Correspondence to: Giannino Del Sal; Email: delsal@lncib.it Submitted: 03/15/13; Accepted: 04/20/13http://dx.doi.org/10.4161/cc.24757Introduction The relevance of the DNA damage response (DDR) pathway  in providing a cell-intrinsic barrier against cancer progression has clearly emerged in the last years.",Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nature 2006; 444:638- 42; PMID:17136094; http://dx.doi.org/10.1038/ nature05327 2.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Oncogene 2006; 25:5906-11; PMID:16998505;  http://dx.doi.org/10.1038/sj.onc.1209873 4.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat Rev Cancer 2012; 12:68-78; PMID:22193408;  http://dx.doi.org/10.1038/nrc31815.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Breast Cancer Res 2003; 5:45-52; PMID:12559046; http://dx.doi.org/10.1186/bcr557 6.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Oncogene 2008; 27:2501- 6; PMID:17982490; http://dx.doi.org/10.1038/ sj.onc.1210885 7.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
J Natl Cancer Inst 2000; 92:564- 9; PMID:10749912; http://dx.doi.org/10.1093/ jnci/92.7.5648.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Mol Cell Biol 2003; 23:2225- 38; PMID:12640109; http://dx.doi.org/10.1128/ MCB.23.7.2225-2238.2003 9.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
PLoS ONE 2011; 6:e25454; PMID:21980462;  http://dx.doi.org/10.1371/journal.pone.0025454 10.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Proc Natl Acad Sci USA 2010; 107:1506- 11; PMID:20080624; http://dx.doi.org/10.1073/ pnas.0907763107,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Genes Cancer 2010; 1:210-24; PMID:21779448;  http://dx.doi.org/10.1177/1947601910366860 40.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Mol Cell Biol 2009; 29:2841- 51; PMID:19273599; http://dx.doi.org/10.1128/ MCB.01971-08 41.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Cell 2011; 147:382- 95; PMID:22000016; http://dx.doi.org/10.1016/j.cell.2011.09.032 42.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat Biotechnol 2011; 29:373-4; PMID:21552220;  http://dx.doi.org/10.1038/nbt0511-373 43.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Cancer Res  2010; 70:1793-803; PMID:20145152; http://dx.doi.org/10.1158/0008-5472.CAN-09-3112 44.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Clin Cancer Res 2012; 18:2344-51;  PMID:22371451; http://dx.doi.org/10.1158/1078- 0432.CCR-11-2425 45.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
J Clin Oncol  2010; 28:1145-53; PMID:20100965; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
PLoS ONE  2011; 6:e23271; PMID:21876743; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat Rev Cancer 2011; 11:849-64; PMID:22113163; http://dx.doi.org/10.1038/nrc3166 49.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat  Rev Drug Discov 2010; 9:775-89; PMID:20885409; http://dx.doi.org/10.1038/nrd317926.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat Rev  Mol Cell Biol 2010; 11:220-8; PMID:20177397;  http://dx.doi.org/10.1038/nrm2858 29.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Science  1999; 286:1162-6; PMID:10550055; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
J Clin Oncol 2008; 26:1275-81; PMID:18250347; http://dx.doi.org/10.1200/ JCO.2007.14.4147 32.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
J Clin Invest 2013; 123:150-63; PMID:23241956;  http://dx.doi.org/10.1172/JCI64946 35.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Mol Cell  2010; 39:493-506; PMID:20797623; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Oncogene 2010; 29:1787- 97; PMID:20023698; http://dx.doi.org/10.1038/onc.2009.468 37.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Mol Cell Biol 2007; 27:1859-67; PMID:17194750; http://dx.doi.org/10.1128/ MCB.01395-06 38.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Cell Biosci 2011; 1:4; PMID:21711587;  http://dx.doi.org/10.1186/2045-3701-1-411.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
EMBO Mol Med 2011; 3:279- 90; PMID:21472990; http://dx.doi.org/10.1002/ emmm.201100136 12.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Mol Cell 2011; 41:210-20;  PMID:21195000; http://dx.doi.org/10.1016/j.mol- cel.2010.12.005 13.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat Rev Cancer 2004;  4:814-9; PMID:15510162; http://dx.doi.org/10.1038/ nrc1457 14.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Carcinogenesis 2012; 33:2007-17;  PMID:22822097; http://dx.doi.org/10.1093/carcin/bgs232 15.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat Rev Cancer 2012; 12:587-98; PMID:22918414; http://dx.doi.org/10.1038/nrc3342 16.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nature 2012; 481:287-94;  PMID:22258607; http://dx.doi.org/10.1038/ nature10760 18.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat Rev Genet 2009; 10:704- 14; PMID:19763153; http://dx.doi.org/10.1038/ nrg2634 19.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Cell 2009; 136:215-33; PMID:19167326;  http://dx.doi.org/10.1016/j.cell.2009.01.002 20.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Nat  Rev Mol Cell Biol 2009; 10:141-8; PMID:19145236;  http://dx.doi.org/10.1038/nrm2619 21.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Cell 2007; 131:1109-23;  PMID:18083101; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
EMBO Mol Med 2012; 4:1214-29; PMID:23125021; http://dx.doi.org/10.1002/ emmm.201201483 23.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Cell 2010; 141:1195- 207; PMID:20603000; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
Proc Natl Acad Sci USA 2006; 103:2257- 61; PMID:16461460; http://dx.doi.org/10.1073/ pnas.0510565103 25.,OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
PLoS ONE 2011; 6:e20980;  PMID:21738599; http://dx.doi.org/10.1371/journal.pone.0020980,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/cc-12-1679.PMC3713126.pdf
"Cell Cycle 12:10, 1704–1712; May 15, 2013; © 2013 Landes Bioscience RepoR t 1704 Cell Cycle Volume 12 Issue 11*Correspondence to: Ernst Malle and Frank Madeo; Email: ernst.malle@medunigraz.at and frank.madeo@uni-graz.at Submitted: 02/25/13; Revised: 04/24/13; Accepted: 04/24/13http://dx.doi.org/10.4161/cc.24801Introduction During inflammation, the activation of phagocytes both in vivo  and in vitro can result in the generation and release of superox - ide anion radical and hydrogen peroxide (respiratory burst) as well as in the secretion of myeloperoxidase.",Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J  Leukoc Biol 2005; 77:598-625; PMID:15689384;  http://dx.doi.org/10.1189/jlb.1204697 2.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Free Radic Biol Med  1991; 10:101-9; PMID:1849864; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Methods Enzymol 1986; 132:585-93;  PMID:3547027; http://dx.doi.org/10.1016/S0076- 6879(86)32043-3 4.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Biochim Biophys Acta 2006; 1761:392-415; PMID:16698314; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Kidney Int 2003; 64:1956-67; PMID:14633118; http://dx.doi.org/10.1046/j.1523- 1755.2003.00336.x 6.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Curr Med Chem 2006; 13:3271-90; PMID:17168851;  http://dx.doi.org/10.2174/092986706778773095 7.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
IUBMB Life 2000; 50:259-66; PMID:11327319;  http://dx.doi.org/10.1080/152165400510809589.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Antioxid Redox  Signal 2002; 4:5-15; PMID:11970838; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Arterioscler Thromb Vasc Biol 2004; 24:1309- 14; PMID:15142860; http://dx.doi.org/10.1161/01.ATV.0000131784.50633.4f 11.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mutagenesis  2004; 19:157-62; PMID:14981163; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Arch Biochem Biophys  2004; 423:170-81; PMID:14871479; http://dx.doi.org/10.1016/j.abb.2003.12.012 13.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Yeast 2011; 28:595-609; PMID:21761455; http://dx.doi.org/10.1002/yea.1889 14.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Apoptosis  2010; 15:257-68; PMID:20238475; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Cell 2002; 9:911-7;  PMID:11983181; http://dx.doi.org/10.1016/S1097- 2765(02)00501-4 18.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J Cell Sci 2004; 117:115- 26; PMID:14657274; http://dx.doi.org/10.1242/ jcs.00848 19.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Cycle  2007; 6:1072-6; PMID:17471024; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Cell  2007; 25:233-46; PMID:17244531; http://dx.doi.org/10.1016/j.molcel.2006.12.021 21.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
EMBO J  2011; 30:2779-92; PMID:21673659; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Death  Dis 2011; 2:e161; PMID:21593793; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Biol Cell 2002; 13:2598-606; PMID:12181332;  http://dx.doi.org/10.1091/mbc.E01-12-0161 24.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell 2005; 120:25- 36; PMID:15652479; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Biochem J 1999; 340:539-48;  PMID:10333500; http://dx.doi.org/10.1042/0264- 6021:3400539 54.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Biochem Biophys Res Commun  2012; 425:157-61; PMID:22819842; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Biol Pharm Bull 2007; 30:324-30; PMID:17268074;  http://dx.doi.org/10.1248/bpb.30.324 56.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Toxicology  2010; 270:112-20; PMID:20152877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Biochem Biophys Res  Commun 2011; 410:895-900; PMID:21708126;  http://dx.doi.org/10.1016/j.bbrc.2011.06.089 58.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Eur J Biochem  2000; 267:4495-503; PMID:10880973; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Cell 2012; 46:552-4; PMID:22681882;  http://dx.doi.org/10.1016/j.molcel.2012.05.032 60.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Cell 2012; 46:561-72; PMID:22633370;  http://dx.doi.org/10.1016/j.molcel.2012.04.027 61.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
PLoS Biol 2012; 10:e1001281;  PMID:22412352; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J Biol Chem 2008; 283:7554-60; PMID:18192273; http://dx.doi.org/10.1074/jbc.M708477200 63.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Cycle 2011; 10:3973- 8; PMID:22071627; http://dx.doi.org/10.4161/ cc.10.22.1821240.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Arterioscler Thromb Vasc  Biol 1995; 15:982-9; PMID:7541296; http://dx.doi.org/10.1161/01.ATV.15.7.982 41.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J Biol Chem 2008; 283:19151-63; PMID:18474590; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J Cell Biol 2004; 166:969-74;  PMID:15381687; http://dx.doi.org/10.1083/ jcb.200404138 43.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Biol Cell 2006; 17:1802-11;  PMID:16436509; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Cell Biochem 1982;  49:143-9; PMID:6298593; http://dx.doi.org/10.1007/ BF00231175 45.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Biochem  J 1999; 344:443-9; PMID:10567227; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Signal 2007; 19:705-14;  PMID:17107772; http://dx.doi.org/10.1016/j.cell- sig.2006.08.019 50.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Signal 2007; 19:219-28; PMID:16959471;  http://dx.doi.org/10.1016/j.cellsig.2006.06.013 51.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J Biol Chem 2002; 277:20518- 26; PMID:11925431; http://dx.doi.org/10.1074/jbc.M200212200 52.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Biochim Biophys Acta 2012; 1823:420-9;  PMID:22008466; http://dx.doi.org/10.1016/j.bbam - cr.2011.09.01925.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Cell 2006; 24:211-20; PMID:17052455;  http://dx.doi.org/10.1016/j.molcel.2006.09.008 26.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Cycle 2010; 9:4046; http://dx.doi.org/10.4161/ cc.9.20.13523 27.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Cycle  2010; 9:3991-6; PMID:20935467; http://dx.doi.org/10.4161/cc.9.19.13210 28.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Cycle 2010; 9:2836-42; PMID:20647757; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Cycle 2012; 11:3472-80; PMID:22918244;  http://dx.doi.org/10.4161/cc.21789 30.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Rep 2012; 2:257- 69; PMID:22854025; http://dx.doi.org/10.1016/j.cel- rep.2012.06.017 31.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Science 2001; 292:288-90;  PMID:11292860; http://dx.doi.org/10.1126/sci- ence.1059497 32.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Mol Microbiol 2001; 39:1166-73; PMID:11251834;  http://dx.doi.org/10.1111/j.1365-2958.2001.02317.x 33.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J Cell Biol 2004; 164:501- 7; PMID:14970189; http://dx.doi.org/10.1083/ jcb.200310014 34.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Nat  Cell Biol 2009; 11:1305-14; PMID:19801973; http://dx.doi.org/10.1038/ncb1975 35.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
Cell Cycle 2013; 12:346-52; PMID:23255134; http://dx.doi.org/10.4161/cc.23199 38.,Non-OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J Inorg Biochem 2010; 104:759-64; PMID:20400181; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
J Lipid  Res 2008; 49:782-9; PMID:18202433; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/44/06/cc-12-1704.PMC3713129.pdf
"The Carbon Farming Initiative Handbook Version 1.0 (Australian Department of Climate Change and Energy Efficiency, 2012), accessed 10 June 2013 at http://www.climatechange.gov.au/sites/climatechange/files/files/reducing-carbon/CFI- Handbook-20120403-PDF.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c1/22/srep02179.PMC3713190.pdf
"(Ecosystem Marketplace and New Carbon Finance, 2009), accessed 28 December 2012 at http://ecosystemmarketplace.com/documents/cms_documents/StateOfTheVoluntaryCarbonMarkets_2009.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c1/22/srep02179.PMC3713190.pdf
"Managing Your Farm Business in a Variable Climate, Riding the Diary Roller Coaster Forum (Australian Department of Agriculture, Forestry & Fisheries and Dairy Australia, 2011), accessed 19 November 2012 at http://frds.dairyaustralia.com.au/wp-content/uploads/2012/01/WP956-John-Mulvaney-riding-the-rollercoaster.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c1/22/srep02179.PMC3713190.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Lam, S.K., Chen, D., Mosier, A.R.",Non-OADS,/arxiv_data1/oa_pdf/c1/22/srep02179.PMC3713190.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2179 | DOI: 10.1038/srep02179 6",Non-OADS,/arxiv_data1/oa_pdf/c1/22/srep02179.PMC3713190.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/93/inj-17-43.PMC3713240.pdf
Int Neurourol J 2013;17:55-8.Editorial  http://dx.doi.org/10.5213/inj.2013.17.2.43 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/61/93/inj-17-43.PMC3713240.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/c2/inj-17-44.PMC3713241.pdf
The rationale for the use of a balloon is to prevent the  intrusion or blockage of the fecal materials or vaginal wall into Review Article http://dx.doi.org/10.5213/inj.2013.17.2.44 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/df/c2/inj-17-44.PMC3713241.pdf
www.einj.org     45 Lee and Yoon  •  IAP in Awake Rat Cystometry http://dx.doi.org/10.5213/inj.2013.17.2.44INJ the opening of the catheter tip and to make it possible to trans - mit the pressure to the transducer continuously by maintaining  a small volume of fluid at the tip of the catheter.,Non-OADS,/arxiv_data1/oa_pdf/df/c2/inj-17-44.PMC3713241.pdf
46    www.einj.orgLee and Yoon  •  IAP in Awake Rat Cystometry http://dx.doi.org/10.5213/inj.2013.17.2.44INJ proved using the IAP methodology that all conscious rats of  both sexes use this physiologic abdominal straining (Fig.,Non-OADS,/arxiv_data1/oa_pdf/df/c2/inj-17-44.PMC3713241.pdf
www.einj.org     47 Lee and Yoon  •  IAP in Awake Rat Cystometry http://dx.doi.org/10.5213/inj.2013.17.2.44INJ not an appropriate control in studies of detrusor overactivity  because they show detrusor overactivity of similar frequency  and amplitude as found in SHRs [7].,Non-OADS,/arxiv_data1/oa_pdf/df/c2/inj-17-44.PMC3713241.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
"Therefore, in addition to stress frequency, dif - ferences in stress perception and coping strategies should be  considered as factors causing or deteriorating stress symptoms  in patients with CP/CPPS.Review Article http://dx.doi.org/10.5213/inj.2013.17.2.48 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
"www.einj.org     49 Kwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ  Physical disease and psychiatric disorders coexist in CP/CPPS  [14], with as many as 78% of patients with CP/CPPS reporting  depression [15] and 60% meeting the criteria for a major de - pressive disorder [16].",Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
50    www.einj.orgKwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ Table 1.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
"www.einj.org     51 Kwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ tients with severe congestive heart failure, myocardial infarction,  unstable angina, hemodialysis-dependent end-stage renal dis - ease, or active Crohn’s disease [24,41].",Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
52    www.einj.orgKwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ Psychosocial Domain of UPOINT The following psychosocial questionnaires may be useful if it is  believed that psychosocial parameters may be important on the  basis of probing questions asked during the history taking.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
www.einj.org     53 Kwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ factors with CP/CPPS remain unclear.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
54    www.einj.orgKwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ cluding depression and catastrophizing and can serve as an in - dicator of allostatic load.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
www.einj.org     55 Kwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ astrophizing over time.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
56    www.einj.orgKwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ 17.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
http://dx.doi.org/10.1007/s00345- 013-1067-6.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
"www.einj.org     57 Kwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ houn EA, Pontari MA, et al.",OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
Available from: http://www.mappnetwork.org/ 47.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
58    www.einj.orgKwon and Chang  •  Catastrophizing and Depression in CP/CPPS http://dx.doi.org/10.5213/inj.2013.17.2.48INJ and pain processing.,Non-OADS,/arxiv_data1/oa_pdf/62/3f/inj-17-48.PMC3713242.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
LUTS can reduce quality of life by imped - ing normal activities and causing complications such as acute Original Article http://dx.doi.org/10.5213/inj.2013.17.2.59 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
•  Transurethral Procedures for Benign Prostatic Enlargement http://dx.doi.org/10.5213/inj.2013.17.2.59INJ urinary retention or urinary tract infection.,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
•  Transurethral Procedures for Benign Prostatic Enlargement http://dx.doi.org/10.5213/inj.2013.17.2.59INJ Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
a)Supplementary material for authors can be found via http://www.einj.org/src/sm/inj-17-59-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
•  Transurethral Procedures for Benign Prostatic Enlargement http://dx.doi.org/10.5213/inj.2013.17.2.59INJ Table 2.,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
a)Supplementary material for authors can be found via http://www.einj.org/src/sm/inj-17-59-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
•  Transurethral Procedures for Benign Prostatic Enlargement http://dx.doi.org/10.5213/inj.2013.17.2.59INJ tistically significantly lower complication rate than TURP (P<   0.0001).,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
"•  Transurethral Procedures for Benign Prostatic Enlargement http://dx.doi.org/10.5213/inj.2013.17.2.59INJ cal treatment, and watchful waiting [10].",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
"•  Transurethral Procedures for Benign Prostatic Enlargement http://dx.doi.org/10.5213/inj.2013.17.2.59INJ developed, such as open prostatectomy, HoLEP , KTP , TURP , bi - polar TURP , and bipolar TUVP .",Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
•  Transurethral Procedures for Benign Prostatic Enlargement http://dx.doi.org/10.5213/inj.2013.17.2.59INJ formed our analysis of the articles that showed the highest level  of evidence.,OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
SUPPLEMENTARY MATERIALS Supplementary material can be found via http://www.einj.org/ src/sm/inj-17-59-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/b6/inj-17-59.PMC3713243.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/9c/inj-17-67.PMC3713244.pdf
Diabetic wom -Original Article http://dx.doi.org/10.5213/inj.2013.17.2.67 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/5c/9c/inj-17-67.PMC3713244.pdf
"•  Bladder Wall Thickness and Diabetes Mellitus http://dx.doi.org/10.5213/inj.2013.17.2.67INJ en with OAB may also have an increased risk for bladder wall  thickness, which may have prognostic potential.",Non-OADS,/arxiv_data1/oa_pdf/5c/9c/inj-17-67.PMC3713244.pdf
"•  Bladder Wall Thickness and Diabetes Mellitus http://dx.doi.org/10.5213/inj.2013.17.2.67INJ cholesterol, and triglycerides were measured by automated en - zymatic photometry (Architect ci16200, Abbott Laboratories,  Abbott Park, IL, USA).",OADS,/arxiv_data1/oa_pdf/5c/9c/inj-17-67.PMC3713244.pdf
•  Bladder Wall Thickness and Diabetes Mellitus http://dx.doi.org/10.5213/inj.2013.17.2.67INJ did the controls.,Non-OADS,/arxiv_data1/oa_pdf/5c/9c/inj-17-67.PMC3713244.pdf
•  Bladder Wall Thickness and Diabetes Mellitus http://dx.doi.org/10.5213/inj.2013.17.2.67INJ suggested to play a role in the hypertrophy of bladder smooth  muscle cells [21].,Non-OADS,/arxiv_data1/oa_pdf/5c/9c/inj-17-67.PMC3713244.pdf
•  Bladder Wall Thickness and Diabetes Mellitus http://dx.doi.org/10.5213/inj.2013.17.2.67INJ reactions and ultrastructural damage in the chronically ischemic  bladder.,Non-OADS,/arxiv_data1/oa_pdf/5c/9c/inj-17-67.PMC3713244.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/6c/inj-17-73.PMC3713245.pdf
Original Article http://dx.doi.org/10.5213/inj.2013.17.2.73 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/8a/6c/inj-17-73.PMC3713245.pdf
"•  Free PSA Provides Precise Data on Prostate Volume http://dx.doi.org/10.5213/inj.2013.17.2.73INJ  In general, the proportion of free or complexed PSA can be  used to improve the cancer specificity of the PSA assay.",Non-OADS,/arxiv_data1/oa_pdf/8a/6c/inj-17-73.PMC3713245.pdf
•  Free PSA Provides Precise Data on Prostate Volume http://dx.doi.org/10.5213/inj.2013.17.2.73INJ cost-effective and routine evaluation of patients with BPH.,Non-OADS,/arxiv_data1/oa_pdf/8a/6c/inj-17-73.PMC3713245.pdf
"•  Free PSA Provides Precise Data on Prostate Volume http://dx.doi.org/10.5213/inj.2013.17.2.73INJ showed that AUC of fPSA are 0.781, 0.718, and 0.700.",OADS,/arxiv_data1/oa_pdf/8a/6c/inj-17-73.PMC3713245.pdf
•  Free PSA Provides Precise Data on Prostate Volume http://dx.doi.org/10.5213/inj.2013.17.2.73INJ a predictor of prostatic enlargement in men without prostate cancer.,Non-OADS,/arxiv_data1/oa_pdf/8a/6c/inj-17-73.PMC3713245.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/c7/inj-17-78.PMC3713246.pdf
As each of these primary symptoms has an influence on the Original Article http://dx.doi.org/10.5213/inj.2013.17.2.78 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/00/c7/inj-17-78.PMC3713246.pdf
"•  Overactive Bladder Symptoms in Patients With Bladder Pain Syndrome http://dx.doi.org/10.5213/inj.2013.17.2.78INJ perception of urgency and has slightly different characteristics,  doctors might distinguish between the disorders if they analyze  symptoms such as urgency through close observation.",Non-OADS,/arxiv_data1/oa_pdf/00/c7/inj-17-78.PMC3713246.pdf
•  Overactive Bladder Symptoms in Patients With Bladder Pain Syndrome http://dx.doi.org/10.5213/inj.2013.17.2.78INJ ment.,Non-OADS,/arxiv_data1/oa_pdf/00/c7/inj-17-78.PMC3713246.pdf
"•  Overactive Bladder Symptoms in Patients With Bladder Pain Syndrome http://dx.doi.org/10.5213/inj.2013.17.2.78INJ pain (persistent and/or sudden), and OAB mainly involves sud - den urgency because of incontinence or the fear of impending  incontinence (sudden).",Non-OADS,/arxiv_data1/oa_pdf/00/c7/inj-17-78.PMC3713246.pdf
"•  Overactive Bladder Symptoms in Patients With Bladder Pain Syndrome http://dx.doi.org/10.5213/inj.2013.17.2.78INJ  In 6 patients with BPS/IC and significant remaining OAB  symptoms after low-dose triple therapy, we used antimuscarinic  agents and identified effects and side effects.",Non-OADS,/arxiv_data1/oa_pdf/00/c7/inj-17-78.PMC3713246.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/8e/inj-17-83.PMC3713247.pdf
If we can predict unfavorable QoL  outcomes before HoLEP and select patients accordingly during Original Article http://dx.doi.org/10.5213/inj.2013.17.2.83 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/fb/8e/inj-17-83.PMC3713247.pdf
"•  Preoperative Factors Affecting QoL After HoLEP During the Learning Curve http://dx.doi.org/10.5213/inj.2013.17.2.83INJ the learning curve, we can minimize these unfavorable outcomes  and increase practitioner confidence in HoLEP .",Non-OADS,/arxiv_data1/oa_pdf/fb/8e/inj-17-83.PMC3713247.pdf
•  Preoperative Factors Affecting QoL After HoLEP During the Learning Curve http://dx.doi.org/10.5213/inj.2013.17.2.83INJ presented in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fb/8e/inj-17-83.PMC3713247.pdf
"•  Preoperative Factors Affecting QoL After HoLEP During the Learning Curve http://dx.doi.org/10.5213/inj.2013.17.2.83INJ voiding symptom subscore (P<0.001), storage symptom sub - score (P=0.001), and QoL score (P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/fb/8e/inj-17-83.PMC3713247.pdf
•  Preoperative Factors Affecting QoL After HoLEP During the Learning Curve http://dx.doi.org/10.5213/inj.2013.17.2.83INJ such as BOO and DUA affect the surgical outcome.,Non-OADS,/arxiv_data1/oa_pdf/fb/8e/inj-17-83.PMC3713247.pdf
•  Preoperative Factors Affecting QoL After HoLEP During the Learning Curve http://dx.doi.org/10.5213/inj.2013.17.2.83INJ that in the low QoL group.,Non-OADS,/arxiv_data1/oa_pdf/fb/8e/inj-17-83.PMC3713247.pdf
•  Preoperative Factors Affecting QoL After HoLEP During the Learning Curve http://dx.doi.org/10.5213/inj.2013.17.2.83INJ Prospective evaluation of the learning curve for holmium laser enu - cleation of the prostate.,Non-OADS,/arxiv_data1/oa_pdf/fb/8e/inj-17-83.PMC3713247.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/a6/inj-17-90.PMC3713248.pdf
"In the physical examination, right costover -Case Report http://dx.doi.org/10.5213/inj.2013.17.2.90 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/59/a6/inj-17-90.PMC3713248.pdf
•  Ureter Migration of Clip Following Partial Nephrectomy http://dx.doi.org/10.5213/inj.2013.17.2.90INJ tebral angle tenderness was observed.,Non-OADS,/arxiv_data1/oa_pdf/59/a6/inj-17-90.PMC3713248.pdf
•  Ureter Migration of Clip Following Partial Nephrectomy http://dx.doi.org/10.5213/inj.2013.17.2.90INJ tality rate.,Non-OADS,/arxiv_data1/oa_pdf/59/a6/inj-17-90.PMC3713248.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/8f/inj-17-93.PMC3713249.pdf
Two Case Report http://dx.doi.org/10.5213/inj.2013.17.2.93 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/cc/8f/inj-17-93.PMC3713249.pdf
•  Ureteral Penetration by Bone Drilling http://dx.doi.org/10.5213/inj.2013.17.2.93INJ penetrating holes leaking urine at the same level of the right  distal ureter were intraoperatively identified.,Non-OADS,/arxiv_data1/oa_pdf/cc/8f/inj-17-93.PMC3713249.pdf
"•  Ureteral Penetration by Bone Drilling http://dx.doi.org/10.5213/inj.2013.17.2.93INJ Therefore, we suspect the main cause of the ureteric penetration  could be a machinery drill used on the pelvic bone because such  an instrument can generate instantaneous moving power.",Non-OADS,/arxiv_data1/oa_pdf/cc/8f/inj-17-93.PMC3713249.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/70/inj-17-96.PMC3713250.pdf
"Jang Hwan Kim Department of Urology, Y onsei University College of Medicine E-mail: jkim@yuhs.acBook Review http://dx.doi.org/10.5213/inj.2013.17.2.96 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/ec/70/inj-17-96.PMC3713250.pdf
The homology searches were performed using theNational Center for Biotechnology Information microbi- al and nucleotide Basic Local Alignment Search Tool (BLAST) network service ( http://blast.ncbi.nlm.nih.gov/ Blast.cgi )( Z h a n ge ta l .,OADS,/arxiv_data1/oa_pdf/41/ab/11356_2012_Article_1426.PMC3713259.pdf
"Reverse transcription was performed on 1μg total RNA with the RT 2miRNA First Strand Kit (Qiagen) and used for Human Cancer microRNA PCR Arrays (MAH-102 from SABiosciences, miRNA list available at http://www.sabiosciences.com/mirna_pcr_product/HTML/MAH-102A.html ).",OADS,/arxiv_data1/oa_pdf/d8/2d/13277_2013_Article_748.PMC3713270.pdf
Database http://extranet.edqm.eu/publications/ recherches_sw.shtmlChemometric evaluation of the column classification system 6541,OADS,/arxiv_data1/oa_pdf/c2/9b/216_2013_Article_7097.PMC3713273.pdf
"Original Article Corresponding author:  Shogo Hayashi  Medical Education Center, Aichi Medical University School of  Medicine, Nagakute, Aichi 480-1195, Japan Tel: +81-561-62-3311, Fax: +81-561-63-1037, E-mail: sho5-884@umin.ac.jp This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.101 pISSN 2093-3665   eISSN 2093-3673 Heterogeneity of glandular cells in the human  salivary glands: an immunohistochemical  study using elderly adult and fetal specimens  Yukio Katori1, Shogo Hayashi2, Y oshitaka Takanashi3, Ji Hyun Kim4, Shinichi Abe5, Gen Murakami6,  Tetsuaki Kawase3   1Division of Otorhinolaryngology, Sendai Municipal Hospital, Sendai, 2Medical Education Center, Aichi Medical University School of Medicine, Nagakute,  3Department of Otolaryngology-Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan, 4Department of Anatomy,  Chonbuk National University College of Medicine, Jeonju, Korea, 5Department of Anatomy, Tokyo Dental College, Chiba, 6Division of Internal Medicine,  Iwamizawa Kojin-kai Hospital, Iwamizawa, Japan   Abstract:  Using immunohistochemical staining for alpha-smooth muscle actin (α-SMA), glial fibrillary acidic protein (GFAP),  S100 protein (S100), p63, cytokeratin 14 (CK14), and cytokeratin 19 (CK19), we studied acinar and myoepithelial cells of major  and minor salivary glands obtained from 14 donated cadavers (78–92 years old) and 5 donated fetuses (aborted at 15–16 weeks  of gestation).",Non-OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Anat Cell Biol 2013;46: 101-112 Yukio Katori, et al 102 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.101commonly used as a marker for the neuroendocrine and  gastrointestinal tumors [15].",OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Human salivary glands http://dx.doi.org/10.5115/acb.2013.46.2.101Anat Cell Biol 2013;46:101-112 103 www.acbjournal.orgperoxidase (HRP)-labeled antibody (1:1,000, Histofine Simple  Stain Max-PO, Nichirei, Tokyo, Japan) for 30 minutes, and  immunoreactivity was detected using an HRP-catalyzed  reaction with diaminobenzidine (Histofine Simple Stain DAB,  Nichirei) for 3–5 minutes.",Non-OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Anat Cell Biol 2013;46: 101-112 Yukio Katori, et al 104 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.101large clusters but rather appeared randomly intermingled.",OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
Human salivary glands http://dx.doi.org/10.5115/acb.2013.46.2.101Anat Cell Biol 2013;46:101-112 105 www.acbjournal.orgstrongly expressed in all myoepithelial-like cells.,Non-OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Anat Cell Biol 2013;46: 101-112 Yukio Katori, et al 106 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.101we demonstrated the possibility to distinguish the individual  glands on the basis of their immunohistochemical staining  patterns.",OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Human salivary glands http://dx.doi.org/10.5115/acb.2013.46.2.101Anat Cell Biol 2013;46:101-112 107 www.acbjournal.orgearly stage of development, pharyngeal gland cells expressed  SMA, GFAP , and/or S100 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Anat Cell Biol 2013;46: 101-112 Yukio Katori, et al 108 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.101tissues obtained from cadavers of elderly individuals have  not been studied extensively.",OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Human salivary glands http://dx.doi.org/10.5115/acb.2013.46.2.101Anat Cell Biol 2013;46:101-112 109 www.acbjournal.orgsimilar to that of the minor glands, unlike the nearby sub - man  dibular glands.",Non-OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Anat Cell Biol 2013;46: 101-112 Yukio Katori, et al 110 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.101persisting in myoepithelial cells of the adult minor glands?",Non-OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Human salivary glands http://dx.doi.org/10.5115/acb.2013.46.2.101Anat Cell Biol 2013;46:101-112 111 www.acbjournal.orgthe most basic observation in this study—the small glands  expressed nerve markers, whereas the large glands did not— should also be noted.",Non-OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Anat Cell Biol 2013;46: 101-112 Yukio Katori, et al 112 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.101Philadelphia: Lippincott-Raven; 1997. p.405-29.",OADS,/arxiv_data1/oa_pdf/5f/96/acb-46-101.PMC3713274.pdf
"Original Article Corresponding author:  Vahid Bayati  Cellular and Molecular Research Center, School of Medicine, Ahvaz  Jundishapur University of Medical Sciences, Ahvaz 61357-15794, Iran Tel: +98-9125332499, Fax: +98-6113336380, E-mail: bayati-v@ajums.ac.ir  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.113 pISSN 2093-3665   eISSN 2093-3673 Expression of surface markers and myogenic  potential of rat bone marrow- and adipose- derived stem cells: a comparative study  Vahid Bayati1,2, Mahmoud Hashemitabar1,2, Roohollah Gazor3, Reza Nejatbakhsh4, Dariush Bijannejad1,2  1Cellular and Molecular Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, 2Department of Anatomical Science,  School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, 3Department of Anatomy and Cell Biology, Gilan University of Medical  Sciences, Rasht, 4Department of Anatomical Sciences, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran Abstract:  In recent years, examination and comparison of the biological characteristics of bone marrow- and adipose-derived  mesenchymal stem cells (MSCs) from various perspectives have come into the focus of stem cell research, as these cells should  be well characterized in order to utilize them in future cellular therapies.",Non-OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
"Anat Cell Biol 2013;46: 113-121 Vahid Bayati, et al 114 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.113and lymphocytes.",OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
Comparison of mesenchymal stem cells  http://dx.doi.org/10.5115/acb.2013.46.2.113Anat Cell Biol 2013;46:113-121 115 www.acbjournal.orgmultipotentiality of the BMSCs and ASCs.,OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
"Anat Cell Biol 2013;46: 113-121 Vahid Bayati, et al 116 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.113Results  Two types of cells were observed in culture flasks 24 hours  after isolation of the BMSCs.",OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
Comparison of mesenchymal stem cells  http://dx.doi.org/10.5115/acb.2013.46.2.113Anat Cell Biol 2013;46:113-121 117 www.acbjournal.orghematopoietic cell surface marker (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
"Anat Cell Biol 2013;46: 113-121 Vahid Bayati, et al 118 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.113and inhibit inflammation, and 4) the lack of immunogenicity  and an immunomodulatory capacity [2, 3].",Non-OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
"Comparison of mesenchymal stem cells  http://dx.doi.org/10.5115/acb.2013.46.2.113Anat Cell Biol 2013;46:113-121 119 www.acbjournal.orgisolation and culture, and species-related differences [23- 25].",OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
"Anat Cell Biol 2013;46: 113-121 Vahid Bayati, et al 120 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.113hybrid myofibers [29].",OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
http://dx.doi.org/10.3727/096368912X659871.,Non-OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
http://dx.doi.org/10.1002/term.1488.,Non-OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
http://dx.doi.org/10.1002/term.1488.,Non-OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
Comparison of mesenchymal stem cells  http://dx.doi.org/10.5115/acb.2013.46.2.113Anat Cell Biol 2013;46:113-121 121 www.acbjournal.orgstatement.,OADS,/arxiv_data1/oa_pdf/d4/11/acb-46-113.PMC3713275.pdf
"Original Article Corresponding author:  Saber A. Sakr Department of Zoology, Faculty of Medicine, Menoufia University,  Shebin El-kom, Egypt  Tel: +201001812099, Fax: +22482235690, E-mail: sabsak@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.122 pISSN 2093-3665   eISSN 2093-3673 Effect of Ocimum basilicum  extract on cadmium- induced testicular histomorphometric and  immunohistochemical alterations in albino rats Saber A. Sakr1, Hanna.",Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
"Effect of O. basilicum  on Cd induced testicular alteration in albino rats http://dx.doi.org/10.5115/acb.2013.46.2.122Anat Cell Biol 2013;46:122-130 123 www.acbjournal.orgkidney, and spleen [7].",Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
"Z. Nooh 124 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.122Immunohistochemical study For immunohistochemical localization of Ki-67, Bax, and  Bcl-2, ﬁxed wax sections were stained using the avidin-biotin  peroxidase method.",Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
"Effect of O. basilicum  on Cd induced testicular alteration in albino rats http://dx.doi.org/10.5115/acb.2013.46.2.122Anat Cell Biol 2013;46:122-130 125 www.acbjournal.orgfollowing semi-quantitative scale: (-), negative; (+), equi - vocally positive; (++), weakly positive; (+++), positive; and  (++++), strongly positive [27].",Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
Z. Nooh 126 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.122ment of animals with Cd+ Ocimum  extract upregulated the  expression of Bcl-2 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
Effect of O. basilicum  on Cd induced testicular alteration in albino rats http://dx.doi.org/10.5115/acb.2013.46.2.122Anat Cell Biol 2013;46:122-130 127 www.acbjournal.orgKi-67 in control rats (Fig.,Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
"Z. Nooh 128 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.122of apoptosis by exposure to Cd has been reported by other  investigators [33, 34].",Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
Effect of O. basilicum  on Cd induced testicular alteration in albino rats http://dx.doi.org/10.5115/acb.2013.46.2.122Anat Cell Biol 2013;46:122-130 129 www.acbjournal.orgtions after an experimental administration to rats.,Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
Z. Nooh 130 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.122perspective.,Non-OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
Internet  J Altern Med 2010;8. http://dx.doi.org/10.5580/89d.46.,OADS,/arxiv_data1/oa_pdf/0f/e9/acb-46-122.PMC3713276.pdf
"ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.131 pISSN 2093-3665   eISSN 2093-3673 Characterization of nestin expression in  astrocytes in the rat hippocampal CA1 region  following transient forebrain ischemia  Jeong Min Cho, Y oo-Jin Shin, Jang-Mi Park, Jin Kim, Mun-Y ong Lee Department of Anatomy and Cell Death Disease Research Center, The Catholic University of Korea College of Medicine, Seoul, Korea   Abstract:  Recent studies have suggested that nestin facilitates cellular structural remodeling in vasculature-associated cells in  response to ischemic injury.",Non-OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Anat Cell Biol 2013;46: 131-140 Jeong Min Cho, et al 132 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.131ventricle and the subgranular zone (SGZ) of the hippocampus  [15, 16].",OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Post-ischemic nestin induction in astrocytes http://dx.doi.org/10.5115/acb.2013.46.2.131Anat Cell Biol 2013;46:131-140 133 www.acbjournal.orgCounterstaining of cell nuclei was carried out with DAPI  (4',6-diamidino-2'-phenyindole, 1:1,000, Roche, Mannheim,  Germany) for 10 min.",OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Anat Cell Biol 2013;46: 131-140 Jeong Min Cho, et al 134 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.131between nestin induction and astroglial responses in the  ischemic hippocampus, we performed double-labeling with  nestin and GFAP.",OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
Post-ischemic nestin induction in astrocytes http://dx.doi.org/10.5115/acb.2013.46.2.131Anat Cell Biol 2013;46:131-140 135 www.acbjournal.orgF).,Non-OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Anat Cell Biol 2013;46: 131-140 Jeong Min Cho, et al 136 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.131pression in astrocytes of the CA1 dendritic layers increased  progressively until 14–21 days after ischemia, when the  highest level of induction was observed (83–85% of GFAP- positive cells).",Non-OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Post-ischemic nestin induction in astrocytes http://dx.doi.org/10.5115/acb.2013.46.2.131Anat Cell Biol 2013;46:131-140 137 www.acbjournal.orgwere not immunoreactive for nestin in the hippocampal CA1  region of control and ischemic rats, corresponding to GFAP- positive, nestin-negative astrocytes (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Anat Cell Biol 2013;46: 131-140 Jeong Min Cho, et al 138 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.131receives its primary inputs from entorhinal cortical neurons  [41], which are resistant to ischemia, it seems that nestin  might be induced in reactive astrocytes only in areas that  have undergone irreversible neuronal damage.",OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
Post-ischemic nestin induction in astrocytes http://dx.doi.org/10.5115/acb.2013.46.2.131Anat Cell Biol 2013;46:131-140 139 www.acbjournal.org8.,Non-OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Anat Cell Biol 2013;46: 131-140 Jeong Min Cho, et al 140 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.131Academic Press; 2004. p.635-704.",OADS,/arxiv_data1/oa_pdf/40/0f/acb-46-131.PMC3713277.pdf
"Original Article Corresponding author:  Shinichi Abe Department of Anatomy, Tokyo Dental College, 1-2-2 Masago, Mihama- ku, Chiba 261-8502, Japan Tel: +81-43-270-3757, Fax: +81-43-277-4010, E-mail: abesh@tdc.ac.jp This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.141 pISSN 2093-3665   eISSN 2093-3673 Fetal anatomy of the upper pharyngeal  muscles with special reference to the nerve  supply: is it an enteric plexus or simply an  intramuscular nerve?,Non-OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
"Anat Cell Biol 2013;46: 141-148 Shinichi Abe, et al 142 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.141nerves supplying the CPS and CPM in human fetuses with  a crown-rump length (CRL) of 20–89 mm.",Non-OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
Nerve supply to the upper pharyngeal muscles http://dx.doi.org/10.5115/acb.2013.46.2.141Anat Cell Biol 2013;46:141-148 143 www.acbjournal.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
"Anat Cell Biol 2013;46: 141-148 Shinichi Abe, et al 144 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.141lysis for S100 protein revealed thin nerves not only in the  pharyngeal walls, but also in the surrounding structures, such  as the palate, tongue, larynx, middle ear, jugular foramen,  and prevertebral muscles.",OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
Nerve supply to the upper pharyngeal muscles http://dx.doi.org/10.5115/acb.2013.46.2.141Anat Cell Biol 2013;46:141-148 145 www.acbjournal.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
"Anat Cell Biol 2013;46: 141-148 Shinichi Abe, et al 146 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.141nerve plexus in adults may be established by exposure of  the fetal intramuscular nerves to the posterior aspect of  the pharyngeal wall because of muscle degeneration and  subsequent rearrangement of the topographical relationship  between the muscles after birth.",Non-OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
"Nerve supply to the upper pharyngeal muscles http://dx.doi.org/10.5115/acb.2013.46.2.141Anat Cell Biol 2013;46:141-148 147 www.acbjournal.orgglossopharyngeal nerve, vagus nerve, or both).",Non-OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
"Anat Cell Biol 2013;46: 141-148 Shinichi Abe, et al 148 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.14115.",OADS,/arxiv_data1/oa_pdf/2f/ae/acb-46-141.PMC3713278.pdf
"Original Article This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.149 pISSN 2093-3665   eISSN 2093-3673 Influence of developing ligaments on the  muscles in contact with them: a study of  the annular ligament of the radius and the  sacrospinous ligament in mid-term human  fetuses Shogo Hayashi1,2, Ji Hyun Kim3, Jose Francisco Rodriguez-Vazquez4, Gen Murakami5, Yoshitaka  Fukuzawa1, Ken Asamoto2, Takashi Nakano2 1Medical Education Center, 2Department of Anatomy, Aichi Medical University School of Medicine, Aichi, Japan, 3Department of Anatomy, Chonbuk  National University Medical School, Jeonju, Korea, 4Department of Anatomy and Embryology II, Complutense University School of Medicine, Madrid,  Spain, 5Division of Internal Medicine, Iwamizawa Kojin-kai Hospital, Hokkaido, Japan Abstract:  The supinator muscle originates from the annular ligament of the radius, and the muscle fibers and ligament take  a similar winding course.",Non-OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
"Anat Cell Biol 2013;46: 149-156 Shogo Hayashi, et al 150 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.149interspersed by the coccygeus muscle fibers, and Hammer et  al.",OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
Development of ligaments and muscles http://dx.doi.org/10.5115/acb.2013.46.2.149Anat Cell Biol 2013;46:149-156 151 www.acbjournal.orgthe ANL.,Non-OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
"Anat Cell Biol 2013;46: 149-156 Shogo Hayashi, et al 152 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.149Fig.",OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
Development of ligaments and muscles http://dx.doi.org/10.5115/acb.2013.46.2.149Anat Cell Biol 2013;46:149-156 153 www.acbjournal.orgthe sacrotuberous ligament.,Non-OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
"Anat Cell Biol 2013;46: 149-156 Shogo Hayashi, et al 154 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.149initial development of the ANL and SSL, the two appear to  paradoxically injure parts of the “mother” muscles.",Non-OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
Development of ligaments and muscles http://dx.doi.org/10.5115/acb.2013.46.2.149Anat Cell Biol 2013;46:149-156 155 www.acbjournal.orginduce formation of the intramuscular tendon.,Non-OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
"Anat Cell Biol 2013;46: 149-156 Shogo Hayashi, et al 156 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.149Magnusson SP .",OADS,/arxiv_data1/oa_pdf/a1/17/acb-46-149.PMC3713279.pdf
"Original Article Corresponding author:  Young-il Hwang  Department of Anatomy, Seoul National University College of  Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-740-8209, Fax: +82-2-745-9528, E-mail: hyi830@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/5e/65/acb-46-157.PMC3713280.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.157 pISSN 2093-3665   eISSN 2093-3673 Students’ perception of anatomy education at  a Korean medical college with respect to time  and contents Min Joon Cho, Y oung-il Hwang  Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea Abstract:  Among medical education institutions worldwide, the time allotted for anatomy instruction has decreased without  any reasonable time optimization suggestions.",Non-OADS,/arxiv_data1/oa_pdf/5e/65/acb-46-157.PMC3713280.pdf
Anat Cell Biol 2013;46: 157-162 Min Joon Cho and Y oung-il Hwang 158 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.157Another point of contention concerning anatomy edu - cation is hands-on cadaver dissection.,Non-OADS,/arxiv_data1/oa_pdf/5e/65/acb-46-157.PMC3713280.pdf
Anatomy education in Korea http://dx.doi.org/10.5115/acb.2013.46.2.157Anat Cell Biol 2013;46:157-162 159 www.acbjournal.org120 hours of dissection laboratory.,Non-OADS,/arxiv_data1/oa_pdf/5e/65/acb-46-157.PMC3713280.pdf
"Anat Cell Biol 2013;46: 157-162 Min Joon Cho and Y oung-il Hwang 160 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.157what excessive (lectures, 13.4%; laboratory, 8.6%) or insuf - ficient (lectures, 23.3%; laboratory, 20.0%).",Non-OADS,/arxiv_data1/oa_pdf/5e/65/acb-46-157.PMC3713280.pdf
"Anatomy education in Korea http://dx.doi.org/10.5115/acb.2013.46.2.157Anat Cell Biol 2013;46:157-162 161 www.acbjournal.orgfor this purpose [25, 26], sometimes in association with  problem-based or team-based learning.",Non-OADS,/arxiv_data1/oa_pdf/5e/65/acb-46-157.PMC3713280.pdf
Anat Cell Biol 2013;46: 157-162 Min Joon Cho and Y oung-il Hwang 162 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.157Surgeon 2004;2:79-90.,OADS,/arxiv_data1/oa_pdf/5e/65/acb-46-157.PMC3713280.pdf
Available  from: http://www.gmc-uk.org/education/undergraduate/ historic_policy.asp.,Non-OADS,/arxiv_data1/oa_pdf/5e/65/acb-46-157.PMC3713280.pdf
"Case Report Corresponding author:  David A. Ebenezer Department of Anatomy, Velammal Medical College Hospital and  Research Institute, Anuppanadi,  Madurai, Tamil Nadu 625009, India Tel: +91-452-2510000, Fax: +91-452-2510000, E-mail: davidebenezer@ yahoo.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/d9/75/acb-46-163.PMC3713281.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.163 pISSN 2093-3665   eISSN 2093-3673 Rare multiple variations in brachial plexus  and related structures in the left upper limb of  a Dravidian male cadaver  David A. Ebenezer1, Bertha A. D. Rathinam2 1Department of Anatomy, Velammal Medical College Hospital and Research Institute, Madurai, 2Department of Anatomy, All India Institute of Medical  Sciences, Bhopal, India  Abstract:  Anatomical variations of the nerves, muscles, and vessels in the upper limb have been described in many anatomical  studies; however, the occurrence of 6 variations in an ipsilateral limb is very rare.",Non-OADS,/arxiv_data1/oa_pdf/d9/75/acb-46-163.PMC3713281.pdf
Anat Cell Biol 2013;46: 163-166 David A. Ebenezer and Bertha A. D. Rathinam 164 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.163bifurcated into upper and lower divisions on the left side by  an axillary arch and a common arterial trunk from the third  part of the axillary artery (Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/75/acb-46-163.PMC3713281.pdf
Variant brachial plexus and its relations http://dx.doi.org/10.5115/acb.2013.46.2.163Anat Cell Biol 2013;46:163-166 165 www.acbjournal.orgwhich descended medial to the axillary artery and divided  at the level of the upper border of the teres major into the  medial root of the median nerve and the ulnar nerve.,Non-OADS,/arxiv_data1/oa_pdf/d9/75/acb-46-163.PMC3713281.pdf
Anat Cell Biol 2013;46: 163-166 David A. Ebenezer and Bertha A. D. Rathinam 166 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.163in the peripheral nerves is used to explain certain unexpected  signs and symptoms noted in medical practice.,Non-OADS,/arxiv_data1/oa_pdf/d9/75/acb-46-163.PMC3713281.pdf
"Case Report Corresponding author:  Chang Ho Song Department of Anatomy, Chonbuk National University Medical School  and Institute for Medical Sciences, Chonbuk National University, 567  Baekje-daero, Deokjin-gu, Jeonju 561-756, Korea Tel: +82-63-270-3101, Fax: +82-63-274-9880, E-mail: asch@jbnu.ac.kr  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/80/31/acb-46-167.PMC3713282.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.167 pISSN 2093-3665   eISSN 2093-3673 Right-sided aortic arch with the  retroesophageal left subclavian artery as   the fourth branch Ok Hee Chai, Eui-Hyeog Han, Hyoung Tae Kim, Chang Ho Song  Department of Anatomy, Chonbuk National University Medical School and Institute for Medical Sciences, Chonbuk National University, Jeonju, Korea Abstract:  We present a rare variation of the right-sided aortic arch with the retroesophageal left subclavian artery as the forth  branch found in a cadaver of an 89-year-old Korean woman during a routine dissection.",Non-OADS,/arxiv_data1/oa_pdf/80/31/acb-46-167.PMC3713282.pdf
"Anat Cell Biol 2013;46: 167-170 Ok Hee Chai, et al 168 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.167was fixed and stored in 10% formalin.",OADS,/arxiv_data1/oa_pdf/80/31/acb-46-167.PMC3713282.pdf
"Right-sided aortic arch http://dx.doi.org/10.5115/acb.2013.46.2.167Anat Cell Biol 2013;46:167-170 169 www.acbjournal.orgside of the anterior wall of the aortic arch, the left common  carotid artery ascended anterolaterally to the left in front of  the trachea and divided into the external and internal carotid  arteries (Fig.",Non-OADS,/arxiv_data1/oa_pdf/80/31/acb-46-167.PMC3713282.pdf
"Anat Cell Biol 2013;46: 167-170 Ok Hee Chai, et al 170 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.167system.",OADS,/arxiv_data1/oa_pdf/80/31/acb-46-167.PMC3713282.pdf
"Review Article Corresponding author:  Jong Eun Lee Department of Anatomy, BK 21 Project for Medical Science, Yonsei  University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul  120-752, Korea Tel: +82-2-2228-1646, Fax: +82-2-365-0700, E-mail: jelee@yuhs.ac This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.85 pISSN 2093-3665   eISSN 2093-3673 Biocompatability of carbon nanotubes with  stem cells to treat CNS injuries Kiran Kumar Bokara1, Jong Y oul Kim1, Y oung Il Lee2,3, Kyungeun Yun1, Tom J Webster4, Jong Eun Lee1,5 1Department of Anatomy, Y onsei University College of Medicine, Seoul, 2Institute of Tissue Engineering (ITREN), Dankook University, 3Department of  Anatomy, Dankook University College of Medicine,  Cheonan, Korea, 4Department of Orthopedics, Brown University, Providence, RI, USA, 5BK 21 Project  for Brain Research Institute, Y onsei University College of Medicine, Seoul, Korea Abstract:  Cases reporting traumatic injuries to the brain and spinal cord are extended range of disorders that affect a large  percentage of the world’s population.",Non-OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
"Anat Cell Biol 2013;46: 85-92 Kiran Kumar Bokara, et al 86 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.85progeny with all neural lineages, and are posited to exist in  embryonic and fetal germinal zones and participate in CNS  organogenesis [8, 9].",OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
"CNTs and their application in CNS injuries http://dx.doi.org/10.5115/acb.2013.46.2.85Anat Cell Biol 2013;46:85-92 87 www.acbjournal.orgneuronal electrical signaling [31], decrease astrocyte for - mation, macrophage density (cells which synthesize  unwanted glial scar tissue in the brain) [32] and shown  to increase the differentiation of NSCs to neurons [33]  suggesting the promise for the use of CNTs as novel stem  cell delivery vehicles for treating stroke damaged neural  tissue [34, 35] in vivo .",Non-OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
"Anat Cell Biol 2013;46: 85-92 Kiran Kumar Bokara, et al 88 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.85neuron preferred a CNT surrounding to a PCU one [33, 34,  39, 40].",Non-OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
CNTs and their application in CNS injuries http://dx.doi.org/10.5115/acb.2013.46.2.85Anat Cell Biol 2013;46:85-92 89 www.acbjournal.orgthe usage of CNTs as permissive substrates/scaffolds for  cell adhesion and growth.,Non-OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
"Anat Cell Biol 2013;46: 85-92 Kiran Kumar Bokara, et al 90 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.85on what features of nanoparticles make them more or less  biocompatible.",OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
CNTs and their application in CNS injuries http://dx.doi.org/10.5115/acb.2013.46.2.85Anat Cell Biol 2013;46:85-92 91 www.acbjournal.org20.,Non-OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
"Anat Cell Biol 2013;46: 85-92 Kiran Kumar Bokara, et al 92 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.85AA, Baughman RH, Romero MI.",OADS,/arxiv_data1/oa_pdf/5f/5e/acb-46-85.PMC3713283.pdf
"Review Article Corresponding author:  Kun Hwang Department of Plastic Surgery and Center for Advanced Medical  Education by BK21 Project, Inha University School of Medicine, 27  Inhang-ro, Jung-gu, Incheon 400-711, Korea Tel: +82-32-890-3514, Fax: +82-32-890-2918, E-mail: jokerhg@inha.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2013.",Non-OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/ 10.5115/acb.2013.46.2.93 pISSN 2093-3665   eISSN 2093-3673 Surgical anatomy of the upper eyelid relating  to upper blepharoplasty or blepharoptosis  surgery Kun Hwang Department of Plastic Surgery and Center for Advanced Medical Education by BK21 Project, Inha University School of Medicine, Incheon, Korea  Abstract:  Eyelid anatomy, including thickness measurements, was examined in numerous age groups.",OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
Anat Cell Biol 2013;46: 93-100 Kun Hwang 94 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.93[2].,OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
Surgical anatomy of the upper eyelid http://dx.doi.org/10.5115/acb.2013.46.2.93Anat Cell Biol 2013;46:93-100 95 www.acbjournal.orgtwitch (type II).,Non-OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
"Anat Cell Biol 2013;46: 93-100 Kun Hwang 96 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.93(88%) and pre-tarsal (87%) areas are in agreement with those  reported by Goodmurphy and Ovalle (89%) [10], based on  his measurements of the palpebral portion (89%) (Table 2).",OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
Surgical anatomy of the upper eyelid http://dx.doi.org/10.5115/acb.2013.46.2.93Anat Cell Biol 2013;46:93-100 97 www.acbjournal.orgnates from the arcus marginalis of the frontal bone and  consists of 2 layers.,Non-OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
"Anat Cell Biol 2013;46: 93-100 Kun Hwang 98 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.93which is shared with the superior rectus, is described as an  additional insertion of the levator palpebrae superioris [28].",Non-OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
Surgical anatomy of the upper eyelid http://dx.doi.org/10.5115/acb.2013.46.2.93Anat Cell Biol 2013;46:93-100 99 www.acbjournal.orgHwang et al.,Non-OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
Anat Cell Biol 2013;46: 93-100 Kun Hwang 100 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.2.932.,OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
Available from: http://en.wikipedia.org/wiki/ Form_follows_function.,Non-OADS,/arxiv_data1/oa_pdf/69/81/acb-46-93.PMC3713284.pdf
"Keywords   Cerebral ischemia, Electrical stimulation, Stroke, Cell proliferation, Motor skillsAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 301-310 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/97/b2/arm-37-301.PMC3713286.pdf
"301 Received May 8, 2012; Accepted November 14, 2012 Corresponding author: Chung-Yong Yang  Department of Physical Medicine and Rehabilitation, Design Hospital, 734-9 Ua-dong 3-ga, Deokjin-gu, Jeonju 561-826, Korea Tel: +82-63-240-2505, Fax: +82-63-240-2009, E-mail: cyang@ricres.org  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/b2/arm-37-301.PMC3713286.pdf
"Keywords   Brain-derived neurotrophic factor, Polymorphism, Stroke, Recovery, Brain plasticityAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 311-319 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/20/9b/arm-37-311.PMC3713287.pdf
"311 Received November 1, 2012; Accepted December 24, 2012 Corresponding author: Nam-Jong Paik Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro  173beon-gil, Bundang-gu, Seongnam 463-707, Korea Tel: +82-31-787-7731, Fax: +82-31-712-3913, E-mail: njpaik@snu.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/9b/arm-37-311.PMC3713287.pdf
"Keywords   Reproducibility of results, Biomechanics, DeglutitionAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 320-327 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/fd/18/arm-37-320.PMC3713288.pdf
"Keywords   Cerebral palsy, Botulinum A toxin, Upper limb, SchoolAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 328-335 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/37/94/arm-37-328.PMC3713289.pdf
"Keywords   Spinal cord injuries, Abdominal obesity, Exercise, Health behavior, Socioeconomic factorsAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 336-346 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/47/54/arm-37-336.PMC3713290.pdf
"Keywords   Task performance, Analysis, Postural balance, AttentionAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 347-354 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/06/b8/arm-37-347.PMC3713291.pdf
"Keywords   Radiculopathy, Thermography, Magnetic resonance imaging, Electrodiagnosis, Muscle atrophyAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 355-363 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/87/23/arm-37-355.PMC3713292.pdf
"Keywords   Cardiovascular system, Cardiopulmonary exercise test, Ergometry, Systolic pressure, Hemo  dynamicsAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 364-372 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/b4/b0/arm-37-364.PMC3713293.pdf
"Keywords   Knee, Osteoarthritis, BalanceAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 373-378 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/d3/ea/arm-37-373.PMC3713294.pdf
"Keywords   Plantar fasciitis, Extracorporeal shock wave therapy, Dose-related EffectAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 379-388 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/60/5e/arm-37-379.PMC3713295.pdf
"Keywords   Balance, Posture, Elderly, Fatigue, AnkleAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 389-395 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/27/1a/arm-37-389.PMC3713296.pdf
"Keywords   Cancer, Lymphedema, Physiotherapy, Quality of life, PainAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 396-402 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/24/99/arm-37-396.PMC3713297.pdf
"Keywords   Long-term care insurance, Validity, Time, Activities of daily livingAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 403-412 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/33/9b/arm-37-403.PMC3713298.pdf
"Keywords   Abstracts, Publications, Rehabilitation, Journal articleAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2013;37(3): 413-419 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/8a/9b/arm-37-413.PMC3713299.pdf
"The data base also included  the title, authors, and affiliations.Two physicians from physical medicine and rehabili - tation independently investigated whether subsequent  articles were published by searching the PubMed (http:// www.ncbi.nlm.nih.gov/PubMed/) database, KoreaMed  database (http://www.koreamed.org/), and Google  Scholar (http://scholar.google.com/) between the pe - riods of January 2008 and June 2012.",OADS,/arxiv_data1/oa_pdf/8a/9b/arm-37-413.PMC3713299.pdf
"Keywords   Cauda equina syndrome, Chemotherapy, Intrathecal injectionsAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(3): 420-425 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/e3/61/arm-37-420.PMC3713300.pdf
"Keywords   Epiglottis, Dysphagia, Balloon dilationAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(3): 426-429 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/1c/83/arm-37-426.PMC3713301.pdf
"Keywords   Osteoporosis, Bisphosphonates, Stress fractureAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(3): 430-432 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/69/c5/arm-37-430.PMC3713302.pdf
"Keywords   Ultrasonography-guided, Zygomaticus, Needle electromyographyAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(3): 433-437 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/8e/9a/arm-37-433.PMC3713303.pdf
"Keywords   Atlanto-occipital joint, Dysphagia, Cranial nervesAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(3): 438-442 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/fe/56/arm-37-438.PMC3713304.pdf
"Keywords   User computer interface, Cervical cord injury syndromeAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(3): 443-448 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/5e/51/arm-37-443.PMC3713305.pdf
"How - ever, while using the MintoClick 1.0 (http://jj21.org/ wordpress/?p=274), a mouse button (Fig.",Non-OADS,/arxiv_data1/oa_pdf/5e/51/arm-37-443.PMC3713305.pdf
"Keywords   Varicella-zoster virus, Cranial nervesAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(3): 449-452 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/a7/c3/arm-37-449.PMC3713306.pdf
"Keywords   Spinal cord injuries, Epidural analgesia, ParalysisAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2013;37(3): 453-458 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.",Non-OADS,/arxiv_data1/oa_pdf/91/70/arm-37-453.PMC3713307.pdf
"459 www.e-arm.orgCorrection: The Effect of a Hand-Stretching  Device During the Management of Spasticity in  Chronic Hemiparetic Stroke Patients  Eun Hyuk Kim, MD1, Min Cheol Jang, MD1, Jeong Pyo Seo1,  Sung Ho Jang, MD1, Jun Chan Song, PhD2, Hae Min Jo, MD1 1Department of Physical Medicine and Rehabilitation, Yeungnam University College of Medicine, Daegu;  2Department of Physical Therapy, Daegu Health College, Daegu, Korea http://dx.doi.org/10.5535/arm.2013.37.2.235 Ann Rehabil Med 2013;37(2):235-240 To the Editor, We found that the second author name was published incorrectly.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/arm-37-459.PMC3713308.pdf
"Yours sincerely, Hae Min JoErratum Corresponding author: Hae Min Jo Department of Physical Medicine and Rehabilitation, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea Tel: +82-53-620-3456, Fax: +82-53-625-3508, E-mail: jhm090@hanmail.net  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/87/arm-37-459.PMC3713308.pdf
Copyright © 2013 by Korean Academy of Rehabilitation MedicineAnn Rehabil Med 2013;37(3): 459 pISSN: 2234-0645 • eISSN: 2234-0653 http://dx.doi.org/10.5535/arm.2013.37.3.,Non-OADS,/arxiv_data1/oa_pdf/ec/87/arm-37-459.PMC3713308.pdf
"The meanvalues of the Reaction Level Scale (RLS) (see Sup- plementary Table 4 for criteria, only available in the online version of the journal; please ﬁnd this material with the following direct link to the article:http://www.informahealthcare.com/doi/abs/10.3109/03009734.",Non-OADS,/arxiv_data1/oa_pdf/b6/93/UPS-118-169.PMC3713382.pdf
Available from http://www.epa.gov/QUALITY/qs- docs/g6- ﬁnal.pdf.accessed 28 March 2012.,OADS,/arxiv_data1/oa_pdf/b6/93/UPS-118-169.PMC3713382.pdf
"The accompanying letter described the purpose of the study, provided brief information about embryodonation and current legislation, and asked partici-pants for voluntary anonymous participation in thestudy (Supplement A, only available in the onlineversion of the journal; please ﬁnd this material with the following direct link to the article: http://www.informahealthcare.com/doi/abs/10.3109/03009734.",Non-OADS,/arxiv_data1/oa_pdf/05/6a/UPS-118-187.PMC3713384.pdf
"Two versions of the questionnaire were sent out, one aimed at women (Supplement B, only available inthe online version of the journal;please ﬁnd this material with the following direct link to the article:http://www.informahealthcare.com /doi/abs/10.3109/ 03009734.2013.808294)and the other one at men(Supplement C, only available in the online versionof the journal;please ﬁnd this material with the following direct link to the article: http://www.informahealthcare.com/doi/abs/10.3109/03009734.",Non-OADS,/arxiv_data1/oa_pdf/05/6a/UPS-118-187.PMC3713384.pdf
Accessed from: http://www.ucr.uu.se/qivf/index.php/behandlingsresultat [last accessed 19 Mar 2012].,Non-OADS,/arxiv_data1/oa_pdf/05/6a/UPS-118-187.PMC3713384.pdf
"    Journal of Epidemiology and  Global Health    ISSN (Online): 2210 -6014  ISSN (Print): 2210 -6006   Journal Home Page:  https://www.atlantis -press.com/journals/jegh      Perinatal factors and breast cancer risk among Hispanics   Maureen Sanderson, Adriana Pérez, Mirabel L. Weriwoh, Leah R.  Alexander,  Gerson Peltz, Vincent Agboto, Heather O’Hara, Waseem Khoder   To cite this article : Maureen Sanderson, Adriana Pérez, Mirabel L. Weriwoh, Leah R.   Alexander, Gerson Peltz, Vincent Agboto, Heather O’Hara, Waseem Khoder  (2013 )  Perinatal factors and breast cancer risk among Hispanics , Journal of  Epidemiology and  Global Health 3:2 , 89–94, DOI: https://doi.org/ 10.1016/j.jegh.2013.02.004  To link to this article : https://doi.org/10.1016/j.jegh.2013.02.004    Published online: 23  April 2019",Non-OADS,/arxiv_data1/oa_pdf/a8/08/JEGH-3-2-89.PMC3713414.pdf
"Conclusions: The results tended to differ slightly from previous studies of this topic perhaps owing to the different hormonal milieu among Hispanics relative to Caucasians, African Americans and Asians in whom all previous studies of this topic 0263-2373/$ - see front matter ª2013MinistryofHealth,SaudiArabia.PublishedbyElsevierLtd.http://dx.doi.org/10.1016/j.jegh.2013.02.004*Corresponding author at: Department of Family and Com- munity Medicine, Meharry Medical College, 1005 Dr. D.B.",Non-OADS,/arxiv_data1/oa_pdf/a8/08/JEGH-3-2-89.PMC3713414.pdf
"E-mail address: msanderson@mmc.edu (M. Sanderson).Journal of Epidemiology and Global Health (2013) 3,8 9–94 http:// www.elsevier.com/locate/jegh This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a8/08/JEGH-3-2-89.PMC3713414.pdf
"ª2013MinistryofHealth,SaudiArabia.PublishedbyElsevierLtd.Thisisanopen accessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/ by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/a8/08/JEGH-3-2-89.PMC3713414.pdf
"Available from http://seer.can- cer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site; 2011.",OADS,/arxiv_data1/oa_pdf/a8/08/JEGH-3-2-89.PMC3713414.pdf
7Corresponding author E-mail jturner@nimr.mrc.ac.uk Article is online at http://www.genesde v.org/cgi/doi/10.1101/gad.219477.113.,Non-OADS,/arxiv_data1/oa_pdf/36/7b/1484.PMC3713429.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4d/df/srep02208.PMC3713515.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2208 | DOI: 10.1038/srep02208 6",Non-OADS,/arxiv_data1/oa_pdf/4d/df/srep02208.PMC3713515.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2209 | DOI: 10.1038/srep02209 4",Non-OADS,/arxiv_data1/oa_pdf/f8/99/srep02209.PMC3713516.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/61/srep02222.PMC3713525.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2222 | DOI: 10.1038/srep02222 7",Non-OADS,/arxiv_data1/oa_pdf/67/61/srep02222.PMC3713525.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b5/dd/srep02221.PMC3713528.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2221 | DOI: 10.1038/srep02221 5",Non-OADS,/arxiv_data1/oa_pdf/b5/dd/srep02221.PMC3713528.pdf
A program to generate the con-version process typical of the closed benchmarks that can be applied to any network selected by the user is freely available at https://github.com/raldecoa/ClosedBenchmarks.,OADS,/arxiv_data1/oa_pdf/fd/78/srep02216.PMC3713530.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2216 | DOI: 10.1038/srep02216 11",Non-OADS,/arxiv_data1/oa_pdf/fd/78/srep02216.PMC3713530.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2210 | DOI: 10.1038/srep02210 9",Non-OADS,/arxiv_data1/oa_pdf/be/71/srep02210.PMC3713532.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2220 | DOI: 10.1038/srep02220 6",Non-OADS,/arxiv_data1/oa_pdf/5c/3c/srep02220.PMC3713564.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a5/77/srep02223.PMC3713565.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2223 | DOI: 10.1038/srep02223 9",Non-OADS,/arxiv_data1/oa_pdf/a5/77/srep02223.PMC3713565.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/13/5e/srep02217.PMC3713566.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2217 | DOI: 10.1038/srep02217 6",Non-OADS,/arxiv_data1/oa_pdf/13/5e/srep02217.PMC3713566.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/00/fc/JHRS-6-19.PMC3713570.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/00/fc/JHRS-6-19.PMC3713570.pdf
The Assisted  Reproductive Technology (Regulation) Rules ‑ 2010; Draft; New Delhi   available at http://icmr.nic.in/guide/ART%20REGULATION%20Draft%20 Rules%201.pdf (Last accessed 23‑5‑2012) 16.,Non-OADS,/arxiv_data1/oa_pdf/87/0d/JHRS-6-3.PMC3713573.pdf
Available at:  http://www.fertilitysociety.com.au/rtac/.,Non-OADS,/arxiv_data1/oa_pdf/87/0d/JHRS-6-3.PMC3713573.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/87/0d/JHRS-6-3.PMC3713573.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/02/7c/JHRS-6-82.PMC3713586.pdf
Available at: http://sedac.ciesin.columbia.edu/data/collection/gpw-v3 (last accessed April 9 2013) www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 810 | DOI: 10.1038/srep00810 6,Non-OADS,/arxiv_data1/oa_pdf/8e/09/srep00810.PMC3713588.pdf
URL http://www.iata.org (last accessed on april 9 2013).,Non-OADS,/arxiv_data1/oa_pdf/8e/09/srep00810.PMC3713588.pdf
URL http://www.oag.com (last accesses on April 9 2013).,Non-OADS,/arxiv_data1/oa_pdf/8e/09/srep00810.PMC3713588.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8e/09/srep00810.PMC3713588.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 810 | DOI: 10.1038/srep00810 7",Non-OADS,/arxiv_data1/oa_pdf/8e/09/srep00810.PMC3713588.pdf
Available from: http://www.emro.who.int/rc56/media/pdf/EMRC5603en.pdf .,OADS,/arxiv_data1/oa_pdf/ee/f3/SJG-18-1.PMC3713589.pdf
Available  from:http://www.scot.org.sa.,Non-OADS,/arxiv_data1/oa_pdf/ee/f3/SJG-18-1.PMC3713589.pdf
Available from: http://www.nci.edu.eg.,Non-OADS,/arxiv_data1/oa_pdf/ee/f3/SJG-18-1.PMC3713589.pdf
Available from http://nastad.org/Docs/Public/Resource/2006711_NYS_HepC_Mgt_Guidelines.pdf.,OADS,/arxiv_data1/oa_pdf/ee/f3/SJG-18-1.PMC3713589.pdf
Available from: http://www.hpamidas.org.uk/documents/reports/HCV/Murex_HCV_AgAb_Report_v8_FINAL.pf.,OADS,/arxiv_data1/oa_pdf/ee/f3/SJG-18-1.PMC3713589.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/2c/hct093.PMC3713590.pdf
URL: http://www.islamset.com/bioethics.,Non-OADS,/arxiv_data1/oa_pdf/aa/bb/jmehm-1-1.PMC3713653.pdf
URL: http://www.islamset.com/bioethics/incept.html    18.,Non-OADS,/arxiv_data1/oa_pdf/aa/bb/jmehm-1-1.PMC3713653.pdf
URL: http://islam-usa.com/im18.html    22.,Non-OADS,/arxiv_data1/oa_pdf/aa/bb/jmehm-1-1.PMC3713653.pdf
Available from: http://www.medana.unibas.ch/cirs/(Last accessed  on 2013 Jan 02).,Non-OADS,/arxiv_data1/oa_pdf/88/ae/JOACP-29-147.PMC3713656.pdf
Available from: https://www.pasos‑ains.de/indexSSL.,Non-OADS,/arxiv_data1/oa_pdf/88/ae/JOACP-29-147.PMC3713656.pdf
Available from: http://www.anzca.edu.au/communications/ anzca‑bulletin/bulletin‑release‑2008/anzca‑bulletin‑2008‑mar.,Non-OADS,/arxiv_data1/oa_pdf/88/ae/JOACP-29-147.PMC3713656.pdf
Available from: http://www.aagbi.org/ sites/default/files/working_arrangements_for_consultant_ anaesthetists_2011_0.pdf [Last accessed on 2013 March 05].,Non-OADS,/arxiv_data1/oa_pdf/aa/55/JOACP-29-149.PMC3713657.pdf
Available from: http://www.acgme.org/acgmeweb/Portals/0/dh_dutyhoursCommonPR07012007.,OADS,/arxiv_data1/oa_pdf/aa/55/JOACP-29-149.PMC3713657.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/aa/55/JOACP-29-149.PMC3713657.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/aa/55/JOACP-29-149.PMC3713657.pdf
"18. International Classification of Sleep Disorders Diagnostic and  Coding Manual, Available from: http://www.esst.org/adds/ICSD.",Non-OADS,/arxiv_data1/oa_pdf/c2/ca/JOACP-29-151.PMC3713658.pdf
Available from: http://epworthsleepinessscale.com/about‑epworth‑sleepiness/[Last  accessed on 2012 Dec 16].,Non-OADS,/arxiv_data1/oa_pdf/c2/ca/JOACP-29-151.PMC3713658.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/de/e4/JOACP-29-160.PMC3713659.pdf
Accessed from:  http://www.anzca.edu.au/resources/professional‑documents/ps9.,Non-OADS,/arxiv_data1/oa_pdf/90/ae/JOACP-29-211.PMC3713670.pdf
Available from: http://www.anzca.edu.au/ resources/professional‑documents/ps7.html.,Non-OADS,/arxiv_data1/oa_pdf/90/ae/JOACP-29-211.PMC3713670.pdf
Available from: http://www.google.com/patents/ US4248219 [Last updated on 2012 August; cited 2012 Aug 13].,OADS,/arxiv_data1/oa_pdf/d5/60/JOACP-29-221.PMC3713672.pdf
Available  from: http://www.quickfacts.census.gov/qfd/states/00000.,OADS,/arxiv_data1/oa_pdf/d5/60/JOACP-29-221.PMC3713672.pdf
Available from: http://www.pedsanesthesia.org/ meetings/2010winter/syllabus/posters.,Non-OADS,/arxiv_data1/oa_pdf/e4/7b/JOACP-29-235.PMC3713674.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/e4/7b/JOACP-29-235.PMC3713674.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/f0/86/JOACP-29-248.PMC3713678.pdf
Available from: http://www.en.wikipedia.org/wiki/ Eosinophilia [Last accessed on 2012 Sep 01].,Non-OADS,/arxiv_data1/oa_pdf/7f/05/JOACP-29-270.PMC3713689.pdf
Available from: http://www.en.wikipedia.org/wiki/ Eosinophilia [Last accessed on 2012 Sep 01].,Non-OADS,/arxiv_data1/oa_pdf/84/de/JOACP-29-271.PMC3713690.pdf
"*21#16 Azar Ave, Keshavarz Blvd, Tehran, Iran   Phone: +982166419661  Email: mehr@tums.ac.ir      Received: 01 Jan  2012  Accepted: 04 Feb 2012  Published: 01 Mar  2012  J Med Ethics Hist Med, 201 2, 5:2   http://journals.tums.ac.ir/abs/20739   © 201 2 Parsapoor A.  et al.",Non-OADS,/arxiv_data1/oa_pdf/db/d8/jmehm-5-2.PMC3713703.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/17/3a/bbs043.PMC3713711.pdf
a nice example of this (http://www.broadinstitute .org/cmap/).,Non-OADS,/arxiv_data1/oa_pdf/17/3a/bbs043.PMC3713711.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/f1/bbs078.PMC3713713.pdf
"Bioconductor is basedon the R packaging system, which is highly standar-dized and has been a driving force behind thewide adoption of both R and Bioconductor.Ta b l e 2 : List of tools and resources for reproducible biomedical data analysis mentioned in this review Name Description/usage URL Online protocol storing and sharing elabprotocols Web-based Laboratory Protocol & SOP Management http://www .elabprotocols.com figshare Web-based tool for storing and sharing all sorts of research output http://www .figshare.com Databases and data management tools LabKey Server Biomedical research data management with powerful programming interfaces for analysishttp://www .labkey .com/ ImmPort The Immunology Database and Analysis Portal http://www .immport.org Analysis tools Bioconductor Collection of R packages for high-throughput biological data analysis http://www .bioconductor .org/ Biopython Python tools for computational molecular biology http://www.biopython.orgBioPerl Perl tools for bioinformatics, genomics and life science research http://www .bioperl.org Analysis platforms with graphical user interface RStudio Integrated development environment (IDE) for R http://www .rstudio.org/ GenePattern Genomic analysis platform with web-based interface http://www .broadinstitute.org/ cancer/software/genepattern/ GenomeSpace Genomic analysis platform linked with multiple tools including GenePattern, Galaxy and Cytospacehttp://www .genomespace.org/ Code sharing and versioning tools GitHub Web-based tool for software development and collaboration based on the Git version control systemhttp://www .github.com/ Authoring tools GenePattern Word PluginMicrosoft Word add-in for the GenePattern Reproducible Research Documenthttp://www .broadinstitute.org/ cancer/software/genepattern/ Sweave Integration of R code into La T eX documents http://www .statistik.lmu.de/ /C24leisch/ Sweave/ knitr Elegant, flexible and fast dynamic report generation with R. knitr is integrated in RStudio for ease of use.http://yihui.name/knitr/Comparability and reproducibility of biomedical data 397",Non-OADS,/arxiv_data1/oa_pdf/56/f1/bbs078.PMC3713713.pdf
"Infact, this article was written using the Sweave lan- guage and processed using RStudio and the source file (along with all versions of it) is available fromGitHub (http://github.com/raphg/BiB-review- CR).",OADS,/arxiv_data1/oa_pdf/56/f1/bbs078.PMC3713713.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"INTRODUCTION The Rat Genome Database (RGD, http://rgd.mcw.",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://www.geneontology.org/ (15 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
http://www.ncbi.nlm.nih.gov/sites/entrez?,Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://www.ensembl.org/index.html (15 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
http://www.ebi.ac.uk/GOA/rat_release.,Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://genome.ucsc.edu/cgi- bin/hgGateway?hgsid ¼286942711&clade ¼mammal&org ¼Rat&db ¼0 (15 February 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://ctdbase.org/ (15 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://pid.nci.nih.gov/index.shtml (15 February 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://rgd.mcw.edu/wg/tool- menu?100 (15 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://www.ncbi.nlm.nih.gov/guide/ (15 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://www.genenames.org/ (15 February 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"http://rgd.mcw.edu/fgb2/gbrowse/rgd_ 904/ (15 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
http://rgd.mcw.,Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"ftp://rgd.mcw.edu/pub/ (15 February 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"https://database.riken.jp/sw/en/Home/cria254s 94i/ (15 February 2013, date last accessed).",OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
http://www.informatics.jax.,Non-OADS,/arxiv_data1/oa_pdf/56/5c/bbt007.PMC3713714.pdf
"For additional information on adolescent services see Appendix I, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/06/b9/aids-27-1971.PMC3713766.pdf
"However, outcomes did not differ between those who had and who did not have CD4þcell counts at initiation (Appendix 2, http://links.lww.com/QAD/ A344).",Non-OADS,/arxiv_data1/oa_pdf/06/b9/aids-27-1971.PMC3713766.pdf
Available from: http://www.who.int/ childgrowth/publications/en/.,Non-OADS,/arxiv_data1/oa_pdf/06/b9/aids-27-1971.PMC3713766.pdf
The work cannot be changed in any way or used commercially.http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/a1/9b/tp-96-42.PMC3713767.pdf
URL: http://www.vesq.org.au/Definitions.html       2.,OADS,/arxiv_data1/oa_pdf/81/96/jmehm-2-2.PMC3713799.pdf
URL: http://www.floridainstitute.comResourcesglossary1.html,Non-OADS,/arxiv_data1/oa_pdf/81/96/jmehm-2-2.PMC3713799.pdf
URL:  http://en.wikipedia.org/wik i/Emotions_in_Decision_Making     10.,Non-OADS,/arxiv_data1/oa_pdf/81/96/jmehm-2-2.PMC3713799.pdf
URL: http://changingminds.org/explanations/emotions/emotion_decision.htm     11.,Non-OADS,/arxiv_data1/oa_pdf/81/96/jmehm-2-2.PMC3713799.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013   Journal of Medical Ethics and History of Medicine                                             Occupational  therapists  and patients’  rights: their level of Clinical  knowledge       Leila Dehghan1, Hamid Dalvand1*, Hojjat Allah Haghgoo2, Seyed Ali Hosseini3 and Masoud  Karimlou4      1PhD student of Occupational Therapy, Department of Occupational Therapy, University of Social Welfare & Rehabili- tation Sciences, Tehran, Iran;  2Assistant Professor, Department of Occupational Therapy, University of Social Welfare & Rehabilitation Sciences,  Tehran, Iran;   3Associate Professor, Department of Occupational Therapy, University of Social Welfare & Rehabilitation Sciences,  Tehran, Iran;   4Associate Professor, Department of Biostatistics and Computer Science, Un iversity of Welfare & Rehabilitation,  Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/57/b8/jmehm-6-3.PMC3713801.pdf
"Postal Code: 1985713834  Tel: +989122063968  fax: +982122180018  E-mail: hamiddalvand@gmail.com  , h.dalvand@uswr.ac.ir      Received: 20 Aug 2012  Accepted: 14 Jan 2013  Published: 22 Jan 2013    J Med Ethics Hist Med, 2013, 6:3  http://journals.tums.ac.ir/abs/22986    © 2013 Leila Dehghan et al.",Non-OADS,/arxiv_data1/oa_pdf/57/b8/jmehm-6-3.PMC3713801.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Leila Dehghan et al.",OADS,/arxiv_data1/oa_pdf/57/b8/jmehm-6-3.PMC3713801.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Leila Dehghan et al.",OADS,/arxiv_data1/oa_pdf/57/b8/jmehm-6-3.PMC3713801.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Leila Dehghan et al.",OADS,/arxiv_data1/oa_pdf/57/b8/jmehm-6-3.PMC3713801.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Leila Dehghan et al.",OADS,/arxiv_data1/oa_pdf/57/b8/jmehm-6-3.PMC3713801.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Leila Dehghan et al.",OADS,/arxiv_data1/oa_pdf/57/b8/jmehm-6-3.PMC3713801.pdf
"Phone: +982166419661  Email: poonehsalari@gmail.com     Received: 06 Apr 2011  Accepted: 11 Jun 2011  Published: 26 Jun 2011  J Med Ethics Hist Med, 20 11, 4:6   http://journals.tums.ac.ir/abs/18557    © 2011 Mohammadreza Javadi, Fariba Asghari and Pooneh Salari ; licensee  Tehran Univ.",Non-OADS,/arxiv_data1/oa_pdf/4b/76/jmehm-4-6.PMC3713883.pdf
http://www.psa.org.au/site.php?id -628.,Non-OADS,/arxiv_data1/oa_pdf/4b/76/jmehm-4-6.PMC3713883.pdf
http://www.psych.org/search.aspx?SearchPhrase=%22P rinciples+of+Informed+C onsent+in+Psychiatry%22   (accessed  on 2008)  9.,Non-OADS,/arxiv_data1/oa_pdf/12/51/jmehm-2-5.PMC3713884.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/34/c4/simycol_75_1_001.PMC3713885.pdf
"A Bayesian analysis was  conducted with MrBayes v. 3.1.2 (Huelsenbeck & Ronqvist 2001) in two parallel runs, using the default settings but with the following  adjustments: the GTR model (trees 1–3, 5) with gamma-distributed  rate and the HKY+ γ-model (tree 4) were selected for the partitions using the Findmodel freeware (http://hcv.lanl.gov/content/hcv-db/findmodel/findmodel.html), and a MCMC heated chain was set  with a “temperature” value of 0.05.",OADS,/arxiv_data1/oa_pdf/34/c4/simycol_75_1_001.PMC3713885.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/e7/71/simycol_75_1_002.PMC3713886.pdf
"However, additional  internal primers LR3R (http://www.biology.duke.edu/fungi/mycolab/ primers.htm), LR16 (Moncalvo et al.",OADS,/arxiv_data1/oa_pdf/e7/71/simycol_75_1_002.PMC3713886.pdf
"2007), 4Peaks v. 1.7.2 (http://www.mekentosj.com/)  and SeqMan v. 8.0.2. from the DNASTAR Lasergene® software  package.",OADS,/arxiv_data1/oa_pdf/e7/71/simycol_75_1_002.PMC3713886.pdf
3Sequence for this locus obtained from: http://genome.jgi-psf.org/Mycfi1/Mycfi1.home.html,OADS,/arxiv_data1/oa_pdf/e7/71/simycol_75_1_002.PMC3713886.pdf
Available from http://www.geneious.com.,Non-OADS,/arxiv_data1/oa_pdf/e7/71/simycol_75_1_002.PMC3713886.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/c5/a9/simycol_75_1_003.PMC3713887.pdf
"Geneious  v5.4, Available from http://www.geneious.com/.",Non-OADS,/arxiv_data1/oa_pdf/c5/a9/simycol_75_1_003.PMC3713887.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/47/e0/simycol_75_1_004.PMC3713888.pdf
"Phylogenetic analyses Multiple sequence alignments were generated with MAFFT v. 6.864b  (http://mafft.cbrc.jp/alignment/server/index.html), and adjusted by  eye.",OADS,/arxiv_data1/oa_pdf/47/e0/simycol_75_1_004.PMC3713888.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/48/27/simycol_75_1_005.PMC3713889.pdf
Sequence alignement and phylogenetic analyses A basic alignment of the obtained sequence data was first done  using MAFFT v. 7 (http://mafft.cbrc.jp/alignment /server/index.,OADS,/arxiv_data1/oa_pdf/48/27/simycol_75_1_005.PMC3713889.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/11/e9/simycol_75_1_006.PMC3713890.pdf
Phylogenetic analyses A basic alignment of the obtained sequence data was first done  using MAFFT v. 7 [(http://mafft.cbrc.jp/alignment /server/index.,OADS,/arxiv_data1/oa_pdf/11/e9/simycol_75_1_006.PMC3713890.pdf
http://noticias.juridicas.com/b ase_datos/Penal/lo10-1995.l2t3.html  (accessed on  26.05.2009)  11.,Non-OADS,/arxiv_data1/oa_pdf/4c/1b/jmehm-2-3.PMC3713891.pdf
http://noticias.juridicas .com/base_datos/Penal/lo5-1995.html (accessed on 26.05.2009)  12.,Non-OADS,/arxiv_data1/oa_pdf/4c/1b/jmehm-2-3.PMC3713891.pdf
http://noticias.juridicas.com/b ase_datos/Penal/lo10-1995.l2t3.html   (accessed on  26.05.2009),Non-OADS,/arxiv_data1/oa_pdf/4c/1b/jmehm-2-3.PMC3713891.pdf
Eubios J Asian Int  Bioeth 2007; 17(3): 65-96. http://www.eubios.info/EJAIB52007.pdf  (accessed on Jul 2009)  2.,Non-OADS,/arxiv_data1/oa_pdf/ee/d7/jmehm-2-15.PMC3713900.pdf
"2006,  http://icmr.nic.in/bioethics/cc_biothics/p resentations/int_chennai/CR_Pakistan.pdf  (accessed on Jul 2009)  3.",Non-OADS,/arxiv_data1/oa_pdf/ee/d7/jmehm-2-15.PMC3713900.pdf
http://siut.org/bioethics  (accessed on Jul 2009)  5.,Non-OADS,/arxiv_data1/oa_pdf/ee/d7/jmehm-2-15.PMC3713900.pdf
URL: http://www.vesq.org.au/Definitions.html       2.,OADS,/arxiv_data1/oa_pdf/ce/69/jmehm-1-2.PMC3713901.pdf
URL: http://www.floridainstitute.comResourcesglossary1.html    4.,Non-OADS,/arxiv_data1/oa_pdf/ce/69/jmehm-1-2.PMC3713901.pdf
URL:  http://en.wikipedia.org/wiki/Emotions_in_Decision_Making     10.,Non-OADS,/arxiv_data1/oa_pdf/ce/69/jmehm-1-2.PMC3713901.pdf
URL: http://changingminds.org/explanations/emotions/emotion_decision.htm     11.,Non-OADS,/arxiv_data1/oa_pdf/ce/69/jmehm-1-2.PMC3713901.pdf
http://tourism.chn.ir/en/Geogr aphy/Geograph_nxt2/index.aspx (accessed  on 2005)  2.,Non-OADS,/arxiv_data1/oa_pdf/e6/84/jmehm-2-13.PMC3713903.pdf
http://www.cais-soas.com /CAIS/Science/dru.htm  (accessed on 2008)  23.,Non-OADS,/arxiv_data1/oa_pdf/e6/84/jmehm-2-13.PMC3713903.pdf
http://encyclopedia.thefreedictionay.com/AliRabbanal-Tabari  (ac- cessed on 2008)   25.,Non-OADS,/arxiv_data1/oa_pdf/e6/84/jmehm-2-13.PMC3713903.pdf
2003.  http://books.nap.edu/openbookphp?Record_id=10700&page=86  (accessed on 2008)  34.,Non-OADS,/arxiv_data1/oa_pdf/e6/84/jmehm-2-13.PMC3713903.pdf
"Corresponding author:   Dr. Seyed Mahmoud Tabatabaei    E-mail: smtabataba_md@yahoo.com       Received: 15 Jan 2012  Accepted: 18 Feb 2012   Published: 03 Mar  2012    J Med Ethics Hist Med, 201 2, 5:3   http://journals.tums.ac.ir/abs/20744    © 201 2  Seyed Mahmoud Tabatabaei  et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/27/jmehm-5-3.PMC3713906.pdf
http://www.ghavanin.ir/PaperDetail.asp?id=294  (accessed on Nov 2009 )  11.,Non-OADS,/arxiv_data1/oa_pdf/b9/26/jmehm-2-21.PMC3713908.pdf
"  Journal of  Medical Ethics and History of Medicine                                            Reform in medical ethics curriculum: a step by step approach based on  available resources     Fariba Asghari1, Azim Mirzazadeh2, Aniseh Samadi3, Aliakbar Nejati Safa4, Ali Jafarian5, Ali  Vasheghani Farahani6 and Seyed Hasan Emami Razavi7    1 Assistant Professor, Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences   2 Assistant Professor, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran   3 Researcher, Medical Ethics and History of Medicine Research Center, Tehran University of Medical Sciences   4 Associate Professor, Department of Psych iatry, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences,  Tehran, Iran   5 Associate Professor, Department of General Surgery, Imam Khomeini Hospital Complex, School of Medicine, Tehran  University of Medical Sciences   6 Assistant Professor, Department of Cardiology, Sina hospital, Tehran University of Medical Sciences, Tehran, Iran   7 Professor, Department of General Surgery, Imam Khomeini Hospital Complex, School of Medicine, Tehran University of  Medical Sciences     Corresponding author:   Azim M irzazadeh   Department of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran   PO Box: 14185-481, Tehran, Iran  Tel: 00 -98-21-66939922  Fax: 00 -98-21-66939922  Email: mirzazad@t ums.ac.ir       Received: 11 Nov 201 0  Accepted: 07 Aug  2011  Published: 14 Aug  2011  J Med Ethics Hist Med, 201 1, 4:8   http://journals.tums.ac.ir/abs/19013    © 201 1 Fariba Asghari et al.",Non-OADS,/arxiv_data1/oa_pdf/91/c5/jmehm-4-8.PMC3713913.pdf
"*21#16 Azar Ave, Keshavarz Blvd, Tehran, Iran   Phone: +982166419661  Email: mehr@tums.ac.ir        Received: 20 May  2011  Accepted: 31 Jul  2012  Published: 02 Aug  2012    J Med Ethics Hist Med, 201 2, 5:5   http://journals.tums.ac.ir/abs/21490    © 201 2 Alireza Parsapo or et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/3c/jmehm-5-5.PMC3713914.pdf
"The Patients Association, Survey of The UK Public Patients' Rights main report, December 2005,  http://www.patients -association.org.uk  /DBIMGS/file/The%20Public%20Perception%20of%20Patients%E2%80%99%20Rights%20Within%20The%20UK.pdf  (accessed in 201 0).",Non-OADS,/arxiv_data1/oa_pdf/b9/3c/jmehm-5-5.PMC3713914.pdf
"  Journal of  Medical Ethics and History of Medicine                                            The Implementation of the Sharia Law in Medical Practice : A Balance   between  Medical Ethics and Patients Rights     Hossein Dargahi     Associate Professor of Allied Health Sciences, Tehran University of Medical Sciences ,   13, Fardaanesh, Qods St., Enghelab Ave, Tehran, Iran  Tel: 0098 –  021 – 88965608  Fax: 0098 – 021 – 88997050   E-mail: hdargahi@sina.tums.ac.ir      Received: 10 Nov 2010  Accepted:  15 Jul 2011  Published: 27 Jul 2011  J Med Ethics Hist Med, 20 11, 4:7  http://journals.tums.ac.ir/abs/187 93    © 2011 Hossein Dargahi ; licensee  Tehran Univ.",Non-OADS,/arxiv_data1/oa_pdf/26/59/jmehm-4-7.PMC3713915.pdf
http://www.cannonhospital.org/p age_id=97  (accessed in 2011).,OADS,/arxiv_data1/oa_pdf/26/59/jmehm-4-7.PMC3713915.pdf
http://www.patienttalk .info/ AHA_ patient_ bill_ofrights.,Non-OADS,/arxiv_data1/oa_pdf/26/59/jmehm-4-7.PMC3713915.pdf
http://www.uni-konstanz.de/ag- moral/mut/mjt-intro.htm ( accessed on April 2009)  21.,Non-OADS,/arxiv_data1/oa_pdf/83/f1/jmehm-2-7.PMC3713919.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013   Journal of Medical Ethics and History of Medicine                                             The absent discourse  of communication:  understanding  ethics of  provider ‐patient relationship  in six hospitals  in urban India       Rakhi Ghoshal1*, Neha Madhiwalla2, Amar Jesani3, Padmaja Samant4, Vijaya Badhwar5, Sweta  Surve6  1PhD Fellow and Senior Researcher, Centre for Studies in Ethics and Rights, Mumbai;   2M.A, and Coordinator, Centre for Studies in Ethics and Rights, Mumbai;   3MBBS and Editor, Indian Journal of Medical Ethics;   4MD and Associate Professor, KEM Hospital, Mumbai;   5MD, Professor, D Y Patil Medical College and Research Centre, Mumbai;   6MA.",Non-OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
"and Junior Researcher, Centre for Studies in Ethics and Rights, Mumbai        Corresponding Author :   Rakhi Ghoshal  E-mail: rakhi.ghoshal@gmail.com     Received: 06 Sep 2012  Accepted: 14 Jan 2013  Published: 23 Jan 2013    J Med Ethics Hist Med, 2013, 6:2  http://journals.tums.ac.ir/abs/22985    © 2013 Rakhi Ghoshal et al.",Non-OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Rakhi Ghoshal et al.",OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Rakhi Ghoshal et al.",OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Rakhi Ghoshal et al.",OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Rakhi Ghoshal et al.",OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Rakhi Ghoshal et al.",OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Rakhi Ghoshal et al.",OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Rakhi Ghoshal et al.",OADS,/arxiv_data1/oa_pdf/1c/0a/jmehm-6-2.PMC3713920.pdf
Uhttp://www.newscientist.com/article/mg20227106.000 -decoding -antiquity -eight -scripts -that-still-cant -be- read.html U  (accessed on Sep 2009)   2.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://en.wikipedia.org/wiki/Industrial_Revolution U  (accessed on Sep 2009)   4.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://www.gap -system.org/~history/Mathematicians/Galileo.html U  (accessed on Sep  2009)   6.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
http://en.wikipedia.org/wiki/Scientific_Revolution   (accessed on Sep 2009)   7.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
The Naked Scientists: Science Radio & science Po d- casts Uhttp://www.thenakedscientists.com/HTML/content/news/news/858 U (accessed on Sep 2009)   8.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://bccp.lbl.gov/PDFs/DarkEnergy%20-%20NYTimes.pdf U (accessed on Sep  2009)   9.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://en.wikipedia.org/wiki/Philosophe U (accessed on Sep 2009)   11.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://encyclopedia2.thefreedictionary.com/Romantic - period U (accessed on Sep 2009)   12.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://www.newscientist.com/article/mg20126905.100 - immoral -advances -is-science-out -of-control.html U (accessed on Sep 2009)   16.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://www.indiaenvironmentportal.org.in/content/rice -output -may-drop-10-million -tonnes -says -pawar U (ac- cessed on Sep 2009)   19.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://www.sciencenews.org/view/generic/id/3743/title/Wrong_Number_Plastic_ingredient_spurs_chromosoma l_defects U (accessed on Sep 2009)   20.,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
Uhttp://www.health -enz.com/poisons/plastics.shtml U (accessed  on Sep 2009).,Non-OADS,/arxiv_data1/oa_pdf/7d/6d/jmehm-2-18.PMC3713923.pdf
"  Journal of  Medical Ethics and History of Medicine                                            The challenge of truth telling across cultures: a case study     Farzaneh Zahedi     MD, Endocrinology and Metabolism Research Centre, Medical Ethics and History of Medicine Research Centre, Tehran  University of  Medical Sciences   5th floor, Shariati Hospital, North Kargar Avenue,   Tehran 141 14-13137, Iran   Tel: (+98 21) 88220037-8   Fax: (+98 21) 88220052   Email: fzahedi@sina.tums.ac.ir        Received: 09 Feb  2011   Accepted:  01 Nov  2011  Published:  27 Dec 2011  J Med Ethics Hist Med, 201 1, 4:11    http://journals.tums.ac.ir/abs/20244      © 201 2 Farzaneh Zahedi ; licensee Tehran Univ.",Non-OADS,/arxiv_data1/oa_pdf/de/9a/jmehm-4-11.PMC3713926.pdf
Available   at: http://journals.tums.ac.ir/upload_files/pdf/ 13464.pdf  (accessed in 2010)   30.,Non-OADS,/arxiv_data1/oa_pdf/de/9a/jmehm-4-11.PMC3713926.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013   Journal of Medical Ethics and History of Medicine                                               Teaching  medical ethics: problem ‐based learning  or small group  discussion?",Non-OADS,/arxiv_data1/oa_pdf/5f/cd/jmehm-6-1.PMC3713927.pdf
"Phone: +98 9121245422  Fax: +98 251 6122949  E-mail: adeli@muq.ac.ir      Received: 20 Jan 2012  Accepted: 12 Dec 2012 Published: 01 Jan 2013   J Med Ethics Hist Med, 2013, 6:1  http://journals.tums.ac.ir/abs/22980     © 2013 Akram Heidari et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/cd/jmehm-6-1.PMC3713927.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Akram Heidari et al.",OADS,/arxiv_data1/oa_pdf/5f/cd/jmehm-6-1.PMC3713927.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Akram Heidari et al.",OADS,/arxiv_data1/oa_pdf/5f/cd/jmehm-6-1.PMC3713927.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Akram Heidari et al.",OADS,/arxiv_data1/oa_pdf/5f/cd/jmehm-6-1.PMC3713927.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Akram Heidari et al.",OADS,/arxiv_data1/oa_pdf/5f/cd/jmehm-6-1.PMC3713927.pdf
"Downloaded from  http://journals.tums.ac.ir/  on Tuesday, March 12, 2013 Akram Heidari et al.",OADS,/arxiv_data1/oa_pdf/5f/cd/jmehm-6-1.PMC3713927.pdf
http://www.iranhiv.co m/epidemiology_iran.htm   (accessed on Nov 2008).,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
http://www.irshafa.ir/post-3841.aspx   (accessed on Dec 2008)  7.,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
http://www.who.int/hiv/pub/guidelines/art/en/index.html   (accessed on Dec 2008)  9.,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
2005.  http://aidsinfo.nih.gov/guidelines/perinatal/PER_022405.pdf  (accessed on Dec 2008)   20.,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
http://www.who.int/hiv/pub/ vct/en/hivtestingpolicy04.pdf  (accessed on  Dec 2008)  28.,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
http://data.unaids.org/pub/ExternalDocumen t/2007/20070905_rghr_statement_testing_en.pdf   (accessed on Dec 2008)  32.,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
http://www.who.int/hiv/who_pitc_guidelines.pdf  (accessed on Dec 2008)  33.,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
http://www.who.int/globalatlas/predefinedRe ports/EFS2008/short/EFSCountryProfiles2008_IR.pdf  (accessed on Nov 2008).,OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
http://www.who.int/hiv/pub/guideline s/pmtct_scaleup2007/en/index.html    (accessed on Nov 2008).,Non-OADS,/arxiv_data1/oa_pdf/ac/ef/jmehm-2-1.PMC3713930.pdf
"Box: 51900  Abu Dhabi, UAE   Telephone: 971- 56-7330240  Fax: 971- 2-6102000  Email: awaness@skmc.ae       Received: 07 Sep  2011   Accepted:  30 Oct 201 1  Published:  06 Nov 2011   J Med Ethics Hist Med, 201 1, 4:10  http://journals.tums.ac.ir/abs/1 9532    © 201 1 Abdelkarim Waness ; licensee  Tehran Univ.",Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://www.bma.org.uk/healthcare_policy/professional_values/DoctorsPublicPU.jsp (accessed in 2011)   2.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://muttaqun.com/quran/e/index.html (accessed in 2010)   3.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://www.catholicity.com/catechism/respecting_human_life.htm l (accessed in 2010)   4.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://encyclopedia.farlex.com/ahimsa (accessed in 2010)   5.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://www.unos.org/donation/index.php?topic=history (accesse d in 2011)   12.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://www.law.cornell.edu/uscode/html/uscode42/usc_sec_42_00000274---e000 -.html (accessed  in 2011).,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://www.transparency.org/publications/gcr/gcr_2009 (accessed in 2010)   15.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://www.reuters.com.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://psychology.suite101.com/article.cfm/religion_and_medicine_working_together (accessed in 2010)   29.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://www.clickrally.com/india -introduces -new -law-to-stem -organ -tourist -trafficking/  (accessed in  2011)   30.,Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
http://www.who.int/bulletin/volumes/85/12/06- 039370/en/ (accessed in 2011),Non-OADS,/arxiv_data1/oa_pdf/d8/b0/jmehm-4-10.PMC3713933.pdf
"Phone: +982188250062   Email: naseragha@gmail.com      Received: 09 Jul 201 1  Accepted: 08 Oct 2 011  Published: 12 Oct 2011   J Med Ethics Hist Med, 201 1, 4:9   http://journals.tums.ac.ir/abs/19 413    © 201 1 Naser Aghababaei, Hojjatollah Farahani and Javad Hatami ; licensee Tehran Univ.",Non-OADS,/arxiv_data1/oa_pdf/48/71/jmehm-4-9.PMC3713934.pdf
http://www.sacred- texts.com/isl/masnavi/ (accessed on May 2009),Non-OADS,/arxiv_data1/oa_pdf/2e/38/jmehm-2-6.PMC3713936.pdf
Geneva:  World Health Organization; 2003.  http://www.who.int/3by5/publications/documents/en/ 3by5StrategyMakingItHappen.pdf  (accessed on Oct 2009)   4.,Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
"Towards universal access: s caling up priority HIV/AIDS interventions in the  health sector, progress report; 2009. http://www.who.int/hiv/pub/2009progressreport/en/index.html  (accessed on Oct  2009)   5.",Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
Islamic Republic of Iran Country Report on Monitoring of the United Nations General Assembly Spe cial  Session on HIV and AIDS; January 2008.    http://data.unaids.org/pub/Report/2008/iran_2008_country_progress_report_en.pdf  (accessed on Sep 2009)   6.,Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
"Geneva: World Health Organization, 2003.  http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf  (accessed on Oct 2009)   12.",Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
Geneva; 2007. http://www.who.int/hiv/pub/meetingrepor ts/art_meeting/en/index.html   (accessed on Oct 2009)   16.,Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
"Towards universal access: scaling up priority HIV/AIDS interventions in the  health sector; Progress report, 2009. http://www.who.int/hiv/pub/2009progressreport/en/print.html   (accessed on Oct  2009)   17.",Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
"Was hington DC: national Alliance of State and Territorial AIDS Directors and The  AIDS Treatment Data Network, 1997. http://www.atdn.org/access/adap/report.html  (accessed on Oct 2009)   19.",Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
Geneva: World Health Organization; 2003. http://www.who.int/3by5/publications/guidelines/en/execsumm.pdf   (accessed on Oct 2009)   29.,Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
Geneva:  WHO; 2004. http://www.who.int/ethics/en/ethics_equity_HIV_e.pdf  (accessed on Oct 2009)   39.,Non-OADS,/arxiv_data1/oa_pdf/13/80/jmehm-3-1.PMC3713939.pdf
http://nahad.tums.ac.ir/group/75  (accessed on May 2009)  6.,Non-OADS,/arxiv_data1/oa_pdf/bb/45/jmehm-2-4.PMC3713940.pdf
http://www.makaremshirazi.org/persian/estefta/index.php  (accessed on May 2009)    7.,Non-OADS,/arxiv_data1/oa_pdf/bb/45/jmehm-2-4.PMC3713940.pdf
Available at: http://mehr.tums.ac.ir/Codes.aspx  (accessed on May 2009)  11.,Non-OADS,/arxiv_data1/oa_pdf/bb/45/jmehm-2-4.PMC3713940.pdf
"Email: Karorim@yahoo.co.uk      Received: 23 Nov 2011   Accepted:  27 Dec 2011  Published:  07 Feb 2012  J Med Ethics Hist Med, 201 2, 5:1    http://journals.tums.ac.ir/abs/20181     © 201 2 Karori Mbugua ; licensee Tehran Univ.",Non-OADS,/arxiv_data1/oa_pdf/ae/37/jmehm-5-1.PMC3713942.pdf
http://www.pharmacoeconomy/80-1388- 10-28-18-09-51/390-dr –ghiasi -html (accessed on  2010)   3.,Non-OADS,/arxiv_data1/oa_pdf/78/b6/jmehm-4-2.PMC3713951.pdf
http://www.bih.ir/201007112169.html (accessed on 2010)   9.,Non-OADS,/arxiv_data1/oa_pdf/78/b6/jmehm-4-2.PMC3713951.pdf
Uhttp://www.actionbioscience.org/biotech/mccrary.html#primer U  (accessed on Oct 2008)   2.,Non-OADS,/arxiv_data1/oa_pdf/b8/26/jmehm-2-17.PMC3713953.pdf
Uhttp://www.pmdc.org.pk/ethics.html U (accessed on 10 Oct 2008).,Non-OADS,/arxiv_data1/oa_pdf/b8/26/jmehm-2-17.PMC3713953.pdf
Uhttp://www.siut.org/bioethics/pgdcourse.html U  (accessed on 10 Oct 2008)   5.,Non-OADS,/arxiv_data1/oa_pdf/b8/26/jmehm-2-17.PMC3713953.pdf
Uhttp://www.nationmaster.com/encyclopedia/Keamari_Town U (accessed on 1 Dec 2008)   6.,Non-OADS,/arxiv_data1/oa_pdf/b8/26/jmehm-2-17.PMC3713953.pdf
Uhttp://www.zu.edu.pk/history -university.htm U (accessed on 1  Dec  2008)    7.,Non-OADS,/arxiv_data1/oa_pdf/b8/26/jmehm-2-17.PMC3713953.pdf
Uhttp://www.beep.ac.uk/content/487.0.html U (acces sed 15 May 2009)   8.,Non-OADS,/arxiv_data1/oa_pdf/b8/26/jmehm-2-17.PMC3713953.pdf
http://www.ada.org/prof/prac/law/code/index.asp  (accessed on Dec 2004)   4.,Non-OADS,/arxiv_data1/oa_pdf/0d/ff/jmehm-2-20.PMC3713957.pdf
a. http://en.wikipedia.org/wiki/Environmental_ethics-97k    (accessed on 2008)  2.,Non-OADS,/arxiv_data1/oa_pdf/16/60/jmehm-2-10.PMC3714002.pdf
a. http://plato.stanford.edu/entries/ethics-environmental   (accessed  on 2008)  3.,Non-OADS,/arxiv_data1/oa_pdf/16/60/jmehm-2-10.PMC3714002.pdf
http://en.wikipedia.org /wiki/Rachel_Carson -138k  (accessed on 2009)  7.,Non-OADS,/arxiv_data1/oa_pdf/16/60/jmehm-2-10.PMC3714002.pdf
http://en.wikipedia.org/wiki/Earth_Day   (accessed on 2009)  8.,Non-OADS,/arxiv_data1/oa_pdf/16/60/jmehm-2-10.PMC3714002.pdf
http://en.wikipedia.org/wiki/Discover_ (magazine) - 32k  (accessed on 2009)  10.,Non-OADS,/arxiv_data1/oa_pdf/16/60/jmehm-2-10.PMC3714002.pdf
http://en.wikipedia.org/wiki/Scientific_opinion_on_climate_change  (accessed on 2007)  22.,Non-OADS,/arxiv_data1/oa_pdf/16/60/jmehm-2-10.PMC3714002.pdf
http://www.dh.sa.gov.au/reproductive - technology/other.asp  (accessed in 2006).,Non-OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
"Health Canada, “A Chronology of the Assisted Human Reproduction Act.”  http://www.hc -gc.ca/hl - vs/reprod/hc -sc/general/chronolgy_e.html  (accessed in 2006).",Non-OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
http://laws.justice.gc.ca/en/a -13.4/218740.html  (accessed   in 2006).,Non-OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
http://www.ncbio.org  (accessed in 2006).,OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
http://www.who.ihld/.netherlands.html  (accessed in 2006).,Non-OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
http://www.who.ihld.newzealand.html  (accessed in 2006).,Non-OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
"South Africa Law Commission, “Report on the Review of the Child Care  Act,” December 2002.  http://law.wits.ac.za/salc.html  (accessed in 2006).",Non-OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
"Human Fertilisation and Embryology Act, 2008. on  http://www.dh.gov.uk/en/Publicationsandstatistics/Legislation/Actsandbills/DH_080211  (accessed in 2010)   19.",Non-OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
http://www.legislation.gov.hk/BLIS_export.nsf/findEngLawb?OpenAgent  (accessed in 2006)   20.,Non-OADS,/arxiv_data1/oa_pdf/67/75/jmehm-3-2.PMC3714004.pdf
http://www.cerebromente.org.br/n11/mente/eisntein/cerebro -homens.html  (accessed on 2011)   10.,Non-OADS,/arxiv_data1/oa_pdf/73/e4/jmehm-4-5.PMC3714006.pdf
"The ethics OSCE: standardized patient scenarios for teaching and evaluating bioethics, 1994.  http://wings.buffalo.edu/bioethics/osce.html (accessed in 2010)   13.",Non-OADS,/arxiv_data1/oa_pdf/bb/32/jmehm-3-5.PMC3714008.pdf
http://www.med -ed-online.org  (accessed in 2010),Non-OADS,/arxiv_data1/oa_pdf/bb/32/jmehm-3-5.PMC3714008.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/8e/djt145.PMC3714019.pdf
http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/71/8e/djt145.PMC3714019.pdf
1990. http://www.nytimes.com/1990/08/26/magazine/doctor -talk- to-e.html?pagewanted=5   2.,Non-OADS,/arxiv_data1/oa_pdf/55/20/jmehm-4-3.PMC3714107.pdf
"http://www.phenomenologyonline.com/inquiry/33.html  (accessed  on Fe b 2009)   31. van Mannen M. Researching Lived Experience: Human Science for an Action Sensitive Pedagogy, 2nd ed.",Non-OADS,/arxiv_data1/oa_pdf/32/a2/jmehm-3-4.PMC3714119.pdf
"Email: fahimehjalali2007@gmail.com    Tel: +983413205218     Received: 21 Apr  2012  Accepted: 07 Aug  2012  Published: 08 Oct  2012    J Med Ethics Hist Med, 201 2, 5:6   http://journals.tums.ac.ir/abs/22177    © 201 2 Fariba Borhani  et al.",Non-OADS,/arxiv_data1/oa_pdf/2f/06/jmehm-5-6.PMC3714120.pdf
http://jax.shands.org/education/medtech/ (accessed on 29 Sept 2006)  7.,Non-OADS,/arxiv_data1/oa_pdf/1a/0d/jmehm-2-8.PMC3714122.pdf
"*21#16 Azar Ave, Keshavarz Blvd, Tehran, Iran   Phone: +982166419661  Email: mehr@tums.ac.ir      Received: 05 Dec  2011  Accepted: 24 Jan 2012  Published: 29 Mar 2012    J Med Ethics Hist Med, 201 2, 5:4   http://journals.tums.ac.ir/abs/20749   © 201 2 Alireza Parsapoor  et al.",Non-OADS,/arxiv_data1/oa_pdf/87/3d/jmehm-5-4.PMC3714124.pdf
"Joint Commission Interna tional Accreditation Standards for Hospitals, 4th Edition, 2010.  http://www.jointcommissioninternational.org/AccreditationManuals/EBIAS400/1553/ (accessed in 2011).",Non-OADS,/arxiv_data1/oa_pdf/87/3d/jmehm-5-4.PMC3714124.pdf
"The Patients Association, Survey of The UK Public Patients' rights Main Report, December  2005.http://www.patients -association.org.uk   /DBIMGS/file/The%20Public%20Perception%20of%20Patients%E2%80%99%20Rights%20Within%20The%20UK.pdf  (accessed in 2011).",Non-OADS,/arxiv_data1/oa_pdf/87/3d/jmehm-5-4.PMC3714124.pdf
"The EU Charter of Patients’ Rights - A civic assessment, Active Citizenship Network, 2011.  http://www.activecitizenship.net/files/european _day/2011/european_conference/abstract.pdf  (accessed in 2011)   15.",Non-OADS,/arxiv_data1/oa_pdf/87/3d/jmehm-5-4.PMC3714124.pdf
"17,18 Recently, Kubinak et al.19 seri- ally passaged Friend virus (FV) through a single strain of inbred congenic mice to test how differences at MHC (major histocompatibility complex) loci could influence patterns of viral adaptation and Variation in host resistance could limit the spread  of more broadly virulent pathogens Victoria C Barclay Center for i nfectious d isease d ynamics; d epartment of Biology; Penn State University; University Park, P a US a Keywords:  virulence, resistance, specialization, tolerance, trade-offs *Correspondence to: Victoria C Barclay; Email: vcb11@psu.edu Submitted: 05/15/13; Accepted: 05/16/13http://dx.doi.org/10.4161/viru.25061Comment on: Kubinak JL, et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Virulence 2013; 4:410-8; PMID:23645287; http://dx.doi.org/10.4161/viru.24724virulence evolution.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Science  2003; 299:1735-7; PMID:12637745; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Expert Rev Vaccines 2005; 4:77-88; PMID:15757475;  http://dx.doi.org/10.1586/14760584.4.1.77 14.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Philos T rans R Soc Lond  B Biol Sci 2010; 365:1997-2007; PMID:20478894;  http://dx.doi.org/10.1098/rstb.2010.0044 15.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Virulence 2013; 4:410-8; PMID:23645287;  http://dx.doi.org/10.4161/viru.24724 17.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Curr Opin Immunol 2002; 14:609-14;  PMID:12183161; http://dx.doi.org/10.1016/S0952- 7915(02)00381-3 18.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Science 1998; 282:1432-5; PMID:9822369; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Proc Biol Sci 2010; 277:979-88; PMID:20071384; http://dx.doi.org/10.1098/ rspb.2009.2084 21.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Am Nat 1999; 153:145-64; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Science 2007; 318:812-4; PMID:17975068;  http://dx.doi.org/10.1126/science.1148526 23.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Cell Host Microbe 2009; 6:203-5; PMID:19748463;  http://dx.doi.org/10.1016/j.chom.2009.08.010 24.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
T rends Ecol Evol 2010; 25:267-74; PMID:20092909; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Malar J 2008; 7:257; PMID:19087299;  http://dx.doi.org/10.1186/1475-2875-7-257 26.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Proc Natl Acad Sci U S A  2007; 104:19914-9; PMID:18056635; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Mol Ecol  2008; 17:485-99; PMID:18173510; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Vaccine 2008;  26(Suppl 3):C1-3; PMID:18773533; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Proc Biol Sci 2004; 271:1557- 64; PMID:15306300; http://dx.doi.org/10.1098/ rspb.2004.2736 6.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Proc Biol Sci 2012; 279:4677- 85; PMID:23015626; http://dx.doi.org/10.1098/ rspb.2012.1792 7.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
PLoS Biol 2004;  2:E230; PMID:15221031; http://dx.doi.org/10.1371/ journal.pbio.0020230 9.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
PLoS Biol 2012; 10:e1001368;  PMID:22870063; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Annu Rev Phytopathol  2002; 40:381-410; PMID:12147765; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
T rends Ecol  Evol 2008; 23:631-7; PMID:18715674; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Immunogenetics 2012; 64:525-33;  PMID:22460528; http://dx.doi.org/10.1007/s00251- 012-0614-4 35.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Biol Lett 2013; 9:20120900;  PMID:23221872; http://dx.doi.org/10.1098/ rsbl.2012.0900 36.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Nature 2010; 464:275- 8; PMID:20182425; http://dx.doi.org/10.1038/ nature08798 30.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Virology 2000; 267:36-48; PMID:10648181;  http://dx.doi.org/10.1006/viro.1999.0104 31.,Non-OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Ecol Lett 2006; 9:485-98;  PMID:16623733; http://dx.doi.org/10.1111/j.1461- 0248.2006.00885.x 32.,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
Proc Natl Acad Sci U S A 2003; 100:567-71; PMID:12525705; http://dx.doi.org/10.1073/ pnas.0233733100,OADS,/arxiv_data1/oa_pdf/ae/56/viru-4-347.PMC3714125.pdf
"4 The development of model organisms  as research tools in life sciences has been crucial for the advancement of knowledge Developing Galleria mellonella as a model host   for human pathogens Simon M Cook and Jason d Mc arthur* illawarra Health and Medical r esearch i nstitute; School of Biological Sciences; University of Wollongong; Wollongong, NSW australia Keywords:  model organism, infection, Galleria mellonella,  immunity, pathogenesis *Correspondence to: Jason D McArthur; Email: jasonm@uow.edu.au Submitted: 05/30/13; Accepted: 05/31/13http://dx.doi.org/10.4161/viru.25240Comment on: Loh JMS, et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Virulence 2013; 4:419-28; PMID:23652836; http://dx.doi.org/10.4161/viru.24930across many disciplines.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Infect Immun 2005; 73:3842- 50; PMID:15972469; http://dx.doi.org/10.1128/ IAI.73.7.3842-3850.2005 14.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Infect Immun 2009;  77:4345-55; PMID:19620339; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Virulence 2010; 1:475- 82; PMID:21178491; http://dx.doi.org/10.4161/ viru.1.6.12985 16.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Mycopathologia 2004; 158:73-9; PMID:15487324; http://dx.doi.org/10.1023/ B:MYCO.0000038434.55764.16 17.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Mycopathologia  2006; 161:377-84; PMID:16761185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Microbiology 2006; 152:223- 32; PMID:16385132; http://dx.doi.org/10.1099/ mic.0.28452-0 21.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
FEMS Immunol Med Microbiol 2000; 27:163- 9; PMID:10640612; http://dx.doi.org/10.1111/j.1574-695X.2000.tb01427.x 22.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
FEMS Immunol Med Microbiol 2002; 34:153-7;  PMID:12381467; http://dx.doi.org/10.1111/j.1574- 695X.2002.tb00617.x 23.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Microbes Infect  2010; 12:488-96; PMID:20223293; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Antimicrob Agents Chemother  2009; 53:2605-9; PMID:19332683; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
"Antimicrob Agents Chemother 2011; 55:3534-7; PMID:21502628; http://dx.doi.org/10.1128/ AAC.00230-11on the collation of data, the standard - ization of techniques and the dissemi - nation of this information will further  advance the usefulness of G. mellonella  as  a model organism.",Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Virulence 2011;  2:521-7; PMID:22186764; http://dx.doi.org/10.4161/ viru.2.6.18520 2.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
FEMS Microbiol Rev 2004; 28:101-12; PMID:14975532; http://dx.doi.org/10.1016/j.fem- sre.2003.09.002 4.,OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Stud Hist Philos Sci 2011; 42:313-23;  http://dx.doi.org/10.1016/j.shpsa.2010.11.039 6.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Virulence 2013; 4:419-28; PMID:23652836;  http://dx.doi.org/10.4161/viru.24930.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Parasitology 2006; 132:767-73; PMID:16497252;  http://dx.doi.org/10.1017/S0031182006009929 9.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
BMC Genomics 2011; 12:308; PMID:21663692; http://dx.doi.org/10.1186/1471-2164-12-308 10.,OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Virulence 2012; 3:497- 503; PMID:23076277; http://dx.doi.org/10.4161/viru.21972 11.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Mol Microbiol 2006; 62:339- 55; PMID:16978259; http://dx.doi.org/10.1111/ j.1365-2958.2006.05362.x 12.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
J Antimicrob Chemother  2011; 66:1785-90; PMID:21622972; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
PLoS Pathog 2012; 8:e1002834;  PMID:22876178; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Microbiology  2009; 155:3564-71; PMID:19696101; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
J  Bacteriol 2001; 183:7126-34; PMID:11717271;  http://dx.doi.org/10.1128/JB.183.24.7126-7134.2001 34.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Infect Immun 2003; 71:2404-13; PMID:12704110; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
J Infect Dis 2009; 199:532-6;  PMID:19125671; http://dx.doi.org/10.1086/59651127.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
PLoS One 2011; 6:e22674;  PMID:21829642; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Infect Immun 2012; 80:1015- 24; PMID:22232188; http://dx.doi.org/10.1128/IAI.06279-11 29.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Appl Environ Microbiol 2010; 76:310-7; PMID:19897755;  http://dx.doi.org/10.1128/AEM.01301-09 30.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Microbiology 2010; 156:3456- 68; PMID:20688820; http://dx.doi.org/10.1099/ mic.0.040782-0 31.,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
J Bacteriol 2000; 182:3843- 5; PMID:10851003; http://dx.doi.org/10.1128/ JB.182.13.3843-3845.2000,Non-OADS,/arxiv_data1/oa_pdf/0e/6f/viru-4-350.PMC3714126.pdf
Cell 2002; 108:13-6; PMID:11792317;  http://dx.doi.org/10.1016/S0092-8674(01)00637-7 2.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Rev Microbiol 2007; 5:801-12; PMID:17853907; http://dx.doi.org/10.1038/nrmi- cro1750 3.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nature 2005; 437:356- 61; PMID:16163346; http://dx.doi.org/10.1038/nature04160 4.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Res Microbiol 2008; 159:367-73;  PMID:18541415; http://dx.doi.org/10.1016/j.res- mic.2008.04.006 5.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol  2003; 185:6220-3; PMID:14526037; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2004; 186:3677-86;  PMID:15175280; http://dx.doi.org/10.1128/ JB.186.12.3677-3686.20047.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2004; 186:8287- 94; PMID:15576777; http://dx.doi.org/10.1128/ JB.186.24.8287-8294.2004 8.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol  2004; 53:9-18; PMID:15225299; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Arch Virol 2012;  157:1843-9; PMID:22752841; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Annu Rev Microbiol  2000; 54:799-825; PMID:11018145; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2003; 49:277-300; PMID:12886937; http://dx.doi.org/10.1046/j.1365- 2958.2003.03580.x 15.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
T rends Microbiol  2002; 10:515-21; PMID:12419616; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
T rends Microbiol 2001; 9:481-5; PMID:11597449; http://dx.doi.org/10.1016/S0966-842X(01)02173-4 17.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2005; 187:3311- 8; PMID:15866915; http://dx.doi.org/10.1128/JB.187.10.3311-3318.2005 19.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Mol Biol 2000; 299:27- 51; PMID:10860721; http://dx.doi.org/10.1006/ jmbi.2000.3729 51.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Theor Popul Biol 2002; 61:471-80; PMID:12167366;  http://dx.doi.org/10.1006/tpbi.2002.1590 53.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Virology 1998; 241:345- 56; PMID:9499809; http://dx.doi.org/10.1006/ viro.1997.8959 55.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Virology 2000; 270:65- 75; PMID:10772980; http://dx.doi.org/10.1006/ viro.2000.0226 56.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J  Bacteriol 2007; 189:1482-7; PMID:17041060; http://dx.doi.org/10.1128/JB.01111-06 58.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Appl Environ Microbiol 2000; 66:895-903; PMID:10698748; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Curr Opin Microbiol 2005; 8:473-9; PMID:15979388;  http://dx.doi.org/10.1016/j.mib.2005.06.006 60.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Biotechnol 2004; 22:31-6; PMID:14704699; http://dx.doi.org/10.1038/ nbt0104-31 61.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Infect Dis 2010; 201:1096-104; PMID:20196657;  http://dx.doi.org/10.1086/651135 62.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Antimicrob Agents  Chemother 2007; 51:2765-73; PMID:17517843;  http://dx.doi.org/10.1128/AAC.01513-06 63.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Microbiology 2005; 151:2133-40;  PMID:16000704; http://dx.doi.org/10.1099/ mic.0.27849-0 65.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Rev Microbiol 2004; 2:166- 73; PMID:15040264; http://dx.doi.org/10.1038/ nrmicro822 66.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Curr Opin Microbiol  2005; 8:459-65; PMID:15979389; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Science 2009; 323:139-41;  PMID:19119236; http://dx.doi.org/10.1126/sci- ence.1164783 35.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2003; 185:4603- 8; PMID:12867471; http://dx.doi.org/10.1128/ JB.185.15.4603-4608.2003 38.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol  1991; 5:933-9; PMID:1830359; http://dx.doi.org/10.1111/j.1365-2958.1991.tb00768.x 39.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Microbiology  2007; 153:676-85; PMID:17322187; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
PLoS One 2009; 4:e6532; PMID:19672290; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Annu Rev Microbiol  2003; 57:677-701; PMID:14527295; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Cell Host Microbe 2012; 11:19- 32; PMID:22264510; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat  Rev Microbiol 2009; 7:654-65; PMID:19680249;  http://dx.doi.org/10.1038/nrmicro2199 46.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Lancet  2000; 356:1324; PMID:11073024; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Curr Opin Microbiol 2011; 14:92- 8; PMID:21215681; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Genes Nutr  2010; http://dx.doi.org/10.1007/s12263-010-0188-420.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Clin Microbiol 2007; 45:2590- 8; PMID:17522270; http://dx.doi.org/10.1128/ JCM.00729-07 21.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Appl Environ Microbiol 2005; 71:4979- 85; PMID:16151076; http://dx.doi.org/10.1128/ AEM.71.9.4979-4985.2005 22.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2001; 39:260-71; PMID:11136448;  http://dx.doi.org/10.1046/j.1365-2958.2001.02234.x 24.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Arch  Virol 2012; 157:1807-11; PMID:22684535; http://dx.doi.org/10.1007/s00705-012-1361-4 25.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol  2009; 191:3462-8; PMID:19329640; http://dx.doi.org/10.1128/JB.01804-08 26.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2006; 62:1035-47; PMID:17078814; http://dx.doi.org/10.1111/j.1365-2958.2006.05441.x 27.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Adv Virus Res 2012; 82:91-118; PMID:22420852; http://dx.doi.org/10.1016/B978-0-12-394621- 8.00014-5 28.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Science  1996; 272:1910-4; PMID:8658163; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2000; 182:5530- 8; PMID:10986258; http://dx.doi.org/10.1128/JB.182.19.5530-5538.2000 31.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Gut Microbes 2013; 4:4-16; PMID:23022738; http://dx.doi.org/10.4161/gmic.22371 33.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Vet Microbiol 2008; 129:418-25; PMID:18187273;  http://dx.doi.org/10.1016/j.vetmic.2007.11.032,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Infect Immun 2003; 71:1784- 93; PMID:12654792; http://dx.doi.org/10.1128/ IAI.71.4.1784-1793.2003 98.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Microbiology 1999;  145:1683-93; PMID:10439407; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Microbiology  2008; 154:3430-6; PMID:18957596; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2007; 66:206-19; PMID:17725558; http://dx.doi.org/10.1111/j.1365-2958.2007.05906.x 101.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Med  Microbiol 2005; 54:129-35; PMID:15673505; http://dx.doi.org/10.1099/jmm.0.45821-0 102.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2011; 193:2726-34; PMID:21441508; http://dx.doi.org/10.1128/ JB.00787-10 103.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Virol 2009; 83:12037- 45; PMID:19776116; http://dx.doi.org/10.1128/ JVI.01256-09 104.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Infect Genet Evol 2005;  5:1-9; PMID:15567133; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Cell Host Microbe  2009; 6:125-36; PMID:19683679; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Cell Host Microbe  2012; 11:129-39; PMID:22341462; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2003; 185:6950-67; PMID:14617659;  http://dx.doi.org/10.1128/JB.185.23.6950-6967.2003 109.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
PLoS Pathog 2012; 8:e1002727; PMID:22685398;  http://dx.doi.org/10.1371/journal.ppat.1002727 111.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Proc Natl Acad Sci U S A 2004; 101:4614- 9; PMID:15070766; http://dx.doi.org/10.1073/ pnas.040093210182.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Genome Res 2003;  13(6A):1042-55; PMID:12799345; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Lancet  2001; 357:1225-40; PMID:11418146; http://dx.doi.org/10.1016/S0140-6736(00)04403-2 88.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2000; 38:694-705; PMID:11115106; http://dx.doi.org/10.1046/j.1365-2958.2000.02169.x 91.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Rev Microbiol 2009; 7:526-36;  PMID:19528959; http://dx.doi.org/10.1038/nrmi- cro2164 92.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2007; 64:1274-88; PMID:17542920; http://dx.doi.org/10.1111/j.1365- 2958.2007.05739.x 94.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol  1998; 27:107-20; PMID:9466260; http://dx.doi.org/10.1046/j.1365-2958.1998.00663.x 96.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2002; 184:5971-8; PMID:12374831; http://dx.doi.org/10.1128/ JB.184.21.5971-5978.200267.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Appl Environ Microbiol 2012; 78:7662- 70; PMID:22923402; http://dx.doi.org/10.1128/ AEM.02275-12 68.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Infect Dis 2000; 181:664-70;  PMID:10669353; http://dx.doi.org/10.1086/315239 69.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Lancet 1999; 353:1588-9;  PMID:10334263; http://dx.doi.org/10.1016/S0140- 6736(99)00621-2 70.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Infect Immun 2003; 71:3028- 33; PMID:12761079; http://dx.doi.org/10.1128/ IAI.71.6.3028-3033.2003 71.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 1998; 29:527-43; PMID:9720870; http://dx.doi.org/10.1046/j.1365-2958.1998.00947.x 72.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol  2006; 188:2726-9; PMID:16547063; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Microbes Infect  2001; 3:585-94; PMID:11418332; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Bacteriophage and the toxigenicity of Clostridium  botulinum type C. Science 1971; 172:480-2;  PMID:4927679; http://dx.doi.org/10.1126/sci- ence.172.3982.480 75.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Gene 2000; 258:127-39; PMID:11111050; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol  1998; 28:1255-67; PMID:9680214; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2002; 44:957-70; PMID:12010491;  http://dx.doi.org/10.1046/j.1365-2958.2002.02950.x 81.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2001; 183:2081- 5; PMID:11222608; http://dx.doi.org/10.1128/ JB.183.6.2081-2085.2001,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
"Bacteriophage 2012; 2:89-97; PMID:23050219;  http://dx.doi.org/10.4161/bact.21363 140. Zimmer M, Scherer S, Loessner MJ.",Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Bacteriol 2002; 184:4359-68; PMID:12142405;  http://dx.doi.org/10.1128/JB.184.16.4359-4368.2002 141.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Microbiology  1995; 141:323-7; PMID:7704261; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Science 1989; 243:507-12; PMID:2536191; http://dx.doi.org/10.1126/sci- ence.2536191 143.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Genet 2006; 38:779-86; PMID:16804543; http://dx.doi.org/10.1038/ng1830 144.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2003; 48:811-21;  PMID:12694623; http://dx.doi.org/10.1046/j.1365-2958.2003.03471.x 145.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
FEMS Microbiol Rev 2004; 28:127-81; PMID:15109783;  http://dx.doi.org/10.1016/j.femsre.2003.08.001 148.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
EMBO J 2005; 24:3647- 57; PMID:16193065; http://dx.doi.org/10.1038/ sj.emboj.7600826 149.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Rev Gastroenterol Hepatol  2012; 9:599-608; PMID:22907164; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Microbiol Mol Biol Rev 2000; 64:548-72; PMID:10974126;  http://dx.doi.org/10.1128/MMBR.64.3.548-572.2000 126.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
FEMS Microbiol Rev 2012; 36:131- 48; PMID:22091839; http://dx.doi.org/10.1111/ j.1574-6976.2011.00310.x 127.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Rev Microbiol 2005; 3:969-78; PMID:16261177;  http://dx.doi.org/10.1038/nrmicro1288 128.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Int J Food Microbiol 2012; 158:1-8;  PMID:22795797; http://dx.doi.org/10.1016/j.ijfood - micro.2012.03.004 130.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nature  2002; 418:884-9; PMID:12192412; http://dx.doi.org/10.1038/nature01026 131.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
J Gen Microbiol 1977; 103:45-50; PMID:201726;  http://dx.doi.org/10.1099/00221287-103-1-45112.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
EMBO Rep 2013; 14:95- 102; PMID:23174673; http://dx.doi.org/10.1038/ embor.2012.186 113.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2004; 52:917-24; PMID:15130114;  http://dx.doi.org/10.1111/j.1365-2958.2004.04036.x 114.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Rev Microbiol 2007; 5:48-56; PMID:17143318;  http://dx.doi.org/10.1038/nrmicro1557 116.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Rev Microbiol 2012; 10:39-50; PMID:22120588;  http://dx.doi.org/10.1038/nrmicro2695 117.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
ISME J 2009; 3:271-82; PMID:19005496;  http://dx.doi.org/10.1038/ismej.2008.109 118.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
PLoS One 2010; 5:e15678;  PMID:21187931; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Commun 2010;  1:147-9; PMID:21266997; http://dx.doi.org/10.1038/ ncomms1146 120.,OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nat Rev Microbiol 2012; 10:841-51; PMID:23147702; http://dx.doi.org/10.1038/nrmi- cro2907 121.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Nature 2001;  413:860-4; PMID:11677611; http://dx.doi.org/10.1038/35101627 122.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Microbiology 2007; 153:2083-92; PMID:17600053;  http://dx.doi.org/10.1099/mic.0.2007/006031-0 123.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
Mol Microbiol 2011; 82:1015-37;  PMID:22032623; http://dx.doi.org/10.1111/j.1365- 2958.2011.07867.x 124.,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
PLoS One 2011; 6:e16861; PMID:21347299;  http://dx.doi.org/10.1371/journal.pone.0016861,Non-OADS,/arxiv_data1/oa_pdf/d2/45/viru-4-354.PMC3714127.pdf
"2 HUS is characterized by acute  renal failure, thrombocytopenia, and microangiopathic hemo - lytic anemia and is a potentially fatal cause of acute renal failure  *Correspondence to: Analía Inés Etcheverría;   Email: analiain@vet.unicen.edu.arSubmitted: 12/04/13; Revised: 04/09/13; Accepted: 04/10/13http://dx.doi.org/10.4161/viru.24642Shiga toxin-producing Escherichia coli  (ST eC) cause  hemorrhagic colitis (HC) and hemolytic uremic syndrome  (HUS) in humans.",Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Infect Dis 2004; 189:355-9;  PMID:14745691; http://dx.doi.org/10.1086/381130 4.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Appl Environ Microbiol 2004; 70:1708- 16; PMID:15006796; http://dx.doi.org/10.1128/ AEM.70.3.1708-1716.2004 6.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Lett Appl Microbiol 1994;  19:304-7; PMID:7765442; http://dx.doi.org/10.1111/ j.1472-765X.1994.tb00461.x 7.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Ann Intern Med 1999; 130:202-9;  PMID:10049198; http://dx.doi.org/10.7326/0003- 4819-130-3-199902020-00005 11.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Arch Intern Med 1999; 159:1758-64; PMID:10448779; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
N Engl J Med 2011; 365:1771-80; PMID:21696328; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Appl Microbiol 2003;  94(Suppl):94S-103S; PMID:12675941; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Am J Epidemiol 2007; 165:425-34; PMID:17158472; http://dx.doi.org/10.1093/aje/ kwk023 18.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Curr Microbiol  2012; 65:337-43; PMID:22706777; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Proc Natl Acad Sci U S A 2000; 97:2999- 3003; PMID:10725380; http://dx.doi.org/10.1073/ pnas.97.7.2999 20.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Appl Microbiol 2003; 95:256-66;  PMID:12859756; http://dx.doi.org/10.1046/j.1365-2672.2003.01981.x 22.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Bulletin de L ’Institut Pasteur  1998; 96:151-64; http://dx.doi.org/10.1016/S0020-2452(98)80010-9 23.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Food Microbiol 1997; 14:273-82; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Meat Sci 2010; 86:418-21; PMID:20646836; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Toxicon 2001; 39:1629-35; PMID:11595626; http://dx.doi.org/10.1016/S0041- 0101(01)00150-7 28.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Anim Sci 2007; 85(Suppl):E45-62;  PMID:17085726; http://dx.doi.org/10.2527/jas.2006- 508,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun 2003; 71:1505-12; PMID:12595469; http://dx.doi.org/10.1128/ IAI.71.3.1505-1512.2003 60.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Appl Environ Microbiol 2007; 73:1563-8; PMID:17220263; http://dx.doi.org/10.1128/ AEM.01742-06 61.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Appl Environ Microbiol 2005; 71:93-7; PMID:15640175; http://dx.doi.org/10.1128/ AEM.71.1.93-97.2005 62.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Gut 2000; 47:377-81; PMID:10940275;  http://dx.doi.org/10.1136/gut.47.3.377 64.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Epidemiol Infect 1999; 122:185- 92; PMID:10355781; http://dx.doi.org/10.1017/ S0950268898001976 65.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Mol Microbiol 2011; 80:219-30; PMID:21306441; http://dx.doi.org/10.1111/j.1365- 2958.2011.07568.x 66.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
PLoS Pathog  2010; 6:e1000743; PMID:20126447; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
PLoS Pathog 2010; 6:e1000898; PMID:20485572; http://dx.doi.org/10.1371/journal.ppat.1000898 68.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun  2005; 73:679-86; PMID:15664905; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun 2012; 80:903- 13; PMID:22144484; http://dx.doi.org/10.1128/ IAI.05907-11 70.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
T rends Microbiol 1998; 6:282-7; PMID:9717217;  http://dx.doi.org/10.1016/S0966-842X(98)01288-8 71.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Int J Med Microbiol 2010; 300:440- 8; PMID:20452276; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Dairy Sci 2012; 95:5340-3; PMID:22916940; http://dx.doi.org/10.3168/ jds.2011-5140 46.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Res Vet Sci 2003; 74:283-6; PMID:12726748; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Int J Food Microbiol 2004; 96:189-98; PMID:15364473;  http://dx.doi.org/10.1016/j.ijfoodmicro.2004.03.018 50.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Eur J Epidemiol 2000; 16:757-62; PMID:11142505; http://dx.doi.org/10.1023/A:1026746016896 52.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Appl Microbiol 2009; 106:1260-7;  PMID:19187162; http://dx.doi.org/10.1111/j.1365- 2672.2008.04088.x 54.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Appl Environ Microbiol 2006; 72:2254-9; PMID:16517683; http://dx.doi.org/10.1128/ AEM.72.3.2254-2259.2006 55.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Appl Environ Microbiol  2009; 75:6947-53; PMID:19734327; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Appl Environ Microbiol  2010; 76:5510-9; PMID:20581183; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Lett Appl Microbiol 1999; 29:85-9; PMID:10499295; http://dx.doi.org/10.1046/j.1365- 2672.1999.00585.x 58.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Appl Environ Microbiol  2002; 68:2269-77; PMID:11976097; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Appl Environ Microbiol 2011;  77:73-9; PMID:21037301; http://dx.doi.org/10.1128/ AEM.01445-10 30.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Infect Dis 2002; 185:74-84;  PMID:11756984; http://dx.doi.org/10.1086/338115 32.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Clin  Microbiol 2002; 40:271-4; PMID:11773130; http://dx.doi.org/10.1128/JCM.40.1.271-274.2002 33.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun 2001; 69:6999- 7009; PMID:11598075; http://dx.doi.org/10.1128/ IAI.69.11.6999-7009.2001 37.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Curr Microbiol 2011; 62:1411-5;  PMID:21279513; http://dx.doi.org/10.1007/s00284- 011-9877-5 38.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Crit Rev Microbiol 2007; 33:67-87; PMID:17453930; http://dx.doi.org/10.1080/10408410601172172 41.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Vet Microbiol 2004;  100:3-9; PMID:15135507; http://dx.doi.org/10.1016/ S0378-1135(03)00127-5,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Epidemiol Infect  2001; 127:555-60; PMID:11811890; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Vaccine 2004; 22:362-9;  PMID:14670317; http://dx.doi.org/10.1016/j.vac- cine.2003.08.007 94.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Appl Microbiol 2006; 100:384-9;  PMID:16430515; http://dx.doi.org/10.1111/j.1365- 2672.2005.02779.x.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun 2000; 68:1400-7; PMID:10678953;  http://dx.doi.org/10.1128/IAI.68.3.1400-1407.2000 82.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
FEMS  Microbiol Lett 2007; 271:258-64; PMID:17451446; http://dx.doi.org/10.1111/j.1574-6968.2007.00724.x 83.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Mol  Microbiol 2000; 35:275-88; PMID:10652089; http://dx.doi.org/10.1046/j.1365-2958.2000.01690.x 84.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
FEMS Microbiol Lett 2006; 258:43-9;  PMID:16630253; http://dx.doi.org/10.1111/j.1574- 6968.2006.00198.x 85.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun 2000; 68:2148-55; PMID:10722613; http://dx.doi.org/10.1128/ IAI.68.4.2148-2155.2000 86.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun  2001; 69:6660-9; PMID:11598035; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
J Clin Microbiol 2009; 47:1781- 4; PMID:19357209; http://dx.doi.org/10.1128/JCM.00260-09 73.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Proc Natl Acad Sci U S A  2007; 104:10637-42; PMID:17563352; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Cell Microbiol 2009; 11:121-37;  PMID:19016776; http://dx.doi.org/10.1111/j.1462- 5822.2008.01244.x 75.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Microbiology  2004; 150:3631-45; PMID:15528651; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun 2005; 73:1735-43;  PMID:15731074; http://dx.doi.org/10.1128/ IAI.73.3.1735-1743.2005 77.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Infect Immun  2006; 74:2233-44; PMID:16552054; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Environ Microbiol 2008; 10:589-604;  PMID:18237301; http://dx.doi.org/10.1111/j.1462- 2920.2007.01479.x 80.,OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
Environ Microbiol 2009; 11:1803- 14; PMID:19508554; http://dx.doi.org/10.1111/ j.1462-2920.2009.01905.x,Non-OADS,/arxiv_data1/oa_pdf/1d/e4/viru-4-366.PMC3714128.pdf
"1-4 “Prion” amyloid  states in yeast and bacteria that lack the infectious characteristics  Correspondence to: Laura Manuelidis; Email: laura.manuelidis@yale.edu Submitted: 03/12/13; Revised: 04/25/13; Accepted: 04/26/13http://dx.doi.org/10.4161/viru.24838Transmissible encephalopathies (TSEs) are believed by many  to arise by spontaneous conversion of host prion protein (PrP) into an infectious amyloid (PrP-res, PrP Sc) without nucleic acid.",Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Brain Pathol 2012; 22:58-66;  PMID:21645162; http://dx.doi.org/10.1111/j.1750- 3639.2011.00508.x 3.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S A 2000; 97:5574- 9; PMID:10805813; http://dx.doi.org/10.1073/ pnas.97.10.5574 4.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Neurosci 2012;  32:12396-405; PMID:22956830; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Neural T ransm 2006; 113:1243-51;  PMID:16362635; http://dx.doi.org/10.1007/s00702-005-0385-2 6.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
T rends Neurosci  1998; 21:15-9; PMID:9464679; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Mol Med 2007; 13:190-8;  PMID:17592554; http://dx.doi.org/10.2119/2006- 00073.Karpuj 8.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Vis Exp 2012;  PMID:23168797; http://dx.doi.org/10.3791/4075 9.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S A 2012; 109:E1938- 46; PMID:22711839; http://dx.doi.org/10.1073/ pnas.1206999109 11.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Cell  Biochem 2007; 100:897-915; PMID:17044041;  http://dx.doi.org/10.1002/jcb.21090 12.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Gen Virol 2012; 93:2518- 27; PMID:22915693; http://dx.doi.org/10.1099/ vir.0.045849-0 13.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Cell 1995; 83:79-90; PMID:7553876; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Virol 2012; 86:10494-504;  PMID:22811520; http://dx.doi.org/10.1128/ JVI.01286-12 15.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Science 2004; 305:673-6; PMID:15286374;  http://dx.doi.org/10.1126/science.1100195 16.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
PLoS Pathog  2011; 7:e1002370; PMID:22114554; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Biol Chem 2010; 285:14083- 7; PMID:20304915; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Virol 2012; 86:1874- 6; PMID:22090130; http://dx.doi.org/10.1128/ JVI.06216-11 20.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Acta Neuropathol 2011;  121:135-43; PMID:20535485; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Neurovirol  2011; 17:131-45; PMID:21165784; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Cell Biochem 2009; 106:220-31; PMID:19097123;  http://dx.doi.org/10.1002/jcb.21988 23.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Science 1997;  277:94-8; PMID:9204907; http://dx.doi.org/10.1126/ science.277.5322.94 24.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
PLoS One 2007; 2:e435;  PMID:17502917; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Gen Virol 2006; 87:3737- 40; PMID:17098992; http://dx.doi.org/10.1099/vir.0.82011-0 26.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S A 2001; 98:9289- 94; PMID:11470899; http://dx.doi.org/10.1073/ pnas.161055198 27.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Science 1977; 197:943- 60; PMID:142303; http://dx.doi.org/10.1126/sci- ence.142303 28.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Pathol 2006; 209:4- 14; PMID:16575799; http://dx.doi.org/10.1002/ path.1962,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S  A 1986; 83:6146-50; PMID:3090551; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Virology 2009; 385:343- 50; PMID:19138779; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Immunol 2012; 189:1540-4;  PMID:22772447; http://dx.doi.org/10.4049/jimmu-nol.1103332 62.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Cell 2011; 146:448-61; PMID:21782231;  http://dx.doi.org/10.1016/j.cell.2011.06.041 63.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Cell 2011; 146:348-50; PMID:21816270; http://dx.doi.org/10.1016/j.cell.2011.07.018 64.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Prion 2007; 1:161-9; PMID:19164893; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Acta Neuropathol 2010; 119:177-87; PMID:20052481; http://dx.doi.org/10.1007/s00401- 009-0633-x 66.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
EMBO J 2013; 32:756- 69; PMID:23395905; http://dx.doi.org/10.1038/ emboj.2013.6 68.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Nat Precedings 2009:3344; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
PLoS Genet 2012; 8:e1002626;  PMID:22511878; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S A 1976; 73:223- 7; PMID:1108016; http://dx.doi.org/10.1073/ pnas.73.1.223 71.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S A 2007; 104:1965- 70; PMID:17267596; http://dx.doi.org/10.1073/ pnas.0610999104 46.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S A 2012; 109:3113- 8; PMID:22323583; http://dx.doi.org/10.1073/ pnas.1118090109 47.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Ann Inst Pasteur (Paris)  1997; 8:311-26; http://dx.doi.org/10.1016/S0924- 4204(97)86597-3 48.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Virol 2000; 74:8614- 22; PMID:10954563; http://dx.doi.org/10.1128/JVI.74.18.8614-8622.2000 51.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S A 2003; 100:675-9; PMID:12525699; http://dx.doi.org/10.1073/ pnas.0237313100 52.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Viruses 2012; 4:3389-419; PMID:23342365; http://dx.doi.org/10.3390/ v4123389 53.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
PLoS Pathog  2012; 8:e1002538; PMID:22359509; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Proc Natl Acad Sci U S A 2004; 101:8768- 73; PMID:15161970; http://dx.doi.org/10.1073/ pnas.0400158101 55.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Science 2005; 310:493-6;  PMID:16239476; http://dx.doi.org/10.1126/sci- ence.1118155 56.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J Neurovirol 2008;  14:352-61; PMID:18989813; http://dx.doi.org/10.1080/13550280802105283 57.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Zoonoses  Public Health 2007; 54:185-90; PMID:17542960;  http://dx.doi.org/10.1111/j.1863-2378.2007.01040.x 31.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
J  Cell Biochem 2011; 112:3630-7; PMID:21793041;  http://dx.doi.org/10.1002/jcb.23286 32.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Chem Biol 1998; 5:R245-9;  PMID:9818143; http://dx.doi.org/10.1016/S1074- 5521(98)90108-9 33.,OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Virulence 2011; 2:188- 99; PMID:21527829; http://dx.doi.org/10.4161/viru.2.3.15880 34.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Virology 1996; 216:46- 59; PMID:8615006; http://dx.doi.org/10.1006/viro.1996.0033 35.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Nature 1978; 271:778-9; PMID:342977; http://dx.doi.org/10.1038/271778a0 36.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Viral Immunol 2003;  16:123-39; PMID:12828865; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
PLoS Pathog 2012; 8:e1002973;  PMID:23166488; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
PLoS Pathog  2013; 9:e1003219; PMID:23505374; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
Neurobiol Dis 2000; 7:299- 309; PMID:10964602; http://dx.doi.org/10.1006/ nbdi.2000.0301,Non-OADS,/arxiv_data1/oa_pdf/1c/c0/viru-4-373.PMC3714129.pdf
"For example, the Salmonella enterica  serovar Typhimurium asd  gene encodes aspartate-semi - aldehyde dehydrogenase, responsible for the formation of diami - nopimelic acid (DAP), an essential component for gram-negative  *Correspondence to: David W. Pascual; Email: pascuald@ufl.edu Submitted: 03/03/13; Revised: 04/29/13; Accepted: 04/30/13http://dx.doi.org/10.4161/viru.24886Live attenuated vaccines are adept in stimulating protective  immunity.",Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Infect Immun 2001; 69:547-50; PMID:11119550; http://dx.doi.org/10.1128/ IAI.69.1.547-550.2001 30.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Adv Exp Med Biol 2008; 631:7- 21; PMID:18792679; http://dx.doi.org/10.1007/978- 0-387-78885-2_2 31.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Infect Immun 2009; 77:1071- 82; PMID:19103774; http://dx.doi.org/10.1128/IAI.00693-08 32.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Infect Immun 2010; 78:1304- 13; PMID:20086087; http://dx.doi.org/10.1128/ IAI.01122-09 33.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Crit Rev Immunol  2010; 30:255-70; PMID:20370633; http://dx.doi.org/10.1615/CritRevImmunol.v30.i3.30 34.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Phys Biol 2012; 9:036005;  PMID:22562964; http://dx.doi.org/10.1088/1478- 3975/9/3/036005 36.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
J Biomed Biotechnol 2011;  2011:632396; PMID:22007145; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Langmuir 2009; 25:4588-94; PMID:19260649; http://dx.doi.org/10.1021/la8033319 38.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
PLoS One 2012; 7:e36283;  PMID:22558420; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
PLoS One 2012; 7:e46828; PMID:23056473;  http://dx.doi.org/10.1371/journal.pone.0046828 41.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Vaccine 2010; 28:1069-74; PMID:19914192; http://dx.doi.org/10.1016/j.vac- cine.2009.10.113 43.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Front Biol 2013; 8:60-77; http://dx.doi.org/10.1007/ s11515-012-1196-015.,OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
"Int J Food Microbiol 1997; 35:223-30; PMID:9105931; http://dx.doi.org/10.1016/S0168- 1605(96)01236-6 16. Cooper GL, Venables LM, Woodward MJ, Hormaeche CE.",OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Hum Gene Ther  2007; 18:746-52; PMID:17696764; http://dx.doi.org/10.1089/hum.2007.053 19.,OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Eur J Immunol 1999; 29:693- 9; PMID:10064087; http://dx.doi.org/10.1002/ (SICI)1521-4141(199902)29:02<693::AID-IMMU693>3.0.CO;2-V 20.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Infect Immun  2009; 77:3424-31; PMID:19506014; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Vaccine 1996; 14:19-24; PMID:8821644; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
J Infect Dis 1996; 173:1408- 14; PMID:8648213; http://dx.doi.org/10.1093/ infdis/173.6.1408 27.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Infect Immun 2000; 68:3419-25; PMID:10816493; http://dx.doi.org/10.1128/IAI.68.6.3419-3425.2000References 1.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Gene 1990; 94:29-35;  PMID:2227450; http://dx.doi.org/10.1016/0378-1119(90)90464-3 2.,OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
J Microbiol  2010; 48:486-95; PMID:20799091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Nature 1981; 291:238-9; PMID:7015147; http://dx.doi.org/10.1038/291238a0 5.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
J  Clin Invest 1992; 90:412-20; PMID:1644914; http://dx.doi.org/10.1172/JCI115876 6.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Vaccine 1992; 10:443-6; PMID:1609547; http://dx.doi.org/10.1016/0264-410X(92)90392-W 7.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Vaccine 1991; 9:29-34; PMID:2008797; http://dx.doi.org/10.1016/0264- 410X(91)90313-U 10.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Vaccine  2006; 24:4285-9; PMID:16584815; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Vaccine  2001; 19:3432-6; PMID:11348707; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Vaccine 2002; 20:3034-41;  PMID:12126917; http://dx.doi.org/10.1016/S0264-410X(02)00227-X,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Mol Microbiol 1990; 4:1807-18; PMID:1707122;  http://dx.doi.org/10.1111/j.1365-2958.1990.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
J Immunol 2010;  185:5677-82; PMID:21048152; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
Clin Vaccine Immunol 2009;  16:21-8; PMID:18987167; http://dx.doi.org/10.1128/ CVI.00333-08,Non-OADS,/arxiv_data1/oa_pdf/39/3a/viru-4-384.PMC3714130.pdf
"These yeast form colonies, produce germ tubes and fila - ments, and secret extracellular polymeric substance (EPS) that  *Correspondence to: Juliana C. Junqueira; Email: julianacjunqueira@  hotmail.comSubmitted: 02/04/13; Revised: 05/24/13; Accepted: 05/28/13http://dx.doi.org/10.4161/viru.25199The Candida  genus expresses virulence factors that, when  combined with immunosuppression and other risk factors,  can cause different manifestations of oral candidiasis.",Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Mycoses 2003; 46:299-306; PMID:12950898; http://dx.doi.org/10.1046/j.1439-0507.2003.00896.x 2.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Surg Oral Med Oral Pathol Oral Radiol Endod  2009; 108:203-10; PMID:19615660; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Clin Microbiol Infect  2009; 15:364-71; PMID:19431223; http://dx.doi.org/10.1111/j.1469-0691.2009.02707.x 4.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral  Dis 2009; 15:229-34; PMID:19207880; http://dx.doi.org/10.1111/j.1601-0825.2009.01514.x 5.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Mycoses 2009; 52:53-9; PMID:18498298; http://dx.doi.org/10.1111/j.1439-0507.2008.01542.x 6.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J Appl Oral Sci 2011;  19:6-10; PMID:21437462; http://dx.doi.org/10.1590/ S1678-77572011000100003 7.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Rev Inst Med T rop Sao Paulo 2012; 54:17-24;  PMID:22370749; http://dx.doi.org/10.1590/S0036-46652012000100004 8.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Mycoses 2005; 48:365-77; PMID:16262871; http://dx.doi.org/10.1111/j.1439-0507.2005.01165.x 9.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Acta Microbiol Immunol Hung 2007; 54:201- 35; PMID:17896473; http://dx.doi.org/10.1556/ AMicr.54.2007.3.1 10.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
BMC Microbiol 2011; 11:247;  PMID:22053894; http://dx.doi.org/10.1186/1471-2180-11-24711.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Curr Microbiol 2010; 61:534-40; PMID:20401483; http://dx.doi.org/10.1007/s00284- 010-9649-7 12.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Dis 2008; 14:582-90; PMID:19076549; http://dx.doi.org/10.1111/ j.1601-0825.2007.01424.x 13.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Crit Rev Microbiol 2009; 35:340-55; PMID:19863383;  http://dx.doi.org/10.3109/10408410903241436 14.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Antimicrob Agents  Chemother 2002; 46:1773-80; PMID:12019089;  http://dx.doi.org/10.1128/AAC.46.6.1773-1780.2002 15.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Crit Rev Microbiol 2011;  37:328-36; PMID:21777047; http://dx.doi.org/10.31 09/1040841X.2011.585606 16.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J Oral Microbiol 2011; 3:5771;  PMID:21547018; http://dx.doi.org/10.3402/jom.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Arch Oral Biol 2008; 53:388-97;  PMID:18191810; http://dx.doi.org/10.1016/j.archo- ralbio.2007.11.009 18.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J Asthma 2005; 42:601-4; PMID:16169797; http://dx.doi.org/10.1080/02770900500216259 20.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96:283-7; PMID:12973284;  http://dx.doi.org/10.1016/S1079-2104(03)00224-5 21.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Acta Odontol Scand  1988; 46:267-72; PMID:3063051; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Drugs Aging 2008; 25:119-30; PMID:18257599;  http://dx.doi.org/10.2165/00002512-200825020- 0000423.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Diabet Med 2006; 23:455-9; PMID:16681553; http://dx.doi.org/10.1111/j.1464-5491.2005.01701.x 24.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J Oral Pathol 1986; 15:61-5; PMID:3083063;  http://dx.doi.org/10.1111/j.1600-0714.1986.tb00578.x 25.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Dis 2008; 14:138-43; PMID:18302673; http://dx.doi.org/10.1111/j.1601- 0825.2006.01357.x 26.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
BMC Microbiol  2008; 8:135; PMID:18694525; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Periodontol 2000 2009; 49:39-59;  PMID:19152525; http://dx.doi.org/10.1111/j.1600- 0757.2008.00291.x 30.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Aust  Dent J 2010; 55(Suppl 1):48-54; PMID:20553244;  http://dx.doi.org/10.1111/j.1834-7819.2010.01198.x 31.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Periodontol 2000 2011; 55:250-65; PMID:21134239; http://dx.doi.org/10.1111/j.1600- 0757.2009.00338.x 32.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J Prosthodont 2011; 20:251-60;  PMID:21463383; http://dx.doi.org/10.1111/j.1532- 849X.2011.00698.x 33.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Int J  Med Microbiol 2011; 301:417-22; PMID:21555244;  http://dx.doi.org/10.1016/j.ijmm.2011.04.009 34.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Curr  Opin Microbiol 2012; 15:406-12; PMID:22609181;  http://dx.doi.org/10.1016/j.mib.2012.04.005 35.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Clin Microbiol Rev  2001; 14:398-429; PMID:11292645; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Nat Protoc 2012; 7:637-42; PMID:22402633;  http://dx.doi.org/10.1038/nprot.2012.011 62.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J Med Microbiol  2004; 53:495-500; PMID:15150327; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J Infect Chemother  2004; 10:253-5; PMID:15365870; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Biol Pharm Bull 2008; 31:278- 83; PMID:18239287; http://dx.doi.org/10.1248/bpb.31.278 66.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Surg Oral Med Oral Pathol Oral  Radiol Endod 2010; 109:392-401; PMID:20060338;  http://dx.doi.org/10.1016/j.tripleo.2009.10.006 67.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Biol Pharm Bull 2012; 35:861- 5; PMID:22687476; http://dx.doi.org/10.1248/ bpb.35.861 68.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
FEMS Microbiol Lett  2012; 328:130-7; PMID:22211961; http://dx.doi.org/10.1111/j.1574-6968.2011.02490.x 69.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Surg Oral Med Oral Pathol Oral  Radiol Endod 2002; 93:155-60; PMID:11862203;  http://dx.doi.org/10.1067/moe.2002.120051 70.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
PLoS One 2009; 4:e7967;  PMID:19956771; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J  Nutr Health Aging 2012; 16:575-9; PMID:22660000;  http://dx.doi.org/10.1007/s12603-012-0007-2 50.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Med Mycol 2006; 44:103-11; PMID:16519012;  http://dx.doi.org/10.1080/13693780500086527 51.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Lasers Med  Sci 2009; 24:877-84; PMID:19408038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Braz J Infect  Dis 2004; 8:217-26; PMID:15476054; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Clin  Vaccine Immunol 2010; 17:668-73; PMID:20130126; http://dx.doi.org/10.1128/CVI.00380-09 55.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Infect Immun  2012; 80:1736-43; PMID:22392931; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Infect Immun  2010; 78:3650-9; PMID:20605982; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Curr Opin  Microbiol 2004; 7:324-9; PMID:15288620; http://dx.doi.org/10.1016/j.mib.2004.06.001 59.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Braz Oral Res 2004; 18:202-7; PMID:15619872; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Microbes Infect 2007; 9:615-22; PMID:17383212; http://dx.doi.org/10.1016/j.micinf.2007.01.01236.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Adv Exp Med Biol 2012; 710:95-105;  PMID:22127889; http://dx.doi.org/10.1007/978-1- 4419-5638-5_10 37.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Nihon Ishinkin Gakkai Zasshi  2010; 51:13-21; PMID:20185867; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Surg Oral Med Oral Pathol Oral Radiol Endod  2011; 111:71-7; PMID:21176823; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114:67-74; PMID:22727094; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Int Endod J 2009; 42:839-44; PMID:19712195; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Surg Oral Med Oral Pathol 1994; 78:216-21; PMID:7936592; http://dx.doi.org/10.1016/0030- 4220(94)90150-3 46.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
FEMS Microbiol Lett  2008; 283:129-39; PMID:18422625; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
J Oral Pathol Med 1993; 22:54-6; PMID:8445543;  http://dx.doi.org/10.1111/j.1600-0714.1993.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
Oral Surg  Oral Med Oral Pathol Oral Radiol 2012; 114:52- 60; PMID:22727092; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/63/b1/viru-4-391.PMC3714131.pdf
"Several strains of the Bcc species B. multivorans ,  B. cenocepacia , B. cepacia , and B. dolosa  have been shown to be  highly transmissible between patients, with B. cenocepacia  and  *Correspondence to: Leo Eberl; Email: leberl@botinst.uzh.ch Submitted: 04/30/13; Revised: 06/07/13; Accepted: 06/09/13http://dx.doi.org/10.4161/viru.25338The Burkholderia cepacia  complex (Bcc) consists of 17  closely related species that are problematic opportunistic  bacterial pathogens for cystic fibrosis patients and  immunocompromised individuals.",Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Environ Microbiol 2003; 5:719-29; PMID:12919407; http://dx.doi.org/10.1046/j.1462- 2920.2003.00471.x 2.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Nat Rev Microbiol 2005; 3:144-56;  PMID:15643431; http://dx.doi.org/10.1038/nrmi-cro1085 3.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Environ Microbiol 2005; 7:1673-85;  PMID:16232283; http://dx.doi.org/10.1111/j.1462- 2920.2005.00891.x4.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
nov. Int J Syst Evol Microbiol  2009; 59:102-11; PMID:19126732; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Appl  Microbiol 2008; 104:1539-51; PMID:18217926;  http://dx.doi.org/10.1111/j.1365-2672.2007.03706.x7.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Clin Microbiol Infect 2010; 16:821-30; PMID:20880411; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Lancet  1990; 336:1094-6; PMID:1977981; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol 2002; 184:1187-91; PMID:11807080;  http://dx.doi.org/10.1128/jb.184.4.1187-1191.2002,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
ISME J 2008; 2:27-36; PMID:18049456; http://dx.doi.org/10.1038/ismej.2007.76 39.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol  1997; 24:555-66; PMID:9179849; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol  2004; 51:903-12; PMID:14731288; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
FEMS Microbiol  Rev 2008; 32:842-57; PMID:18557946; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Chem Rev 2011; 111:160- 73; PMID:21166386; http://dx.doi.org/10.1021/cr100354f 43.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Virulence 2010; 1:404-8; PMID:21178479;  http://dx.doi.org/10.4161/viru.1.5.12704 44.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol 2012; 83:840-55;  PMID:22221091; http://dx.doi.org/10.1111/j.1365- 2958.2012.07968.x 45.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol 2009; 191:7270- 8; PMID:19801414; http://dx.doi.org/10.1128/ JB.00681-09 46.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Proc Natl Acad Sci U S A  2012; 109:15479-84; PMID:22949660; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Microbiology  2008; 154:1845-58; PMID:18599814; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
T rends Microbiol 2011; 19:145-52;  PMID:21227698; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Eukaryot Cell 2011; 10:1034-42; PMID:21666074; http://dx.doi.org/10.1128/EC.05060-11 51.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol  2009; 191:5013-9; PMID:19482924; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Infect Immun 2004; 72:1537-47; PMID:14977960; http://dx.doi.org/10.1128/ IAI.72.3.1537-1547.2004 25.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol 2007; 189:3006-16; PMID:17277056;  http://dx.doi.org/10.1128/JB.01544-06 26.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Appl Environ Microbiol 2005; 71:5208-18; PMID:16151106; http://dx.doi.org/10.1128/AEM.71.9.5208-5218.2005 27.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
PLoS  One 2012; 7:e49966; PMID:23185499; http://dx.doi.org/10.1371/journal.pone.0049966 28.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Microbiology 2009; 155:1377-85; PMID:19383698;  http://dx.doi.org/10.1099/mic.0.026849-0 29.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol 2004; 186:5460- 72; PMID:15292148; http://dx.doi.org/10.1128/ JB.186.16.5460-5472.2004 30.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol 2006; 188:3365-70; PMID:16621831; http://dx.doi.org/10.1128/JB.188.9.3365-3370.2006 31.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol 2009; 191:2447-60; PMID:19201791;  http://dx.doi.org/10.1128/JB.01746-08 32.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol 2013; 87:94-111; PMID:23136852; http://dx.doi.org/10.1111/ mmi.12085 33.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
PLoS One 2012; 7:e37611;  PMID:22624054; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Environ Microbiol 2013; 15:372-85; PMID:22830644; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Clin Microbiol 2004; 42:3052-8; PMID:15243059;  http://dx.doi.org/10.1128/JCM.42.7.3052-3058.2004 11.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Proc Natl Acad Sci U S A 2013; 110:E250- 9; PMID:23271804; http://dx.doi.org/10.1073/ pnas.1207025110 13.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Eur J Clin Microbiol Infect Dis  2009; 28:1275-9; PMID:19575248; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Infect Immun  2005; 73:4982-92; PMID:16041013; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Microbiology 2003; 149:3649- 58; PMID:14663096; http://dx.doi.org/10.1099/ mic.0.26540-0 18.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Annu Rev Cell Dev Biol  2005; 21:319-46; PMID:16212498; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Infect Immun 2001;  69:4661-6; PMID:11402012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Res Microbiol 2004; 155:238-44; PMID:15142620;  http://dx.doi.org/10.1016/j.resmic.2004.01.006 22.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Syst  Appl Microbiol 2001; 24:1-14; PMID:11403388;  http://dx.doi.org/10.1078/0723-2020-00013 23.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Future  Microbiol 2007; 2:555-63; PMID:17927476; http://dx.doi.org/10.2217/17460913.2.5.555,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Electrophoresis 2003; 24:740- 50; PMID:12601746; http://dx.doi.org/10.1002/ elps.200390089 82.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol  2009; 191:261-77; PMID:18931103; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol 1998; 30:285-93;  PMID:9791174; http://dx.doi.org/10.1046/j.1365-2958.1998.01061.x 84.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Microbiologyopen  2013; 2:105-22; PMID:23281338; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Infect Immun  2006; 74:5374-81; PMID:16926432; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol 2003; 49:905-18; PMID:12890017; http://dx.doi.org/10.1046/j.1365- 2958.2003.03615.x 87.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol  2005; 58:1322-39; PMID:16313619; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol 2010; 77:549-61;  PMID:20545856; http://dx.doi.org/10.1111/j.1365- 2958.2010.07249.x 89.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Bacteriol  2001; 183:2888-96; PMID:11292810; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Appl Environ Microbiol 2001; 67:4538-45; PMID:11571153; http://dx.doi.org/10.1128/ AEM.67.10.4538-4545.2001 91.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Biochem J 2008; 411:307- 18; PMID:18215132; http://dx.doi.org/10.1042/BJ20071276 92.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Glycobiology 2012; 22:1387-98;  PMID:22763039; http://dx.doi.org/10.1093/glycob/ cws105 93.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Structure 2010; 18:59-72; PMID:20152153; http://dx.doi.org/10.1016/j.str.2009.10.02166.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Lancet 2002; 359:2002-3; PMID:12076559; http://dx.doi.org/10.1016/S0140-6736(02)08836-0 67.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
World J Microbiol Biotechnol 2012; 28:2113-23;  PMID:22806034; http://dx.doi.org/10.1007/s11274- 012-1016-3 68.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Infect Immun  2010; 78:4088-100; PMID:20643851; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Infect Immun 2009; 77:4102-10; PMID:19528212; http://dx.doi.org/10.1128/IAI.00398-09 70.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
PLoS One  2010; 5:e11467; PMID:20635002; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
FEMS Microbiol Lett 2002; 207:1-7; PMID:11886742;  http://dx.doi.org/10.1111/j.1574-6968.2002.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
FEMS Microbiol Lett 2005; 244:297-304;  PMID:15766782; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Infect Dis  2011; 203:383-92; PMID:21208930; http://dx.doi.org/10.1093/infdis/jiq054 76.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Appl Environ Microbiol 2006; 72:1579- 87; PMID:16461713; http://dx.doi.org/10.1128/ AEM.72.2.1579-1587.2006 78.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Appl Environ Microbiol  2010; 76:4675-83; PMID:20511428; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol 2010; 77:1220-36; PMID:20624216;  http://dx.doi.org/10.1111/j.1365-2958.2010.07285.x 54.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
PLoS  One 2013; 8:e55112; PMID:23383071; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Structure 2011; 19:56- 69; PMID:21220116; http://dx.doi.org/10.1016/j.str.2010.11.010 57.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Microbiol Mol Biol Rev 2013; 77:1- 52; PMID:23471616; http://dx.doi.org/10.1128/ MMBR.00043-12 58.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Microbiologyopen 2012; 1:225-42;  PMID:22950027; http://dx.doi.org/10.1002/mbo3.24 59.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol 2002; 46:411-26;  PMID:12406218; http://dx.doi.org/10.1046/j.1365- 2958.2002.03182.x 60.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Plant Pathol J 2009; 25:429-32; http://dx.doi.org/10.5423/PPJ.2009.25.4.429 62.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Phytopathology 2007; 97:195-201; PMID:18944375;  http://dx.doi.org/10.1094/PHYTO-97-2-0195 63.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Plant Pathol J 2010; 26:223-30; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Int J Syst Evol Microbiol  2008; 58:1580-90; PMID:18599699; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Emerg Infect Dis 2007; 13:458- 61; PMID:17552100; http://dx.doi.org/10.3201/ eid1303.060403,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Bioorg Med Chem 2012; 20:4737- 43; PMID:22748377; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Antimicrob Agents  Chemother 2006; 50:318-23; PMID:16377703;  http://dx.doi.org/10.1128/AAC.50.1.318-323.2006 110.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Res Microbiol 2009; 160:144-51; PMID:19146953;  http://dx.doi.org/10.1016/j.resmic.2008.12.003 111.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Antimicrob Agents Chemother 2011; 55:2655- 61; PMID:21422204; http://dx.doi.org/10.1128/ AAC.00045-11 112.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Future Microbiol  2009; 4:341-58; PMID:19327118; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Microbiology 2010; 156:896- 908; PMID:19942656; http://dx.doi.org/10.1099/ mic.0.035139-0 102.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Mol Microbiol 2011; 82:327- 41; PMID:21883527; http://dx.doi.org/10.1111/j.1365-2958.2011.07814.x 103.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Hosp Infect 2008; 70:361-8; PMID:18977555; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Eur J Clin Microbiol Infect Dis 2007; 26:213-6;  PMID:17265071; http://dx.doi.org/10.1007/s10096- 007-0256-x 105.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Antimicrob Chemother 2009; 64:801-9; PMID:19633000; http://dx.doi.org/10.1093/jac/dkp253 106.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Antimicrob Agents Chemother 2011; 55:1912- 9; PMID:21357299; http://dx.doi.org/10.1128/ AAC.01571-1094.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
PLoS Pathog 2011; 7:e1002238;  PMID:21909279; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Cyst Fibros 2007; 6:145-52;  PMID:16860003; http://dx.doi.org/10.1016/j.jcf.2006.06.004 96.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Appl Environ Microbiol  2010; 76:441-50; PMID:19948863; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Biochem Biophys Res Commun 2003; 312:323-33; PMID:14637140; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Clin Microbiol 2008; 46:1470- 3; PMID:18256220; http://dx.doi.org/10.1128/JCM.02273-07 99.,Non-OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
J Biol Chem 2006; 281:2526-32;  PMID:16316987; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
Appl Environ Microbiol 2010; 76:4302- 17; PMID:20435760; http://dx.doi.org/10.1128/ AEM.03086-09,OADS,/arxiv_data1/oa_pdf/1f/6e/viru-4-400.PMC3714132.pdf
"www.landesbioscience.com Virulence 419Virulence 4:5, 419–428; July 1, 2013; © 2013 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Siouxsie Wiles and Thomas Proft; Email: s.wiles@auckland.ac.nz and t.proft@auckland.ac.nz Submitted: 12/05/12; Revised: 04/29/13; Accepted: 05/03/13http://dx.doi.org/10.4161/viru.24930Introduction Group A streptococcus (GAS, Streptococcus pyogenes ) is a human  pathogen responsible for a diverse range of infections from  uncomplicated pharyngitis and tonsillitis to more severe and life threatening diseases such as necrotizing fasciitis.",Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Lancet Infect Dis 2005; 5:685-94; PMID:16253886;  http://dx.doi.org/10.1016/S1473-3099(05)70267-X 2.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Adv Exp Med Biol  2008; 609:29-42; PMID:18193655; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
J Bacteriol 2007; 189:1514-22; PMID:17142387;  http://dx.doi.org/10.1128/JB.01132-06 5.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Lancet Infect Dis 2003; 3:191-200; PMID:12679262; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
PLoS One 2009;  4:e7279; PMID:19794915; http://dx.doi.org/10.1371/journal.pone.0007279 8.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
J Clin Invest 1998; 102:550-60;  PMID:9691092; http://dx.doi.org/10.1172/JCI3065 9.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Clin Infect  Dis 2002; 34:28-38; PMID:11731942; http://dx.doi.org/10.1086/324621 10.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Clin Infect Dis 2002; 35:268-76; PMID:12115092;  http://dx.doi.org/10.1086/341409 12.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
J Med Microbiol 1993; 39:165-78; PMID:8366514;  http://dx.doi.org/10.1099/00222615-39-3-165 13.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Clin Infect Dis  2002; 34:454-60; PMID:11797171; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Pediatrics 2004; 113:e168-72; PMID:14993572;  http://dx.doi.org/10.1542/peds.113.3.e168 15.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
J Clin Microbiol  2009; 47:2658-61; PMID:19515840; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Proc Natl Acad Sci U S A  2010; 107:4693-8; PMID:20179180; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Mol Microbiol  2000; 37:981-8; PMID:10972817; http://dx.doi.org/10.1046/j.1365-2958.2000.02056.x 24.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
J Antimicrob Chemother  2011; 66:1785-90; PMID:21622972; http://dx.doi.org/10.1093/jac/dkr198 26.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Microb Pathog  2011; 51:389-95; PMID:21964409; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Eur J Clin Microbiol Infect Dis 2012; 31:2653- 60; PMID:22466968; http://dx.doi.org/10.1007/ s10096-012-1609-7 28.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Infect Immun 2012; 80:2780-90; PMID:22645286;  http://dx.doi.org/10.1128/IAI.00510-12 29.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
J Mol Microbiol Biotechnol 2011; 21:191-6; PMID:22286046; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Appl  Environ Microbiol 2010; 76:310-7; PMID:19897755;  http://dx.doi.org/10.1128/AEM.01301-09 31.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
J Med Microbiol 2011; 60:661- 9; PMID:21233296; http://dx.doi.org/10.1099/ jmm.0.026658-0 32.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
BMC Microbiol 2011; 11:11; PMID:21241461; http://dx.doi.org/10.1186/1471-2180-11-11 34.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Virulence 2011;  2:521-7; PMID:22186764; http://dx.doi.org/10.4161/viru.2.6.18520 36.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Immunol Rev  2004; 198:116-26; PMID:15199959; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
N Engl J Med 2002; 346:1200-6; PMID:11961148; http://dx.doi.org/10.1056/ NEJMoa013169 57.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Proc Natl Acad Sci U S A  2002; 99:4668-73; PMID:11917108; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
J Infect Dis 2005; 192:760-70;  PMID:16088825; http://dx.doi.org/10.1086/43061847.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Microbes  Infect 2011; 13:1191-8; PMID:21782965; http://dx.doi.org/10.1016/j.micinf.2011.07.001 49.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Gene 1996; 177:137-47;  PMID:8921859; http://dx.doi.org/10.1016/0378- 1119(96)84178-3 50.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Microbiology 1998;  144:3079-86; PMID:9846743; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Mol  Microbiol 2011; 79:1629-42; PMID:21231972;  http://dx.doi.org/10.1111/j.1365-2958.2011.07550.x 52.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
T rends Microbiol 2003; 11:224-32;  PMID:12781526; http://dx.doi.org/10.1016/S0966- 842X(03)00098-2 41.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Mol Microbiol  2012; 83:1035-47; PMID:22320452; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Mol Microbiol 2007; 64:968-83; PMID:17501921;  http://dx.doi.org/10.1111/j.1365-2958.2007.05704.x 45.,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
Infect  Immun 2009; 77:32-44; PMID:18852238; http://dx.doi.org/10.1128/IAI.00772-08,Non-OADS,/arxiv_data1/oa_pdf/e6/3c/viru-4-419.PMC3714134.pdf
"www.landesbioscience.com Virulence 429Virulence 4:5, 429–431; July 1, 2013; © 2013 Landes BioscienceVIRULENCE PROFILE  AUtOPhA gIC PUNC tUm Keywords:  virulence, infectious diseases,  mycology, Drosophila , zebrafish Submitted: 05/28/13 Accepted: 05/29/13http://dx.doi.org/10.4161/viru.25259 Correspondence to: Dimitrios P Kontoyiannis;   Email: dkontoyi@mdanderson.orgTell us about your early days I was born in Athens, Greece, 50 years  ago.",Non-OADS,/arxiv_data1/oa_pdf/dc/c7/viru-4-429.PMC3714135.pdf
http://conventions.coe.int   (accessed on June 2009)   10.,Non-OADS,/arxiv_data1/oa_pdf/f9/b8/jmehm-2-11.PMC3714136.pdf
http://www.europarl.europa.eu   (accessed on June 2009)   11.,Non-OADS,/arxiv_data1/oa_pdf/f9/b8/jmehm-2-11.PMC3714136.pdf
http://www.africa -union.org    (accessed on June 2009)   12.,Non-OADS,/arxiv_data1/oa_pdf/f9/b8/jmehm-2-11.PMC3714136.pdf
http://www.g7.utoronto.ca   (accessed in June 2009),Non-OADS,/arxiv_data1/oa_pdf/f9/b8/jmehm-2-11.PMC3714136.pdf
"This is an open access article published under the terms of the Creative Commons License ‘‘Attribution-NonCommercial-NoDerivative 3.0’’ (http://creativecommons.org/licenses/by-nc-nd/3.0/) which permits non-commercial use, distribution, and reproduction, provided the original work is properly cited and not altered.",Non-OADS,/arxiv_data1/oa_pdf/47/8c/40264_2012_Article_1973.PMC3714138.pdf
"[4]An ED visit record qualified as ADR- related in one of two ways: (i) there was an ICD- 10-CA diagnosis code for ADR (Appendix table SI,Supplemental Digital Content [SDC], http://links.adisonline.com/DSZ/A73) listed in the ‘MainProblem’ or ‘Other Problems’ fields; or (ii) therewas an ICD-10-CA code of external cause forADR (Appendix table SII, online SDC) listed as‘Other Problems’.",Non-OADS,/arxiv_data1/oa_pdf/47/8c/40264_2012_Article_1973.PMC3714138.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/cc/not034.PMC3714149.pdf
"dei Dipartimenti di Discipline Odontostomatologiche, Ortodontiche eChirurgiche, di Oftalmologia, di Patologia dellaTesta e del Collo, del Cavo Orale e dellaComunicazione Audio Verbale e ScienzeOrtopediche, Tramautologiche, Riabilitative ePlastico-Ricostruttive, Seconda Universita `di Napoli, Naples, Italy and 5Dipartimento di Chimica Farmaceutica e Tossicologica, Facolta ` di Farmacia, Universita `degli Studi di Napoli ‘Federico II’, Naples, ItalyE-mail: chiariot@unina.it or frlembo@unina.it SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Andia DC, de Oliveira NF, Casarin RC et al.",Non-OADS,/arxiv_data1/oa_pdf/13/1b/jid2013139a.PMC3714355.pdf
"Jennifer C. Jones1,2,3,K a r e nS a b a t i n i1,2, Xiaoyan Liao1,2,4,H aT .T r a n1,2, Candace L. Lynch1,2, Robert E. Morey1,2, Victoria Glenn-Pratola1,2, Francesca S. Boscolo1,2, Qinghong Yang5, Mana M. Parast5, Ying Liu4,6, Suzanne E. Peterson1,2, Louise C. Laurent1,2,4, Jeanne F. Loring1,2 a n dY u - C h i e hW a n g1,2 1Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California,USA; 2Center for Regenerative Medicine, The Scripps Research Institute, La Jolla, California,USA;3California State University, Channel Islands, California, USA;4Department of Reproductive Medicine, University of California,San Diego, San Diego, California, USA and 5Department of Pathology, University of California, San Diego, San Diego, California, USAE-mail: ycwang@scripps.edu 6Current address: Department of Neurosurgery, University of Texas Health Science Center,Houston, Texas, USA SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Fang D, Leishear K, Nguyen TK et al.",Non-OADS,/arxiv_data1/oa_pdf/13/1b/jid2013139a.PMC3714355.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Three-Dimensional Morphology of Touch Domes in Human Hairy Skin by Correlative Light and Scanning ElectronMicroscopy Journal of Investigative Dermatology (2013) 133, 2108–2111; doi:10.1038/jid.2013.60; published online 18 April 2013 TO THE EDITOR The presence of tactile structures inhuman hairy skin was ﬁrst reported byPinkus in 1902.",Non-OADS,/arxiv_data1/oa_pdf/13/1b/jid2013139a.PMC3714355.pdf
"10       http://www.medsci.org  1079  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1079 -1084.  doi: 10.7150/ ijms.6407   Research Paper   Effects of Lipid Emulsion and Multivitamins on the  Growth of Microorganisms in Peripheral Parenteral  Nutrition Solutions  Takashi Kuwahara1, , Shinya Kaneda1, Kazuyuki Shimono1, Yoshifumi Inoue2   1.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/ijmsv10p1079.PMC3714382.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a6/29/ijmsv10p1079.PMC3714382.pdf
"10     http://www.medsci.org  1080  amino acids, glucose , and electrolytes, but not contain  lipid emulsion  (LE)  and multivitamins  (MV).",Non-OADS,/arxiv_data1/oa_pdf/a6/29/ijmsv10p1079.PMC3714382.pdf
10       http://www.medsci.org  1081  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a6/29/ijmsv10p1079.PMC3714382.pdf
"10     http://www.medsci.org  1082  cillus cereu s, Serratia marcescens, Staphylococcus aureus ,  and Candida albicans  in PPN solutions.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/ijmsv10p1079.PMC3714382.pdf
10     http://www.medsci.org  1083    Figure 4 .,Non-OADS,/arxiv_data1/oa_pdf/a6/29/ijmsv10p1079.PMC3714382.pdf
"10     http://www.medsci.org  1084  the following s: if microbial contamination occurs,  1)  Bacillus cereus and Serrati a marcescens can grow rapidly  in PPN solutions consisting of amino acids, glucose  and electrolytes ; 2) Staphylococcus aureus  cannot grow  without LE and MV, but can grow rapidly with MV ;  3) Candida albicans  can grow sl ightly without  LE and  MV, and the addit ion of LE or MV accelerate s its  growth.",Non-OADS,/arxiv_data1/oa_pdf/a6/29/ijmsv10p1079.PMC3714382.pdf
"10       http://www.medsci.org  1085  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1085 -1091.  doi: 10.7150/ ijms.6003   Research Paper   Utility and Stability of Transnasal Endoscopy for Exam- ination of the Pharynx  - A Prospective Study and  Comparison with Transoral Endoscop y  Masaru Tsuboi, Makoto Arai, Daisuke Maruoka, Tomoaki Matsumura, Tomoo Nakagawa, Tatsuro  Katsuno, Osamu Yokosuka   Department of Gastroenterology and Neph rology, Graduate School of Medicine, Chiba University, Chiba, Japan .",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
"10     http://www.medsci.org  1086  the time and operation of pre-  and post -procedures, as  well as the cost.",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
"Similar  models are sold in the U.S. and Europe (Olympus Co.,  http://www.olympus -global.com/en/).",Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
10     http://www.medsci.org  1087  Table 1a .,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
10     http://www.medsci.org  1088  Factors Associated with completion of phary n- geal observation — A comparison of characteristics  between the compl etely  and incomplete ly observed  groups is shown in Tab le 2.,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
10     http://www.medsci.org  1089  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
10     http://www.medsci.org  1090  the effectiveness of IEE and helped us to recognize  superficial neoplastic lesions in the head and neck  region [16-19].,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
10     http://www.medsci.org  1091  17.,Non-OADS,/arxiv_data1/oa_pdf/ce/d5/ijmsv10p1085.PMC3714383.pdf
"10       http://www.medsci.org  1092  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1092 -1098.  doi: 10.7150/ ijms.6251   Research Paper   Citrobacter Peritoneal D ialysis P eritonitis: R are Occu r- rence with Poor Outcome s  Chia -Ter Chao1,2, Szu-Ying Lee3, Wei-Shun Yang4, Huei -Wen Chen2, Cheng -Chung Fang2,5, Chung -Jen  Yen2,6, Chih -Kang Chiang2,7, Kuan -Yu Hung2, Jenq -Wen Huang2  1.",Non-OADS,/arxiv_data1/oa_pdf/11/a6/ijmsv10p1092.PMC3714384.pdf
This is  an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/11/a6/ijmsv10p1092.PMC3714384.pdf
"10     http://www.medsci.org  1093  gradually increasing , as the number of cases caused  by g ram-positive bacteria continues to decline , due to  the impro vement in exchange systems and the use of  topical anti -staphylococcal medications  [4-7].",Non-OADS,/arxiv_data1/oa_pdf/11/a6/ijmsv10p1092.PMC3714384.pdf
"10     http://www.medsci.org  1094  cefazolin/aminoglycoside (before 1998) or  cefazolin/ceftazidime (after 1998), according to I n- ternational Society for Peritoneal Dialysis ( ISPD )  recommendations, unless otherwise indicated [12, 25,  26].",Non-OADS,/arxiv_data1/oa_pdf/11/a6/ijmsv10p1092.PMC3714384.pdf
10     http://www.medsci.org  1095  from 3  episodes (27%) showed polymicrobial growth  (all included  C. freundii ).,Non-OADS,/arxiv_data1/oa_pdf/11/a6/ijmsv10p1092.PMC3714384.pdf
10     http://www.medsci.org  1096  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/11/a6/ijmsv10p1092.PMC3714384.pdf
"10     http://www.medsci.org  1097  barrier dysfunction, and defective immunologic d e- fense mechanisms [34].",Non-OADS,/arxiv_data1/oa_pdf/11/a6/ijmsv10p1092.PMC3714384.pdf
10     http://www.medsci.org  1098  References   1.,Non-OADS,/arxiv_data1/oa_pdf/11/a6/ijmsv10p1092.PMC3714384.pdf
"10       http://www.medsci.org  1099  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1099 -1107.  doi: 10.7150/ ijms.5924   Research Paper   The Effect of Intraoperative Use of High- Dose Re m- ifentanil on Postoperative Insulin Resistance and Muscle  Protein Catabolism: A Randomized Controlled Study   Hideki Taniguchi1,2,, Toshio Sasaki2, Hisae Fujita2, Osami Takano2, Tsutomu Hayashi3, Haruhiko Cho3,  Takaki Yoshikawa3, Akira Tsuburaya3   1.",Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
"10     http://www.medsci.org  1100  management methods  are known as “enhanced r e- covery after surgery programs.” In the programs,  measures taken throughout the perioperative period  to reduce postoperative insulin resistance are believed to have effects on the  enhanced recovery after surgery   [2, 3] .",Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
10     http://www.medsci.org  1101  radial artery of the left arm after induction of general  anaesthesia.,Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
10     http://www.medsci.org  1102  loss.,Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
10     http://www.medsci.org  1103    Fig 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
10     http://www.medsci.org  1104    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
10     http://www.medsci.org  1105  metabolic assessment of 3 -MH/Cr is possible with  blood in a shorter time than with urine  [18].,Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
10     http://www.medsci.org  1106    Fig 5.,Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
10     http://www.medsci.org  1107  This study had several limitations.,Non-OADS,/arxiv_data1/oa_pdf/8c/6b/ijmsv10p1099.PMC3714385.pdf
"10       http://www.medsci.org  1108  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1108 -1112.  doi: 10.7150/ ijms.6598   Research Paper   The Importance of Needle Echogenity in Ultrasound  Guided Axillary Brachial Plexus Block: A Randomized  Controlled  Clinical Study   Cevdet DUGER1, Ahmet Cemil ISBIR1, Kenan KAYGUSUZ1, Iclal OZDEMIR KOL1, Sinan GURSOY1,  Hayati OZTURK2, Caner MIMAROĞLU1  1.",Non-OADS,/arxiv_data1/oa_pdf/77/10/ijmsv10p1108.PMC3714386.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0 /).,Non-OADS,/arxiv_data1/oa_pdf/77/10/ijmsv10p1108.PMC3714386.pdf
10     http://www.medsci.org  1109  innovations include both ultrasound technology and  needle visualization.,Non-OADS,/arxiv_data1/oa_pdf/77/10/ijmsv10p1108.PMC3714386.pdf
"10     http://www.medsci.org  1110  We performed a pilot study of 15 patients (5 in  each group) before our main study, and calculated  that a sample size of 30 patients in each group would  be sufficient at an assumed  20% difference in duration  of block procedure.",Non-OADS,/arxiv_data1/oa_pdf/77/10/ijmsv10p1108.PMC3714386.pdf
"10     http://www.medsci.org  1111  has been performed successfully by using nerve  stimulators (2, 7 , 8).",Non-OADS,/arxiv_data1/oa_pdf/77/10/ijmsv10p1108.PMC3714386.pdf
10     http://www.medsci.org  1112  peripheral nerve blocks in a porcine model.,Non-OADS,/arxiv_data1/oa_pdf/77/10/ijmsv10p1108.PMC3714386.pdf
"10       http://www.medsci.org  1113  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1113 -1120.  doi: 10.7150/ ijms.6843   Research Paper   Meta- Analysis of Adiponectin Polymorphisms and  Col- orectal Cancer Risk   Chuncui Ye*, Jun Wang*, Shiyun Tan, Jun Zhang, Ming Li, Peng Sun   Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei, China.",Non-OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
"10     http://www.medsci.org  1114  ponectin levels are also  observed in CRC patients,  suggesting the role of  adiponectin in the pathogenesis  of CRC  [6].",Non-OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
10       http://www.medsci.org  1115  Results   Study characteristics   The search strategy retrieved 71 potentially rel- evant studies.,OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
10     http://www.medsci.org  1116  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
"10       http://www.medsci.org  1117  For rs266729C/G polymorphism, 5 studies with  2945 cases and 3361 controls were identified.",Non-OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
10     http://www.medsci.org  1118    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
10       http://www.medsci.org  1119       Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
"10     http://www.medsci.org  1120  To our knowledge, this is the first meta -analysis   which comprehensively assessed the associations  between  polymorphisms in the ADIPOQ  gene  and  CRC risk.",Non-OADS,/arxiv_data1/oa_pdf/ef/bc/ijmsv10p1113.PMC3714387.pdf
"10       http://www.medsci.org  1121  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1121 -1134.  doi: 10.7150/ ijms.5918   Research Paper   In-Vivo Functional Study on the Involvement of CFTR,  SLC26A6, NHE- 1 and CA Isoenzymes II and XII in  Uterine Fluid pH, Volume and Electrolyte Regulation in  Rats under Different Sex- Steroid Influence   Khadijeh Gholami1, Sekaran Muniandy1 and Naguib Salleh2,  1.",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10     http://www.medsci.org  1122  SLC26A6 , a Cl -/HCO3 -exchanger family has been  reported to be expressed in the uterus and was shown  to participate in the pH increase under the influence  of sex -steroid [3, 8] .",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10     http://www.medsci.org  1123  proportion of different cell types in the vaginal smear  according to the description by Marcondez et al, [18].",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10     http://www.medsci.org  1124  timated semi -quantitatively on a scale of 0– 4 as: 0 - no  detectable s tain; 1-  faint; 2 - moderate; 3 - strong; and 4 -  very intense, as were previously reported [22, 23] .",OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10       http://www.medsci.org  1125  Effects on uterine fluid secretion rate   In figure 2a, the rate of uterine fluid secretion  was the highest at Ps and Es (0.95 & 0.9 µl/min r e- spectively).",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10       http://www.medsci.org  1126   Effects on uterine fluid HCO 3- concentration   In figure 3a, HCO 3- concentration was the highest  at Ps (41mmol/l), followed by Es (39mmol/l).",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10       http://www.medsci.org  1127  Effects on uterine fluid Cl- concentration   In figure 4a, Cl- concentration was the highest at  Ps (95mmol/l) and Es (95mmol/l) Glibenclamide,  DIDS and ACTZ administration caused a significant  decrease in Cl- concentration in these groups.",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10     http://www.medsci.org  1128  Effects on uterine fluid Na+ concentration   In figure 5a, Na+ concentration was the highest at  Ps (152mmol/l) followed by  Es (150mmol/l) with  glibenclamide, DIDS and ACTZ administration  caused its level to decrease.",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10       http://www.medsci.org  1129  Expression of CFTR, SLC26A6, CAII & XII an d  NHE -1 at oestrous cycle phases   In figure 6 and table 1, high CFTR expression  was observed at the apical membrane of the luminal  and glandular epithelia at Es while low expression  was seen in the stroma.",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
10     http://www.medsci.org  1130    Fig 6.,Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
10     http://www.medsci.org  1131    Fig 7.,Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
"10       http://www.medsci.org  1132  In this study, the inhibitory effect of  glibenclamide indicated that CFTR was involved in  the increase in volume, pH, Na+, Cl- and HCO 3- con- centrations under E influence.",Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
10     http://www.medsci.org  1133  generation.,Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
10     http://www.medsci.org  1134  11.,Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
2010; 1804:  410-21. doi: http://dx.doi.org/10.1016/j.bba pap.2009.10.021.,OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
Biochem Bioph Res Co. 2000; 276: 40 -4. doi: http://dx.doi.org/10.1006/bbrc.2000.3426 .,Non-OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
2004; 6:  343-50. http://www.nature.com/ncb/journal/v6/n4/suppinfo/   ncb1115_S1.html .,OADS,/arxiv_data1/oa_pdf/a9/4f/ijmsv10p1121.PMC3714388.pdf
10       http://www.medsci.org  1135  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1135 .,Non-OADS,/arxiv_data1/oa_pdf/2e/05/ijmsv10p1135.PMC3714389.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2e/05/ijmsv10p1135.PMC3714389.pdf
"10       http://www.medsci.org  1136  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1136 -1148.  doi: 10.7150/ ijms.6121   Research Paper   Spatial Localization of Genes Determined by Intran u- clear DNA Fragmentation with the Fusion Proteins  Lamin KRED and Histone KRED und Visible Light   Waldemar Waldeck1, Gabriele Mueller1,  Karl -Heinz Glatting3, Agnes Hotz -Wagenblatt3, Nicolle Diessl4,  Sasithorn Chotewutmonti4, Jörg Langows ki1, Wolfhard Semmler2, Manfred Wiessler2 and Klaus Braun2   1.",OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10     http://www.medsci.org  1137  chromosomes indicate a central nuclear position of  small chromosomes whereas the large chromosomes  are peripherally  positioned [16].,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10       http://www.medsci.org  1138      Fig 1.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10     http://www.medsci.org  1139  DNA isolation - RNase treatment   To avoid RNA contamination of our DNA fra g- ments an enzymatic treatment of the nuclei  with  RNase was conducted immediately after illumination.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
We used the Blast2GO tool  (http://www.blast2go.com/b2glaunch) for function- al annotation of FASTA nucleotide sequences  (http://husar.dkfz -heidelberg.de/menu/ w2h/w2hd kfz/) .,OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
ANALYSIS produces the graphical display of annot a- tion data with GO graphs (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
"10     http://www.medsci.org  1140  annotation, visualization and integrated discovery   using the Database for Annotation, Visualization and  Integrated Discovery (DAVID) ( http://david.abcc.",OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10     http://www.medsci.org  1141  Table 2. lists the annotation clusters 1- 3 with the enrichment scores 6.74; 3.1; and 2.92 of the gene bundle of the most prominent 7 of  100 entries which offer the highest read counts of the KRED -lamin B1 probe 30 min after illumination in DAVID functional annotations  analys is which gave clusters of GO term enrichment.,OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10       http://www.medsci.org  1142  The graph ( Figure 3) give s insight into the extent  of genetic breakpoints caused by ROS versus the a f- fected genes .,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10       http://www.medsci.org  1143    Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10       http://www.medsci.org  1144  Table 7. shows the contrasting juxtaposition of the mapping the first 100 genes of the KRED -lamin B1 and histone H2A- KRED bundles.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
HomoloGene data (http://www.ncbi.nlm.nih.gov/ homologene/) indicate that this gene is present in the common ancestor of eukaryotes offering orthology  from human down to Saccharomyces cerevisi a.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10     http://www.medsci.org  1145  membranes where they play a vital role in tissue a r- chitecture and cell behaviour.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
"10     http://www.medsci.org  1146  Various groups indicated a non -random but  highly organized structure of the gene s as shown in  Nicolini’s, Harper’s, Zink’s and Cremers’ research  work [5, 11, 100 -103].",Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10     http://www.medsci.org  1147  chromosome territories during the 1950s to 1980s.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
10     http://www.medsci.org  1148  68.,Non-OADS,/arxiv_data1/oa_pdf/eb/3f/ijmsv10p1136.PMC3714390.pdf
"10       http://www.medsci.org  1149  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1149 -1156.  doi: 10.7150/ ijms.6275   Research Paper   Dracorhodin Perchlorate  Induced Human Breast Ca n- cer MCF -7 Apoptosis through Mitochondrial Pathways   Jing- hua Yu1*, Gui -bin Zheng2*, Chun- yu Liu3*, Li-ying Zhang4, Hong -mei Gao5, Ya-hong Zhang 6,  Chun -yan Dai 1, Lin Huang 7, Xian -ying Meng2, Wen- yan Zhang 1, Xiao-fang Yu1  1.",Non-OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
10     http://www.medsci.org  1150  [1-3] in traditional Chinese  medicine  named  as  “dragon’s blood”.,Non-OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
"10     http://www.medsci.org  1151  Observation of morphological changes by light  microscopy   The MCF -7 cells were treated with 60 µmol/L  DP for 24 h, and/or 20 µmol/L caspase 9 inhibitor,  the  morphological  changes were observed by phase co n- trast microscopy (Leica,  Nusslich,  Germany).",OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
10     http://www.medsci.org  1152  µmol/L  at 24 h (Figure 1B).,Non-OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
"10       http://www.medsci.org  1153    Figure  3 Dracorhodin perchlorate decreased mitochondrial membrane potential, and af fected the expression of mitochondrial related protein.",Non-OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
10       http://www.medsci.org  1154    Figure  4.,Non-OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
"10       http://www.medsci.org  1155  It was known that MCF -7 cells d id not express  caspase -3 due to the functional  47-bp deletion inside  the exon 3 of the CASP -3 gene,  which was important  to apopto sis [9] .",Non-OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
"10     http://www.medsci.org  1156  Author biography   Dr Xiao -fang Yu was called back as experts of  ""Tho usand Talents Program ” by Organization D e- partment of the CPC Central Committee in 2010 , now  is working as the director of the Institute of Virology  and AID S Research of Jilin University , who majors in  the relationship between virus and host cell, and cance r research, he had published high level of paper  in Nature, Science, and so on.",Non-OADS,/arxiv_data1/oa_pdf/14/7a/ijmsv10p1149.PMC3714391.pdf
"10       http://www.medsci.org  1157  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1157 -1165.  doi: 10.7150/ ijms.5638   Research Paper   Designer Cytokine Hyper Interleukin 11 (H11) is a  Megakaryopoietic Factor  Hanna Dams -Kozlowska1,2, Eliza Kwiatkowska -Borowczyk1,2, Katarzyna Gryska2, Andrzej Mackiewicz1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
"10     http://www.medsci.org  1158  benefit, it does not cure thrombocytopenia.",Non-OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
"10     http://www.medsci.org  1159  Liquid Cell Cultures   Lin-CD34+ cells were cultured in the serum free  medium X -Vivo10 (Lonza, Verviers, Belgium) at 37 °C,  in 5% CO 2, with 95% humidity.",Non-OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
10       http://www.medsci.org  1160  Results   Isolation and analysis of CB Lin-CD34+ cells.,Non-OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
10     http://www.medsci.org  1161      Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
"10     http://www.medsci.org  1162  mean number of total PLP rich colonies stimulated by  H11 was 13.5(±3.3), while by rhIL -11 and control were  6.7 (±3.1) and 4.3 (±5.1), respectively.",OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
10     http://www.medsci.org  1163    Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
"10       http://www.medsci.org  1164  Discussion   Since IL -11 enhances megakaryocytopoiesis [11,  13], the designer molecule based on IL- 11 but more  potent e.g.",Non-OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
10     http://www.medsci.org  1165  rophage [27].,Non-OADS,/arxiv_data1/oa_pdf/b3/78/ijmsv10p1157.PMC3714392.pdf
"10       http://www.medsci.org  1166  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1166 -1173.  doi: 10.7150/ ijms.5747   Research Paper   Survival, Classifications, and Desmosomal Plaque Genes  in Non- Small Cell Lung Cancer   Laura  Boyero1, Abel  Sánchez -Palencia2, Mª Teresa  Miranda- León3, Fernando Hernández -Escobar2, Jose  Antonio  Gómez -Capilla1, and Mª Esther Fárez -Vidal1  1.",Non-OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
"10     http://www.medsci.org  1167  The substantial improvements in survival rates  achieved by therapeutic advances in numerous cancer  types since 1975 have not been observed in cancers of  the lung or pancreas, and  the mean 5 -year survival  rate is only 67% for patients wi th Tumor, Node and  Metastasis (TNM) stage IA NSCLC and 57% for  TNM -stage IB NSCLC [1].",Non-OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
"10     http://www.medsci.org  1168  until death or, for survivors, until June 2010.",Non-OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
10     http://www.medsci.org  1169  currence.,Non-OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
"10     http://www.medsci.org  1170  gene was overexpressed in 58.3% (7/12) of AC cas es  and 100% (28/28) of SCC cases in microarray anal- yses, and in 66.7% (8/12) of AC cases and 88.9% (8/9)  of SCC cases in qPCR analyses.",OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
10     http://www.medsci.org  1171  Table 4.,Non-OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
10     http://www.medsci.org  1172  but a significant difference was found for TNM -stage  IA when the 7th edition was employed.,Non-OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
10     http://www.medsci.org  1173  mittee for Lung Cancer Registration.,Non-OADS,/arxiv_data1/oa_pdf/34/af/ijmsv10p1166.PMC3714393.pdf
"10       http://www.medsci.org  1174  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(9): 1174 -1180.  doi: 10.7150/ ijms.5800   Research Paper   Cognitive and Emotional Factors Affecting Avoidable  Decision -Making Delay i n Acute Myocardial Infarction  Male Adults   Giulio Vidotto1, Giorgio Bertolotti2, AnnaMaria Zotti2, Stefano Marchi3, Luigi Tavazzi4   1.",Non-OADS,/arxiv_data1/oa_pdf/77/3c/ijmsv10p1174.PMC3714394.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/77/3c/ijmsv10p1174.PMC3714394.pdf
"10     http://www.medsci.org  1175  AMI made in the last years, strictly related to the  precocity of the intervention in a USA population7  found that duration of pre -hospi tal delay has r e- mained essential unvaried in the last 20 years.",Non-OADS,/arxiv_data1/oa_pdf/77/3c/ijmsv10p1174.PMC3714394.pdf
"10     http://www.medsci.org  1176  demographic and c linical characteristics were com- parable to the general population in terms of the  principal parameters26; in particular, the percentages  of the four admission time categories were very sim i- lar (see Table 1).",Non-OADS,/arxiv_data1/oa_pdf/77/3c/ijmsv10p1174.PMC3714394.pdf
"10     http://www.medsci.org  1177  RESULTS   The estimated standardized path coefficients and  overall fit indices for the model, based on the correl a- tion matrix  presented in table 3, are shown in Figure 1;  the results indicate that the model fits the data ad e- quately.",OADS,/arxiv_data1/oa_pdf/77/3c/ijmsv10p1174.PMC3714394.pdf
"10     http://www.medsci.org  1178  Somatic Awareness (SA), Psychological Upset (PU),  and Fear and health Worries (FW) have the following  four estimation functions:   PH = 0.70 PO,  SA = 0.10 EI + 0.12 PH,   PU = 0.45 EI,   FW = 0.16 EI + 0.17 PU.",Non-OADS,/arxiv_data1/oa_pdf/77/3c/ijmsv10p1174.PMC3714394.pdf
10     http://www.medsci.org  1179  agement should be not easy in daily practice.42  A limitation of the study could be found i n the  inability to generalize findings to population of  women.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/ijmsv10p1174.PMC3714394.pdf
10     http://www.medsci.org  1180  39.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/ijmsv10p1174.PMC3714394.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.277 Role of Lubiprostone on Gastrointestinal Motilit y Jae Yeoul Jun Department of Physiology, Chosun University School of Medicine,  Gwangju, Korea Received: May 24, 2013 Revised: June 4, 2013 Accepted: June 6, 20 13 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/e7/41/jnm-19-277.PMC3714403.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.279 Can Electrical Stimulation Therapy Be Helpful  for Patients With Chronic Constipation  Refractory to Biofeedback Therapy?",Non-OADS,/arxiv_data1/oa_pdf/bc/7e/jnm-19-279.PMC3714404.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.281 Evaluation of Esophageal Motor Function With  High-resolution Manometry Jeffrey L Conklin Division of Digestive Diseases, The David Geffen School of Medi cine at UCLA, Los Angeles, CA, USA For several decades esophageal manometry has been the test of choice to evaluate disorders of esophageal motor function.",Non-OADS,/arxiv_data1/oa_pdf/4d/01/jnm-19-281.PMC3714405.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.295 What Indigestion Means to the Malays?",Non-OADS,/arxiv_data1/oa_pdf/cf/b1/jnm-19-295.PMC3714406.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.301 Irritable Bowel Syndrome and Migraine:  Bystanders or Partners?",Non-OADS,/arxiv_data1/oa_pdf/77/ad/jnm-19-301.PMC3714407.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.312 Lubiprostone Increases Small Intestinal  Smooth Muscle Contractions Through a  Prostaglandin E Receptor 1 (EP 1)-mediated Pathway Walter W Chan1,2 and Hiroshi Mashimo1,2,3* 1Division of Gastroenterology, Hepatology and Endoscopy, Brigham  and Women ’s Hospital, Boston, MA, USA;2Harvard Medical School,  Boston, MA, USA; and3Division of Gastroen terology, VA Boston Health System, Boston, MA, USA Background/Aims Lubiprostone, a chloride channel type 2 (ClC-2) activator, was thought to treat constipation by enhancing intestinal secretion.",Non-OADS,/arxiv_data1/oa_pdf/9b/e6/jnm-19-312.PMC3714408.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.319 Received: October 13, 2012 Revised: April 22, 2013 Accepted: Apri l 30, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/78/0e/jnm-19-319.PMC3714409.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.324 Relevance of Ultrastructural Alterations of  Intercellular Junction Morphology in Inflamed  Human Esophagus Chia-Chin Liu,1 Jeng Woei Lee,1 Tso-Tsai Liu,2 Chih-Hsun Yi2 and Chien-Lin Chen2* 1Department of Life Sciences, Tzu Chi University, Hualien, Taiwa n; and  2Department of Medicine, Buddhist Tzu Chi General Hospital and T zu  Chi University, Hualien, Taiwan Background/Aims  Detailed characterization of the ultrastructural morphology of in tercellular space in gastroesophageal reflux disease has not  been fully studied.",Non-OADS,/arxiv_data1/oa_pdf/36/0d/jnm-19-324.PMC3714410.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.332 Specific Movement of Esophagus During  Transient Lower Esophageal Sphincter  Relaxation in Gastroesophageal Reflux Disease Hoon Il Kim,1 Su Jin Hong,1* Jae Pil Han,1 Jung Yeon Seo,1 Kyoung Hwa Hwang,1 Hyo Jin Maeng,1 Tae Hee Lee2 and Joon  Seong Lee2 1Department of Internal Medicine, Soonchunhyang University Colle ge of Medicine, Bucheon, Gyeonggi-do, Korea; and2Department of  Internal Medicine, Soonchunhyang University College of Medicine , Seoul, Korea Background/Aims Transient lower esophageal sphincter relaxation (TLESR) is the main mechanism of gastroesophageal reflux disease (GERD).",Non-OADS,/arxiv_data1/oa_pdf/b1/fb/jnm-19-332.PMC3714411.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.338 Obesity Is Associated With Increasing Esophageal  A c i d  E x p o s u r e  i n  K o r e a n  P a t i e n t s  W i t h   Gastroesophageal Reflux Disease Symptoms Hee Sun Jung, Myung Gyu Choi,* Myong Ki Baeg, Chul Hyun Lim, Jin Soo Kim, Yu Kyung Cho, In Seok Lee, Sang Woo  Kim and Kyu Yong Choi Division of Gastroenterology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic Un iversity of Korea,  Seoul, Korea Background/Aims Obesity is regarded as an important contributor to the increasing occurrence of gastroesophageal reflux disease.",Non-OADS,/arxiv_data1/oa_pdf/7f/0b/jnm-19-338.PMC3714412.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.344 Association of Sleep Dysfunction and Emotional  Status With Gastroesophageal Reflux Disease in  Korea Ji Yeon Kim,1,2 Nayoung Kim,1,2* Pyoung Ju Seo,1 Jung Won Lee,2 Min Soo Kim,1 Sung Eun Kim,1 So Young Jo,1  Dong Ho Lee1,2 and Hyun Chae Jung2 1Department of Internal Medicine, Seoul National University Bund ang Hospital, Seongnam, Gyeonggi-do, Korea; and2Department of Internal  Medicine and Liver Research Institute, Seoul National Universit y College of Medicine, Seoul, Korea Background/Aims Sleep disturbances and emotional dysfunction are commonly associated with gastroeophageal reflux disease (GERD).",Non-OADS,/arxiv_data1/oa_pdf/40/ee/jnm-19-344.PMC3714413.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.355 Gastric Motility Following Ingestion of a Solid  Meal in a Cohort of Adult Asthmatics Wadu Arachchige Dharshika Lakmali Amarasiri,1* Arunasalam Pathmeswaran,2 Arjuna Priyadharshin de Silva,3 Anuradha  Supun Dassanayake,4 Channa Dhammika Ranasinha4 and Hithanadura Janaka de Silva3 Departments of1Physiology,2Public Health,3Medicine and4Pharmacology, Faculty of Medicine, University of Kelaniya, Raga ma, Sri Lanka Background/Aims Asthmatics have abnormal esophageal motility and increased prevalence of gastroesophageal reflux disease (GERD).",Non-OADS,/arxiv_data1/oa_pdf/24/17/jnm-19-355.PMC3714414.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.366 Electrical Stimulation Therapy in Chronic  Functional Constipation: Five Years’ Experience  in Patients Refractory to Biofeedback Therapy  and With Rectal Hyposensitivity Kee Wook Jung, Dong-Hoon Yang, In Ja Yoon, So Young Seo, Hyun Sook Koo, Hyo Jeong Lee, Ho Su Lee, Ji-Beom Kim,  Jong Wook Kim, Soo Kyung Park, Sang Hyoung Park, Kyung Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Hwoon-Yong Jung, Suk-Kyun Yang, Jin-Ho Kim and Seung-Jae Myung *  Asan Digestive Disease Research Institute, Department of Gastro enterology, Asan Medical Center, University of Ulsan College of  Medicine,  Seoul, Korea Background/Aims Biofeedback therapy (BFT) can be unsuccessful in constipated patients, even those with pelvic floor dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/ad/ec/jnm-19-366.PMC3714415.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.374 Received: February 24, 2013 Revised: June 1, 2013 Accepted: June 1, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/88/92/jnm-19-374.PMC3714416.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.381 Regional Differences in Hospitalizations and  Cholecystectomies for Biliary Dyskinesia Klaus Bielefeldt Division of Gastroen terology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Background/Aims Published studies suggest that socioeconomic  factors contribute to incr easing cholecystectomy rates for biliary dy skinesia (BD) .",Non-OADS,/arxiv_data1/oa_pdf/92/5c/jnm-19-381.PMC3714417.pdf
Admissions were normalized to  state population numbers as determined by the 2010 census  (http://www.census.gov/2010census/data/).,Non-OADS,/arxiv_data1/oa_pdf/92/5c/jnm-19-381.PMC3714417.pdf
"To account for differences in physi- cian workforce, information about clinically active physicians  (https://www.aamc.org/downlo ad/263512/data/statedata2011.",Non-OADS,/arxiv_data1/oa_pdf/92/5c/jnm-19-381.PMC3714417.pdf
"pdf), gastroenterologists (http://www.hipaaspace.com/Medical.",Non-OADS,/arxiv_data1/oa_pdf/92/5c/jnm-19-381.PMC3714417.pdf
"As obesity is associated with biliary disease,  most notably cholecystolithiasis, we obtained published obesity rates for the different states (http://www.cdc.gov/obesity/data/  adult.html).",Non-OADS,/arxiv_data1/oa_pdf/92/5c/jnm-19-381.PMC3714417.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.390 Lung Transplantation Triggered “Jackhammer  Esophagus”: A Case Report and Review of  Literature Mohammed Q Khan,1* Imran Y Nizami,2 Basha J Khan2 and Hamad I Al-Ashgar1 1Section of Gastroenterology, Department of Medicine and2Section of Lung Transplant, Organ Transplant Center, King Faisa l Specialist Hospital  & Research Center, Riyadh, Saudi Arabia A 19-years-old girl was referred for lung transplant due to end stage lung disease secondary to idiopathic bilateral  bronchiectasis.",Non-OADS,/arxiv_data1/oa_pdf/7e/3e/jnm-19-390.PMC3714418.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.395 Technique of Functional and Motility Test:  How to Perform Antroduodenal Manometry Tanisa Patcharatrakul1,2 and Sutep Gonlachanvit1* 1Gastrointestinal Motility Research Unit, Division of Gastroente rology,  Department of Medicine, Chulalongkorn University, Bang kok, Thailand;  and2King Chulalongkorn Memorial Hospit al, Thai Red Cross Society, B angkok, Thailand Antroduodenal manometry is one of the met hods to evaluate stomach and d uodenal motility.",Non-OADS,/arxiv_data1/oa_pdf/36/3d/jnm-19-395.PMC3714419.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.405 Successful Surgical Repair of Anterior  Rectocele in Patient With Constipation Ki Su Kim,1 Moo In Park,1* Sung Eun Kim1 and Seung-Hyun Lee2  Departments of1Internal Medicine and2Surgery, Kosin University College of Medicine, Busan, Korea Received: January 2, 2013 Revised: April 12, 2013 Accepted: April  15, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/0c/d3/jnm-19-405.PMC3714420.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.407 Extremely High Panesophageal Pressurization  in Type II Achalasia Hyung Hun Kim * and Myung-Gyu Choi  Department of Internal Medicine, The Catholic University of Kor ea College of Medicine, Seoul, Korea Received: February 13, 2013 Revised: March 7, 2013 Accepted: Marc h 11, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/4f/05/jnm-19-407.PMC3714421.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.409 Overlap Between Postprandial Distress and  Epigastric Pain Syndromes in Functional Dyspepsia:  Its Implications for Research and Clinical Practice (Am J Gastroenterol 2013;108:767-774) Received: June 12, 2013 Revised: June 21, 2013 Accepted: June 21,  2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/c8/3c/jnm-19-409.PMC3714422.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.412 Should Acid Suppressive Therapy Improve  Chronic Cough?",Non-OADS,/arxiv_data1/oa_pdf/13/b1/jnm-19-412.PMC3714423.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.415 Interpretation of a Manometric Trace of  the Upper Esophageal Sphincter TO THE EDITOR:  While reporting the complexity behind the  interpretation of the manometric trace of the upper esophageal  sphincter (UES), Bhatia and Shah1 wrote: “It is a technically de- manding procedure due to the anatomy of the UES, as is the  movement of the sphincter during swallowing.”  We agree with the authors that some of the difficulties are  due to the movement of the sphincter during swallowing.",Non-OADS,/arxiv_data1/oa_pdf/79/96/jnm-19-415.PMC3714424.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.417 Role of Helicobacter pylor iin Functional  Dyspepsia: More Controversies Than Answers TO THE EDITOR:  We read the recent article by Kim et al1 with  great interest.",Non-OADS,/arxiv_data1/oa_pdf/81/fc/jnm-19-417.PMC3714425.pdf
"3   July,  2013 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.3.418 Psychosocial Factors an d Rectal Hyposensitivit y Figure.",Non-OADS,/arxiv_data1/oa_pdf/46/21/jnm-19-418.PMC3714426.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE100 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.2.100 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):100-105 Effects of insulin-sensitizing agents and insulin  resistance in women with polycystic ovary syndrome Kyu Ri Hwang1,2, Young Min Choi1,3, Jin Ju Kim1,4, Soo Jin Chae5, Kyung Eui Park1, Hye Won Jeon1,2, Seung Yup Ku1,3,   Seok Hyun Kim1, Jung Gu Kim1, Shin Yong Moon1,3  1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul; 2Department of Obstetrics and Gynecology,   SMG-SNU Boramae Medical Center, Seoul; 3The Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University  College of Medicine, Seoul; 4Seoul National University Hospital Healthcare System Gangnam Center, Seoul National University College of Medicine,  Seoul; 5Maria Fertility Hospital, Seoul, Korea Objective: The aim of this study was to investigate the effect of insulin sensitizing agents on hormonal and metabolic parameters as well as  menstrual patterns in women with polycystic ovary syndrome (PCOS).",Non-OADS,/arxiv_data1/oa_pdf/57/ea/cerm-40-100.PMC3714427.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/ea/cerm-40-100.PMC3714427.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.100 Clin Exp Reprod Med 2013;40(2):100-105 1024.,OADS,/arxiv_data1/oa_pdf/57/ea/cerm-40-100.PMC3714427.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.100 Clin Exp Reprod Med 2013;40(2):100-105 104et al.,OADS,/arxiv_data1/oa_pdf/57/ea/cerm-40-100.PMC3714427.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE47 REVIEW http://dx.doi.org/10.5653/cerm.2013.40.2.47 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):47-54 Stem cell maintenance in a different niche Jeong Mook Lim1,2, Ji Yeon Ahn2, Seung Tae Lee3 1WCU Biomodulation Program, 2Department of Agricultural Biotechnology, Seoul National University, Seoul; 3Department of Animal Biotechnology,  College of Animal Life Science, Kangwon National University, Chuncheon, Korea To overcome the difficulty of controlling stem cell fate and function in applications to regenerative medicine, a number of alternative appro­aches have been made.",Non-OADS,/arxiv_data1/oa_pdf/2b/d1/cerm-40-47.PMC3714428.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/d1/cerm-40-47.PMC3714428.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.47 Clin Exp Reprod Med 2013;40(2):47-54 48wealth of information that should assist in the development of inno ­ vative 3D culture systems.,OADS,/arxiv_data1/oa_pdf/2b/d1/cerm-40-47.PMC3714428.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.47 Clin Exp Reprod Med 2013;40(2):47-54 50Figure 4.,OADS,/arxiv_data1/oa_pdf/2b/d1/cerm-40-47.PMC3714428.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.47 Clin Exp Reprod Med 2013;40(2):47-54 52has been developed and the microenvironmental influence of this  3D niche on self­renewal was evaluated in mouse ESCs (mESCs) [53].,OADS,/arxiv_data1/oa_pdf/2b/d1/cerm-40-47.PMC3714428.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.47 Clin Exp Reprod Med 2013;40(2):47-54 541991;5:2814­23.,OADS,/arxiv_data1/oa_pdf/2b/d1/cerm-40-47.PMC3714428.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE55 REVIEW http://dx.doi.org/10.5653/cerm.2013.40.2.55 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):55-59 Update on the treatment of endometriosis Sung Hoon Kim, Hee Dong Chae, Chung-Hoon Kim, Byung Moon Kang Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Endometriosis is defined as the presence of functional endometrial tissue outside the uterus, causing diverse progressive symptoms such as in­fertility, pelvic pain, and dysmenorrhea.",Non-OADS,/arxiv_data1/oa_pdf/af/9b/cerm-40-55.PMC3714429.pdf
"However, pain recurrence Received: Aug 29, 2012 ∙ Revised: Sep 12, 2012 ∙ Accepted: Sep 30, 2012 Corresponding author: Sung Hoon KimDepartment of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaTel: +82-2-3010-3628  Fax: +82-2-476-7331  E-mail: kimsung@amc.seoul.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/9b/cerm-40-55.PMC3714429.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.55 Clin Exp Reprod Med 2013;40(2):55-59 56or re ­operation rate has been reported being from 24% to 54%.,OADS,/arxiv_data1/oa_pdf/af/9b/cerm-40-55.PMC3714429.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.55 Clin Exp Reprod Med 2013;40(2):55-59 58life suitable for once ­daily administration.,Non-OADS,/arxiv_data1/oa_pdf/af/9b/cerm-40-55.PMC3714429.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE60 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.2.60 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):60-66 Effect of genistein administration on the recovery of  spermatogenesis in the busulfan-treated rat testis Heejun Chi, Kangwoo Chun, Hyukjun Son, Jonghyun Kim, Giyoung Kim, Sungil Roh i-Dream Research Center, MizMedi Hospital, Seoul, Korea Objective: Impairment of spermatogenesis has been identified as an inevitable side effect of cancer treatment.",Non-OADS,/arxiv_data1/oa_pdf/cc/fa/cerm-40-60.PMC3714430.pdf
"Exposure to low doses of phytoestrogens in the perinatal period affects Leydig cell function in adult rats, causing  Received: Apr 9, 2013 ∙ Revised: May 21, 2013 ∙ Accepted: May 21, 2013 Corresponding author: Heejun Chii-Dream Research Center, MizMedi Hospital, 295 Gangseo-ro, Gangseo-gu, Seoul 157-723, KoreaTel: +82-2-2007-1840  Fax: +82-2-2007-1852  E-mail: ivf129@mizmedi.net  This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/fa/cerm-40-60.PMC3714430.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.60 Clin Exp Reprod Med 2013;40(2):60-66 62Results 1.,OADS,/arxiv_data1/oa_pdf/cc/fa/cerm-40-60.PMC3714430.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.60 Clin Exp Reprod Med 2013;40(2):60-66 64high levels of ITT may be detrimental to spermatogenesis is a change  in the pattern of stem cell factor (SCF) expression [10].,Non-OADS,/arxiv_data1/oa_pdf/cc/fa/cerm-40-60.PMC3714430.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.60 Clin Exp Reprod Med 2013;40(2):60-66 66different androgens.,OADS,/arxiv_data1/oa_pdf/cc/fa/cerm-40-60.PMC3714430.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE67 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.2.67 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):67-75 Peroxisome proliferator-activated receptor γ agonist  suppresses human telomerase reverse transcriptase expression and aromatase activity in eutopic endometrial stromal cells from endometriosis  Hye Jin Chang1*, Jae Hoon Lee2,3*, Kyung Joo Hwang2, Mi Ran Kim2, Jung Hyun Yoo4 1Health Promotion Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam; 2Department of  Obstetrics and Gynecology, Ajou University School of Medicine, Suwon; 3Department of Molecular Science and Technology, Ajou University, Suwon;   4Department of Obstetrics and Gynecology, Bundang Jesaeng Hospital, Seongnam, Korea Objective: To investigate the effect of peroxisome proliferator activated receptor γ (PPARγ) agonist on the cell proliferation properties and ex - pression of human telomerase reverse transcriptase (hTERT) and aromatase in cultured endometrial stromal cell (ESC) from patients with endo - metriosis.",Non-OADS,/arxiv_data1/oa_pdf/6f/78/cerm-40-67.PMC3714431.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/78/cerm-40-67.PMC3714431.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.67 Clin Exp Reprod Med 2013;40(2):67-75 68the disease.,OADS,/arxiv_data1/oa_pdf/6f/78/cerm-40-67.PMC3714431.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.2.67 Clin Exp Reprod Med 2013;40(2):67-75 70liferation of eutopic endometrium by PPARγ agonist in endometrio - sis, cultured ESCs from patients with endometriosis were treated with  different concentrations of a PPARγ agonist, rosiglitazone.",Non-OADS,/arxiv_data1/oa_pdf/6f/78/cerm-40-67.PMC3714431.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.2.67 Clin Exp Reprod Med 2013;40(2):67-75 72environmental toxin exposure), with obvious divergence in molecu- lar pathways downstream [7].",Non-OADS,/arxiv_data1/oa_pdf/6f/78/cerm-40-67.PMC3714431.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.67 Clin Exp Reprod Med 2013;40(2):67-75 74eutopic endometrial stromal cells from women with endometri- osis.,OADS,/arxiv_data1/oa_pdf/6f/78/cerm-40-67.PMC3714431.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE76 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.2.76 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):76-82 Blood glucose levels, insulin concentrations, and  insulin resistance in healthy women and women with premenstrual syndrome: a comparative study  Safar Zarei1, Leili Mosalanejad2, Mohamed Amin Ghobadifar3  1Department of Physiology, 2Department of Psychiatry, 3Student Research Committee, School of Medicine, Jahrom University of Medical Sciences,  Jahrom, Iran Objective:  To compare the blood glucose levels, insulin concentrations, and insulin resistance during the two phases of the menstrual cycle  between healthy women and patients with premenstrual syndrome (PMS).",Non-OADS,/arxiv_data1/oa_pdf/47/ca/cerm-40-76.PMC3714432.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/ca/cerm-40-76.PMC3714432.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.76 Clin Exp Reprod Med 2013;40(2):76-82 78quired for each study group.,Non-OADS,/arxiv_data1/oa_pdf/47/ca/cerm-40-76.PMC3714432.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.76 Clin Exp Reprod Med 2013;40(2):76-82 80were not significantly different during the follicular phase ( p= 0.368).,Non-OADS,/arxiv_data1/oa_pdf/47/ca/cerm-40-76.PMC3714432.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.76 Clin Exp Reprod Med 2013;40(2):76-82 8215.,OADS,/arxiv_data1/oa_pdf/47/ca/cerm-40-76.PMC3714432.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE83 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.2.83 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):83-89 Cessation of gonadotropin-releasing hormone  antagonist on triggering day in flexible multiple-dose protocol: A randomized controlled study Hye Jin Chang1, Jung Ryeol Lee2,3, Byung Chul Jee2,3, Chang Suk Suh2,3, Won Don Lee4, Seok Hyun Kim3 1Health Promotion Center, 2Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam; 3Department of  Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul; 4Maria Infertility Hospital, Seoul, Korea Objective: To investigate outcomes of stimulated IVF cycles in which GnRH antagonist was omitted on the ovulation triggering day.",Non-OADS,/arxiv_data1/oa_pdf/e8/12/cerm-40-83.PMC3714433.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/12/cerm-40-83.PMC3714433.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.83 Clin Exp Reprod Med 2013;40(2):83-89 84sponse to the LH surge [8].,OADS,/arxiv_data1/oa_pdf/e8/12/cerm-40-83.PMC3714433.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.83 Clin Exp Reprod Med 2013;40(2):83-89 86A premature LH rise was defined as LH ≥ 10 mIU/mL and premature  progesterone rise as progesterone ≥ 1.0 ng/mL.,Non-OADS,/arxiv_data1/oa_pdf/e8/12/cerm-40-83.PMC3714433.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.2.83 Clin Exp Reprod Med 2013;40(2):83-89 88Concerns have been raised regarding the possible adverse effects  of GnRH antagonist on endometrial receptivity, and these potential  effects of GnRH antagonist have been claimed to be causes of a low - er pregnancy rate [29,30].",Non-OADS,/arxiv_data1/oa_pdf/e8/12/cerm-40-83.PMC3714433.pdf
http://dx.doi.org/10.1016/j.ejogrb.2013.03.006.,OADS,/arxiv_data1/oa_pdf/e8/12/cerm-40-83.PMC3714433.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE90 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.2.90 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):90-94 The effectiveness of earlier oocyte retrieval in the  case of a premature luteinizing hormone surge on hCG day in in vitro fertilization–embryo transfer cycles Min Hye Choi1,2, Sun Hwa Cha1, Chan Woo Park1, Jin Young Kim1, Kwang Moon Yang1, In Ok Song1, Mi Kyoung Koong1,   Inn Soo Kang1, Hye Ok Kim1  1Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Cheil General Hospital, Kwandong University  College of Medicine, Seoul ; 2Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Bundang Cheil  Women’s Hospital, Seongnam, Korea Objective: To evaluate the efficacy of earlier oocyte retrieval in IVF patients with a premature LH surge on hCG day.",Non-OADS,/arxiv_data1/oa_pdf/c8/bc/cerm-40-90.PMC3714434.pdf
"In many studies, the 36-hour interval to hCG administration and oocyte retrieval has been found to have the greatest effectiveness with regard to the fertiliza-tion rate and pregnancy rate [3-6].Received: Jun 3, 2013 ∙ Revised: Jun 17, 2013 ∙ Accepted: Jun 18, 2013 Corresponding author: Hye Ok KimDepartment of Obstetrics and Gynecology, Cheil General Hospital and Women’s Health Care Center, Kwandong University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu, Seoul 100-380, Korea Tel: +82-2-2000-7549  Fax: +82-2-2000-7790  E-mail: ok58163@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/bc/cerm-40-90.PMC3714434.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.2.90 Clin Exp Reprod Med 2013;40(2):90-94 92(73.2 ± 38.9% vs. 47.8 ± 42.9%, p= 0.024) was significantly lower in  the earlier OPU group than the timed OPU group, respectively (Table 2).",OADS,/arxiv_data1/oa_pdf/c8/bc/cerm-40-90.PMC3714434.pdf
" http://dx.doi.org/10.5653/cerm.2013.40.2.90 Clin Exp Reprod Med 2013;40(2):90-94 94trolled, multicentre trial.",OADS,/arxiv_data1/oa_pdf/c8/bc/cerm-40-90.PMC3714434.pdf
"THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE95 ORIGINAL ARTICLE http://dx.doi.org/10.5653/cerm.2013.40.2.95 pISSN 2233-8233 · eISSN 2233-8241Clin Exp Reprod Med 2013;40(2):95-99 Association between serum anti-Müllerian hormone  level and ovarian response to mild stimulation in normoovulatory women and anovulatory women with polycystic ovary syndrome Ju Yeong Kim1, Gwang Yi1, Yeo Rang Kim2, Jae Yeon Chung2, Ji Hyun Ahn2, You Kyoung Uhm2, Byung Chul Jee1,3,   Chang Suk Suh1,3, Seok Hyun Kim2,3 1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam; 2Department of Obstetrics and Gynecology,  Seoul National University Hospital, Seoul; 3Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea Objective: To evaluate the correlation between serum levels of anti-Müllerian hormone (AMH) and ovarian response to mild stimulation in  normoovulatory women and anovulatory women with polycystic ovary syndrome (PCOS).Methods: Seventy-four cycles of mild stimulation (clomiphene citrate+gonadotropin followed by timed intercourse or intrauterine insemina-tion) performed in normoovulatory women (57 cycles) and anovulatory women with PCOS (17 cycles).",Non-OADS,/arxiv_data1/oa_pdf/46/b6/cerm-40-95.PMC3714435.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/b6/cerm-40-95.PMC3714435.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.95 Clin Exp Reprod Med 2013;40(2):95-99 96seen in normal responders.,OADS,/arxiv_data1/oa_pdf/46/b6/cerm-40-95.PMC3714435.pdf
 http://dx.doi.org/10.5653/cerm.2013.40.2.95 Clin Exp Reprod Med 2013;40(2):95-99 98CC+gonadotropin was positively correlated with the serum AMH  level in normoovulatory women as it would be in conventional ovari- an stimulation in IVF patients.,Non-OADS,/arxiv_data1/oa_pdf/46/b6/cerm-40-95.PMC3714435.pdf
"MATERIALS AND METHODS From November 2011 to February 2012, we collectedMycobiology 2013 June, 41(2): 100-107 http://dx.doi.org/10.5941/MYCO.2013.41.2.100 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: funguy@korea.kr Received  March 20, 2013 Revised  April 17, 2013 Accepted  May 2, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/da/mb-41-100.PMC3714438.pdf
in KACC homepage (http://www.genebank.go.kr).,Non-OADS,/arxiv_data1/oa_pdf/62/da/mb-41-100.PMC3714438.pdf
Selected strains from this study have been preserved in the Korean Agricultural Culture Collection (KACC; http://www.genebank.go.kr) and are accessible for future research.,Non-OADS,/arxiv_data1/oa_pdf/62/da/mb-41-100.PMC3714438.pdf
"In our screening for microorganisms with the potential to be used as microbial fungicides for the simultaneouscontrol of gray mold and powdery mildew, an effective Mycobiology 2013 June, 41(2): 108-111 http://dx.doi.org/10.5941/MYCO.2013.41.2.108 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: bsyun@jbnu.ac.kr Received  March 20, 2013 Accepted  May 21, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/a9/mb-41-108.PMC3714439.pdf
"Cultural features were Mycobiology 2013 June, 41(2): 112-115 http://dx.doi.org/10.5941/MYCO.2013.41.2.112 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: shunyu@cnu.ac.kr Received  February 27, 2013 Revised  March 27, 2013 Accepted  April 15, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/8b/mb-41-112.PMC3714440.pdf
"The sequences were comparedusing the NCBI BLAST program (http://www.ncbi.nlm.nih.gov/Mycobiology 2013 June, 41(2): 116-119 http://dx.doi.org/10.5941/MYCO.2013.41.2.116 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: younslee@kangwon.ac.kr Received  February 4, 2013 Revised  March 4, 2013 Accepted  April 17, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/e1/mb-41-116.PMC3714441.pdf
"Mycobiology 2013 June, 41(2): 67-72 http://dx.doi.org/10.5941/MYCO.2013.41.2.67pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: whjung@cau.ac.kr Received  June 7, 2013 Accepted  June 8, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/94/mb-41-67.PMC3714442.pdf
"Labia entire, chemical substances present or absent ··· 5Mycobiology 2013 June, 41(2): 73-76 http://dx.doi.org/10.5941/MYCO.2013.41.2.73 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jshur1@sunchon.ac.kr Received  April 3, 2013 Revised  April 29, 2013 Accepted  May 2, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/c2/mb-41-73.PMC3714443.pdf
Available from: http://home.hiroshima-u.ac.jp/ lichen/cklist.htm.,Non-OADS,/arxiv_data1/oa_pdf/e1/c2/mb-41-73.PMC3714443.pdf
Available from:http://www.biologie.unihamburg.de/checklists/lichens/asia/ taiwan_l.htm.,Non-OADS,/arxiv_data1/oa_pdf/e1/c2/mb-41-73.PMC3714443.pdf
"Sites OF1, OF2, and OF3 were located near theMycobiology 2013 June, 41(2): 77-81 http://dx.doi.org/10.5941/MYCO.2013.41.2.77pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: eomah@knue.ac.kr Received  February 27, 2013 Accepted  March 31, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/28/mb-41-77.PMC3714444.pdf
"These surface-sterilizedleaves were cut into 4 segments that were 5 mm in lengthand then placed into 3 types of culture medium: potatoMycobiology 2013 June, 41(2): 82-85 http://dx.doi.org/10.5941/MYCO.2013.41.2.82 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: eomah@knue.ac.kr Received  March 8, 2013 Revised  April 12, 2013 Accepted  May 30, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/f3/mb-41-82.PMC3714445.pdf
"Identificationby morphological features has limitations, including laborious Mycobiology 2013 June, 41(2): 86-93 http://dx.doi.org/10.5941/MYCO.2013.41.2.86 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: jongklee@kangwon.ac.kr Received  April 1, 2013 Revised  May 13, 2013 Accepted  May 21, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/16/mb-41-86.PMC3714446.pdf
"The biochemical parameters determined weretotal cholesterol (TC), high-density lipoprotein-cholesterol(HDL-c), low-density lipoprotein-cholesterol (LDL-c),triglyceride levels (TG), the atherogenic index (AI), andthe cardiac risk factor (CRF).Mycobiology 2013 June, 41(2): 94-99 http://dx.doi.org/10.5941/MYCO.2013.41.2.94 pISSN 1229-8093  eISSN 2092-9323 © The Korean Society of Mycology *Corresponding author E-mail: selpest@knu.ac.kr Received  February 27, 2013 Revised  March 27, 2013 Accepted  April 15, 2013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/97/mb-41-94.PMC3714447.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgJ Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/cb/7e/jgo-24-209.PMC3714456.pdf
3:209-211 http://dx.doi.org/10.3802/jgo.2013.24.3.209,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/jgo-24-209.PMC3714456.pdf
"Eric Pujade-Lauraine http://dx.doi.org/10.3802/jgo.2013.24.3.209 210  www.ejgo.org chemotherapy response rate from 12% to 27% (p=0.001) and  PFS from 3.4 to 6.7 months (hazard ratio, 0.48; p<0.001) sug - gesting synergy between bevacizumab and chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/cb/7e/jgo-24-209.PMC3714456.pdf
http://dx.doi.org/10.1111/ajco.12074.,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/jgo-24-209.PMC3714456.pdf
http://dx.doi.org/10.1002/ijc.28259.,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/jgo-24-209.PMC3714456.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgJ Gynecol Oncol Vol.",Non-OADS,/arxiv_data1/oa_pdf/b7/c6/jgo-24-212.PMC3714457.pdf
"3:212-214 http://dx.doi.org/10.3802/jgo.2013.24.3.212 Recently, consensus guideline for the early detection of cervical cancer in Korea has been developed and published.",Non-OADS,/arxiv_data1/oa_pdf/b7/c6/jgo-24-212.PMC3714457.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.212 214  www.ejgo.org HPV-positive is a great concern.,Non-OADS,/arxiv_data1/oa_pdf/b7/c6/jgo-24-212.PMC3714457.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  In cervical intraepithelial neoplasia (CIN), p16INK4a immunohistochemistry has been reported to be a useful diagnostic  biomarker.",Non-OADS,/arxiv_data1/oa_pdf/f7/2d/jgo-24-215.PMC3714458.pdf
3:215-221 http://dx.doi.org/10.3802/jgo.2013.24.3.215,OADS,/arxiv_data1/oa_pdf/f7/2d/jgo-24-215.PMC3714458.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.215 216  www.ejgo.org treat only patients that are at high risk of progression, and to  observe low risk patients that may regress spontaneously, it  is not easy to predict the outcome of each patient.",Non-OADS,/arxiv_data1/oa_pdf/f7/2d/jgo-24-215.PMC3714458.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.215 218  www.ejgo.org ing was determined by the direct sequencing method [19],  which was determined based on an approximately 200 bases  of L1 sequence and a search of the NCBI database (GenBank  sequences; http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) using  Sequencing Analysis ver.",OADS,/arxiv_data1/oa_pdf/f7/2d/jgo-24-215.PMC3714458.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.215 220  www.ejgo.org which could be predicted by p16INK4a immunohistochemistry.,Non-OADS,/arxiv_data1/oa_pdf/f7/2d/jgo-24-215.PMC3714458.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The aim of this study was to investigate the prognostic factors and treatment outcome of patients with adeno car ci- noma of the uterine cervix who underwent radical hysterectomy with systematic lymphadenectomy.",Non-OADS,/arxiv_data1/oa_pdf/89/8f/jgo-24-222.PMC3714459.pdf
3:222-228 http://dx.doi.org/10.3802/jgo.2013.24.3.222,OADS,/arxiv_data1/oa_pdf/89/8f/jgo-24-222.PMC3714459.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.222 224  www.ejgo.org tastasis, LVSI, parametrial invasion, DSI, vaginal invasion, and  corpus invasion (p<0.001 for all 6 risk factors), which should  explain why the patients with ovarian metastasis showed  extremely poor survival (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/89/8f/jgo-24-222.PMC3714459.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.222 226  www.ejgo.org DISCUSSION In this retrospective analysis, we demonstrated that LNM,  LVSI, and PI were independent prognostic factors for ADC of  the uterine cervix, and their survival was stratified by the com - bination of three independent prognostic factors.",OADS,/arxiv_data1/oa_pdf/89/8f/jgo-24-222.PMC3714459.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.222 228  www.ejgo.org Acta Obstet Gynecol Scand 2002;81:1144-51.,Non-OADS,/arxiv_data1/oa_pdf/89/8f/jgo-24-222.PMC3714459.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The purpose of the present study was to evaluate treatment outcomes and prognostic factors in cervical cancer  patients with isolated para-aortic lymph node (PALN) metastases.",Non-OADS,/arxiv_data1/oa_pdf/f9/5b/jgo-24-229.PMC3714460.pdf
3:229-235 http://dx.doi.org/10.3802/jgo.2013.24.3.229,OADS,/arxiv_data1/oa_pdf/f9/5b/jgo-24-229.PMC3714460.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.229 230  www.ejgo.org Cervical cancer has been reported to spread more widely by  the lymphatic pathway than by the hematogenous pathway  [3].,Non-OADS,/arxiv_data1/oa_pdf/f9/5b/jgo-24-229.PMC3714460.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.229 232  www.ejgo.org involvement (p=0.085), cervical mass size (p=0.142), and Cyfra  21-1 (p=0.200) were not statistically significant.",OADS,/arxiv_data1/oa_pdf/f9/5b/jgo-24-229.PMC3714460.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.229 234  www.ejgo.org there has been no report in PALN metastatic cervical cancer.,Non-OADS,/arxiv_data1/oa_pdf/f9/5b/jgo-24-229.PMC3714460.pdf
NOW AVAILABLE ONLINE  at http://www.ejgo.org,Non-OADS,/arxiv_data1/oa_pdf/f9/5b/jgo-24-229.PMC3714460.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The malignant potential of intraepithelial neoplasia of the vulva and vagina after treatment is not well defined.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/jgo-24-236.PMC3714461.pdf
3:236-241 http://dx.doi.org/10.3802/jgo.2013.24.3.236,OADS,/arxiv_data1/oa_pdf/dc/47/jgo-24-236.PMC3714461.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.236 238  www.ejgo.org For eight patients (1.9%), the initial treatment within the first  12 months was photodynamic therapy or local drug applica - tion such as imiquimod.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/jgo-24-236.PMC3714461.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.236 240  www.ejgo.org a retrospective cohort study, treatment results may have been  influenced by selection bias.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/jgo-24-236.PMC3714461.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To analyze the prognostic factors related to the recurrence rate of vulvar cancer.",Non-OADS,/arxiv_data1/oa_pdf/81/c3/jgo-24-242.PMC3714462.pdf
3:242-248 http://dx.doi.org/10.3802/jgo.2013.24.3.242,OADS,/arxiv_data1/oa_pdf/81/c3/jgo-24-242.PMC3714462.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.242 244  www.ejgo.org Paget disease, and the last two were 1 sebaceous carcinoma  and 1 malignant sweat gland tumor.",Non-OADS,/arxiv_data1/oa_pdf/81/c3/jgo-24-242.PMC3714462.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.242 246  www.ejgo.org the cut-off >4 mm.,Non-OADS,/arxiv_data1/oa_pdf/81/c3/jgo-24-242.PMC3714462.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.242 248  www.ejgo.org 8.,OADS,/arxiv_data1/oa_pdf/81/c3/jgo-24-242.PMC3714462.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  This study mainly aimed to investigate the association of ovarian cancer mortality with reproductive factors and body  mass index among Japanese women aged 40-79 years.",Non-OADS,/arxiv_data1/oa_pdf/c5/bc/jgo-24-249.PMC3714463.pdf
3:249-257 http://dx.doi.org/10.3802/jgo.2013.24.3.249,OADS,/arxiv_data1/oa_pdf/c5/bc/jgo-24-249.PMC3714463.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.249 250  www.ejgo.org such as increased notification of OC from the concerned  authorities and institutions due to better diagnostic facilities,  changing dietary patterns and adoption of westernised  lifestyles may contribute to the rising trend of OC [1,9].",Non-OADS,/arxiv_data1/oa_pdf/c5/bc/jgo-24-249.PMC3714463.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.249 252  www.ejgo.org Table 1.,OADS,/arxiv_data1/oa_pdf/c5/bc/jgo-24-249.PMC3714463.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.249 254  www.ejgo.org 5.54; 95% CI, 1.68 to 18.22; p=0.005) models as compared to  married women.",Non-OADS,/arxiv_data1/oa_pdf/c5/bc/jgo-24-249.PMC3714463.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.249 256  www.ejgo.org CONFLICT OF INTEREST No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/c5/bc/jgo-24-249.PMC3714463.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  To determine the efficacy, progression-free survival (PFS) and overall survival (OS) for the combination of intravenous  bevacizumab and oral cyclophosphamide in heavily pretreated patients with recurrent ovarian carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/35/83/jgo-24-258.PMC3714464.pdf
3:258-264 http://dx.doi.org/10.3802/jgo.2013.24.3.258,OADS,/arxiv_data1/oa_pdf/35/83/jgo-24-258.PMC3714464.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.258 260  www.ejgo.org phosphamide (OS-BC) was calculated from date of first receipt  of drug to date of death or date of last known status.,OADS,/arxiv_data1/oa_pdf/35/83/jgo-24-258.PMC3714464.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.258 262  www.ejgo.org months) compared with 9 months (range, 2 to 51 months)  for non-responders (p=0.004) (Fig.",OADS,/arxiv_data1/oa_pdf/35/83/jgo-24-258.PMC3714464.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.258 264  www.ejgo.org criteria.,OADS,/arxiv_data1/oa_pdf/35/83/jgo-24-258.PMC3714464.pdf
Available from: http://seer.cancer.gov/statfacts/html/ovary.html.,Non-OADS,/arxiv_data1/oa_pdf/35/83/jgo-24-258.PMC3714464.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  Over-expression of thrombin in ovarian cancer cells is associated with poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/25/60/jgo-24-265.PMC3714465.pdf
3:265-272 http://dx.doi.org/10.3802/jgo.2013.24.3.265,OADS,/arxiv_data1/oa_pdf/25/60/jgo-24-265.PMC3714465.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.265 266  www.ejgo.org cytokeratin to vimentin expression, and 3) over-expression of  the matrix metallo-proteinases (MMPs) [9].",Non-OADS,/arxiv_data1/oa_pdf/25/60/jgo-24-265.PMC3714465.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.265 268  www.ejgo.org RESULTS 1.,OADS,/arxiv_data1/oa_pdf/25/60/jgo-24-265.PMC3714465.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.265 270  www.ejgo.org DISCUSSION In this study, we showed that thrombin directly induced EMT  in SKOV3 cells and this was associated with a time- and dose- dependent down-regulation of E-cadherin accompanied  by an up-regulation of N-cadherin and vimentin.",OADS,/arxiv_data1/oa_pdf/25/60/jgo-24-265.PMC3714465.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.265 272  www.ejgo.org cancer.,Non-OADS,/arxiv_data1/oa_pdf/25/60/jgo-24-265.PMC3714465.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The purpose of this study was to investigate whether selective cyclooxygenase (COX) inhibitors promote paclitaxel- induced apoptosis in taxane-resistant ovarian cancer cells by suppressing MDR1 /P-glycoprotein (P-gp) expression.",Non-OADS,/arxiv_data1/oa_pdf/51/57/jgo-24-273.PMC3714466.pdf
3:273-279 http://dx.doi.org/10.3802/jgo.2013.24.3.273,OADS,/arxiv_data1/oa_pdf/51/57/jgo-24-273.PMC3714466.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.273 274  www.ejgo.org the presence of structurally and functionally different che - motherapeutic agents, and is the main cause of therapeutic  failure in ovarian cancers [4].",Non-OADS,/arxiv_data1/oa_pdf/51/57/jgo-24-273.PMC3714466.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.273 276  www.ejgo.org 3.,OADS,/arxiv_data1/oa_pdf/51/57/jgo-24-273.PMC3714466.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.273 278  www.ejgo.org in taxane-resistant ovarian cancer cells by suppressing MDR1 / P-gp expression, and to clarify whether these effects depend  on the COX pathway.",Non-OADS,/arxiv_data1/oa_pdf/51/57/jgo-24-273.PMC3714466.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgObjective:  The objective of this study is to examine the course of fatigue in female cancer patients during the first months after  treatment.",Non-OADS,/arxiv_data1/oa_pdf/65/02/jgo-24-280.PMC3714467.pdf
3:280-286 http://dx.doi.org/10.3802/jgo.2013.24.3.280,OADS,/arxiv_data1/oa_pdf/65/02/jgo-24-280.PMC3714467.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.280 282  www.ejgo.org [12] and has good psychometric properties [16,17].",OADS,/arxiv_data1/oa_pdf/65/02/jgo-24-280.PMC3714467.pdf
"http://dx.doi.org/10.3802/jgo.2013.24.3.280 284  www.ejgo.org score, corresponding to 9% explained variance (Table 6).",OADS,/arxiv_data1/oa_pdf/65/02/jgo-24-280.PMC3714467.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.280 286  www.ejgo.org 2003;362:640-50.,OADS,/arxiv_data1/oa_pdf/65/02/jgo-24-280.PMC3714467.pdf
"Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.www.ejgo.orgFertility-sparing surgery was optimal to patients with tumor diameter smaller than 2 cm.",Non-OADS,/arxiv_data1/oa_pdf/3b/84/jgo-24-287.PMC3714468.pdf
3:287-290 http://dx.doi.org/10.3802/jgo.2013.24.3.287,OADS,/arxiv_data1/oa_pdf/3b/84/jgo-24-287.PMC3714468.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.287 288  www.ejgo.org 2.,Non-OADS,/arxiv_data1/oa_pdf/3b/84/jgo-24-287.PMC3714468.pdf
http://dx.doi.org/10.3802/jgo.2013.24.3.287 290  www.ejgo.org trachelectomy in bulky stage IB1 cervical cancer: a case report.,Non-OADS,/arxiv_data1/oa_pdf/3b/84/jgo-24-287.PMC3714468.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4a/a1/2190.PMC3714469.pdf
"According to India ’s 2011 Census, t h em e a nl i f ee x p e c t a n c yi nI n d i ai s 67.3 years for males and 69.6 years forfemales (http://www.ce nsusindia.gov.in/ 2011-prov-results/data_ ﬁles/india/ Final_PPT_2011_chapter8.pdf).",OADS,/arxiv_data1/oa_pdf/4a/a1/2190.PMC3714469.pdf
"Corresponding author: Michael C. Sachs, sachsmc@u.washington.edu.Received 3 October 2012 and accepted 17 January 2013.DOI: 10.2337/dc12-2020This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2020/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/5a/ff/2423.PMC3714470.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5a/ff/2423.PMC3714470.pdf
"Corresponding author: Norbert Stefan, norbert .stefan@med.uni-tuebingen.de.Received 30 August 2012 and accepted 28 January 2013.DOI: 10.2337/dc12-1760 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-1760/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/8e/53/2331.PMC3714475.pdf
"Corresponding author: Guy-Marino Hinnouho, guy-marino.hinnouho@inserm.fr.Received 16 August 2012 and accepted 6 February 2013.DOI: 10.2337/dc12-1654This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1654/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/41/ea/2294.PMC3714476.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/41/ea/2294.PMC3714476.pdf
Ho-meostasis model assessment (HOMA) ofinsulin resistance (HOMA-IR) calculationwas based on model-derived estimates(rather than linear approximations) using the HOMA2 calculator version 2.2 (http://www.dtu.ox.ac.uk/index.php?,Non-OADS,/arxiv_data1/oa_pdf/41/ea/2294.PMC3714476.pdf
Received 23 October 2012 and accepted 13 January 2013.DOI: 10.2337/dc12-2166This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2166/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/75/1f/2311.PMC3714477.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/75/1f/2311.PMC3714477.pdf
Available from http://www.brain-map.org.,Non-OADS,/arxiv_data1/oa_pdf/75/1f/2311.PMC3714477.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/60/90/2430.PMC3714478.pdf
Available from http://www.cdc.gov/chronicdisease/resources/publications/AAG/ddt.htm.,OADS,/arxiv_data1/oa_pdf/60/90/2430.PMC3714478.pdf
Avail-able from http://www.cdc.gov/diabetes/ statistics/complications_national.htm.,Non-OADS,/arxiv_data1/oa_pdf/60/90/2430.PMC3714478.pdf
Available from http://www.cdc.gov/violenceprevention/overview/social-eco logicalmodel.html.,Non-OADS,/arxiv_data1/oa_pdf/60/90/2430.PMC3714478.pdf
Available from http://www.ers.usda.,Non-OADS,/arxiv_data1/oa_pdf/60/90/2430.PMC3714478.pdf
Available from http://apps.ams.usda.gov/foodde serts/foodDeserts.,Non-OADS,/arxiv_data1/oa_pdf/60/90/2430.PMC3714478.pdf
DOI: 10.2337/dc12-2521 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2521/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/3a/2c/2317.PMC3714479.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3a/2c/2317.PMC3714479.pdf
"NCT00432809, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1596/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/e5/1b/2175.PMC3714483.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e5/1b/2175.PMC3714483.pdf
Available fromhttp://iom.edu/Activi ties/Quality/VSRT/ 2013-APR-25.aspx.,OADS,/arxiv_data1/oa_pdf/7c/62/2146.PMC3714486.pdf
"NCT00000620, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1391/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/d3/c7/2162.PMC3714487.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d3/c7/2162.PMC3714487.pdf
"Corresponding author: Luciano Bernardi, lbern1ps@unipv.it.Received 17 October 2012 and accepted 14 January 2013.DOI: 10.2337/dc12-2113This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2113/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/9b/35/2183.PMC3714488.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9b/35/2183.PMC3714488.pdf
"Corresponding author: Julio A. Chirinos, julio.chirinos@uphs.upenn.edu.Received 23 July 2012 and accepted 4 January 2013.DOI: 10.2337/dc12-1463This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1463/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/c7/e3/2359.PMC3714490.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c7/e3/2359.PMC3714490.pdf
"ANZCTRN 12606000436572, www.anzctr.org.au This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2196/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/c1/4f/2372.PMC3714491.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c1/4f/2372.PMC3714491.pdf
HOMA2-IR was calculated with serum glucose and C-peptide values us-ing the validated calculator (accessed athttp://www.dtu.ox.ac.uk).,OADS,/arxiv_data1/oa_pdf/c1/4f/2372.PMC3714491.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/35/d3/2211.PMC3714492.pdf
DOI: 10.2337/dc13-0356 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0356/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/8d/93/2254.PMC3714493.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/8d/93/2254.PMC3714493.pdf
Available from http://www.cdc.gov/ diabetes/pubs/pdf/ndfs_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/93/2254.PMC3714493.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7c/ae/2395.PMC3714495.pdf
*A complete list of the RIACE Investigators can be found in the Supplementary Data online at http://care.diabetesjournals.org/lookup/s uppl/doi:10 .2337/dc12-2264/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/83/fa/2301.PMC3714498.pdf
"NCT00979628, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1988/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/a9/aa/2169.PMC3714500.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a9/aa/2169.PMC3714500.pdf
"Corresponding author: Kathryn S. Taylor, kathryn.taylor@phc.ox.ac.uk.Received 28 July 2012 and accepted 4 January 2013.DOI: 10.2337/dc12-1513This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1513/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/a6/06/2366.PMC3714501.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a6/06/2366.PMC3714501.pdf
Avail- able from http://www.mortality-trends.,Non-OADS,/arxiv_data1/oa_pdf/a6/06/2366.PMC3714501.pdf
Available from http://guidence.nice.ord.uk/CG87.Accessed 11 July 2012 9.,Non-OADS,/arxiv_data1/oa_pdf/a6/06/2366.PMC3714501.pdf
Available from http://www.sign.ac.uk/guidlines/full text/116/index.html.,Non-OADS,/arxiv_data1/oa_pdf/a6/06/2366.PMC3714501.pdf
Available from http://www.nhlbi.nih.gov/hbp/detect/categ.htm.,OADS,/arxiv_data1/oa_pdf/a6/06/2366.PMC3714501.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/56/71/2271.PMC3714503.pdf
Available from http://www.ndep.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/56/71/2271.PMC3714503.pdf
Available from http://www.cdc.gov/nchs/data/nhanes/A1c_webnotice.pdf.,OADS,/arxiv_data1/oa_pdf/56/71/2271.PMC3714503.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0f/5e/2440.PMC3714504.pdf
Web site: http://professional.diabetes.org/ce.,Non-OADS,/arxiv_data1/oa_pdf/44/c1/2449.PMC3714506.pdf
"Other Events Diabetes Innovation 2013 3–5 October 2013 Omni Shoreham HotelWashington, DCE-mail: nancy.felsheim@joslin.harvard.edu Web site: http://www.diabetesinnovation.org IR2013 XII International Symposium on Insulin Receptors and Insulin Action 7–9 November 2013 Barcelona, SpainWeb site: http://www.ir2013.com8th World Congress on Developmental Origins of Health and Disease 17–20 November 2013 SUNTEC SingaporeWeb site: http://www.dohad2013.org 7th International Conference on Advanced Technologies and Treatments for Diabetes 5–8 February 2014 Vienna, AustriaE-mail: attd@kenes.com Web site: www.kenes.com/attd2014 care.diabetesjournals.org D IABETES CARE,VOLUME 36, A UGUST 2013 2449",Non-OADS,/arxiv_data1/oa_pdf/44/c1/2449.PMC3714506.pdf
"Corresponding author: Laurent Crenier, lcrenier@ulb.ac.be.Received 9 October 2012 and accepted 7 January 2013.DOI: 10.2337/dc12-2058This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2058/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/36/98/2148.PMC3714507.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/36/98/2148.PMC3714507.pdf
"When raw glucose data were not available, printed glucose pro ﬁles were scanned and digitized with Engauge Dig-itizer software (http://digitizer.source- forge.net) to retrieve numeric data.",OADS,/arxiv_data1/oa_pdf/36/98/2148.PMC3714507.pdf
"NCT00032487, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2082/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/ec/17/2408.PMC3714508.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ec/17/2408.PMC3714508.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7f/8d/2346.PMC3714509.pdf
"Corresponding author: Joanne Sloan-Lancaster, j.s.lancas@lilly.com.Received 9 September 2012 and accepted 5 February 2013.DOI: 10.2337/dc12-1835This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1835/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/76/49/2239.PMC3714510.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/76/49/2239.PMC3714510.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT00928876.,Non-OADS,/arxiv_data1/oa_pdf/76/49/2239.PMC3714510.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b7/05/2217.PMC3714511.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/2402.PMC3714512.pdf
"Corresponding author: Dana Dabelea, dana.dabelea@ucdenver.edu.Received 15 May 2012 and accepted 7 January 2013.DOI: 10.2337/dc12-0923This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0923/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/e9/db/2351.PMC3714513.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e9/db/2351.PMC3714513.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a7/28/2415.PMC3714514.pdf
Available from http://www.samhsa.gov/data/nsduh/2k10nsduh/ 2k10results.htm.,OADS,/arxiv_data1/oa_pdf/a7/28/2415.PMC3714514.pdf
"Corresponding author: Junnosuke Miura, jmiura@dmc.twmu.ac.jp.Received 6 June 2012 and accepted 5 February 2013.DOI: 10.2337/dc12-1077This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1077/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/bb/9e/2339.PMC3714516.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/bb/9e/2339.PMC3714516.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/20/3e/2280.PMC3714518.pdf
Available from http://diabetes.niddk.nih.gov/dm/pubs/statistics/.,Non-OADS,/arxiv_data1/oa_pdf/20/3e/2280.PMC3714518.pdf
Bronx News Net- work 29 November 2010.Available from http://www.bronxnewsnetwork.org/2010/11/bronx-health-high-cost-of-undiagnosed.html.Accessed 21 December 2010 9.,Non-OADS,/arxiv_data1/oa_pdf/20/3e/2280.PMC3714518.pdf
Available from http://www.census.gov/ 2010census/.,OADS,/arxiv_data1/oa_pdf/20/3e/2280.PMC3714518.pdf
"NCT01173549, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2391/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/d9/66/2154.PMC3714520.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d9/66/2154.PMC3714520.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/71/43/2247.PMC3714521.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/73/0a/2262.PMC3714522.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c9/78/2388.PMC3714523.pdf
"NCT00911404, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2714/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/40/44/2233.PMC3714525.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/40/44/2233.PMC3714525.pdf
"NCT00160108, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1846/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/05/63/2225.PMC3714527.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/05/63/2225.PMC3714527.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3b/6e/2198.PMC3714528.pdf
Available from http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/3b/6e/2198.PMC3714528.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a5/2e/2266.PMC3714529.pdf
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-0393/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/07/69/2380.PMC3714531.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/07/69/2380.PMC3714531.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ea/2f/2203.PMC3714532.pdf
Available fromhttp://www.cnpp.usda.,Non-OADS,/arxiv_data1/oa_pdf/c8/eb/e113.PMC3714533.pdf
Available from http://www.psy.miami.edu/faculty/alagreca/SCI_manual_2004.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/eb/e113.PMC3714533.pdf
"Corresponding author: Kai McKeever Bullard, hjo1@cdc.gov.Received 9 December 2012 and accepted 25 February 2013.DOI: 10.2337/dc12-2563This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2563/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/9d/ba/2286.PMC3714534.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9d/ba/2286.PMC3714534.pdf
Available from http://www.fas.o rg/sgp/crs/misc/ RL32701.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/ba/2286.PMC3714534.pdf
Available from http://www.cdc.gov/nchs/nhanes/nhanes_question- naires.htm.,Non-OADS,/arxiv_data1/oa_pdf/9d/ba/2286.PMC3714534.pdf
Availablefrom http://www.cdc.gov/nchs/data/se- ries/sr_02/sr02_155.pdf.,OADS,/arxiv_data1/oa_pdf/9d/ba/2286.PMC3714534.pdf
Available from http://www.cdc.gov/nchs/data/nhanes/ A1c_webnotice.pdf.,OADS,/arxiv_data1/oa_pdf/9d/ba/2286.PMC3714534.pdf
Avail- able from http://www.cdc.gov/diabetes/prevention/recognition/registry.htm.,Non-OADS,/arxiv_data1/oa_pdf/9d/ba/2286.PMC3714534.pdf
Available from http://www.cdc.gov/nchs/nhanes/ nhanes2007-2008/PAQ_E.htm.,OADS,/arxiv_data1/oa_pdf/9d/ba/2286.PMC3714534.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/02/66/2324.PMC3714535.pdf
The iHOMA2 program is freely avail- able (http://www.ihoma.co.uk) for academicand noncommercial use.,Non-OADS,/arxiv_data1/oa_pdf/02/66/2324.PMC3714535.pdf
"Developmental Cell Resource C e l l - T y p e - S p e c i ﬁ cP r o ﬁ l i n go fG e n eE x p r e s s i o n and Chromatin Binding without Cell Isolation: Assaying RNA Pol II Occupancy in Neural Stem Cells Tony D. Southall,1Katrina S. Gold,1,2Boris Egger,1,2,3Catherine M. Davidson,1Elizabeth E. Caygill,1Owen J. Marshall,1 and Andrea H. Brand1,* 1The Gurdon Institute and Department of Physiology, Development and Neuroscience, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK 2These authors contributed equally to this work 3Present address: Zoology, Department of Biology, University of Fribourg, Chemin du Muse ´e 10, CH-1700 Fribourg, Switzerland *Correspondence: a.brand@gurdon.cam.ac.uk http://dx.doi.org/10.1016/j.devcel.2013.05.020 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/60/6f/main.PMC3714590.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three ﬁgures, and two tables and can be found with this article online athttp://dx.doi.org/10.1016/j.devcel.2013.05.020 .",OADS,/arxiv_data1/oa_pdf/60/6f/main.PMC3714590.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a9/48/srep02228.PMC3714647.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2228 | DOI: 10.1038/srep02228 6",Non-OADS,/arxiv_data1/oa_pdf/a9/48/srep02228.PMC3714647.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f6/e3/srep02226.PMC3714648.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2226 | DOI: 10.1038/srep02226 5",Non-OADS,/arxiv_data1/oa_pdf/f6/e3/srep02226.PMC3714648.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2229 | DOI: 10.1038/srep02229 7",Non-OADS,/arxiv_data1/oa_pdf/79/d7/srep02229.PMC3714649.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2213 | DOI: 10.1038/srep02213 5",Non-OADS,/arxiv_data1/oa_pdf/e3/9d/srep02213.PMC3714653.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2230 | DOI: 10.1038/srep02230 6",Non-OADS,/arxiv_data1/oa_pdf/e9/81/srep02230.PMC3714654.pdf
"2012;67(9):1019-22, http://dx.doi.org/10.6061/ clinics/2012(09)06.",Non-OADS,/arxiv_data1/oa_pdf/57/b1/cln-68-07-1073.PMC3714739.pdf
"2011;17(1):47-58, http://dx.doi.org/10.2174/138161211795049804.",Non-OADS,/arxiv_data1/oa_pdf/57/b1/cln-68-07-1073.PMC3714739.pdf
"1962;91:1063-5, http://dx.doi.org/10.1021/ jm01240a021.",Non-OADS,/arxiv_data1/oa_pdf/45/83/cln-68-07-899.PMC3714740.pdf
"2012;28(3):278-82, http://dx.doi.org/10.1089/jop.2011.0132.",Non-OADS,/arxiv_data1/oa_pdf/45/83/cln-68-07-899.PMC3714740.pdf
"2009;116(8):1552-7, 1557.e1, http://dx.doi.org/10.1016/j.ophtha.2009.02.",Non-OADS,/arxiv_data1/oa_pdf/45/83/cln-68-07-899.PMC3714740.pdf
"2011;129(10):1312-9, http://dx.doi.org/10.1001/archophthalmol.2011.310.",Non-OADS,/arxiv_data1/oa_pdf/45/83/cln-68-07-899.PMC3714740.pdf
"2009;23(12):2260-2, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/45/83/cln-68-07-899.PMC3714740.pdf
"2012;20(4):266-72, http://dx.doi.org/10.3109/ 09273948.2012.670359.",Non-OADS,/arxiv_data1/oa_pdf/45/83/cln-68-07-899.PMC3714740.pdf
"2011;9:17, http://dx.doi.org/10.1186/1476-7120-9-17.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1987;10(4):800-8, http://dx.doi.org/10.1016/ S0735-1097(87)80273-5.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2005;18(12):1440-63, http://dx.doi.org/10.1016/j.echo.2005.10.005.",OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2003;107(17):2207-12, http://dx.doi.org/10.1161/ 01.CIR.0000066318.21784.43.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2011;301(1):H12- 20, http://dx.doi.org/10.1152/ajpheart.00226.2011.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2004;96(4):1306-11, http://dx.doi.org/10.1152/japplphysiol.00557.2003.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2004;43(11):1015-22, http://dx.doi.org/10.2169/internalmedicine.43.1015.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1993;32(2):112-5, http://dx.doi.org/10.2169/internalmedicine.32.112.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1979;60(3):547-55, http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1990;119(6):1262-7, http://dx.doi.org/10.1016/S0002-8703(05)80173-5.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2000;86(5):567-70, http://dx.doi.org/10.1016/S0002-9149(00)01019-5.20.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2006;151(2):412-8, http://dx.doi.org/10.1016/j.ahj.2005.04.031.",OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2003;42(7):1206-7, http://dx.doi.org/10.1016/S0735-1097(03)00956-2.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2002;90(12):1284-9, http://dx.doi.org/10.1016/S0002-9149(02)02864-3.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1990;65(5):282-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2006;17(7):597-603, http://dx.doi.org/10.1097/01.mca.0000236281.74361.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2006;19(6):772-6, http://dx.doi.org/10.1016/j.echo.2006.",OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1989;118(3):490-4, http://dx.doi.org/10.1016/0002-8703(89) 90262-7.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1988;11(11):743-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2002;34(5):265-70, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1996;28(1):22-30, http://dx.doi.org/10.1161/01.HYP.28.1.22.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"1998;135(1):21-8, http://dx.doi.org/10.1016/ S0002-8703(98)70338-2.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2010;56(4):651-60, http://dx.doi.org/10.1373/clinchem.2009.138586.",Non-OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2007;100(5):870-5, http://dx.doi.org/10.1016/j.amjcard.",OADS,/arxiv_data1/oa_pdf/af/e7/cln-68-07-997.PMC3714741.pdf
"2007;115(4):450-8, http://dx.doi.org/10.1161/ CIRCULATIONAHA.106.637793.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2011;378(9799):1297- 305, http://dx.doi.org/10.1016/S0140-6736(11)60781-2.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2006;37(9):2271-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2009;23(4):1196-204, http://dx.doi.org/10.1096/fj.08-119578.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2006;44(9):3313-7, http://dx.doi.org/10.1128/JCM.00377-06.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2011;26(6):1882-7, http://dx.doi.org/10.1093/ ndt/gfq678.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"1990;17(4):255-63, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2009;80(1):48-55, http://dx.doi.org/10.1902/jop.2009.080289.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"1979;86(2):420-8, http://dx.doi.org/10.1037/ 0033-2909.86.2.420.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2010;68(3):165-70, http://dx.doi.org/10.3109/00016350903583678.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2007;12(6):1611-21, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2007;35(2):81-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2010;8(5):447-53, http://dx.doi.org/10.1370/afm.1167.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2010;14(3):181-5, http://dx.doi.org/10.4103/0972-124X.75914.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2001;12(5):539-42, http://dx.doi.org/10.1034/j.1600-0501.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2011;41(2):43-51, http://dx.doi.org/10.5624/isd.2011.41.2.43.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2004;33(5):291-4, http://dx.doi.org/ 10.1259/dmfr/25500850.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2010;115(4):600-11, http://dx.doi.org/10.1007/s11547-010-0520-5.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2003;31(5):361-7, http://dx.doi.org/10.1034/j.1600-0528.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"1965;10(5):739-51, http://dx.doi.org/10.1016/0003- 9969(65)90127-5.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2005;33(6):400-9, http://dx.doi.org/10.1111/j.1600-0528.2005.",Non-OADS,/arxiv_data1/oa_pdf/ac/8f/cln-68-07-946.PMC3714742.pdf
"2006;64(2B):538-42, http://dx.doi.org/10.1590/ S0004-282X2006000300037.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2008;12(4):540-6, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2003;16(2):165-70, http://dx.doi.org/10.1097/00019052-200304000-00008.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"1993;34(3):453-68, http://dx.doi.org/10.1111/j.1528-1157.1993.tb02586.x.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2002;43(11):1402-09, http://dx.doi.org/10.1046/j.1528-1157.2002.t01-1-26901.x.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2005;4(1):21-31, http://dx.doi.org/ 10.1016/S1474-4422(04)00963-9.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2010;19(10):630-6, http://dx.doi.org/10.1016/j.seizure.",OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2013; 27(2):315-18, http://dx.doi.org/10.1016/j.yebeh.2013.02.011.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2013;27(2):113-9, http://dx.doi.org/10.1007/s40263-012-0006-1.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"1998;51(5):1270-4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2007;74 Suppl 1:S121-7, http://dx.doi.org/10.3949/ccjm.74.Suppl_1.",OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2011;52(6):1150- 9, http://dx.doi.org/10.1111/j.1528-1167.2010.02952.x.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2009;5(9):492-504, http://dx.doi.org/10.1038/nrneurol.2009.118.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2008;7(11):1021- 31, http://dx.doi.org/10.1016/S1474-4422(08)70202-3.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2007;10(1):138-41, http://dx.doi.org/10.1016/j.yebeh.2006.11.010.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2013;26(3):415-20, http://dx.doi.org/10.1016/j.yebeh.2012.12.018.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"Curr Neurol Neurosci Rep. 2010;10(4):319-26, http://dx.doi.org/10.1007/s11910-010- 0116-4.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2011;76(22):1932-38, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2013;123(4):1415-6, http://dx.doi.org/10.1172/ JCI67759.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"9):93-8, http://dx.doi.org/10.1111/j.1528-1167.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2008;13(2):279-83, http://dx.doi.org/10.1016/j.yebeh.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2009;50(4):917-22, http://dx.doi.org/10.1111/j.1528-1167.2008.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2006;77(2):199-202, http://dx.doi.org/10.1136/jnnp.2005.066852.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2008;49(Suppl 9):99-101, http://dx.doi.org/10.1111/j.1528-1167.2008.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2012;25(2):201-7, http://dx.doi.org/10.1097/WCO.0b013e3283506714.",Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2013;27(3):470-1, http://dx.doi.org/10.1016/j.yebeh.",OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
Available at: http://www.cremesp.org.br/pdfs/demografia_2_dezembro.,Non-OADS,/arxiv_data1/oa_pdf/3f/3a/cln-68-07-896.PMC3714776.pdf
"2002;51(10):3120-27, http://dx.doi.org/10.2337/diabetes.51.10.3120.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2009;34(3):481-7, http://dx.doi.org/10.1139/H09-047.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2009;196(1):27-35, http://dx.doi.org/ 10.1111/j.1748-1716.2009.01974.x.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2001;276(25):22883-91, http://dx.doi.org/10.1074/jbc.M010143200.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"1990;13(3):209-18, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"1998;101(11):2377-86, http://dx.doi.org/10.1172/JCI1557.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"1990;268(1):13-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"1992;70(9):1286-90, http://dx.doi.org/10.1139/y92-178.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2008;118(4):346-54, http://dx.doi.org/10.1161/CIRCULATIONAHA.108.772822.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2007;17(6):687-95, http://dx.doi.org/10.1111/j.1600-0838.2006.00631.x.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2010;59(3):395- 9, http://dx.doi.org/10.1016/j.metabol.2009.08.011.",OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2007;6(1):38, http://dx.doi.org/10.1186/1475- 2840-6-38.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2006;50(2):208-15, http://dx.doi.org/10.1590/S0004-27302006000200007.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"1994;55(4):621-25, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2005;5(2):566-71, http://dx.doi.org/10.1002/pmic.200400941.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"1968;40(4):527-8, http://dx.doi.org/10.1677/joe.0.0400527.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"1985;76(2):460-9, http://dx.doi.org/10.1172/JCI111994.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2010;9(1):67, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2008;51(7):1327- 37, http://dx.doi.org/10.1007/s00125-008-0996-x.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2005;28(12):2823-31, http://dx.doi.org/10.2337/diacare.28.12.2823.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"2006;8(3):311-21, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/8e/37/cln-68-07-1010.PMC3714777.pdf
"1997;52(11):1003-09, http://dx.doi.org/10.1136/thx.52.11.1003.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2010;84(15):7418-26, http://dx.doi.org/10.1128/JVI.02290-09.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2002;12(4):273-7, http://dx.doi.org/10.1016/S1047-2797(01) 00264-2.",OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1995;346(8970):280-1, http://dx.doi.org/10.1016/S0140-6736(95)92167-2.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1997;23(6):417-23, http://dx.doi.org/10.1002/(SICI) 1099-0496(199706)23:6 ,417::AID-PPUL4 .3.0.CO;2-F. 9.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2004;37(6):492-8, http://dx.doi.org/10.1002/ppul.20019.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2005;3(6)1:465-73, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1997;8(1):73-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"):S3-S4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1971;32(3):485-6, http://dx.doi.org/10.1016/0009-8981(71)90452-9.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1995;17(2):195-8, http://dx.doi.org/10.1097/ 00007691-199504000-00016.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2001;120(3):718-24, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2003;36(1):108-13, http://dx.doi.org/10.1006/pmed.2002.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1998;53(3):204-12, http://dx.doi.org/10.1136/thx.53.3.204.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2006;7:3, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2012;12:187, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2004;113(5):925-31, http://dx.doi.org/10.1016/j.jaci.2004.01.778.",OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2004;14 Suppl 1:S65-70, http://dx.doi.org/10.1038/sj.jea.7500360.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1995;6(3):289-93, http://dx.doi.org/10.1097/00001648-199505000-00017.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2009;6(3):272-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1991;49(3):270-7, http://dx.doi.org/10.1038/clpt.1991.28.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"1993;16(1):31- 5, http://dx.doi.org/10.1002/ppul.1950160107.CLINICS 2013;68(7):934-939 Parental smoking and wheezing in children Schvartsman C et al.",Non-OADS,/arxiv_data1/oa_pdf/65/48/cln-68-07-934.PMC3714778.pdf
"2008;21(2):123-8, http://dx.doi.org/10.1097/WCO.0b013e3282 f88bb4.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2008;371(9615):813-20, http://dx.doi.org/10.1016/ S0140-6736(08)60380-3.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2013;19(3):313-31, http://dx.doi.org/10.1080/ 09297049.2011.653331.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2012;36(4):1314-30, http://dx.doi.org/10.1016/j.neubiorev.2012.02.005.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2012;54(3):247- 53, http://dx.doi.org/10.1111/j.1469-8749.2011.04150.x.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2009; 124(2):717-28, http://dx.doi.org/10.1542/peds.2008-2816.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2009;85(4):215-24, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2009;94(5):F339-44, http://dx.doi.org/10.1136/adc.2008.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2008;49(2):13- 8, http://dx.doi.org/10.1016/S1875-9572(08)60005-4.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2008;32(1):51-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2006;64(4):926-31, http://dx.doi.org/10.1590/ S0004-282X2006000600007.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2009;85(1):35-41, http://dx.doi.org/10.1590/S0021-75572009000100007.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2002;15(3):603-12, http://dx.doi.org/10.1590/S0102- 79722002000300014.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"http://www.abep.org/novo/Content.aspx?ContentID = 301 (september 20th, 2012)Cognition, behavior and social competence in prematurity Fan RG et al.CLINICS 2013;68(7):915-921 920",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2002;288(6):728-37, http://dx.doi.org/10.1001/jama.288.6.728.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2007;12(5):374-82, http://dx.doi.org/10.1016/j.siny.2007.",OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"http://portal.saude.gov.br/portal/arquivos/pdf/ Manual_Infantil_Fetal.pdf (september 20th, 2012).",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2003;37(3):311-8, http://dx.doi.org/10.1590/S0034-89102003000 300008.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2011;15(2):138-45, http://dx.doi.org/10.1590/S1413-35552011000200009.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"J Pediatr (Rio J) 2011;87(4):281-91, http://dx.doi.org/10.2223/JPED.2096.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2002;60(3-B):748-54, http://dx.doi.org/10.1590/S0004- 282X2002000500013.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2006;95(10):1249- 57, http://dx.doi.org/10.1080/08035250600615127.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2011;100(3):370-8, http://dx.doi.org/10.1111/j.1651-2227.2010.02064.x.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2011;26(7):632-44, http://dx.doi.org/10.1093/arclin/acr061.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
"2011;53(3):256-62, http://dx.doi.org/10.1111/j.1469-8749.2010.03828.x.",Non-OADS,/arxiv_data1/oa_pdf/98/3d/cln-68-07-915.PMC3714779.pdf
Available from: http://www.ompj.webs.,Non-OADS,/arxiv_data1/oa_pdf/d4/fa/DRJ-10-122.PMC3714814.pdf
Start a QR-code reading software (see list of free applica - tions from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/d9/83/DRJ-10-59.PMC3714825.pdf
com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/d9/83/DRJ-10-59.PMC3714825.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/df/95/DRJ-10-7.PMC3714827.pdf
Available from: http://www.orthocj.com/2004/02/ reliable‑porcelain‑bonding/[Last accessed on 1 Aug 2012].,Non-OADS,/arxiv_data1/oa_pdf/9d/52/DRJ-10-81.PMC3714829.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/9d/52/DRJ-10-81.PMC3714829.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/11/e4/DRJ-10-87.PMC3714830.pdf
"2011;12(1):90-100, http://dx.doi.org/10.1097/ PCC.0b013e3181e911a7.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"2007;8(6):524-9, http://dx.doi.org/ 10.1097/01.PCC.0000288672.77782.D4.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"2010;36:1813-25, http://dx.doi.org/10.1007/s00134-010-2005-3.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"2011;39(1):8-13, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"2012;38(5):863-71, http://dx.doi.org/10.1007/s00134-012-2476-5.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"2007;11(5):R101, http://dx.doi.org/10.1186/ cc6118.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"2004;85:1801-13, http://dx.doi.org/10.1099/vir.0.19652-0.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"2004;72(3):445-50, http://dx.doi.org/10.1002/jmv.20007.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"2005;30(6):359-65, http://dx.doi.org/10.1016/j.cyto.",OADS,/arxiv_data1/oa_pdf/49/ac/cln-68-07-1061.PMC3714847.pdf
"1995;274(12):975- 80, http://dx.doi.org/10.1001/jama.1995.03530120067043.",Non-OADS,/arxiv_data1/oa_pdf/45/6d/cln-68-07-974.PMC3714857.pdf
"2011;218(1):1-12, http://dx.doi.org/10.1016/j.atherosclerosis.2011.04.",Non-OADS,/arxiv_data1/oa_pdf/45/6d/cln-68-07-974.PMC3714857.pdf
"1985;54(1):84-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/45/6d/cln-68-07-974.PMC3714857.pdf
"2010;51(1):89-95, http://dx.doi.org/10.1016/j.jvs.2009.07.118.",OADS,/arxiv_data1/oa_pdf/45/6d/cln-68-07-974.PMC3714857.pdf
"2012;41(4):275-81, http://dx.doi.org/10.1024/0301-1526/a000203.",Non-OADS,/arxiv_data1/oa_pdf/45/6d/cln-68-07-974.PMC3714857.pdf
"2000;55(10):M570-7, http://dx.doi.org/10.1093/gerona/55.10.M570.",OADS,/arxiv_data1/oa_pdf/45/6d/cln-68-07-974.PMC3714857.pdf
"2005;42(4):702-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/45/6d/cln-68-07-974.PMC3714857.pdf
"2000;20(1):72-8, http://dx.doi.org/10.1053/ ejvs.2000.1137.Prescribing exercise for claudicants Cucato GG et al.CLINICS 2013;68(7):974-978 978",Non-OADS,/arxiv_data1/oa_pdf/45/6d/cln-68-07-974.PMC3714857.pdf
"http://www.sinais.salud.gob.mx/ basesdedatos/eh_sectorial_morta.html (Accesed Jan 9, 2013).",OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"http://www.sinais.salud.gob.mx/ basesdedatos/eh_sectorial_morbi.html (Accesed Jan 9, 2013).",OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"1982;11(5):260-2, http://dx.doi.org/10.1016/S0196- 0644(82)80096-6.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2005;31(2):159-67, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2005;31(8):958-63, http://dx.doi.org/10.1016/j.burns.",OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"1999;353(9171):2211-2, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2010;36(7):1086-91, http://dx.doi.org/10.1016/j.burns.2010.03.",OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2003;29(6):628-9, http://dx.doi.org/10.1016/S0305-4179(03)00149-9.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"1999;134(1):36-42, http://dx.doi.org/10.1001/archsurg.134.1.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2002;137(7):805-12, http://dx.doi.org/ 10.1001/archsurg.137.7.805.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
http://www.portalesmedicos.com/publicaciones/ articles/1108/2/Valor-pronostico-del-nivel-de-albumina-serica-inicial-en- los-pacientes-quemados.,Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2013;39(1):113-8, http://dx.doi.org/10.1016/j.burns.2012.05.008.",OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"1978;15(2):221- 8, http://dx.doi.org/10.1016/0026-2862(78)90020-1.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2010;65(1):74-9, http://dx.doi.org/10.1097/SAP.0b013e3181c47d71.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"1983;197(5):520-31, http://dx.doi.org/10.1097/00000658-198305000-00004.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2011;39(7):386-91, http://dx.doi.org/10.1097/ CCM.0b013e3181ffe217.",Non-OADS,/arxiv_data1/oa_pdf/b8/74/cln-68-07-940.PMC3714858.pdf
"2008;136(3):380-7, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"2008;70(18):1630-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"1983;17(2):197-210, http://dx.doi.org/10.1016/0304-3959(83)90143-4.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"2002;43(4):207-13, http://dx.doi.org/10.1093/ilar.43.4.207.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"2003;17(7):576-87, http://dx.doi.org/10.1191/0269216303pm815oa.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"2001;27:771-5, http://dx.doi.org/10.1016/S0305- 4179(01)00032-8.",OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"2011;25(5):488-93, http://dx.doi.org/10.1177/0269216310397687.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"1986;1(4):203-7, http://dx.doi.org/10.1016/S0885-3924(86)80042-2.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"1986;25(3):297-312, http://dx.doi.org/10.1016/0304-3959(86)90234-4.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"Pain, 2005;116(3):347-58, http://dx.doi.org/10.1016/j.pain.2005.05.004.",OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"Anesth Analg, 2006;102(6):1768-74, http://dx.doi.org/10.1213/01.ane.0000205751.88422.41.",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
"2009;60(4):284-90, http://dx.doi.org/10.1016/j.phrs.",OADS,/arxiv_data1/oa_pdf/6a/4f/cln-68-07-1057.PMC3714859.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2013/4/1/7/112689 Access this article online Website:    www.jpathinformatics.org DOI:  10.4103/2153-3539.112689 Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7INTRODUCTION “If I have seen further, it is by standing on the shoulders  of giants.” ‑ Sir Isaac Newton The history of pathology informatics is a tale with many  dimensions.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7Unfortunately, circa 1998 the TRANSPATH network was  shut down due to the fact that RESINTEL could not  secure funding for continued operation.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7Africa.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
The  Africa Teledermatology Project (http://africa.telederm.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7with attached digital cameras to allow quick consultations  failed due to the lack of adequate bandwidth, as well as  the high cost of the required equipment.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"[2] Finally in 2008,  the Indian government initiated a project known as the  Pan African e‑Network (http://www.panafricanenetwork.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7necessary as an intermediate step before the images were  sent along to the AFIP .",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"[13,14] 2001 is also significant as it was the year that  the National Health Laboratory Service (NHLS) was  formed in South Africa, with the purpose of incorporating  and electronically connecting all the state laboratories  around the country (http://www.nhls.ac.za/).",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7Unlike other areas of the world such as the USA where  computing hardware and software is relatively cheap and  ubiquitous, in Africa these resources are comparatively  scarce (limited vendors) and more expensive.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7health related databases and registries.",OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7repeated in a number of geographically isolated regions  in the coming years.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7Friedman is first credited with using the term “pathology  informatics” while concomitantly advocating for  the development of separate divisions of pathology  informatics within pathology departments.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7the first online surgical pathology information system  was implemented in 1976 and served as the inspiration  for successive generations of anatomical pathology  systems, including Surepath (1978, T ufts), and in 1983  CoPath (descendants of CoPath remain market leaders  today).",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7resulting in workflow efficiencies and improvements  in patient safety.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7for image‑based pathology informatics to have a  positive effect on the practice of surgical pathology,  cytopathology and hematology.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7but also that digital images would be used to better  screen and characterize malignancies, generate  three‑dimensional (3D) reconstructions, and permit  image analysis using various special stains that revealed  the presence or absence of biochemical markers.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"[119] Today there are many more training  opportunities (http://www.pathologyinformatics.org/ content/training‑opportunities‑pathology‑informatics), but  still not enough to meet the emerging demand for skilled  informaticists.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7Kontron.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"Since  its inception, the API has been a driving force behind  a number of conferences and activities for pathology  informaticists (http://www.pathologyinformatics.org/).",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7pathology education.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7most prolific it was far from the only Brazilian effort in  digital pathology image analysis at the time; there were  also active research groups at the Evangelical Faculty of  Medicine of Parana, Brazil and the Adolfo Lutz Institute,  São Paulo, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
It became a very popular  resource for anatomic pathology in that country and still  enjoys considerable activity today (http://www.sld.cu/ sitios/scap/).,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"The first Virtual Hispano‑American Congress  of Pathology (http://www.conganat.org/) took place in  1997, with the participation of Argentina, Brazil, Cuba,  Dominican Republic, and Mexico.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"[158] Finally, a  multinational virtual health library known as Biblioteca  Virtual en Salud (http://regional.bvsalud.org/) was created  in March 1998 as an initiative of the Pan‑American Health  Organization (a WHO affiliate).",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7In 2006, the Amazon Telemedicine Project developed  a tele‑health system using satellite‑based networking  to reach Amazon Indians in Northern Brazil, with  applications in the areas of telecardiology, teleradiology,  teledentistry, telepathology, and videoconferences.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7With the development of the Internet came the  possibility of sending and receiving digital images across  the world; most historians of our still‑nascent field trace  the lion’s share of the evolution of the current state of  telepathology – and indeed pathology at large – to this  singularly disruptive event.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7China Expectations for telemedicine including telepathology  are very high in China, which is a country with an  extensive national territory.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7Peking University and its first hospital.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7information has been made available online at dispensing  pharmacies.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7accreditation in Australia.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7interest in natural language processing for the automation  of pathology reports waned, instead being supplanted by  research in molecular biology and genetics.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7most notably lung cancer patients with intra‑pulmonary  metastases.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7gastroscopy, tele‑echocardiography, remote transmission  of electrocardiograms, telepsychiatry, teleophthalmology,  teledialysis, tele‑emergency medicine, tele‑oncology,  telecare, telegeriatrics, teledentistry, and maritime  telemedicine.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7was continuously accompanied by Thai colleagues.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7a global perspective.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.wwlab.org/Spring_2004.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.labnews.co.uk/features/ its‑plain‑sailing‑for‑instant‑diagnosis/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.mercyships.org/ au/our‑ships.php.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/727.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from http://www.coopera.cc/es/cooperacion/congoproyectocsm.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.pcd‑online.fr/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.patologioltrefrontiera.it/index.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from:  http://www.mrc.ac.za/mrcnews/may2004/telemedicine.htm.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from:  http://www.coachorg.com/en/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.cihi.ca/CIHI‑ext‑portal/internet/EN/Home/home/cihi000001.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.health.gov.sk.ca/labresults.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.myehealth.ca.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: https://www.myhealth.alberta.ca/ Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.partnershipagai nstcancer.ca/priorities/2007‑ 2012‑initiatives/cancer ‑guidelines‑2007‑2012‑strategic‑initiatives/synoptic ‑ surgical‑reporting‑2/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: https://www.infoway‑inforoute.ca/index.php/ news‑media/2010‑news‑ releases/uhn‑establishes‑first‑telepathology‑syst em‑in‑ontario.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from:  http://www.softwarehistory.org/history/Bauer1.html.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/782.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available  from: http://www.adams1.com/history.html.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.cap.org/apps/cap.portal?_ nfpb=true and cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewe r%2Fshow and _windowLabel=cntvwrPtlt and cntvwrPtlt {actionForm.co ntentReference}=snomed%2FhistPersp.html and _state=maximized and _ pageLabel=cntvwr.,OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.nlm.nih.gov/research/ umls/.,OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.medscape.com/ viewarticle/750134_6.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from:  http://www.aacc.org/members/divisions/history/res_center/Pages/ hischron.aspx.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from:  http://www.jpathinformatics.org/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7135.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available  from: http://www.escuela.med.puc.cl/paginas/telemedicina/Informe_ Preliminar_Patologia/8897.html.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.lbmi.org/michaeladeyinka?language=EN.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.escuela.med.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.telepathology.com/articles/taller/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available  from: http://www.telemedicina.iics.una.py/index.php?option=com_content  and view=article and id=45%3Aportal‑comunitario‑de‑joomla and  catid=1%3Aultimas‑noticias and Itemid=1.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from:  http://www.institutodelcancer.med.ec/index_archivos/pvirtual.htm.,OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.forp.usp.br/mef/digipato/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.conganat.org/inabis2000/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.cbtms.org.br/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.anatopat.fmed.edu.uy/.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7et al.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.cnnic.net.cn/en/index/0O/index.htm.,OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available  from: http://www.miit.gov.cn/n11293472/index.html.,OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.trai.gov.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
Available from: http://www.soumu.,Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7human lung carcinoma growth.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7Health T echnol Inform 2009;150:997‑1001.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7telepathology: A preliminary evaluation on frozen sections, histology and  cytology.",Non-OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"J Pathol Inform 2013, 1:7  http://www.jpathinformatics.org/content/4/1/7a visual discrimination model for the detection of compression artifacts in  virtual pathology images.",OADS,/arxiv_data1/oa_pdf/f7/90/JPI-4-7.PMC3714902.pdf
"2011;37(3):280-97, http://dx.doi.org/10.1055/s-0031-1273092.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2007;101(6):1283-90, http://dx.doi.org/10.1016/j.rmed.2006.10.015.",OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2009;33(6):1467-84, http://dx.doi.org/10.1183/09031936.00086608.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2009;48(15):1255-62, http://dx.doi.org/10.2169/internalmedicine.48.2366.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2012;16(2):511-7, http://dx.doi.org/10.1007/s11325-011-0536-7.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"1993;41(1):31-91, http://dx.doi.org/10.1016/0301-0082(93)90040-Y.",OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2011;44(8-9):623-6, http://dx.doi.org/10.1016/j.clinbiochem.2011.03.028.",OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2010;30(2):122-6, http://dx.doi.org/10.3109/01443610903443913.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2011;44(16):1299-1303, http://dx.doi.org/10.1016/j.clinbiochem.2011.08.",OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2012;51(4):363-8, http://dx.doi.org/10.2169/internal medicine.51.6571.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2003;7(1):35-51, http://dx.doi.org/10.1053/ smrv.2002.0261.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2005;38(9):799-805, http://dx.doi.org/10.1016/j.clinbiochem.",OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2006;61(3):253-66, http://dx.doi.org/10.1590/S1807-59322006000300011.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"2012;67(6):565-72, http://dx.doi.org/10.6061/clinics/2012(06)04.CLINICS 2013;68(7):968-973 IMA and BChE in OSA Yang LX et al.",Non-OADS,/arxiv_data1/oa_pdf/47/33/cln-68-07-968.PMC3714914.pdf
"Curr Pain Headache Rep. 2011;15(5):400-6, http://dx.doi.org/10.1007/s11916-011- 0207-1.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2006;291(2):R245-56, http://dx.doi.org/10.1152/ ajpregu.00920.2005.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1999;81(3):225-35, http://dx.doi.org/10.1016/S0304-3959(98)00258-9.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2005;2(3):137-45, http://dx.doi.org/10.1016/S1550-8579(05)80042-7.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2012;43(3):343-51, http://dx.doi.org/10.1007/ s12160-012-9345-x.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2010; 149(2):365-72, http://dx.doi.org/10.1016/j.pain.2010.02.041.",OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1989;12(4):373-85, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2004;46(5):600-6, http://dx.doi.org/10.1016/j.yhbeh.2004.07.002.",OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1996;54(6):339-43, http://dx.doi.org/10.1016/S0010-7824(96)00202-8.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1999;60(6):357-60, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2002;21(4):358-67, http://dx.doi.org/ 10.1037/0278-6133.21.4.358.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1988;102(3):456-9, http://dx.doi.org/10.1037/0735-7044.102.3.456.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2002;69(1):19-23, http://dx.doi.org/10.1272/jnms.69.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1994;44(1):55-86, http://dx.doi.org/10.1016/0301-0082(94)90057-4.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1999;838(1-2):136-50, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2003;24(3):185-93, http://dx.doi.org/10.3109/01674820309039672.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1998;39 Suppl 8:S2-8, http://dx.doi.org/10.1111/j.1528-1157.1998.tb026 01.x.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2004;115(5):1063-8, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1979;12(2):112-63, http://dx.doi.org/10.1016/0018-506X(79)90017- 5.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1977; 21(2):193-6, http://dx.doi.org/10.3758/BF03198725.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2011;8:9, http://dx.doi.org/10.1186/1743-0003-8-9.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1997;71(2):187-97, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2001;17 Suppl 1:s87-93, http://dx.doi.org/10.1185/0300799039117007.43.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2011;51(1):92-104, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"1996;61(4):166-71, http://dx.doi.org/10.1016/0039-128X(96)00007-4.Nervous threshold across menstrual cycle Barbosa MB et al.CLINICS 2013;68(7):901-908 908",Non-OADS,/arxiv_data1/oa_pdf/7c/24/cln-68-07-901.PMC3714915.pdf
"2006;90(1):97-127, http://dx.doi.org/10.1016/j.mcna.2005.08.012.",OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2012;42(1):20-9, http://dx.doi.org/10.1111/j.1365-2222.2011.03823.x.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2003;111(2 Suppl): S540-547, http://dx.doi.org/10.1067/mai.2003.134.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2007;120(5):1172-7, http://dx.doi.org/10.1016/j.jaci.2007.08.023.",OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2005;5(3):249-53, http://dx.doi.org/10.1097/01.all.0000168790.82206.17.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2004;144(2):218-22, http://dx.doi.org/10.1016/j.jpeds.2003.10.063.",OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2004;169(2):214-9, http://dx.doi.org/10.1164/rccm.200307-973OC.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2010;14(1):119, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2004;103(9):3529-34, http://dx.doi.org/10.1182/blood-2003-06-1850.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2001;109(6):623-7, http://dx.doi.org/ 10.1007/s00439-001-0617-y.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2006;17(8):583-90, http://dx.doi.org/10.1111/j.1399-3038.2006.00463.x.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2004;26(2):155-65, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2004;113(5):932-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2004;63(5): 470-5, http://dx.doi.org/10.1111/j.0001-2815.2004.00183.x.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2003;49(10):1664-7, http://dx.doi.org/10.1373/49.10.1664.27.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2011;189(5):417-23, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"Ann Allergy Asthma Immunol 2011;106:474-80, http://dx.doi.org/10.1016/j.anai.2011.02.021.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"1999;1(2):151-5, http://dx.doi.org/10.1038/sj.gene.6363656.",OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2005;60(9):1146-51, http://dx.doi.org/10.1111/j.1398-9995.2005.00839.x.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"2006;7:32, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/cln-68-07-1004.PMC3714916.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Soc iety and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/d0/e5/cvt012.PMC3714924.pdf
Available from: http://www.newstrackindia.,Non-OADS,/arxiv_data1/oa_pdf/67/02/IJCM-38-109.PMC3714938.pdf
Available from: http://bjs.ojp.usdoj.gov/content/pub/pdf/ iscs08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/02/IJCM-38-109.PMC3714938.pdf
Available  from: http://www.aafp.org/fpm/990100 fm/40.html.,Non-OADS,/arxiv_data1/oa_pdf/43/e7/IJCM-38-114.PMC3714939.pdf
Available from:  http://www.aafp.org/fpm/980700fm/heane.html.,Non-OADS,/arxiv_data1/oa_pdf/43/e7/IJCM-38-114.PMC3714939.pdf
Available from: http://www.aafp.org/fpm/980400 fm/ fpstats.html.,Non-OADS,/arxiv_data1/oa_pdf/43/e7/IJCM-38-114.PMC3714939.pdf
Available from: http://www.rand.org.,Non-OADS,/arxiv_data1/oa_pdf/43/e7/IJCM-38-114.PMC3714939.pdf
Asian hospital and healthcare management available  from: http://www.asianhhm.com/healthcare/management/ primary‑healthcare‑india.htm.,Non-OADS,/arxiv_data1/oa_pdf/43/e7/IJCM-38-114.PMC3714939.pdf
Available from: http://www.gujhealth.gov.in/Portal/News/27_1_ gr_18102006.pdf [Last accessed on 2011 Apr 23].,Non-OADS,/arxiv_data1/oa_pdf/6e/d3/IJCM-38-118.PMC3714940.pdf
Available  from: http://www.polioeradication.org/Dataandmonitoring/ Poliothisweek.aspx.,Non-OADS,/arxiv_data1/oa_pdf/dc/29/IJCM-38-67.PMC3714943.pdf
Available from:  http://www.polioeradication.org/Research/Antivirals.aspx.,Non-OADS,/arxiv_data1/oa_pdf/dc/29/IJCM-38-67.PMC3714943.pdf
Available from:  http://www.thelancet.com.,Non-OADS,/arxiv_data1/oa_pdf/52/b1/IJCM-38-70.PMC3714944.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs360/en/index.html [Last accessed on 2011 Nov].,OADS,/arxiv_data1/oa_pdf/22/80/IJCM-38-86.PMC3714947.pdf
Available from: http://www.who.int/ healthinfo/global burden disease/Global Health Risks report full.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available  from: http://www.who.int/healthinfo/global burden disease/GBD  report 2004update part3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available from http://www.medindia.net/education/ MinistryofHealth/pg192to203.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available from: http://webmail.medindia.net/education/ MinistryofHealth/pg192to203.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available from http://www.medindia.net/ education/MinistryofHealth/pg192to203.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available from: http://webmail.medindia.net/education/ MinistryofHealth/pg49to55.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available from: http://kidwai.kar.nic.in/statistics.htm.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available from: http://www.icmr.nic.in/ncrp/pbcr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
National cancer registry programme report (1981‑2001).Available  from http://www.icmr.nic.in/ncrp/cancer regoverrview.htm.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available from: http://www.icmr.nic.in/ncrp/ncrp_p/ cancer_reg.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
Available from: http://www.ncrpindia.org/Cancer Atlas Indaia/ about.htm.,Non-OADS,/arxiv_data1/oa_pdf/84/0f/IJCM-38-95.PMC3714949.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/58/a5/IJO-61-145.PMC3714950.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7a/8d/IJO-61-148.PMC3714951.pdf
Author Help: Online Submission of the Manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/d0/7c/IJO-61-182.PMC3714959.pdf
"2005;21(4):1186-200, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"1998;27(3):411-3, http://dx.doi.org/ 10.1093/ageing/27.3.411-a.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"1997;26(4):315-8, http://dx.doi.org/10.1093/ ageing/26.4.315.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2002;123(11):1457-60, http://dx.doi.org/10.1016/S0047- 6374(02)00082-9.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2001;56(7):M448-53, http://dx.doi.org/10.1093/gerona/56.7.M448.",OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2005;53(9):1524-31, http://dx.doi.org/10.1111/j.1532-5415.2005.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2002;57(5):M283-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2009;64(6):675-81, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2002;162(20):2333-41, http://dx.doi.org/ 10.1001/archinte.162.20.2333.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2000;17(4):295-302, http://dx.doi.org/10.2165/00002512-200017040-00005.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2006;61(3):260-1, http://dx.doi.org/ 10.1093/gerona/61.3.260.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2010;65(3):255-6, http://dx.doi.org/10.1093/gerona/glp162.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2008;9(2):71-2, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2002;57(3):B115-25, http://dx.doi.org/10.1093/gerona/57.3.B115.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2008;129(11):675-6, http://dx.doi.org/10.1016/j.mad.2008.09.012.",OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2001;56(3):M146-56, http://dx.doi.org/10.1093/gerona/56.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2007;62(7):738-43, http://dx.doi.org/10.1093/gerona/62.7.738.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"1969;9(3):179- 86, http://dx.doi.org/10.1093/geront/9.3_Part_1.179.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2008;24(1):103-12, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2003;61(3B):777-81, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2008;56(12):2292-7, http://dx.doi.org/ 10.1111/j.1532-5415.2008.02041.x.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2011;15(10):852-6, http://dx.doi.org/10.1007/s12603-011-0075-8.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2010;50 Suppl 1:S43-7, http://dx.doi.org/10.1016/S0167-4943(10)70012-1.",OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2010;42(10):520-7, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2004;59(12):1310-7, http://dx.doi.org/10.1093/gerona/59.12.1310.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2013;16(1):55-61, http://dx.doi.org/10.1007/s12603-012-0003-6.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2008;63(10):1089-96, http://dx.doi.org/10.1093/gerona/63.10.1089.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2009;57(3):453-61, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2001;17(6):1345-56, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2003;19(3):829-38, http://dx.doi.org/ 10.1590/S0102-311X2003000300015.",Non-OADS,/arxiv_data1/oa_pdf/70/7f/cln-68-07-979.PMC3714993.pdf
"2009;14(2):121-9, http://dx.doi.org/10.1159/000162664.",Non-OADS,/arxiv_data1/oa_pdf/6c/50/cln-68-07-954.PMC3714994.pdf
"2000;543(20):73-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6c/50/cln-68-07-954.PMC3714994.pdf
"2002; 65(1):15- 26, http://dx.doi.org/10.1016/S0165-5876(02)00120-9.",OADS,/arxiv_data1/oa_pdf/6c/50/cln-68-07-954.PMC3714994.pdf
"1998;17(11):1076-83, http://dx.doi.org/10.1097/ 00006454-199811000-00038.",Non-OADS,/arxiv_data1/oa_pdf/6c/50/cln-68-07-954.PMC3714994.pdf
"2010;76(6):745-52, http://dx.doi.org/10.1590/S1808-86942010000600013.",Non-OADS,/arxiv_data1/oa_pdf/6c/50/cln-68-07-954.PMC3714994.pdf
"1998;74(Supl.1):S21-S30, http://dx.doi.org/10.2223/JPED.483.",Non-OADS,/arxiv_data1/oa_pdf/6c/50/cln-68-07-954.PMC3714994.pdf
"1963;56:899-902, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6c/50/cln-68-07-954.PMC3714994.pdf
"2011;23(4):364-7, http://dx.doi.org/10.1590/S2179-64912011 000400012.",Non-OADS,/arxiv_data1/oa_pdf/6c/50/cln-68-07-954.PMC3714994.pdf
"  Journal of  Medical Ethics and History of Medicine                                              Attachment styles as predictors of empathy in nursing students  Mohammadreza Khodabakhsh      Department of Psychology, Allameh Tabataba´i University, Tehran, Iran   Address:  Faculty of Psychology and Education, Dehkadeh Olympic, Tehran, Iran   Tel: 0 9836- 586-1050  Email: khodabakhsh@ut.ac.ir       Received: 12 May  2012  Accepted: 14 Nov 2012   Published: 20 Nov  2012    J Med Ethics Hist Med, 201 2, 5:8  http://journals.tums.ac.ir/abs/ 22609   © 201 2 Mohammadreza Khodabakhsh ; licensee  Tehran Univ.",Non-OADS,/arxiv_data1/oa_pdf/99/6b/jmehm-5-8.PMC3715012.pdf
"2009;30(25):3171-80, http://dx.doi.org/ 10.1161/CIRCULATIONAHA.108.806174.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"1995;185(1):44-7, http://dx.doi.org/10.1016/0304-3940(94)11221-4.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2004;1016(2):255-62, http://dx.doi.org/10.1016/j.brainres.",OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2010;65(8):789-92, http://dx.doi.org/10.1590/S1807-59322010000800008.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2011;10(4):312-6, http://dx.doi.org/10.1177/1534735411400311.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2011;6(1):23-8, http://dx.doi.org/10.2147/COPD.S15099.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2012;5(1):31, http://dx.doi.org/10.1186/1755-7682-5-31 10.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2011;17(6):260-5, http://dx.doi.org/10.1016/j.rppneu.2011.06.007.11.",OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2010;95(1):35-40, http://dx.doi.org/10.1590/S0066-782X2010005000082.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2009;90(9):1578-83, http://dx.doi.org/10.1016/j.apmr.2009.03.009.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2012;67(8):955-8, http://dx.doi.org/10.6061/clinics/2012(08)16.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2006;44(11):1031- 51, http://dx.doi.org/10.1007/s11517-006-0119-0.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2012;28(11-12):1075-80, http://dx.doi.org/10.1016/j.nut.2012.01.020.",OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2012;6(1):71-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2007;12;416(1):107-12, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"2004;6;1016(2):255-62, http://dx.doi.org/10.1016/j.brainres.2004.05.018.CLINICS 2013;68(7):960-967 Heart and auditory stimulus Roque AL et al.",OADS,/arxiv_data1/oa_pdf/72/f4/cln-68-07-960.PMC3715016.pdf
"As a positive control, cells were incubated with 1mg/mL of actinomycin D (Sigma-Aldrich) for 2 h. Images were processed using ImageJ software (http://rsbweb.nih.",OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2005;13(2):425-32, http://dx.doi.org/10.1016/j.bmc.2004.10.008.",OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2007;84(7):885-92, http://dx.doi.org/10.1097/01.tp.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2011;11(9):1311-8, http://dx.doi.org/10.1016/j.intimp.2011.04.014.",OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2010;88(2):346-59, http://dx.doi.org/10.1002/jnr.22196.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2010;51(5):2568-74, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"1999;40(1): 50-5, http://dx.doi.org/10.1002/(SICI)1097-0045(19990615)40:1 ,50::AID- PROS6.3.0.CO;2-N. 8.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2011;7(7):707-15, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2012;120(7):1458-65, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2011;7(6):598-612, http://dx.doi.org/10.4161/auto.7.6.15103.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2008;82(5):273-99, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2009;27(36):6199-06, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2007;117(9):2408-21, http://dx.doi.org/10.1172/ JCI31095.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2010;70(13):5438-47, http://dx.doi.org/10.1158/ 0008-5472.CAN-09-2544.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2009;9(6):689-93, http://dx.doi.org/10.1016/j.intimp.2008.12.007.",OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2006;66(1):221-31, http://dx.doi.org/10.1158/0008-5472.CAN-05-2001.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2003;278(36):33714-23, http://dx.doi.org/ 10.1074/jbc.M302559200.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2004;194(2):141-55, http://dx.doi.org/10.1016/j.taap.2003.08.017.",OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"1998;60:619-42, http://dx.doi.org/10.1146/annurev.physiol.60.1.619.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2002;286(1):135-41, http://dx.doi.org/10.1016/S0378-1119(01)00814-9.",OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2012;7(4):e34656, http://dx.doi.org/10.1371/ journal.pone.0034656.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"1996; 10(20):2527-39, http://dx.doi.org/10.1101/gad.10.20.2527.FTY720 and cancer cells Pereira FV et al.CLINICS 2013;68(7):1018-1027 1026",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2003;14(7):2844-60, http://dx.doi.org/10.1091/mbc.e03"",-1,""xxx/mbc.e03- 01-0865.",Non-OADS,/arxiv_data1/oa_pdf/ca/93/cln-68-07-1018.PMC3715017.pdf
"2013;64(3):188-94, http://dx.doi.org/10.1177/0003319712467224.",Non-OADS,/arxiv_data1/oa_pdf/9d/51/cln-68-07-1071.PMC3715018.pdf
"2010;55(4):648-59, http://dx.doi.org/10.1053/j.ajkd.2009.12.016.",Non-OADS,/arxiv_data1/oa_pdf/9d/51/cln-68-07-1071.PMC3715018.pdf
"2007;11(5):R100, http://dx.doi.org/10.1186/cc6117.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2007;33(1):96-103, http://dx.doi.org/10.1007/s00134-006-0404-2.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2008;5(3):311-6, http://dx.doi.org/10.1586/17434440.5.3.311.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2009;58:1085-96, http://dx.doi.org/10.1007/s00101-009-1632-y 8.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2008;22(5):367-74, http://dx.doi.org/10.1007/s10877-008-9144-x.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2011;17(1):53-9, http://dx.doi.org/10.1002/lt.22186.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2012;44(2):429-32, http://dx.doi.org/10.1016/j.transproceed.2011.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2011;43(5):1407-11, http://dx.doi.org/ 10.1016/j.transproceed.2011.02.056.",OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2012;56(6):777-86, http://dx.doi.org/10.1111/j.1399-6576.2011.02641.x.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2011;15(1):R33, http://dx.doi.org/10.1186/cc9980.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2012;67(7):760-4, http://dx.doi.org/10.1111/j.1365-2044.2012.07116.x.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2009;108(2):513-7, http://dx.doi.org/10.1213/ ane.0b013e318192a36b.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2010;24(5):772-5, http://dx.doi.org/10.1053/ j.jvca.2010.03.014.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2012;40(1):193-8, http://dx.doi.org/10.1097/ CCM.0b013e31822ea119.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2010;14(1):R18, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2010;14(3):R118, http://dx.doi.org/10.1186/cc9070.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2007;11(3):131, http://dx.doi.org/10.1186/cc5905.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2012;58(1):78-81, http://dx.doi.org/10.5387/fms.58.78.",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"2006;93:1069-76, http://dx.doi.org/10.1002/bjs.5454.Goal-directed fluid during one-lung ventilation Zhang J et al.CLINICS 2013;68(7):1065-1070 1070",Non-OADS,/arxiv_data1/oa_pdf/51/0e/cln-68-07-1065.PMC3715019.pdf
"Tel: +9821- 88622755, +9821- 88622766   Fax: +9821-88622533  Email: hdargahi@sina.tums.ac.ir       Received: 15 Jan  2012  Accepted: 01 Aug 2012  Published: 21 Oct 2012    J Med Ethics Hist Med, 201 2, 5:7   http://journals.tums.ac.ir/abs/ 22269    © 201 2 Hossein Dargahi ; licensee  Tehran Univ.",Non-OADS,/arxiv_data1/oa_pdf/4d/0d/jmehm-5-7.PMC3715020.pdf
http://www.citeman.com/3729 -factors -contributing -to-political-behavior  (accessed in 2008).,Non-OADS,/arxiv_data1/oa_pdf/4d/0d/jmehm-5-7.PMC3715020.pdf
http://hum.sagepub.com/content/33/2/79.short  (accessed in 2011).,Non-OADS,/arxiv_data1/oa_pdf/4d/0d/jmehm-5-7.PMC3715020.pdf
http://jme.sagepub.com/content/16/3/327  (accessed in 2010).,Non-OADS,/arxiv_data1/oa_pdf/4d/0d/jmehm-5-7.PMC3715020.pdf
"2007;11(2):189-98, http://dx.doi.org/10.1007/s10995-006-0156-1.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2004;104(4):727-33, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2012;12:47, http://dx.doi.org/10.1186/1471-2393-12-47.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
Available at http://www.who.int/maternal_child_adolescent/ topics/maternal/adolescent_pregnancy/en/index.html [last accessed 13rdJan 2013].,Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2012;26 Suppl 1:259-84, http://dx.doi.org/10.1111/j.1365-3016.2012.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2006;368(9546):1535-41, http://dx.doi.org/10.1016/S0140- 6736(06)69384-7.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2010;375(9726):1609-23, http://dx.doi.org/10.1016/S0140-6736(10)60518- 1.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2011;378(9797):1139-65, http://dx.doi.org/10.1016/S0140-6736(11)61337- 8.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2012;7(6):603-17, http://dx.doi.org/10.1080/17441692.2012.668919.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2009;87(10):734, http://dx.doi.org/10.2471/BLT.09.071001.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2010;7:16, http://dx.doi.org/10.1186/1742-4755-7-16.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2010;117(13):1586- 92, http://dx.doi.org/10.1111/j.1471-0528.2010.02746.x.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2010;88(2):113-9, http://dx.doi.org/10.2471/BLT.08.057828.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
Available at [http://apps.who.int/iris/bitstream/10665/43185/1/924156315X_eng.pdf].,OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2012;26(6):506-14, http://dx.doi.org/10.1111/ppe.12011.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2008;115(7):842-50, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2011;66(8):1367-72, http://dx.doi.org/10.1590/S1807-59322011000800010.CLINICS 2013;68(7):922-927 Severe maternal morbidity and maternal age Oliveira Jr. FC et al.",Non-OADS,/arxiv_data1/oa_pdf/73/df/cln-68-07-922.PMC3715023.pdf
"2008;371(9631):2201-12, http://dx.doi.org/10.1016/S0140-6736(08)60955- 1.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2002;28(4):859-90, viii, http://dx.doi.org/10.1016/S0889-857X(02)00032- 7.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2008;28(2):241-9, http://dx.doi.org/10.1055/s-2008-10622 67.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2009;48(6):607-12, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2007;9(4):R78, http://dx.doi.org/10.1186/ar2276.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2006;8(1):R13, http://dx.doi.org/10.1186/ar1862.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2006;55(5):791-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2010;49(12):2370-4, http://dx.doi.org/10.1093/rheumatology/keq281.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2010;77(2):125-30, http://dx.doi.org/10.1016/j.jbspin.2009.08.008.",OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"1980;23(8):881-8, http://dx.doi.org/10.1002/ art.1780230802.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2007;19(6):523-9, http://dx.doi.org/10.1097/BOR.0b013e3282f01a8c.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2007;46(6):1005-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"1993;91(6):2556-64, http://dx.doi.org/10.1172/JCI116493.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"1992;35(7):821-30, http://dx.doi.org/10.1002/art.17803 50718.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"1986;163(5):1281-91, http://dx.doi.org/10.1084/jem.163.5.1281.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"1984;160(2):420-34, http://dx.doi.org/10.1084/jem.160.2.420.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"Arthritis Rheum 2004;50:209-15, http://dx.doi.org/10.1002/art.11484.28.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2001;29(12):2517-21, http://dx.doi.org/10.1093/nar/29.12.2517.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"1985;28(7):796-803, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"1997;109(1):32-40, http://dx.doi.org/10.1046/j.1365- 2249.1997.4081308.x.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"Arthritis Rheum 1987;30(11):1320, http://dx.doi.org/10.1002/art.1780301124.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2002;47(1):148-51, http://dx.doi.org/10.1067/mjd.2002.121037.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2006;39(3):249-53, http://dx.doi.org/10.1080/08916930600623791.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2012;41(6):890-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2006;54(11):3682-9, http://dx.doi.org/10.1002/art.22164.",Non-OADS,/arxiv_data1/oa_pdf/53/c6/cln-68-07-909.PMC3715024.pdf
"2012;67(12):1497-500, http://dx.doi.org/10.6061/clinics/ 2012(12)24.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cln-68-07-1072.PMC3715025.pdf
"20 12;1(1):31-42, http://dx.doi.org/10.5812/jnp.7.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cln-68-07-1072.PMC3715025.pdf
"2009;76(5):534- 45, http://dx.doi.org/10.1038/ki.2009.243.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cln-68-07-1072.PMC3715025.pdf
"2013;2(1):73-4, http://dx.doi.org/10.5812/nephropathol.8999.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cln-68-07-1072.PMC3715025.pdf
"2013;11:95, http://dx.doi.org/10.1186/1741- 7015-11-95.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cln-68-07-1072.PMC3715025.pdf
"2012;1(3):130-3, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cln-68-07-1072.PMC3715025.pdf
"2010; 5(7):1211-7, http://dx.doi.org/10.2215/CJN.00460110.Copyright /C2232013 CLINICS – This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licen ses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cln-68-07-1072.PMC3715025.pdf
More than 300 VHL genealogies with VHL mutations and double VHL mutations have been reported (http://www.umd.be/VHL/W_VHL; 74).,Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1995;238(4):343-46, http://dx.doi.org/10.1111/j.1365- 2796.1995.tb01208.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2001;86(12):5658-71, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;19(6):565-612, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;97(9):2990-3011, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;8(10):575-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:3-6, http://dx.doi.org/10.6061/clinics/2012(Sup01)02.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:91-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1998;83(8):2960-3, http://dx.doi.org/10.1210/jc.83.8.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2007;62(4):465-76, http://dx.doi.org/10.1590/S1807-593220070004000 14.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67Suppl 1:99-108, http://dx.doi.org/10.6061/clinics/2012(Sup01) 17.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2008;69 (1):81-87, http://dx.doi.org/10.1111/j.1365-2265.2007.03153.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2006;61(1):59-70, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;18 (10):2828-37, http://dx.doi.org/10.1158/1078-0432.CCR-12-0160.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;42(3):229-233, http://dx.doi.org/10.1038/ng.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;304(23):2611-9, http://dx.doi.org/10.1001/jama.2010.1830.26.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;95 (11):E373-383, http://dx.doi.org/10.1210/jc.2009-2556.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;71(6):486-493, http://dx.doi.org/10.1016/j.ando.2010.08.002.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2000;85(12):4776-80, http://dx.doi.org/10.1210/jc.85.12.4776.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2006;91(9):3478-81, http://dx.doi.org/10.1210/jc.2006-0780.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2008; 93(9):3462-3470, http://dx.doi.org/10.1210/jc.2007-1215.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:99-108, http://dx.doi.org/10.6061/clinics/ 2012(Sup01)17.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:173-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:145-8, http://dx.doi.org/10.6061/clinics/2012(Sup01)24.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:109-12, http://dx.doi.org/10.6061/ clinics/2012(Sup01)18.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;78(5):457-63, http://dx.doi.org/10.1111/j.1399-0004.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2001;86(3):1104-9, http://dx.doi.org/10.1210/jc.86.3.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1993;72(4):1356-63, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:149- 54, http://dx.doi.org/10.6061/clinics/2012(Sup01)25.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2006;312(5777):1228-30, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2007;92(5):1934-7, http://dx.doi.org/10.1210/jc.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2002;87 (2):457-65, http://dx.doi.org/10.1210/jc.87.2.457.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;25(11):2382-91, http://dx.doi.org/10.1002/jbmr.125.Inherited endocrine tumors Toledo SP et al.CLINICS 2013;68(7):1039-1056 1052",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1998;48(3):265-73, http://dx.doi.org/10.1046/j.1365-2265.1998.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1996;129(3):459-64, http://dx.doi.org/10.1016/S0022-3476(96)70084-7.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2006;27(5):535-60, http://dx.doi.org/ 10.1210/er.2006-0017.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:131-9, http://dx.doi.org/10.6061/clinics/2012(Sup01) 22.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;72(4):462-8, http://dx.doi.org/10.1111/j.1365-2265.2009.03672.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:169- 72, http://dx.doi.org/10.6061/clinics/2012(Sup01)28.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:141-4, http://dx.doi.org/10.6061/clinics/ 2012(Sup01)23.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;76(1):147-8, http://dx.doi.org/10.1111/j.1365-2265.2011.04144.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;15(20):6378-85, http://dx.doi.org/10.1158/1078-0432.CCR-09-1237.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:155-60, http://dx.doi.org/10.6061/clinics/2012(Sup01)26.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;94(5):1518-20, http://dx.doi.org/10.1210/jc.2009-0494.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2002;87(12):5658-61, http://dx.doi.org/10.1210/jc.2002-020345.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2000;1(3):182-90, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;32(1):51-8, http://dx.doi.org/10.1002/humu.21385.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;19(6):551-4, http://dx.doi.org/10.1089/thy.2009.0144.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;364(1):43-50, http://dx.doi.org/10.1056/ NEJMoa1008020.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2002;87(12):5367-84, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2002;94(2):323-30, http://dx.doi.org/10.1002/cncr.10228.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:7-11, http://dx.doi.org/10.6061/ clinics/2012(Sup01)03.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;70(4):575-81, http://dx.doi.org/ 10.1111/j.1365-2265.2008.03324.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2005;257(1):69-77, http://dx.doi.org/10.1111/j.1365-2796.2004.01429.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;83(3):329-40, http://dx.doi.org/ 10.1016/j.critrevonc.2012.01.004.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;95(1):308-13, http://dx.doi.org/10.1210/jc.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2008;113(7 Suppl):1807-43, http://dx.doi.org/10.1002/cncr.23648.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:19-28, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;35 (3):563-7, http://dx.doi.org/10.1007/s00268-010-0878-5.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;60(1):118- 24, http://dx.doi.org/10.1016/j.eururo.2011.03.046.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;19(6):2054-9, http://dx.doi.org/10.1245/s10434-012-2276-8.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;26(4):507-15, http://dx.doi.org/10.1016/j.beem.2011.10.008.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;41(3):492-3, http://dx.doi.org/10.1097/MPA.0b013e31822a645e.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1996;97(3):699-705, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;24(6):893-905, http://dx.doi.org/10.1016/j.beem.2010.10.005.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;24;6:67, http://dx.doi.org/10.1186/1750- 1172-6-67.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;97(2):351-359, http://dx.doi.org/ 10.1210/jc.2011-2244.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;97(2): E202-206, http://dx.doi.org/10.1210/jc.2011-2321.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;21(8):914.e1-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;18(6):R253-276, http://dx.doi.org/10.1530/ERC-11-0170.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;24(3):439-449, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;724:266-77, http://dx.doi.org/10.1007/978-1-4614-0653-2_20.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2008;94(1):105-111, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;20(20):3910-3924, http://dx.doi.org/10.1093/hmg/ddr310.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1998;13(12):624-628, http://dx.doi.org/10.1177/088307389801301206.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;36(1):149-153, http://dx.doi.org/10.1097/PAS.0b013e31823d0560.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2013;68(5):97-105, http://dx.doi.org/10.1016/j.neuropharm.2012.05.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;2(4):475-484, http://dx.doi.org/10.1177/1947601911413466.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;118(5):1387-1396, http://dx.doi.org/10.1002/cncr.26390.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;351(1):66-70, http://dx.doi.org/10.1016/j.mce.2011.12.008.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2001;86(10):4970-4973, http://dx.doi.org/10.1210/jc.86.10.4970.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;10(1):141-146, http://dx.doi.org/10.1007/s10689-010-9392-z.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2000;37(11):828-830, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;24(3):371-387, http://dx.doi.org/10.1016/j.beem.2010.02.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:77-84, http://dx.doi.org/10.6061/ clinics/2012(Sup01)14.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;96(5):E863-868, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2013;98(2):E364-369, http://dx.doi.org/10.1210/jc.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;6(5):e20353, http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"Clin Endocrinol 2012;77(6):934-936, http://dx.doi.org/10.1111/j.1365-2265.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1998;83(3):770-774, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;18(5):603-612, http://dx.doi.org/10.1530/ERC-11-0117.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;76 (5):691-697 , http://dx.doi.org/10.1111/j.1365-2265.2011.04293.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:85-89, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2002;87(1):393-397, http://dx.doi.org/10.1210/jc.87.1.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2004;89(11):5823- 5827, http://dx.doi.org/10.1210/jc.2004-0312.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;3(4):181-186, http://dx.doi.org/10.1007/ s12672-012-0109-7.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:63-67, http://dx.doi.org/10.6061/ clinics/2012(Sup01)12.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:57-61, http://dx.doi.org/10.6061/clinics/2012(Sup01) 11.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2013;34 (1): 132-142, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:33-36, http://dx.doi.org/10.6061/clinics/2012(Sup01) 07.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;19(1):37-44, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:161-167, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:125-129, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:43-48, http://dx.doi.org/10.6061/clinics/2012(Sup01) 09.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 suppl 1: 29-32, http://dx.doi.org/10.6061/clinics/2012(Sup01)06 148.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:119-123, http://dx.doi.org/10.6061/clinics/ 2012(Sup01)20.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;96 (11): E1905-914 , http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;76 (3):379-386, http://dx.doi.org/10.1111/j.1365-2265.2011.04220.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;71 Suppl 2:131-138, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2008;247(3):501-510, http://dx.doi.org/10.1097/SLA.0b013e31815efda5.153.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2006;243(2):265-272, http://dx.doi.org/10.1097/01.sla.0000197715.96762.68.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1998;243(6):465-470, http://dx.doi.org/10.1046/j.1365-2796.1998.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1998;133(2):126-129, http://dx.doi.org/10.1001/archsurg.133.2.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;17(1):7-15, http://dx.doi.org/10.4158/EP10050.OR.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2002;87(12):5353-5361, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;6(11):604--605, http://dx.doi.org/10.1038/nrendo.2010.131.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1999;134(10):1119-1123, http://dx.doi.org/10.1001/archsurg.134.10.1119.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2003;40(Pt 6):612-627, http://dx.doi.org/10.1258/000456303770367207.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2005;90(5):2603-2609, http://dx.doi.org/10.1210/jc.2004-1155.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2001;55 (5):689-693, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;94(5):1826-1834, http://dx.doi.org/10.1210/jc.2008-2083.CLINICS 2013;68(7):1039-1056 Inherited endocrine tumors Toledo SP et al.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2006;9 1 (12):4769-4775, http://dx.doi.org/10.1210/jc.2006-1668.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;15(3): 312-318, http://dx.doi.org/ 10.1007/s11102-012-0389-5.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2001;86 (2):542-544, http://dx.doi.org/10.1210/jc.86.2.542.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2007;92(5):1891-1896, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;24(3):389- 399, http://dx.doi.org/10.1016/j.beem.2010.03.003.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;15(3):342-349, http://dx.doi.org/ 10.1007/s11102-011-0325-0.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;67 Suppl 1:37-41, http://dx.doi.org/10.6061/clinics/2012(Sup01)08.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010;65(4):407-415, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2010; 38:77-86 , http://dx.doi.org/10.1159/000318497.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2012;76(1):33-38., http://dx.doi.org/10.1111/j.1365-2265.2011.04184.x.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;58(5):797-803, http://dx.doi.org/10.1161/ HYPERTENSIONAHA.111.175083.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;41(9):664-671, http://dx.doi.org/10.1055/s-0029-1215590.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2005;65(21):9651-c-9658, http://dx.doi.org/10.1158/ 0008-5472.CAN-05-1427.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;96(8):E1279-282, http://dx.doi.org/10.1210/jc.2011-0114.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2011;7(5):257-266, http://dx.doi.org/10.1038/nrendo.2011.40.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2009;11(12):825-835 , http://dx.doi.org/ 10.1097/GIM.0b013e3181be5c97.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2013;34(2):239-277, http://dx.doi.org/10.1210/er.",Non-OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"2006,9;247(1-2):34-40, http://dx.doi.org/10.1016/j.mce.2005.10.028.",OADS,/arxiv_data1/oa_pdf/67/0b/cln-68-07-1039.PMC3715026.pdf
"1993;22(4 Suppl A):6A-13A, http://dx.doi.org/10.1016/0735-1097(93)90455-A.",OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2006;113(6):799-805, http://dx.doi.org/10.1161/ CIRCULATIONAHA.104.492033.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"1993;88(6):2941-52, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2009;30(20):2450-60, http://dx.doi.org/10.1093/eurheartj/ehp359.6.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2003;289(6):730-40, http://dx.doi.org/10.1001/jama.289.6.730.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2006;27(22):2682-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2007;297(22):2502-14, http://dx.doi.org/10.1001/jama.297.22.2502.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2004;44(1):1-9, http://dx.doi.org/10.1016/j.jacc.2004.02.055.",OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2006;27:1270-81, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2008;117:2608-16, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"J Am Coll Cardiol 2005;46:2183-92, http://dx.doi.org/ 10.1016/j.jacc.2005.01.071.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2010;33(1):74-84, http://dx.doi.org/10.1111/j.1540-8159.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2006;3:1285-92, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2008;19(9):939- 44, http://dx.doi.org/10.1111/j.1540-8167.2008.01160.x.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2010;12(1):78-83, http://dx.doi.org/10.1093/ europace/eup347.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2004;109(9):1133-9, http://dx.doi.org/10.1161/01.CIR.0000118502.91105.F6.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2005;16(2):112-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2002;7:139-51, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2006;39(1):93-102, http://dx.doi.org/10.1016/j.jelectrocard.2005.07.004.",OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2007;40(6 Suppl):S174-8, http://dx.doi.org/10.1016/j.jelectrocard.2007.06.017.CLINICS 2013;68(7):986-991 BSPM LV/RV electrical activation in CRT Samesima N et al.",OADS,/arxiv_data1/oa_pdf/05/e6/cln-68-07-986.PMC3715027.pdf
"2002;22(4):534-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"1998;49(4):267- 73, http://dx.doi.org/10.1177/000331979804900404.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2007;81(3):144-9, http://dx.doi.org/10.1016/S0009- 739X(07)71286-1.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2006;34(5):1565-6, http://dx.doi.org/ 10.1097/01.CCM.0000216187.00379.12.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2002;37(11):1543-8, http://dx.doi.org/10.1053/jpsu.2002.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2011;46(1):81-5, http://dx.doi.org/10.1016/j.jpedsurg.",OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"1999;34(10):1453-7, http://dx.doi.org/10.1016/S0022-3468(99)90102-1.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2000;32(6):1307-10, http://dx.doi.org/10.1016/S0041-1345 (00)01238-0.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"1970;101(4):478-83, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2008;68(3):242-8, http://dx.doi.org/10.1080/00365510701646264.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2009;24(2):98-106, http://dx.doi.org/ 10.1590/S0102-86502009000200005.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2010;36(6):1095, http://dx.doi.org/10.1007/s00134-010-1811-y.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2008;8:42, http://dx.doi.org/10.1186/1471-230X-8-42.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2001;99(1):134-41, http://dx.doi.org/10.1006/jsre.2001.6106.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"1999;229(4):478-86, http://dx.doi.org/10.1097/00000658-199904000-00005.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2006;31(5):470-4, http://dx.doi.org/10.1016/j.ejvs.2005.10.031.",OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2012;37(5):473-7, http://dx.doi.org/10.1097/SHK.0b013e318249cb96.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2012;255(4):796- 803, http://dx.doi.org/10.1097/SLA.0b013e31824b1e16.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2012;42(6):741-7, http://dx.doi.org/10.1016/j.jemermed.",OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"1993;218(4):444-54, http://dx.doi.org/10.1097/ 00000658-199310000-00005.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2010;42(5):1624-6, http://dx.doi.org/10.1016/j.transproceed.2009.12.074.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2004;36(2):267-9, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2010;55(7):1878-85, http://dx.doi.org/10.1007/s10620-009-0976-0.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/cln-68-07-1034.PMC3715035.pdf
"2002;27(3):479- 83, http://dx.doi.org/10.1053/jhsu.2002.33198.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2005;87(2):231-5, http://dx.doi.org/10.1302/0301-620X.87B2.14739.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2005;87(2):320-5, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2008;28(2):108-12, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2006;88(5):1035-1042, http://dx.doi.org/10.2106/JBJS.E.00680.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2007;16(1):6-13, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2010;130(12):1499-504, http://dx.doi.org/10.1007/s00402-010-1067-6.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2006;88(2):213-9, http://dx.doi.org/10.1302/0301-620X.88B2.17185.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2006;15(5):324-7, http://dx.doi.org/10.1097/01202412-200609000-00004.CLINICS 2013;68(7):928-933 Obstetric palsy sequelae: surgical treatment Assunc ¸a˜o JH et al.",Non-OADS,/arxiv_data1/oa_pdf/43/b7/cln-68-07-928.PMC3715036.pdf
"2011;142(6):e153-203, http://dx.doi.org/10.1016/j.jtcvs.2011.10.020.",OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2010;105(8):1164-8, http://dx.doi.org/10.1016/j.amjcard.",OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2005;149(6):1099-105, http://dx.doi.org/10.1016/j.ahj.2004.",OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2009;373(9657):82-93, http://dx.doi.org/10.1016/ S0140-6736(08)61622-0.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2011;140(2):534-42, http://dx.doi.org/10.1378/chest.10-2223.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2009;6(8):e1000132, http://dx.doi.org/10.1371/ journal.pmed.1000132.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2004;68(4):338-42, http://dx.doi.org/10.1253/circj.68.338.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2009;54(19):1805-9, http://dx.doi.org/10.1016/j.jacc.2009.07.030.",OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2010;137(5):1078-84, http://dx.doi.org/10.1378/chest.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2010; 105(11):1597-602, http://dx.doi.org/10.1016/j.amjcard.2010.01.023.",OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2011;17(1):19-24, http://dx.doi.org/10.1111/j.1751- 7133.2010.00196.x.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2013;17(3):201-6, http://dx.doi.org/10.1016/j.smrv.2012.06.006.",OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"1999;131(7):485-91, http://dx.doi.org/10.7326/0003- 4819-131-7-199910050-00002.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2011;58(5):811-7, http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2010;11(5):441-6, http://dx.doi.org/10.1016/j.sleep.2009.10.005.",OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2010;117(3):200-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2001;104(21):2517-24, http://dx.doi.org/10.1161/ hc4601.097997.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2008;9(7):727-31, http://dx.doi.org/10.1016/j.sleep.",OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"PLoS One 2010;5(8):e12065, http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2012;141(4):967-73, http://dx.doi.org/10.1378/chest.11-0975.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2004;24(3):443-8, http://dx.doi.org/10.1183/09031936.04.",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
"2010;160(13-14):349-55, http://dx.doi.org/10.1007/s10354- 009-0737-x.Sleep Apnea and Hypertrophic Cardiomyopathy Nerbass FB et al.CLINICS 2013;68(7):992-996 996",Non-OADS,/arxiv_data1/oa_pdf/93/95/cln-68-07-992.PMC3715037.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Blumenthal D. Launching HITECH.,Non-OADS,/arxiv_data1/oa_pdf/c8/01/amiajnl-2012-001217.PMC3715355.pdf
"Washington, DC, 2009: http://www.hhs.gov/healthit/healthnetwork/background/ (accessed 14 May 2012).",Non-OADS,/arxiv_data1/oa_pdf/c8/01/amiajnl-2012-001217.PMC3715355.pdf
2009 June 29: http://hospitals.nyhealth.gov/index.php?PHPSESSID=51f042212dbf5db2ec0ffc15401d4779 (accessed 9 Sep 2009).,Non-OADS,/arxiv_data1/oa_pdf/c8/01/amiajnl-2012-001217.PMC3715355.pdf
New York State Departmentof Health 2010: http://www.health.ny.gov/statistics/sparcs/annual/ip/2009/t2009_08.htm (accessed 16 Jul 2012).,OADS,/arxiv_data1/oa_pdf/c8/01/amiajnl-2012-001217.PMC3715355.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi:10.1093/ntr/nts241 Original investigati On adult smokers’ reactions to Pictorial Health Warning  labels on Cigarette Packs in thailand and Moderating  effects of type of Cigarette smoked: Findings From the  international tobacco Control southeast asia survey Hua-Hie Yong  PhD1, Geoffrey T.  Fong PhD2,3, Pete Driezen MSc4, Ron Borland PhD1, Anne C. K.  Quah PhD5,  Buppha Sirirassamee PhD6, Stephen Hamann EdD7, Maizurah Omar  PhD8  1 VicHealth Centre for Tobacco Control, The Cancer Council Victoria, Carlton, Victoria 3053, Australia; 2 Department of  Psychology, University of Waterloo, Waterloo, ON, Canada; 3 Ontario Institute for Cancer Research, Toronto, ON, Canada;  4 Propel Centre for Population Health Impact, University of Waterloo, Waterloo, ON, Canada; 5 Department of Psychology,  University of Waterloo, Waterloo, ON, Canada; 6 Institute for Population and Social Research, Mahidol University, Bangkok,  Thailand; 7 Thai Health Promotion Foundation, Tobacco Control Research and Knowledge Management Center, Bangkok,  Thailand; 8 National Poison Centre, Universiti Sains Malaysia, Penang, Malaysia Corresponding Author: Hua-Hie Yong, PhD, The Cancer Council Victoria, 1 Rathdowne Street, Carlton, VIC 3053, Australia.",Non-OADS,/arxiv_data1/oa_pdf/78/1e/nts241.PMC3715385.pdf
"Retrieved from http://lists.essential.org/ pipermail/intl-tobacco/2004q3/001120.html Doll, R., Peto, R., Boreham, J., & Sutherland, I.",OADS,/arxiv_data1/oa_pdf/78/1e/nts241.PMC3715385.pdf
"Retrieved from http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2976466/?tool=pubmed Hammond, D. (2011).",OADS,/arxiv_data1/oa_pdf/78/1e/nts241.PMC3715385.pdf
Retrieved from http://jmat.mat.,OADS,/arxiv_data1/oa_pdf/78/1e/nts241.PMC3715385.pdf
"Retrieved from http://www.trc.or.th/en/publication/ Thompson, M. E., Fong, G. T., Hastings, G., Boudreau, C.,  Driezen, P., Hyland, A., .",Non-OADS,/arxiv_data1/oa_pdf/78/1e/nts241.PMC3715385.pdf
"Do not distribute.www.landesbioscience.com  BioArchitecture  25BioAr chitecture 3:2, 25–37; March/April 2013; © 2013 Landes Bioscience Rese ARch p ApeR ReseARch p ApeR *Correspondence to: Edna C. Hardeman; Email: e.hardeman@unsw.edu.au Submitted: 02/01/13; Revised: 05/06/13; Accepted: 05/08/13http://dx.doi.org/10.4161/bioa.24966Introduction The function of skeletal muscle is directly determined by its  architecture; the numbers and size of muscle fibers and rela - tive contribution of fibrotic tissue and fat.",Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Stem Cell Rev 2007; 3:226-37; PMID:17917136; http://dx.doi.org/10.1007/s12015-007-9000-2 2.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Science 2007; 317:807-10; PMID:17690295; http://dx.doi.org/10.1126/science.1144090 3.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Ageing Res Rev 2011; 10:35-42; PMID:19683075; http://dx.doi.org/10.1016/j.arr.2009.08.0014.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Nature 2012; 490:355-60; PMID:23023126; http://dx.doi.org/10.1038/nature11438 5.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Exp Gerontol 2008; 43:550-62; PMID:18364250; http://dx.doi.org/10.1016/j.exger.2008.02.005 6.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Biogerontology 2010; 11:363-76; PMID:20033288; http://dx.doi.org/10.1007/s10522-009-9260-07.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Science 2003; 302:1575-7; PMID:14645852; http://dx.doi.org/10.1126/sci-ence.1087573 8.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Nature 2005; 433:760-4; PMID:15716955; http://dx.doi.org/10.1038/nature03260 9.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Stem Cells 2007; 25:885-94; PMID:17218401; http://dx.doi.org/10.1634/stem-cells.2006-0372,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Clin Nutr 2007; 26:524-34; PMID:17590243; http://dx.doi.org/10.1016/j.clnu.2007.05.005 41.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Int J Biochem Cell Biol 2010; 42:132-6; PMID:19819345; http://dx.doi.org/10.1016/j.biocel.2009.09.021 42.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Physiol Heart Circ Physiol 2011; 300:H2027-34; PMID:21398592; http://dx.doi.org/10.1152/ajp-heart.00004.2011 43.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Endocrinology 2006; 147:659-61; PMID:16418430; http://dx.doi.org/10.1210/en.2005-1469 44.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Pathol 1987; 153:71-82; PMID:3668737; http://dx.doi.org/10.1002/path.1711530110 47.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Appl Physiol 2011; 111:999-1006; PMID:21737825; http://dx.doi.org/10.1152/japplphysiol.00460.2011 50.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Eur J Appl Physiol 2001; 85:457-65; PMID:11606015; http://dx.doi.org/10.1007/s004210100464 51.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Gerontol A Biol Sci Med Sci 2001; 56:B163-71; PMID:11283187; http://dx.doi.org/10.1093/gerona/56.4.B163 53.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Sports Med 2005; 33:43-51; PMID:15610998; http://dx.doi.org/10.1177/0363546504265190 54.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Neuromuscul Disord 2008; 18:857-68; PMID:18672370; http://dx.doi.org/10.1016/j.nmd.2008.06.386 55.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Cell Tissue Res 1987; 249:509-21; PMID:3664601; http://dx.doi.org/10.1007/BF00217322 56.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Exp Gerontol 2010; 45:875-81; PMID:20688143; http://dx.doi.org/10.1016/j.exger.2010.07.006 27.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Aging Cell 2013; PMID:23374245; http://dx.doi.org/10.1111/acel.12051 28.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Neurol Sci 1979; 41:149-73; PMID:438849; http://dx.doi.org/10.1016/0022-510X(79)90035-2 29.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Anat 1980; 158:65-82; PMID:7416047; http://dx.doi.org/10.1002/aja.1001580107 30.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Cell Sci 2010; 123:3052-60; PMID:20736301; http://dx.doi.org/10.1242/jcs.066241 32.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Physiol Cell Physiol 2009; 297:C238-52; PMID:19515904; http://dx.doi.org/10.1152/ajpcell.00161.2009 34.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Physiol Cell Physiol 2011; 301:C1270-9; PMID:21865583; http://dx.doi.org/10.1152/ajp-cell.00257.2011 35.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Physiol Regul Integr Comp Physiol 2006; 290:R1508-14; PMID:16424085; http://dx.doi.org/10.1152/ajp-regu.00486.2005 36.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Exp Gerontol 2008; 43:1094-101; PMID:18824083; http://dx.doi.org/10.1016/j.exger.2008.09.005 37.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Physiol Heart Circ Physiol 2005; 289:H455-65; PMID:15734890; http://dx.doi.org/10.1152/ajpheart.00085.2005 39.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
PLoS One 2010; 5:e13307; PMID:20967266; http://dx.doi.org/10.1371/journal.pone.001330710.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Dev Biol 2006; 294:50-66; PMID:16554047; http://dx.doi.org/10.1016/j.ydbio.2006.02.022 11.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Cell Sci 2005; 118:4813-21; PMID:16219688; http://dx.doi.org/10.1242/jcs.02602 12.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Muscle Nerve 1991; 14:268-79; PMID:2041548; http://dx.doi.org/10.1002/mus.880140311 13.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Voice 1994; 8:53-62; PMID:8167787; http://dx.doi.org/10.1016/S0892-1997(05)80319-4 14.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Muscle Nerve 1995; 18:1147-54; PMID:7659109; http://dx.doi.org/10.1002/mus.880181011 15.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Exp Mol Pathol 1991; 55:217-29; PMID:1660822; http://dx.doi.org/10.1016/0014-4800(91)90002-F 17.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Toxicon 2003; 42:933-45; PMID:15019492; http://dx.doi.org/10.1016/j.toxi-con.2003.11.011 18.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Biol Chem 2003; 278:12601-4; PMID:12556454; http://dx.doi.org/10.1074/jbc.R200027200 19.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Physiol Cell Physiol 2012; 302:C1306-15; PMID:22322971; http://dx.doi.org/10.1152/ajp-cell.00305.2011 20.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Muscle Nerve 1998; 21:1153-65; PMID:9703441; http://dx.doi.org/10.1002/(SICI)1097-4598(199809)21:9<1153::AID-MUS6>3.0.CO;2-6 22.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Med Sci Sports Exerc 1994; 26:432-9; PMID:8201898; http://dx.doi.org/10.1249/00005768-199404000-00006 23.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Anat Rec 2001; 263:139-54; PMID:11360231; http://dx.doi.org/10.1002/ar.1087 24.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Neurol Res 2004; 26:174-85; PMID:15072637; http://dx.doi.org/10.1179/016164104225013806 25.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Neurol Sci 1988; 87:67-74; PMID:3193124; http://dx.doi.org/10.1016/0022-510X(88)90055-X,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Muscle Nerve 2006; 34:577-85; PMID:16881061; http://dx.doi.org/10.1002/mus.20616 69.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Lab Anim 1976; 10:419-42; PMID:979138; http://dx.doi.org/10.1258/002367776780956917 70.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
PLoS One 2010; 5:e12345; PMID:20808812; http://dx.doi.org/10.1371/journal.pone.0012345 72.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Am J Physiol Cell Physiol 2008; 295:C897-904; PMID:18650267; http://dx.doi.org/10.1152/ajpcell.00179.200863.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
PLoS One 2010; 5:e8523; PMID:20049087; http://dx.doi.org/10.1371/journal.pone.0008523 64.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Nat Cell Biol 2010; 12:153-63; PMID:20081841; http://dx.doi.org/10.1038/ncb2015 66.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Nat Cell Biol 2010; 12:143-52; PMID:20081842; http://dx.doi.org/10.1038/ncb2014 67.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Stem Cells 2009; 27:1098-108; PMID:19415780; http://dx.doi.org/10.1002/stem.2857.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Exp Physiol 2010; 95:641-56; PMID:20139167; http://dx.doi.org/10.1113/expphysiol.2009.052019 58.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Cell Biol 2006; 172:233-44; PMID:16401724; http://dx.doi.org/10.1083/jcb.200507083 59.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Muscle Nerve 2011; 43:828-38; PMID:21607967; http://dx.doi.org/10.1002/mus.21965 61.,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Aging Cell 2004; 3:353-61; PMID:15569352; http://dx.doi.org/10.1111/j.1474-9728.2004.00135.x 62.,OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
J Histochem Cytochem 2011; 59:33-46; PMID:21339173; http://dx.doi.org/10.1369/jhc.2010.956995,Non-OADS,/arxiv_data1/oa_pdf/b0/32/bioa-3-25.PMC3715540.pdf
Available at: http://ccpicd.com/ Documents/Excited%20Delirium%20Task%20Force.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ca/1a/wjem-13-536a.PMC3715651.pdf
"At least 60 SNPs have been reported in PARP-1 (http://snp500cancer.nci.nih.gov ), and among them is the most frequently studied functional PARP-1 polymorphism, which includes a 2446T [C tran- sition leading to Val762Ala variation [ 16,17].",Non-OADS,/arxiv_data1/oa_pdf/43/30/40291_2013_Article_36.PMC3715681.pdf
"Topical immunosuppressants(calcineurin inhibitors)—animal toxicology, 15 Feb 2005.Available from URL: http://www.fda.gov/ohrms/dockets/ac/05/ slides/2005-4089s2_01_06_Hill.ppt .",Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
Available from URL: http://www.accessdata.fda.gov/drugsatfda_ docs/nda/2000/50777_Protopic_Approv.pdf .,OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
"Elidel NDA 21–302 approval letter, 13 Dec 2001.Available from URL: http://www.accessdata.fda.gov/drugsatfda_ docs/nda/2001/21-302_ELIDEL_Approv.pdf .",Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
Available from URL: http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAd visoryCommittee/UCM204723.pdf .,Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
Available from URL: http://www.fda.gov/ohrms/dockets/ ac/05/minutes/2005-4089m1_Minutes.pdf .,Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
http://seer.cancer.gov/faststats .,Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
Available from URL: http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255139.pdf .,Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
Available from URL: http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255140.pdf .,Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
Available from URL: http://www.fda.gov/downloads/AdvisoryCommittees/Com mitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM255145.pdf .,Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
http://www.nationaleczema.org/eczema-treat ments/topical-corticosteroids .,Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
http://www.aad.org/skin-co nditions/dermatology- a-to-z/atopic-dermatitis/tips/atopic-dermatitis-tips-for-managing .,Non-OADS,/arxiv_data1/oa_pdf/87/60/40272_2013_Article_13.PMC3715696.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 417 Korean J Urol 2013;54:417-425www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.417 Review Article Divorcing Diagnosis From Treatment: Contemporary Management  of Low-Risk Prostate Cancer Allison S. Glass, Sanoj Punnen, Matthew R. Cooperberg Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Franc isco,  CA, USA Today, the majority of men with newly di agnosed prostate cancer will present with  low-risk features of the disease.",Non-OADS,/arxiv_data1/oa_pdf/2a/b1/kju-54-417.PMC3715703.pdf
"Keywords:  Diagnosis; Disease manage ment; Prostate neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 May, 2013 accepted 20 June, 2013 Corresponding Author: Matthew R. CooperbergDepartment of Urology, UCSF  Helen Diller Family  Comprehensive Cancer Center, University of California, San  Francisco, San Francisco, 1600  Divisadero St, Box 1695, San Francisco, CA 94143-1695, USA TEL: +1-415-885-3660 FAX: +1-415-353-7093E-mail: mcooperberg@urology.",Non-OADS,/arxiv_data1/oa_pdf/2a/b1/kju-54-417.PMC3715703.pdf
http://dx.doi.org/10.1016/j.juro.2013.04.071.,OADS,/arxiv_data1/oa_pdf/2a/b1/kju-54-417.PMC3715703.pdf
Available from: http://www.uroweb.org/gls/pdf/09_  Prostate_Cancer_LR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2a/b1/kju-54-417.PMC3715703.pdf
http://dx.doi.org/10.1016/j.eururo.2012.06.055.,OADS,/arxiv_data1/oa_pdf/2a/b1/kju-54-417.PMC3715703.pdf
http://dx.doi.org/10.1016/j.juro.2013.05.019.,OADS,/arxiv_data1/oa_pdf/2a/b1/kju-54-417.PMC3715703.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 426 Korean J Urol 2013;54:426-432www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.426 Review Article Endoscopic Management of Upper Urinary Tract Urothelial  Carcinoma  Bong Hee Park, Seong Soo Jeon1 Department of Urology, Incheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Incheon, 1Department of Urology,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Upper urinary tract urothelial carcinoma (U TUC) is relatively uncommon.",Non-OADS,/arxiv_data1/oa_pdf/26/97/kju-54-426.PMC3715704.pdf
"Keywords:  Adjuvant treatment; Endoscopy; P ercutaneous resection; Transitional cell  carcinoma; Ureteroscopy This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 May, 2013 accepted 27 May, 2013 Corresponding Author: Seong Soo Jeon Department of Urology, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul 135-710, Korea TEL: +82-2-3410-3555 FAX: +82-2-3410-6992E-mail: seongsoo.jeon@samsung.",Non-OADS,/arxiv_data1/oa_pdf/26/97/kju-54-426.PMC3715704.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 433 Korean J Urol 2013;54:433-436www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.433 Urological Oncology External Validation of the Cancer of the Prostate Risk Assessment-S  Score in Koreans Undergoing Radical Prostatectomy Ki Taek Seong, Ju Hyun Lim, Chang Myon Park, Han Kwon Kim, Jong Yeon Park Department of Urology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea Purpose:  To evaluate the validity of the Universi ty of California San Francisco Cancer  of the Prostate Risk Assessment-S score (C APRA-S score), a biochemical indicator of  recurrent prostate cancer that uses histopathologic data, in Korean prostate cancer  patients.Materials and Methods:  A total of 203 prostate cancer  patients who underwent radical  prostatectomy between February 1997 and November 2010 were observed for longer  than 6 months.",Non-OADS,/arxiv_data1/oa_pdf/d5/df/kju-54-433.PMC3715705.pdf
"Keywords:  Disease-free survival; Prostat ectomy; Prostatic neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 16 April, 2013 accepted 20 May, 2013 Corresponding Author: Jong Yeon Park Department of Urology,  Gangneung Asan Hospital, University of Ulsan College of  Medicine, Gangneung, 38  Bangdong-gil, Gangneung 210-711, Korea TEL: +82-33-610-3357 FAX: +82-33-641-8070E-mail: jypark@gnah.co.kr INTRODUCTION Approximately 217,730 persons were diagnosed with pros- tate cancer in the United St ates in 2010, which makes up  28% of all cancers in men.",Non-OADS,/arxiv_data1/oa_pdf/d5/df/kju-54-433.PMC3715705.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 437 Korean J Urol 2013;54:437-441www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.437 Laparoscopy/Robotics Efficacy of Using Three-Tesla Magnetic Resonance Imaging  Diagnosis of Capsule Invasion for Decision-Making About Neurovascular Bundle Preservation in Robotic-Assisted Radical Prostatectomy Kazushi Tanaka, Katsumi Shigemura, Mototsugu Muramaki, Satoru Takahashi1, Hideaki Miyake,  Masato Fujisawa Division of Urology, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, 1Division of Radiology,  Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan Purpose:  To evaluate the efficacy of using 3-te sla (T) magnetic resonance imaging (MRI)  diagnosis of extracapsular extension (ECE ) for decision-making about neurovascular  bundle (NVB) preservation in robot-assisted  radical prostatectomy (RARP) for prostate  cancer (PC).",Non-OADS,/arxiv_data1/oa_pdf/5d/4f/kju-54-437.PMC3715706.pdf
"Keywords:  Diagnoses; Magnetic resonance im aging; Prostatectomy; Robotics This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 27 February, 2013 accepted 11 April, 2013 Corresponding Author: Kazushi Tanaka Division of Urology, Department  of Surgery Related, Kobe University Graduate School of  Medicine, Kobe 650-0017, Japan TEL: +81-78-382-6155FAX: +81-78-382-6169 E-mail: kazushi@med.kobe-u.ac.jp INTRODUCTION Prostate cancer (PC) increasingly presents as early-stage  disease clinically owing to in creased screening, including  prostate-specific antigen (PSA) screening.",Non-OADS,/arxiv_data1/oa_pdf/5d/4f/kju-54-437.PMC3715706.pdf
http://dx.doi.org/ 10.1007/s00345- 012-0826-0.,Non-OADS,/arxiv_data1/oa_pdf/5d/4f/kju-54-437.PMC3715706.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 442 Korean J Urol 2013;54:442-447www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.442 Voiding Dysfunction/Female Urology Surgical Outcome of Excision and End-to-End Anastomosis for  Bulbar Urethral Stricture Jun-Gyo Suh, Woo Suk Choi, Jae-Seung Paick, Soo Woong Kim Department of Urology, Seoul National University Hospital, Seoul, Korea Purpose:  Although direct-vision internal urethrotomy can be performed for the man- agement of short, bulbar urethral strictur es, excision and end-to-end anastomosis re- mains the best procedure to guarantee a high success rate.",Non-OADS,/arxiv_data1/oa_pdf/c4/e4/kju-54-442.PMC3715707.pdf
"Keywords:  Surgical anastomosis; Treatmen t outcome; Urethral stricture  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 January, 2013 accepted 15 May, 2013 Corresponding Author: Soo Woong Kim Department of Urology, Seoul  National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul  110-744, Korea TEL: +82-2-2072-2426FAX: +82-2-742-4665 E-mail: swkim@snu.ac.kr INTRODUCTION According to the results of a nationwide survey, direct-vi- sion internal urethrotomy (DVIU) is used for most urethral strictures in the United States  [1] and the situation should  be similar in Korea.",Non-OADS,/arxiv_data1/oa_pdf/c4/e4/kju-54-442.PMC3715707.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 448 Korean J Urol 2013;54:448-453www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.448 Endourology/Urolithiasis Predictive Factors for Bleeding During Percutaneous  Nephrolithotomy Jeong Kuk Lee, Bum Soo Kim, Yoon Kyu Park Department of Urology, Kyungpook National University School of Medicine, Daegu, Korea Purpose:  Although percutaneous nephrolithotomy (PCNL) has been accepted as a  standard method for the mana gement of large renal stones, the incidence of renal hem- orrhage is relatively high.",Non-OADS,/arxiv_data1/oa_pdf/e8/4a/kju-54-448.PMC3715708.pdf
"Keywords:  Hemorrhage; Kidney calculi; Percutaneous nephrolithotomy  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 August, 2012 accepted 13 May, 2013 Corresponding Author: Yoon Kyu Park Department of Urology, Kyungpook National University  Medical Center, Kyungpook  National University School of Medicine, 130 Dongdeok-ro,  Jung-gu, Daegu 700-721, Korea TEL: +82-53-420-5852FAX: +82-53-421-9618 E-mail: uropark@knu.ac.kr INTRODUCTION Since the first report of the removal of renal stones via  nephrostomy by Rupel and Brown [1] in 1941, there have been significant improvemen ts in techniques, instru- ments, and experience.",Non-OADS,/arxiv_data1/oa_pdf/e8/4a/kju-54-448.PMC3715708.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 454 Korean J Urol 2013;54:454-459www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.454 Endourology/Urolithiasis Stone Attenuation Value and Cross-Sectional Area on Computed  Tomography Predict the Success of Shock Wave Lithotripsy  Michio Tanaka, Eisuke Yokota1, Yoichiro Toyonaga2, Fumitaka Shimizu3, Yoshiyuki Ishii4,  Makoto Fujime, Shigeo Horie Department of Urology, Juntendo University, Tokyo, 1Department of Urology, Juntendo University Urayasu Hospital, Chiba, 2Department  of Urology, Juntendo University Nerima Hospital, Tokyo, 3Department of Urology, Juntendo University Shizuoka Hospital, Tokyo,  4Department of Urology, Koshigaya Municipal Hospital, Saitama, Japan Purpose:  To identify the parameters on noncontrast computed tomography (NCCT)  that best predict the success of shock wave lithotripsy (SWL).",Non-OADS,/arxiv_data1/oa_pdf/70/77/kju-54-454.PMC3715709.pdf
"Keywords:  Noncontrast computed tomography; Treatment outcome This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 31 December, 2012 accepted 3 April, 2013 Corresponding Author: Michio Tanaka Department of Urology, Juntendo University, 2-1-1, Hongo,  Bunkyo-ku, Tokyo 113-8421,  JapanTEL: +81-3-3813-3111 FAX: +81-3-5802-1227 E-mail: michio-t@juntendo.ac.jp INTRODUCTION  Shock wave lithotripsy (SWL) was invented in the early  1980s and since then has become a standard treatment for renal and ureteral calculi ow ing to its noninvasiveness.",Non-OADS,/arxiv_data1/oa_pdf/70/77/kju-54-454.PMC3715709.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 460 Korean J Urol 2013;54:460-466www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.460 Pediatric Urology Factors Affecting the Outcome of Extracorporeal Shock Wave  Lithotripsy for Unilateral Urinary Stones in Children: A 17-Year Single-Institute Experience U-Seok Jeong, Sinwoo Lee, Junghun Kang, Deok Hyun Han, Kwan Hyun Park1, Minki Baek Department of Urology, Samsung Medical Center, S ungkyunkwan University School of Medicine, Seoul, 1Seoul Samsung Urology  Clinic/Gynecology Health Care Center, Ulsan, Korea Purpose:  Extracorporeal shock wave lithotripsy  (ESWL) is a first-line treatment for  pediatric urinary stone disease.",Non-OADS,/arxiv_data1/oa_pdf/2e/01/kju-54-460.PMC3715710.pdf
"Keywords:  Lithotripsy; Pediatrics; Trea tment outcome; Urinary calculi  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 April, 2013 accepted 30 April, 2013 Corresponding Author: Minki Baek Department of Urology, Samsung  Medical Center, Sungkyunkwan University School of Medicine, 81  Irwon-ro, Gangnam-gu, Seoul  135-710, Korea TEL: +82-2-3410-3553 FAX: +82-2-3410-3027 E-mail: drminkibaek@gmail.com INTRODUCTION Pediatric urinary stones are rare but have lifelong conse- quences.",Non-OADS,/arxiv_data1/oa_pdf/2e/01/kju-54-460.PMC3715710.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 467 Korean J Urol 2013;54:467-471www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.467 Sexual Dysfunction How Serious Is Erectile Dysfunction in Men’s Lives?",Non-OADS,/arxiv_data1/oa_pdf/6c/b8/kju-54-467.PMC3715711.pdf
"Keywords:  Erectile dysfunction; Qual ity of life; Questionnaires This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 April, 2013 accepted 28 May, 2013 Corresponding Author: Ki Hak Moon Department of Urology,  Yeungnam Universi ty College of  Medicine, 170 Hyeonchung-ro,  Nam-gu, Daegu 705-717, Korea TEL: +82-53-620-3692FAX: +82-53-627-5535 E-mail: khmoon@med.yu.ac.kr INTRODUCTION Erectile dysfunction (ED) has been defined as the inability  to achieve or maintain an erection satisfactory for sexual performance [1], and it has a significant negative impact on quality of life (QoL) and the life satisfaction of both the  affected individual and his partner [2,3].",Non-OADS,/arxiv_data1/oa_pdf/6c/b8/kju-54-467.PMC3715711.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 472 Korean J Urol 2013;54:472-476www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.472 Sexual Dysfunction Long-term Treatment Outcomes Between Surgical Correction and  Conservative Management for Penile Fracture: Retrospective Analysis Kleiton Gabriel Ribeiro Yamaçake, Alessandro Tavares, Guilherme Philomeno Padovani,  Giuliano Betoni Guglielmetti, José Cury, Miguel Srougi Division of Urology, Hospital das Clínicas, Unive rsity of São Paulo Medical School, São Paulo, Brazil Purpose:  Early surgical management is the st andard of care for penile fracture.",Non-OADS,/arxiv_data1/oa_pdf/b7/50/kju-54-472.PMC3715712.pdf
"Keywords:  Penis; Surgery; Therapy; Wounds and injuries This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 29 November, 2012 accepted 13 February, 2013 Corresponding Author: Kleiton Gabriel Ribeiro Yamaçake Division of Urology, Hospital das  Clínicas, University of São Paulo  Medical School, Rua Dr. Enéas de Carvalho Aguiar, 455-7 andar,  São Paulo, SP.",Non-OADS,/arxiv_data1/oa_pdf/b7/50/kju-54-472.PMC3715712.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 477 Korean J Urol 2013;54:477-481www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.477 Infection/Inflammation Antimicrobial Resistance Pattern in Enterococcus faecalis  Strains  Isolated From Expressed Prostatic Secretions of Patients With Chronic Bacterial Prostatitis Yumi Seo, Gilho Lee Department of Urology, Dankook University College of Medicine, Cheonan, Korea  Purpose:  Enterococcus faecalis  is one of the most common pathogens linked to chronic  bacterial prostatitis (CBP).",Non-OADS,/arxiv_data1/oa_pdf/eb/b2/kju-54-477.PMC3715713.pdf
"Keywords:  Drug resistance; Enteroco ccus faecalis; Prostatitis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 18 February, 2013 accepted 17 April, 2013 Corresponding Author: Gilho Lee  Department of Urology, Dankook University College of Medicine,  119 Dandae-ro, Dongnam-gu,  Cheonan 330-997, KoreaTEL: +82-41-550-3963 FAX: +82-41-551-6630 E-mail: multiorigins@yahoo.com INTRODUCTION Chronic bacterial prostatitis (CBP) is diagnosed when a pa- tient has recurrent ur inary tract infections (UTIs) caused  by bacteria localized in the prostate.",Non-OADS,/arxiv_data1/oa_pdf/eb/b2/kju-54-477.PMC3715713.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 482 Korean J Urol 2013;54:482-485www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.482 Case Report Bilateral Single Ectopic Ureters Draining Into a Grossly Dilated  Vagina in an Adolescent Female Soumendra Nath Mandal, Gokulakrishnan Puttuthakku Jagadheesan, Mir Reza Kamal,  Satyadip Mukherjee, Ranjit Kumar Das1, Dilip Karmakar Department of Urology, Calcutta National Medical College and Hospital, Kolkata, 1Department of Urology, Kolkata, R.G.",Non-OADS,/arxiv_data1/oa_pdf/96/8c/kju-54-482.PMC3715714.pdf
"Keywords:  Abnormalities; Ureter This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 10 November, 2011 accepted 21 December, 2011 Corresponding Author: Gokulakrishnan Puttuthakku  JagadheesanDepartment of Urology, Calcutta  National Medical College and  Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/96/8c/kju-54-482.PMC3715714.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2013 486 Korean J Urol 2013;54:486-489www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.7.486 Case Report Prostate Metastasis of Malignant Melanoma Muhsin Balaban, Ahmet Selimoglu, Rahim Horuz, Oktay Akca, Selami Albayrak1 Urology Clinics, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul, 1Department of Urology, Medipol University, Istanbul,  Turkey Metastatic malignant melanoma of the prostate  is extremely rare in clinical practice,  and only one case has been reported in the English literature in the past 30 years.",Non-OADS,/arxiv_data1/oa_pdf/2d/7b/kju-54-486.PMC3715715.pdf
"Keywords:  Melanoma; Neoplasm metastasis; Prostate This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 August, 2012 accepted 12 October, 2012 Corresponding Author: Muhsin Balaban Urology Clinics, Dr. Lutfi Kirdar Kartal Training and Research  Hospital, Yeni mh., Pegagaz sok.",Non-OADS,/arxiv_data1/oa_pdf/2d/7b/kju-54-486.PMC3715715.pdf
"Recycling - From E-Waste to Resources, in Sustainable Innovation and Technology Transfer Industrial Sector Studies , http://www.unep.",Non-OADS,/arxiv_data1/oa_pdf/a3/e5/srep02236.PMC3715747.pdf
"The e-waste problem , http://www.greenpeace.org/ international/en/campaigns/toxics/electronics/the-e-waste-problem/ (2005).",Non-OADS,/arxiv_data1/oa_pdf/a3/e5/srep02236.PMC3715747.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a3/e5/srep02236.PMC3715747.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2236 | DOI: 10.1038/srep02236 7",Non-OADS,/arxiv_data1/oa_pdf/a3/e5/srep02236.PMC3715747.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6b/f2/srep02237.PMC3715748.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2237 | DOI: 10.1038/srep02237 7",Non-OADS,/arxiv_data1/oa_pdf/6b/f2/srep02237.PMC3715748.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) Deﬁciency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemia Leukemia (2013) 27, 1585–1588; doi:10.1038/leu.2013.49 Juvenile myelomonocytic leukemia (JMML) is a rare leukemia of infancy and early childhood.",Non-OADS,/arxiv_data1/oa_pdf/c1/a0/leu201349a.PMC3715750.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations Leukemia (2013) 271588–1592; doi:10.1038/leu.2012.346 Acute myeloid leukemia (AML) is a heterogeneous disease with variable treatment outcome.",Non-OADS,/arxiv_data1/oa_pdf/c1/a0/leu201349a.PMC3715750.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu) Landmark analysis of DNMT3A mutations in hematological malignancies Leukemia (2013) 27, 1573–1578; doi:10.1038/leu.2013.65 Methylation of CpG islands is an epigenetic modiﬁcation that is important for cellular development.1Different members of the DNMT gene family are involved in de novo CpG methylation.",Non-OADS,/arxiv_data1/oa_pdf/57/32/leu201315a.PMC3715751.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/ed/CPEMH-9-103.PMC3715754.pdf
The meta-analysis was carried out with the Comprehen-sive Meta-Analysis (version 2.2) software (http://www.meta-analysis.com/).,OADS,/arxiv_data1/oa_pdf/4a/4f/CPEMH-9-69.PMC3715755.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/4f/CPEMH-9-69.PMC3715755.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/f3/CPEMH-9-96.PMC3715757.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/bd/CPEMH-9-88.PMC3715758.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/e0/CPEMH-9-62.PMC3715759.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2231 | DOI: 10.1038/srep02231 7",Non-OADS,/arxiv_data1/oa_pdf/2f/22/srep02231.PMC3715760.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/srep02234.PMC3715761.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2234 | DOI: 10.1038/srep02234 8",Non-OADS,/arxiv_data1/oa_pdf/93/bf/srep02234.PMC3715761.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/41/22/srep02225.PMC3715763.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2225 | DOI: 10.1038/srep02225 7",Non-OADS,/arxiv_data1/oa_pdf/41/22/srep02225.PMC3715763.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8b/d7/srep02239.PMC3715764.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2239 | DOI: 10.1038/srep02239 5",Non-OADS,/arxiv_data1/oa_pdf/8b/d7/srep02239.PMC3715764.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/3b/srep02201.PMC3715782.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2201 | DOI: 10.1038/srep02201 7",Non-OADS,/arxiv_data1/oa_pdf/57/3b/srep02201.PMC3715782.pdf
18).The IRGSP 5.0 Nipponbare genome was downloaded from the RAP-DB database (http://rapdb.dna.affrc.go.jp/download/latest/IRGSPb5.fa.masked.gz) and was used as the reference genome.,OADS,/arxiv_data1/oa_pdf/45/44/ncomms3138.PMC3715847.pdf
"Additional information Accession codes: The raw sequence data of the 30 individuals of the six elite varieties have been deposited into the NCBI Short Read Archive (SRA, http://www.ncbi.nlm.- nih.gov/sra/) under the accession code SRA035256.",Non-OADS,/arxiv_data1/oa_pdf/45/44/ncomms3138.PMC3715847.pdf
"Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: W.W., F.H., J.L.",Non-OADS,/arxiv_data1/oa_pdf/45/44/ncomms3138.PMC3715847.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lyu, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/45/44/ncomms3138.PMC3715847.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3138 ARTICLE NATURE COMMUNICATIONS | 4:2138 | DOI: 10.1038/ncomms3138 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/45/44/ncomms3138.PMC3715847.pdf
"Additional information Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Garcia, G. A. et al.",Non-OADS,/arxiv_data1/oa_pdf/25/bd/ncomms3132.PMC3715848.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3132 6 NATURE COMMUNICATIONS | 4:2132 | DOI: 10.1038/ncomms3132 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/25/bd/ncomms3132.PMC3715848.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/74/ca/ncomms3116.PMC3715849.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Honkura, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/74/ca/ncomms3116.PMC3715849.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3116 10 NATURE COMMUNICATIONS | 4:2116 | DOI: 10.1038/ncomms3116 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/74/ca/ncomms3116.PMC3715849.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/4c/76/ncomms3131.PMC3715850.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hohlbein, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/4c/76/ncomms3131.PMC3715850.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3131 ARTICLE NATURE COMMUNICATIONS | 4:2131 | DOI: 10.1038/ncomms3131 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/4c/76/ncomms3131.PMC3715850.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/d7/ncomms3106.PMC3715851.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wang, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/95/d7/ncomms3106.PMC3715851.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3106 10 NATURE COMMUNICATIONS | 4:2106 | DOI: 10.1038/ncomms3106 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/95/d7/ncomms3106.PMC3715851.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Burnley, P. C. The importance of stress percolation patterns in rocks and other polycrystalline materials.",Non-OADS,/arxiv_data1/oa_pdf/5d/04/ncomms3117.PMC3715852.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3117 6 NATURE COMMUNICATIONS | 4:2117 | DOI: 10.1038/ncomms3117 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/5d/04/ncomms3117.PMC3715852.pdf
"supervised synthesis and project planning, and helped in writing andﬁnalizing the manuscript.Additional Information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/ncomms3016.PMC3715853.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hansen, S. U. et al.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/ncomms3016.PMC3715853.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3016 ARTICLE NATURE COMMUNICATIONS | 4:2016 | DOI: 10.1038/ncomms3016 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/49/ac/ncomms3016.PMC3715853.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/12/b2/emboj2013120a.PMC3715855.pdf
To view a copyof this licence visit http://creativecommons.org/licenses/by-nc-nd/3.0/.A c-di-GMP signalling cascade in E. coli bioﬁlm control S Lindenberg et al 2014 The EMBO Journal VOL 32 |NO 14 |2013 &2013 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/12/b2/emboj2013120a.PMC3715855.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/85/e0/emboj2013146a.PMC3715864.pdf
To view a copy of this licence visit http://creativecommons.org/licenses/by-nc- sa/3.0/.Bace1 controls spindle development and maintenance C Cheret et al 2028 The EMBO Journal VOL 32 |NO 14 |2013 &2013 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/85/e0/emboj2013146a.PMC3715864.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/19/ncomms3107.PMC3715867.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hirasawa, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/70/19/ncomms3107.PMC3715867.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3107 ARTICLE NATURE COMMUNICATIONS | 4:2107 | DOI: 10.1038/ncomms3107 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/70/19/ncomms3107.PMC3715867.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/dd/ncomms3122.PMC3715871.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: China, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/70/dd/ncomms3122.PMC3715871.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3122 ARTICLE NATURE COMMUNICATIONS | 4:2122 | DOI: 10.1038/ncomms3122 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/70/dd/ncomms3122.PMC3715871.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c0/09/ncomms3115.PMC3715873.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wimberly, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/c0/09/ncomms3115.PMC3715873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3115 10 NATURE COMMUNICATIONS | 4:2115 | DOI: 10.1038/ncomms3115 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c0/09/ncomms3115.PMC3715873.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsCompeting ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0e/e4/ncomms3100.PMC3715885.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Bracey, E. F. et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/ncomms3100.PMC3715885.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms3100 12 NATURE COMMUNICATIONS | 4:2100 | DOI: 10.1038/ncomms3100 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0e/e4/ncomms3100.PMC3715885.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/97/5d/IJMPO-34-1.PMC3715970.pdf
"11. nccn guidelines for treatment of head and neck squamous  cell carcinoma, 2012 Available from: http://www.nccn.org/about/news/newsinfo.asp?NewsID=110.",Non-OADS,/arxiv_data1/oa_pdf/3c/f5/IJMPO-34-11.PMC3715971.pdf
"Common toxicity criteria, 2009 Available from: http://www.ctep.cancer.gov/protocoldevelopment/electronic_ applications/docs/ctcaev3.pdf.",Non-OADS,/arxiv_data1/oa_pdf/3c/f5/IJMPO-34-11.PMC3715971.pdf
available from:  http://www.apps.who.int/hpvcentre/statistics/dynamic/ico/ country_pdf/IND.pdf.,OADS,/arxiv_data1/oa_pdf/52/62/IJMPO-34-24.PMC3715974.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/db/f9/IJMPO-34-28.PMC3715975.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ed/a4/IJMPO-34-3.PMC3715976.pdf
"Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International   S295Comparison of operating field sterility in open versus minimally  invasive microdiscectomies of the lumbar spine Charles H. Li1, Andrew Y. Yew1, Jon A. Kimball1, Duncan Q. McBride1, Jeff C. Wang2, Daniel C. Lu1,2 1Departments of Neurosurgery, and 2Orthopedic Surgery, University of California, Los Angeles, USA E‑mail:  Charles H. Li ‑ chli@mednet.ucla.edu; Andrew Y .",Non-OADS,/arxiv_data1/oa_pdf/ce/36/SNI-4-295.PMC3716002.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/3/295/111434 Copyright: © 2013 Li CH.,Non-OADS,/arxiv_data1/oa_pdf/ce/36/SNI-4-295.PMC3716002.pdf
"Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International   S299When does a spinal surgeon need a plastic surgeon?",Non-OADS,/arxiv_data1/oa_pdf/cc/83/SNI-4-299.PMC3716009.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/3/299/111431 Copyright: © 2013 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/cc/83/SNI-4-299.PMC3716009.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/2/1/109469,Non-OADS,/arxiv_data1/oa_pdf/90/94/JCIS-3-1.PMC3716018.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/2/6/109474,Non-OADS,/arxiv_data1/oa_pdf/68/1e/JCIS-3-2.PMC3716019.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/2/3/111236CASE REPORT,Non-OADS,/arxiv_data1/oa_pdf/e5/83/JCIS-3-3.PMC3716020.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/2/4/112799,Non-OADS,/arxiv_data1/oa_pdf/92/92/JCIS-3-4.PMC3716021.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/92/b1/NJS-18-2.PMC3716240.pdf
Available from: http://www.who.int/selection_medicines/ committees/expert/18/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/58/91/NJS-18-1.PMC3716245.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.,Non-OADS,/arxiv_data1/oa_pdf/a8/7b/NJS-18-30.PMC3716246.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/94/52/NJS-18-27.PMC3716248.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/21/7f/NJS-18-34.PMC3716249.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/21/7f/NJS-18-34.PMC3716249.pdf
"OncoImmunology 2013; 2:e23972; http://dx.doi.org/10.4161/onci.23972Introduction Endogenous or naturally occurring antitumor immunity is  difficult to detect and monitor,1 largely due to the absence of  established biomarkers and the unknown identity of the tumor-associated antigens (TAA) that are targeted.",Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Supplemental Materials Supplemental materials may be found here:http://www.landesbioscience.com/journals/oncoimmunology/article/23972purchased from Beckman Coulter.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-101324 2.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Science  1996; 274:94-6; PMID:8810254; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Nat Immunol 2012; 13:1129- 32; PMID:23160205; http://dx.doi.org/10.1038/ ni.2392 5.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa12006907.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Cell Sci 2009; 122:215-25; PMID:19118214; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Exp Med  2010; 207:1791-804; PMID:20660615; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Exp Med  2011; 208:2005-16; PMID:21930765; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Exp Med 2011; 208:1989- 2003; PMID:21930769; http://dx.doi.org/10.1084/jem.20101158 41.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Cancer Res 2007; 67:11195-201;  PMID:18056444; http://dx.doi.org/10.1158/0008- 5472.CAN-07-2637 42.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
FEBS Lett  2004; 574:37-41; PMID:15358536; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Cancer Res 2004; 64:1140- 5; PMID:14871849; http://dx.doi.org/10.1158/0008- 5472.CAN-03-3259 47.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Clin Cancer Res 2013; 19:462- 8; PMID:23169436; http://dx.doi.org/10.1158/1078- 0432.CCR-12-2625 49.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
T ransplantation 2001; 72:764-9; PMID:11571432;  http://dx.doi.org/10.1097/00007890-200109150- 00002 25.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Cancer Res 2005; 65:2938-46;  PMID:15805297; http://dx.doi.org/10.1158/0008- 5472.CAN-04-2874 26.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Cell Physiol 2000; 182:311- 22; PMID:10653597; http://dx.doi.org/10.1002/ (SICI)1097-4652(200003)182:3<311::AID- JCP1>3.0.CO;2-9 27.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Exp Med 2000; 191:1241-6; PMID:10748241; http://dx.doi.org/10.1084/ jem.191.7.1241 28.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Exp Med  1998; 188:589-96; PMID:9687535; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Cancer Res  2007; 67:1326-34; PMID:17283170; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Blood 2010; 116:1272-9; PMID:20472831; http://dx.doi.org/10.1182/blood-2009-12-261487 32.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Eur J Immunol 1993; 23:1859- 65; PMID:8344347; http://dx.doi.org/10.1002/ eji.1830230819 34.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Oncoimmunology 2012; 1:1061-73; PMID:23170254; http://dx.doi.org/10.4161/ onci.20850 37.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Nat  Immunol 2011; 12:597-606; PMID:21685955; http://dx.doi.org/10.1038/ni.205910.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Exp Med 1996; 183:1415- 26; PMID:8666900; http://dx.doi.org/10.1084/ jem.183.4.1415 12.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Immunol 2009; 183:7672- 81; PMID:19933864; http://dx.doi.org/10.4049/jim-munol.0902874 13.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Immunol 2011; 186:5784-90; PMID:21482735;  http://dx.doi.org/10.4049/jimmunol.1003394 14.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
PLoS Pathog  2010; 6:e1000998; PMID:20657824; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
J Clin Invest 2011; 121:2350-60; PMID:21555851;  http://dx.doi.org/10.1172/JCI46102 16.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Nature  2006; 439:682-7; PMID:16382236; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Clin Cancer Res 2007; 13:1757-61; PMID:17363529;  http://dx.doi.org/10.1158/1078-0432.CCR-06-2599 18.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Blood 2009; 114:1545- 52; PMID:19417208; http://dx.doi.org/10.1182/ blood-2009-03-206672 19.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Blood  2009; 114:1528-36; PMID:19420358; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Blood 2009; 114:1537-44; PMID:19423728;  http://dx.doi.org/10.1182/blood-2008-12-195792 21.,Non-OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
Immunity 2004; 20:327-36; PMID:15030776; http://dx.doi.org/10.1016/S1074-7613(04)00050-0,OADS,/arxiv_data1/oa_pdf/d0/22/onci-2-e23972.PMC3716732.pdf
OncoImmunology 2013; 2:e24384; http://dx.doi.org/10.4161/onci.24384management of pancreatic cancer.,Non-OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
Cancer Cell 2005; 7:469- 83; PMID:15894267; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
Gastroenterology 2013; In  press; PMID:23333712; http://dx.doi.org/10.1053/j.gastro.2013.01.020 10.,Non-OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd36265.,OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
Int J Cancer 2009; 125:639- 48; PMID:19425054; http://dx.doi.org/10.1002/ ijc.24355 6.,Non-OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
FEBS J 2011; 278:1064-74; PMID:21261815; http://dx.doi.org/10.1111/j.1742-4658.2011.08025.x 7.,OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
Gastroenterology 2012; 142:1079- 92; PMID:22406637; http://dx.doi.org/10.1053/j.gas- tro.2012.03.002References 1.,Non-OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
Curr Drug Targets  2012; 13:731-43; PMID:22458519; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
N Engl J Med 2011; 364:1817-25; PMID:21561347;  http://dx.doi.org/10.1056/NEJMoa1011923 3.,Non-OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
J Proteome Res 2011; 10:105- 12; PMID:20455595; http://dx.doi.org/10.1021/pr100213b,Non-OADS,/arxiv_data1/oa_pdf/34/2d/onci-2-e24384.PMC3716733.pdf
OncoImmunology 2013; 2:e24385;  http://dx.doi.org/10.4161/onci.24385a similar approach is currently underway.,Non-OADS,/arxiv_data1/oa_pdf/31/29/onci-2-e24385.PMC3716734.pdf
Cell Stress Chaperones 2000; 5:276-90;  PMID:11048651; http://dx.doi.org/10.1379/1466- 1268(2000)005<0276:THAGSP>2.0.CO;2 2.,OADS,/arxiv_data1/oa_pdf/31/29/onci-2-e24385.PMC3716734.pdf
J Immunol 2010;  184:6309-19; PMID:20439916; http://dx.doi.org/10.4049/jimmunol.0903891 4.,Non-OADS,/arxiv_data1/oa_pdf/31/29/onci-2-e24385.PMC3716734.pdf
Handb Exp  Pharmacol 2006; 172:305-29; PMID:16610365; http://dx.doi.org/10.1007/3-540-29717-0_13 6.,Non-OADS,/arxiv_data1/oa_pdf/31/29/onci-2-e24385.PMC3716734.pdf
Cancer  Res 2006; 66:1161-8; PMID:16424054; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/29/onci-2-e24385.PMC3716734.pdf
Cancer Res 2008; 68:3890-8; PMID:18483274;  http://dx.doi.org/10.1158/0008-5472.CAN-08-0156 8.,Non-OADS,/arxiv_data1/oa_pdf/31/29/onci-2-e24385.PMC3716734.pdf
Cancer Res 2013; In print;  PMID:23333935; http://dx.doi.org/10.1158/0008- 5472.CAN-12-17409.,Non-OADS,/arxiv_data1/oa_pdf/31/29/onci-2-e24385.PMC3716734.pdf
Proc Natl Acad Sci U S A  2006; 103:14459-64; PMID:16971487; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/29/onci-2-e24385.PMC3716734.pdf
OncoImmunology 2013; 2:e24438;  http://dx.doi.org/10.4161/onci.24438of cells in which the function of DDR  regulators or effectors is lost.,Non-OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
J Immunol  2009; 183:4921-30; PMID:19801517; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
Blood 2013;  In press; PMID:23430112; http://dx.doi.org/10.1182/ blood-2012-07-4440265.,Non-OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
Nature 2007; 445:656-60; PMID:17251933;  http://dx.doi.org/10.1038/nature05529 6.,Non-OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
Blood  2009; 113:3503-11; PMID:19098271; http://dx.doi.org/10.1182/blood-2008-08-173914 7.,Non-OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
Blood  2013; 121:2512-21; PMID:23349395; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
Nature 2009; 461:1071- 8; PMID:19847258; http://dx.doi.org/10.1038/ nature08467 2.,Non-OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
Semin Cancer Biol 2006; 16:344-7;  PMID:16914325; http://dx.doi.org/10.1016/j.sem- cancer.2006.07.004 3.,Non-OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
Nat Rev Immunol 2009; 9:568-80; PMID:19629084;  http://dx.doi.org/10.1038/nri2604 4.,Non-OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
Nature 2005;  436:1186-90; PMID:15995699; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/b5/onci-2-e24438.PMC3716735.pdf
"OncoImmunology 2013; 2:e24439;  http://dx.doi.org/10.4161/onci.24439the clinical studies, all of them have not yet  reached Phase III trials, and most of them are being employed as toxin or cytokine conjugates.",Non-OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
Biomol Eng 2007; 24:201-15;  PMID:17466589; http://dx.doi.org/10.1016/j.bio- eng.2007.03.004 2.,OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
Nat Rev Drug Discov  2006; 5:147-59; PMID:16424916; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
MAbs 2010; 2:77-83; PMID:20093855; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
Cancer Res 2013; In press;  PMID:23396586; http://dx.doi.org/10.1158/0008- 5472.CAN-12-3920 5.,Non-OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
Protein Eng Des Sel 2006; 19:291-7; PMID:16621915; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
J Biol Chem 2012; 287:4462- 9; PMID:22147690; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
J Infect Dis 2006; 193:172-9;  PMID:16362880; http://dx.doi.org/10.1086/499632 8.,OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
J Biol Chem 2006; 281:20190- 6; PMID:16709567; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
J Exp Med 2010; 207:1863- 70; PMID:20713595; http://dx.doi.org/10.1084/ jem.20092514,Non-OADS,/arxiv_data1/oa_pdf/0e/74/onci-2-e24439.PMC3716736.pdf
OncoImmunology 2013; 2:e24440; http://dx.doi.org/10.4161/onci.24440on MHC Class I molecules to CD8+  T cells.,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
Nat Rev Cancer 2012; 12:265-77;  PMID:22437871; http://dx.doi.org/10.1038/nrc3258 2.,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
Crit Rev  Oncol Hematol 2008; 66:118-34; PMID:18262431;  http://dx.doi.org/10.1016/j.critrevonc.2007.12.007 3.,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
Cancer Immunol Immunother 2005; 54:721-8;  PMID:16010587; http://dx.doi.org/10.1007/s00262- 004-0653-2 4.,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
Cancer Res  2013; 73:19-29; PMID:23087058; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
Cancer Immunol Immunother 2009; 58:1109-15; PMID:19018531; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
Cancer Res 2009; 69:2927-34; PMID:19318559;  http://dx.doi.org/10.1158/0008-5472.CAN-08-39208.,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
Clin Cancer Res 2012; 18:5460-70; PMID:22896657;  http://dx.doi.org/10.1158/1078-0432.CCR-11-3368 9.,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
J Clin Oncol 2005; 23:5779- 87; PMID:16110035; http://dx.doi.org/10.1200/ JCO.2005.06.478,Non-OADS,/arxiv_data1/oa_pdf/d9/f1/onci-2-e24440.PMC3716737.pdf
"OncoImmunology 2013; 2:e24441; http://dx.doi.org/10.4161/onci.24441of PDAC stems from cancer cell-intrinsic  genetic alterations, it is also the result of complex interactions between malignant and stromal cells.",Non-OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781; http://dx.doi.org/10.3322/ caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
N Engl J Med 2010; 362:1605-17; PMID:20427809; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
Clin Cancer Res 2012; 18:4266-76; PMID:22896693; http://dx.doi.org/10.1158/1078-0432.CCR-11-3114 4.,Non-OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
PLoS  One 2013; 8:e54824; PMID:23359812; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
"Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175 6. de la Fuente H, Cibrián D, Sánchez-Madrid F .",Non-OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
FEBS Lett 2012; 586:2897-905; PMID:22819828; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
Ann Oncol 2012; 23(Suppl 8):viii41-6; PMID:22918927; http://dx.doi.org/10.1093/annonc/ mds262 8.,Non-OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
Carcinogenesis 2008; 29:2035-43;  PMID:18689872; http://dx.doi.org/10.1093/carcin/ bgn188 10.,Non-OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
J Immunol 2013; 190:1372-9;  PMID:23269246; http://dx.doi.org/10.4049/jimmu- nol.1201151,Non-OADS,/arxiv_data1/oa_pdf/a9/46/onci-2-e24441.PMC3716738.pdf
OncoImmunology 2013; 2:e24443; http://dx.doi.org/10.4161/onci.24443could be detected in the blood of neuro - blastoma patients.3 MDSCs accumulate in  cancer patients and support both the escape  of malignant cells from immune responses and angiogenesis (reviewed in ref.,Non-OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
J Clin Oncol 2012; 30:3525-32; PMID:22927533;  http://dx.doi.org/10.1200/JCO.2011.40.9169 2.,Non-OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
Fetal Pediatr Pathol  2013; In press; PMID:23438791; http://dx.doi.org/10 .3109/15513815.2012.754527 3.,Non-OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
Clin Cancer Res 2013; 19:1116-25; PMID:23322899;  http://dx.doi.org/10.1158/1078-0432.CCR-12-2528 4.,Non-OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
T rends Immunol 2011; 32:19- 25; PMID:21067974; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
Carcinogenesis 2013; In press; PMID:23349014;  http://dx.doi.org/10.1093/carcin/bgt009 6.,Non-OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
Proc Jpn Acad Ser B Phys Biol Sci 2011; 87:66- 80; PMID:21422740; http://dx.doi.org/10.2183/pjab.87.66 7.,Non-OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
Cancer Res 2007; 67:802-11;  PMID:17234792; http://dx.doi.org/10.1158/0008- 5472.CAN-06-2638 8.,Non-OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
Cancer Immunol Immunother 2007; 56:1443-58;  PMID:17597331; http://dx.doi.org/10.1007/s00262- 007-0289-0,Non-OADS,/arxiv_data1/oa_pdf/4a/68/onci-2-e24443.PMC3716739.pdf
"OncoImmunology 2013; 2:e24452; http://dx.doi.org/10.4161/onci.24452GIST patients, causing clinical outcomes  to improve dramatically.2–5 Prior to ima - tinib, only 5% of GIST patients responded to conventional chemotherapy, and the median survival was 18 months.",Non-OADS,/arxiv_data1/oa_pdf/01/a5/onci-2-e24452.PMC3716740.pdf
Oncogene 2001; 20:5054- 8; PMID:11526490; http://dx.doi.org/10.1038/ sj.onc.1204704 4.,OADS,/arxiv_data1/oa_pdf/01/a5/onci-2-e24452.PMC3716740.pdf
J Biol Chem 2004; 279:31655-63; PMID:15123710; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/01/a5/onci-2-e24452.PMC3716740.pdf
Hum Pathol  2002; 33:466-77; PMID:12094371; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/a5/onci-2-e24452.PMC3716740.pdf
Proc Natl Acad Sci U S A 2013; 110:3501-6; PMID:23382202; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/a5/onci-2-e24452.PMC3716740.pdf
Proc Natl Acad Sci U S A  2012; 109:6662-7; PMID:22451913; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/a5/onci-2-e24452.PMC3716740.pdf
Proc Natl Acad Sci U S A 2012; 109:6656-61;  PMID:22451919; http://dx.doi.org/10.1073/ pnas.1121629109 10.,OADS,/arxiv_data1/oa_pdf/01/a5/onci-2-e24452.PMC3716740.pdf
Oncoimmunology 2012; 1:1202-4; PMID:23170280;  http://dx.doi.org/10.4161/onci.20799,Non-OADS,/arxiv_data1/oa_pdf/01/a5/onci-2-e24452.PMC3716740.pdf
OncoImmunology 2013; 2:e24461; http://dx.doi.org/10.4161/onci.24461ligands and identified both proteins and  lipids that are selectively produced by co-cultures but not when TAMs and cancer cells are grown separately.,OADS,/arxiv_data1/oa_pdf/a4/35/onci-2-e24461.PMC3716741.pdf
Nat Rev  Cancer 2004; 4:71-8; PMID:14708027; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/onci-2-e24461.PMC3716741.pdf
T rends Immunol 2002; 23:549-55;  PMID:12401408; http://dx.doi.org/10.1016/S1471- 4906(02)02302-5,Non-OADS,/arxiv_data1/oa_pdf/a4/35/onci-2-e24461.PMC3716741.pdf
J Lipid Res  2008; 49:1344-52; PMID:18323573; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a4/35/onci-2-e24461.PMC3716741.pdf
Mol Cancer Ther  2012; 11:1311-9; PMID:22416044; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/onci-2-e24461.PMC3716741.pdf
Int J Cancer  2012; 130:1071-81; PMID:21425255; http://dx.doi.org/10.1002/ijc.260794.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/onci-2-e24461.PMC3716741.pdf
J Immunol  2013; 190:3798-805; PMID:23447685; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a4/35/onci-2-e24461.PMC3716741.pdf
"OncoImmunology 2013; 2:e24462; http://dx.doi.org/10.4161/onci.24462cancer (with trastuzumab or lapatinib,  used to inhibit amplified ERBB2/HER2).",Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
N Engl J Med 2011;  364:2507-16; PMID:21639808; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
J Clin Oncol  2013; 31:499-506; PMID:23248252; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
Oncoimmunology 2012;  1:997-9; PMID:23189245; http://dx.doi.org/10.4161/ onci.19865 4.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
J Clin Invest  2013; 123:1371-81; PMID:23454771; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
Clin Cancer Res 2012; 18:5329-40; PMID:22850568;  http://dx.doi.org/10.1158/1078-0432.CCR-12-16326.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
Cancer Res  2010; 70:5213-9; PMID:20551059; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
Clin Cancer Res  2010; 16:6040-8; PMID:21169256; http://dx.doi.org/10.1158/1078-0432.CCR-10-1911 8.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
Clin Cancer Res 2012; 18:1386-94;  PMID:22156613; http://dx.doi.org/10.1158/1078- 0432.CCR-11-2479 9.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
Nature 2013; 494:251-5;  PMID:23302800; http://dx.doi.org/10.1038/ nature1181410.,OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
Cancer Res 2012; 72:3928-37;  PMID:22693252; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2837 12.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
Clin Cancer Res 2013; 19:393-403; PMID:23204132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/ad/onci-2-e24462.PMC3716742.pdf
OncoImmunology 2013; 2:e24481; http://dx.doi.org/10.4161/onci.24481NKG2D for the antineoplastic functions  of NK cells has been illustrated in elegant animal models.,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
Nat Rev Immunol 2009; 9:568-80; PMID:19629084;  http://dx.doi.org/10.1038/nri2604 2.,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
"Oncogene 2008; 27:5944-58;  PMID:18836475; http://dx.doi.org/10.1038/ onc.2008.272 3. von Strandmann EP , Hansen HP , Reiners KS, Schnell R, Borchmann P , Merkert S, et al.",OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
Blood  2006; 107:1955-62; PMID:16210338; http://dx.doi.org/10.1182/blood-2005-05-2177 4.,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
Mol Cancer Ther  2011; 10:1036-45; PMID:21525185; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
Clin Cancer Res  2005; 11:7516-22; PMID:16243826; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
Leukemia 2011; 25:1053-6; PMID:21415850;  http://dx.doi.org/10.1038/leu.2011.42 7.,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
Leukemia  2012; 26:830-4; PMID:22005785; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
Science 2004; 306:1517-9;  PMID:15567854; http://dx.doi.org/10.1126/sci- ence.11034789.,OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
J Exp Med 2009; 206:1495- 503; PMID:19528259; http://dx.doi.org/10.1084/ jem.20090681 10.,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
J Immunol 2012; 189:5037-46; PMID:23066150;  http://dx.doi.org/10.4049/jimmunol.1201321,Non-OADS,/arxiv_data1/oa_pdf/a9/2a/onci-2-e24481.PMC3716743.pdf
"OncoImmunology 2013; 2:e24499; http://dx.doi.org/10.4161/onci.24499patients to immunotherapy are limited,  mostly due to the strong immunosup - pressive microenvironment established within tumors and/or to a weak activa - tion of immune effector cells, resulting in therapeutic failure.",Non-OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938;  http://dx.doi.org/10.1038/nri3175 2.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
Nature 2011; 480:480-9;  PMID:22193102; http://dx.doi.org/10.1038/ nature10673 3.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
Expert Opin Biol Ther  2007; 7:1705-21; PMID:17961093; http://dx.doi.org/10.1517/14712598.7.11.1705 4.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
Mol Ther 2005; 12:153- 63; PMID:15963931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
Virus Res 2010; 153:179-96; PMID:20692305; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
Nat Med 1999; 5:823-7;  PMID:10395329; http://dx.doi.org/10.1038/10548 7.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
J Virol 2006; 80:7100- 10; PMID:16809315; http://dx.doi.org/10.1128/ JVI.02579-058.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
J Immunol 2013; 190:2994-3004;  PMID:23401594; http://dx.doi.org/10.4049/jimmu- nol.1201791 9.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
Nat Rev Immunol  2003; 3:269-79; PMID:12669018; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1e/18/onci-2-e24499.PMC3716744.pdf
"OncoImmunology 2013; 2:e24500; http://dx.doi.org/10.4161/onci.24500promote a graft vs. leukemia (GVL) effect  in subjects who have undergone allogeneic stem cell transplantation, the most cura - tive therapeutic approach for high-risk AML patients.",Non-OADS,/arxiv_data1/oa_pdf/bb/04/onci-2-e24500.PMC3716745.pdf
Nat Med 1997; 3:730-7;  PMID:9212098; http://dx.doi.org/10.1038/nm0797- 730 2.,Non-OADS,/arxiv_data1/oa_pdf/bb/04/onci-2-e24500.PMC3716745.pdf
Blood 2003; 101:3142-9; PMID:12468427;  http://dx.doi.org/10.1182/blood-2002-10-3062 3.,Non-OADS,/arxiv_data1/oa_pdf/bb/04/onci-2-e24500.PMC3716745.pdf
Leukemia  2007; 21:129-35; PMID:17128198; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/04/onci-2-e24500.PMC3716745.pdf
